Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23412.Phospholipids in VLDL,AGRP,Agouti-related protein,40516,0.250523362703495,0.00450897777137315,0.241685766271604,0.259360959135386,0
NMR metabolomics,X23412.Phospholipids in VLDL,CCN1,CCN family member 1,40280,0.360929032950897,0.00659267694239773,0.348007386143797,0.373850679757996,0
NMR metabolomics,X23412.Phospholipids in VLDL,F7,Coagulation factor VII,40376,0.108053608307114,0.00262199427914596,0.102914499519988,0.11319271709424,0
NMR metabolomics,X23412.Phospholipids in VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.112980437336995,0.00277927686639835,0.107533054678854,0.118427819995136,0
NMR metabolomics,X23412.Phospholipids in VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,0.273029115610305,0.00655169930299244,0.26018778497644,0.28587044624417,0
NMR metabolomics,X23412.Phospholipids in VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,0.0784287536857822,0.00193996686742243,0.0746264186256342,0.0822310887459301,0
NMR metabolomics,X23412.Phospholipids in VLDL,LDLR,Low-density lipoprotein receptor,40356,0.403677195721444,0.00361205058557531,0.396597576573717,0.410756814869172,0
NMR metabolomics,X23412.Phospholipids in VLDL,MFGE8,Lactadherin,40332,0.190938807135822,0.00358243075302525,0.183917242859893,0.197960371411752,0
NMR metabolomics,X23412.Phospholipids in VLDL,NPY,Pro-neuropeptide Y,40489,0.321240514701294,0.00559781484729989,0.310268797600586,0.332212231802002,0
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.171551158323115,0.0025559934595478,0.166541411142401,0.176560905503829,0
NMR metabolomics,X23412.Phospholipids in VLDL,PROC,Vitamin K-dependent protein C,40372,0.0905560852008612,0.00221161959285926,0.086221310798857,0.0948908596028653,0
NMR metabolomics,X23412.Phospholipids in VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,40489,0.118397766744093,0.00289343333724838,0.112726637403086,0.1240688960851,0
NMR metabolomics,X23412.Phospholipids in VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,0.150835271215428,0.0036895008286448,0.143603849591284,0.158066692839572,0
NMR metabolomics,X23412.Phospholipids in VLDL,TFPI,Tissue factor pathway inhibitor,40309,0.119125508065183,0.00270878362159633,0.113816292166854,0.124434723963511,0
NMR metabolomics,X23412.Phospholipids in VLDL,RARRES2,Retinoic acid receptor responder protein 2,40424,0.157541807303861,0.00405955983138884,0.149585070034338,0.165498544573383,1.11253725554711e-308
NMR metabolomics,X23412.Phospholipids in VLDL,CCL27,C-C motif chemokine 27,40359,0.202973701641805,0.00524171711874964,0.192699936089056,0.213247467194554,1.11254444029304e-308
NMR metabolomics,X23412.Phospholipids in VLDL,CES1,Liver carboxylesterase 1,40352,0.253746582102094,0.00672225682956193,0.240570958716152,0.266922205488035,1.0652185334683e-298
NMR metabolomics,X23412.Phospholipids in VLDL,FURIN,Furin,40411,0.112038865422224,0.00297406958130717,0.106209689042862,0.117868041801586,1.30366438180318e-297
NMR metabolomics,X23412.Phospholipids in VLDL,LPL,Lipoprotein lipase,40359,-0.15194614710064,0.00405337063169986,-0.159890753538771,-0.144001540662508,8.67488201932775e-295
NMR metabolomics,X23412.Phospholipids in VLDL,CCL23,C-C motif chemokine 23,40422,0.131682509542417,0.00362916980168936,0.124569336731105,0.138795682353728,4.41839452570867e-277
NMR metabolomics,X23412.Phospholipids in VLDL,APCS,Serum amyloid P-component,37882,0.111463944290392,0.00317559545955711,0.10523977718966,0.117688111391124,2.59379522915815e-258
NMR metabolomics,X23412.Phospholipids in VLDL,PTH,Parathyroid hormone,37572,0.244359483689401,0.00696925142567688,0.230699750895074,0.258019216483727,1.57316067398062e-257
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.185036708688248,0.00532455161094961,-0.195472829845709,-0.174600587530787,4.85885887169181e-255
NMR metabolomics,X23412.Phospholipids in VLDL,GHR,Growth hormone receptor,37671,0.0886827559198858,0.00255169626562068,0.0836814312392693,0.0936840806005023,2.47445859348816e-253
NMR metabolomics,X23412.Phospholipids in VLDL,GCG,Pro-glucagon,39980,0.375371239689248,0.011090892200654,0.353633090975966,0.39710938840253,2.48770147767264e-242
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD1,Mothers against decapentaplegic homolog 1,39980,0.240051022277504,0.00715679833452176,0.226023697541841,0.254078347013166,3.43163388662995e-238
NMR metabolomics,X23412.Phospholipids in VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,0.103278794183622,0.00309396711016748,0.0972146186476937,0.10934296971955,2.93385251434548e-236
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB1,DnaJ homolog subfamily B member 1,40305,0.260705597056315,0.00782425996381118,0.245370047527245,0.276041146585385,2.38158337774698e-235
NMR metabolomics,X23412.Phospholipids in VLDL,CD4,T-cell surface glycoprotein CD4,40309,0.0894051325740275,0.00272245876554469,0.0840691133935599,0.0947411517544951,6.85044853539771e-229
NMR metabolomics,X23412.Phospholipids in VLDL,NRP1,Neuropilin-1,40424,-0.0823018797910367,0.00251192112329905,-0.0872252451927028,-0.0773785143893706,6.15830417536174e-228
NMR metabolomics,X23412.Phospholipids in VLDL,PAMR1,Inactive serine protease PAMR1,40332,0.081372942470723,0.0024930163732147,0.0764866303792222,0.0862592545622238,3.0534548896048e-226
NMR metabolomics,X23412.Phospholipids in VLDL,CFP,Properdin,38013,0.0628825437259182,0.00194664055476998,0.059067128238569,0.0666979592132673,1.29467620464153e-220
NMR metabolomics,X23412.Phospholipids in VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,0.193614663924476,0.00603133865188431,0.181793240166783,0.205436087682169,4.07630430633131e-219
NMR metabolomics,X23412.Phospholipids in VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,0.0542728243953168,0.00169329302911582,0.0509539700582498,0.0575916787323838,1.81893329619226e-218
NMR metabolomics,X23412.Phospholipids in VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,0.298474126218017,0.00936890103475059,0.280111080189905,0.316837172246128,6.16560668257634e-216
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS15,Enteropeptidase,40305,0.260416821173056,0.00823078808429293,0.244284476527842,0.27654916581827,4.2349718448897e-213
NMR metabolomics,X23412.Phospholipids in VLDL,TTR,Transthyretin,37871,0.0719895703458167,0.00227743712820451,0.0675257935745359,0.0764533471170976,1.39570041470453e-211
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL6,C-X-C motif chemokine 6,40516,0.216410771829432,0.00695568244122036,0.20277763424464,0.230043909414224,2.04702722352405e-206
NMR metabolomics,X23412.Phospholipids in VLDL,INHBC,Inhibin beta C chain,40332,0.118154998045683,0.00381299843332676,0.110681521116363,0.125628474975004,9.43391006834926e-205
NMR metabolomics,X23412.Phospholipids in VLDL,GPR37,Prosaposin receptor GPR37,40042,0.186083094925209,0.00600828919949359,0.174306848094202,0.197859341756217,1.95365090194602e-204
NMR metabolomics,X23412.Phospholipids in VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,0.219242216520876,0.00708145128956413,0.205362571993331,0.233121861048422,2.14771703237269e-204
NMR metabolomics,X23412.Phospholipids in VLDL,ADIPOQ,Adiponectin,38013,-0.183635292569226,0.00593383054701082,-0.195265600441367,-0.172004984697085,2.97212646764416e-203
NMR metabolomics,X23412.Phospholipids in VLDL,P4HB,Protein disulfide-isomerase,40266,0.10649749326954,0.00346001117118164,0.0997158713740236,0.113279115165056,4.28225152703833e-202
NMR metabolomics,X23412.Phospholipids in VLDL,SLC39A5,Zinc transporter ZIP5,40341,0.147418018485755,0.00479471704994315,0.138020373067866,0.156815663903643,1.06847637898076e-201
NMR metabolomics,X23412.Phospholipids in VLDL,DSG2,Desmoglein-2,40332,-0.0740163248613125,0.00241381714313137,-0.07874740646185,-0.069285243260775,1.17316162614358e-200
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,40141,0.406255284430581,0.0132615056293221,0.38026273339711,0.432247835464052,3.21778253208047e-200
NMR metabolomics,X23412.Phospholipids in VLDL,CPM,Carboxypeptidase M,40415,0.0936933518300647,0.00306967139750605,0.0876767958909529,0.0997099077691766,6.54325715979387e-199
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF9,Protein turtle homolog A,37990,0.216504459453496,0.00711486910103051,0.202559316015476,0.230449602891516,8.66082634859845e-197
NMR metabolomics,X23412.Phospholipids in VLDL,PRAP1,Proline-rich acidic protein 1,37998,0.11379592353079,0.00378895855733648,0.106369564758411,0.12122228230317,6.50767185082026e-192
NMR metabolomics,X23412.Phospholipids in VLDL,SNCA,Alpha-synuclein,37671,0.30447707302209,0.0101861583974773,0.284512202563034,0.324441943481145,4.98344946336275e-190
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA5,Plasma serine protease inhibitor,37835,0.0878743399459778,0.00294474321240444,0.0821026432496651,0.0936460366422905,1.71572494170915e-189
NMR metabolomics,X23412.Phospholipids in VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,0.0489144797684666,0.0016588873074938,0.0456630606457787,0.0521658988911545,5.92057788391626e-186
NMR metabolomics,X23412.Phospholipids in VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,0.271699464511902,0.00925480915828248,0.253560038561668,0.289838890462136,1.56639090514408e-184
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN3,Contactin-3,40332,0.0920727546545852,0.00313979100893447,0.0859187642770736,0.0982267450320967,3.94153342168491e-184
NMR metabolomics,X23412.Phospholipids in VLDL,CFI,Complement factor I,38013,0.0528446380370693,0.00180013516471699,0.049316373114224,0.0563729029599146,1.05058184039727e-183
NMR metabolomics,X23412.Phospholipids in VLDL,SERPIND1,Heparin cofactor 2,37981,0.0718442977560579,0.00245045961708326,0.0670413969065747,0.0766471986055411,3.0258207326674e-183
NMR metabolomics,X23412.Phospholipids in VLDL,CFH,Complement factor H,37301,0.060438445922944,0.0020682593868683,0.0563846575246821,0.0644922343212058,8.41464783689711e-182
NMR metabolomics,X23412.Phospholipids in VLDL,AGR3,Anterior gradient protein 3,39963,0.154707588582359,0.00534577444693895,0.144229870666359,0.165185306498359,2.10633142796163e-179
NMR metabolomics,X23412.Phospholipids in VLDL,SYAP1,Synapse-associated protein 1,37671,0.146716191755656,0.00506475739096136,0.136789267269372,0.156643116241941,6.08250283445079e-179
NMR metabolomics,X23412.Phospholipids in VLDL,CRIP2,Cysteine-rich protein 2,40228,0.0936856079282436,0.00324946474557648,0.0873166570269137,0.100054558829573,3.52826511820794e-178
NMR metabolomics,X23412.Phospholipids in VLDL,CHMP6,Charged multivesicular body protein 6,37990,0.144175796589792,0.00499982343099403,0.134376142665044,0.15397545051454,1.65644341767339e-177
NMR metabolomics,X23412.Phospholipids in VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,0.134850223746423,0.00469042400571445,0.125656992695222,0.144043454797623,2.77869339139212e-177
NMR metabolomics,X23412.Phospholipids in VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,0.215448636710016,0.0075599467925465,0.200631140996625,0.230266132423407,3.43700191668848e-174
NMR metabolomics,X23412.Phospholipids in VLDL,GUSB,Beta-glucuronidase,40419,0.148673438503797,0.00525521876834684,0.138373209717838,0.158973667289757,7.58616003851694e-172
NMR metabolomics,X23412.Phospholipids in VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.09352922740851,0.00330386006176727,0.0870536616874461,0.100004793129574,2.5849973601702e-171
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA4,Kallistatin,37781,0.0608615912325939,0.00215074469165448,0.0566461316369511,0.0650770508282366,3.98070808032684e-171
NMR metabolomics,X23412.Phospholipids in VLDL,FLI1,Friend leukemia integration 1 transcription factor,39980,0.273673624930815,0.00977805230800384,0.254508642407127,0.292838607454502,3.25372252372947e-168
NMR metabolomics,X23412.Phospholipids in VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,0.183804504423671,0.00666653297431531,0.170738099794013,0.196870909053329,1.80049441404937e-163
NMR metabolomics,X23412.Phospholipids in VLDL,BCHE,Cholinesterase,37748,0.0693558078047037,0.00254433510085444,0.064368911007029,0.0743427046023784,2.97906598101677e-159
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF8,Immunoglobulin superfamily member 8,40359,0.0732384620465442,0.00269295762690907,0.0679602650978025,0.078516658995286,3.07921051004294e-159
NMR metabolomics,X23412.Phospholipids in VLDL,LATS1,Serine/threonine-protein kinase LATS1,37598,0.206528874908471,0.00759180928205421,0.191648928715644,0.221408821101297,1.3667513114662e-158
NMR metabolomics,X23412.Phospholipids in VLDL,NCS1,Neuronal calcium sensor 1,40489,0.0695198443326256,0.00257670830701571,0.0644694960508748,0.0745701926143764,7.85681756570921e-157
NMR metabolomics,X23412.Phospholipids in VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,40443,0.074962165558949,0.00277850054112061,0.0695163044983526,0.0804080266195454,8.19013405580985e-157
NMR metabolomics,X23412.Phospholipids in VLDL,F9,Coagulation factor IX,40372,0.0436434419862632,0.0016188864282943,0.0404704245868064,0.04681645938572,1.43753547812613e-156
NMR metabolomics,X23412.Phospholipids in VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,0.338265762611282,0.0125574730827065,0.313653115369178,0.362878409853387,1.04441563969804e-155
NMR metabolomics,X23412.Phospholipids in VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,0.1417972141841,0.00528228368905886,0.131443938153545,0.152150490214656,3.38087308597403e-155
NMR metabolomics,X23412.Phospholipids in VLDL,F10,Coagulation factor X,37987,0.0627892244638455,0.00233655946494016,0.0582095679125628,0.0673688810151282,5.18062877451505e-155
NMR metabolomics,X23412.Phospholipids in VLDL,GSTA1,Glutathione S-transferase A1,40333,0.199963887697692,0.00745694086311885,0.185348283605979,0.214579491789405,5.84303445272622e-155
NMR metabolomics,X23412.Phospholipids in VLDL,KYNU,Kynureninase,40516,0.10778641727441,0.00402098582889236,0.0999052850497811,0.115667549499039,6.89239241965411e-155
NMR metabolomics,X23412.Phospholipids in VLDL,CCL22,C-C motif chemokine 22,40204,0.122990192980598,0.00464190855369339,0.113892052215359,0.132088333745837,2.216854463583e-151
NMR metabolomics,X23412.Phospholipids in VLDL,KDR,Vascular endothelial growth factor receptor 2,40411,0.0602753519588112,0.0022795603228467,0.0558074137260317,0.0647432901915908,7.92474292572928e-151
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD2,Mothers against decapentaplegic homolog 2,37900,0.161954534250963,0.00611682264898493,0.149965561858953,0.173943506642974,1.25448928417819e-150
NMR metabolomics,X23412.Phospholipids in VLDL,STAB2,Stabilin-2,37998,0.0666317815761846,0.0025195386142205,0.0616934858923125,0.0715700772600568,2.56730623020159e-150
NMR metabolomics,X23412.Phospholipids in VLDL,PLAT,Tissue-type plasminogen activator,40490,0.116545527680172,0.004422308732259,0.107877802564944,0.125213252795399,7.04577605010036e-150
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL17,C-X-C motif chemokine 17,40516,0.0984341086352098,0.00373631367650179,0.0911109338292663,0.105757283441153,8.69110656682705e-150
NMR metabolomics,X23412.Phospholipids in VLDL,KLKB1,Plasma kallikrein,37721,0.059958872565662,0.00227139791737189,0.0555069326476131,0.0644108124837109,1.04138421332361e-149
NMR metabolomics,X23412.Phospholipids in VLDL,ERP44,Endoplasmic reticulum resident protein 44,40280,0.0608576597842889,0.0023120022761135,0.0563261353231064,0.0653891842454713,1.71696043894156e-149
NMR metabolomics,X23412.Phospholipids in VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,0.0496361709313493,0.00189264301831046,0.0459265906154608,0.0533457512472378,1.78927587685764e-148
NMR metabolomics,X23412.Phospholipids in VLDL,CREG1,Protein CREG1,40145,0.0853595014563667,0.00325417123010179,0.0789813258453672,0.0917376770673662,1.84222359236812e-148
NMR metabolomics,X23412.Phospholipids in VLDL,NUMB,Protein numb homolog,37598,0.196972322407093,0.00752535157705997,0.182222633316055,0.21172201149813,2.97037582234755e-147
NMR metabolomics,X23412.Phospholipids in VLDL,ASGR1,Asialoglycoprotein receptor 1,40228,0.0691972077271319,0.00264953540746191,0.0640041183285065,0.0743902971257572,3.11486764449074e-147
NMR metabolomics,X23412.Phospholipids in VLDL,SOST,Sclerostin,40330,0.0910886019525588,0.00348901963101868,0.0842501234757621,0.0979270804293554,3.78032277397501e-147
NMR metabolomics,X23412.Phospholipids in VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,0.128209633151519,0.00491477182750488,0.118576680369609,0.137842585933428,7.20291471498067e-147
NMR metabolomics,X23412.Phospholipids in VLDL,GSTA3,Glutathione S-transferase A3,39980,0.178159748711966,0.00682954111372606,0.164773848129063,0.19154564929487,7.39951423803637e-147
NMR metabolomics,X23412.Phospholipids in VLDL,SNAPIN,SNARE-associated protein Snapin,37959,0.134966972118149,0.00516896408391239,0.124835802513681,0.145098141722618,1.15494143177729e-146
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINF2,Alpha-2-antiplasmin,37755,0.0317481887007852,0.0012245877527904,0.029347996705316,0.0341483806962544,1.29703543090883e-144
NMR metabolomics,X23412.Phospholipids in VLDL,PROS1,Vitamin K-dependent protein S,38013,0.0586584367081248,0.00226414757915325,0.0542207074529844,0.0630961659632652,1.74348689982955e-144
NMR metabolomics,X23412.Phospholipids in VLDL,RBP5,Retinol-binding protein 5,40305,0.129124010508467,0.00499723332402594,0.119329433193377,0.138918587823558,3.07262125316321e-144
NMR metabolomics,X23412.Phospholipids in VLDL,NOS3,"Nitric oxide synthase, endothelial",39961,0.127219617255949,0.00494343230721394,0.11753048993381,0.136908744578089,4.68260304909274e-143
NMR metabolomics,X23412.Phospholipids in VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,0.156266141906073,0.00608406897856698,0.144341366708082,0.168190917104064,1.62048298678083e-142
NMR metabolomics,X23412.Phospholipids in VLDL,ATRN,"Attractin, Isoform 2",38013,0.0379324741074879,0.00147612835913959,0.0350392625235744,0.0408256856914015,3.09356657472771e-142
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL2,Angiopoietin-related protein 2,40377,0.0923034420739246,0.00360059629419471,0.0852462733373029,0.0993606108105462,4.58672725195871e-142
NMR metabolomics,X23412.Phospholipids in VLDL,GRP,Gastrin-releasing peptide,37628,0.125823107494826,0.00490994232899404,0.116199620529998,0.135446594459654,2.19815529027081e-141
NMR metabolomics,X23412.Phospholipids in VLDL,FGFR2,Fibroblast growth factor receptor 2,40411,0.0493474054898551,0.00193204502844257,0.0455605972341077,0.0531342137456026,4.58295951457987e-141
NMR metabolomics,X23412.Phospholipids in VLDL,LAT2,Linker for activation of T-cells family member 2,40305,0.281768314055122,0.0110480128403238,0.260114208888087,0.303422419222156,1.20239241836059e-140
NMR metabolomics,X23412.Phospholipids in VLDL,UPB1,Beta-ureidopropionase,37990,0.210211791714413,0.00824470954327558,0.194052161009592,0.226371422419233,4.24083749644487e-140
NMR metabolomics,X23412.Phospholipids in VLDL,ENO3,Beta-enolase,37628,0.130580807141742,0.00512247326355747,0.12054075954517,0.140620854738315,5.8347202675774e-140
NMR metabolomics,X23412.Phospholipids in VLDL,NAA80,N-alpha-acetyltransferase 80,37572,0.272923471123402,0.0107266224181786,0.251899291183771,0.293947651063032,1.94380806676085e-139
NMR metabolomics,X23412.Phospholipids in VLDL,IL16,Pro-interleukin-16,40516,0.0925087997476389,0.00364814098844512,0.0853584434102864,0.0996591560849913,3.96593604326065e-139
NMR metabolomics,X23412.Phospholipids in VLDL,SORT1,Sortilin,40330,0.0832152176318078,0.00328204664852577,0.0767824062006973,0.0896480290629183,4.59795309179507e-139
NMR metabolomics,X23412.Phospholipids in VLDL,ACY1,Aminoacylase-1,40359,0.136191409780679,0.00537585951683627,0.12565472512768,0.146728094433679,7.54957132322074e-139
NMR metabolomics,X23412.Phospholipids in VLDL,GLA,Alpha-galactosidase A,37642,0.0828958989993092,0.0032673471132045,0.0764918986574284,0.0892998993411901,1.08567688221387e-138
NMR metabolomics,X23412.Phospholipids in VLDL,CDHR5,Cadherin-related family member 5,40359,0.0889956002251608,0.0035196186706993,0.0820971476305902,0.0958940528197315,2.44978730933059e-138
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.0590851926299252,0.00234249006136974,0.0544939121096405,0.0636764731502099,1.05149842024643e-137
NMR metabolomics,X23412.Phospholipids in VLDL,DTYMK,Thymidylate kinase,37990,0.157190980554901,0.0062556237008524,0.14492995810123,0.169452003008572,3.18113970848632e-136
NMR metabolomics,X23412.Phospholipids in VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,0.088629540467952,0.00353560205117338,0.0816997604476522,0.0955593204882519,4.51969885520464e-136
NMR metabolomics,X23412.Phospholipids in VLDL,AMBP,Protein AMBP,40470,0.0452246837118902,0.00181061074138705,0.0416758866587716,0.0487734807650088,4.07302565855374e-135
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,40403,0.0612838371526292,0.00245923146137072,0.0564637434883426,0.0661039308169158,1.67049165655127e-134
NMR metabolomics,X23412.Phospholipids in VLDL,AFM,Afamin,38013,0.0420105020761938,0.00168440288572767,0.0387090724201676,0.0453119317322201,2.78284077139212e-134
NMR metabolomics,X23412.Phospholipids in VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,0.103636665253006,0.00416380463091027,0.0954756081764222,0.11179772232959,3.75308766626593e-134
NMR metabolomics,X23412.Phospholipids in VLDL,EEF1D,Elongation factor 1-delta,37990,0.205308928014701,0.00828027871127574,0.189079581740601,0.221538274288802,9.10685166158163e-133
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINF1,Pigment epithelium-derived factor,37790,0.0579830294135166,0.00234163071607057,0.0533934332100182,0.0625726256170149,2.2056417369133e-132
NMR metabolomics,X23412.Phospholipids in VLDL,SNAP29,Synaptosomal-associated protein 29,40411,0.203602274001444,0.00824705729964647,0.187438041694137,0.219766506308751,4.28876723842017e-132
NMR metabolomics,X23412.Phospholipids in VLDL,AP1G2,AP-1 complex subunit gamma-like 2,37900,0.176942203564984,0.00720582382753831,0.162818788863009,0.191065618266959,2.74030633107613e-130
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL13,C-X-C motif chemokine 13,40471,0.140199749290664,0.00573895649509431,0.128951394560279,0.151448104021049,1.9210705687412e-129
NMR metabolomics,X23412.Phospholipids in VLDL,SKAP1,Src kinase-associated phosphoprotein 1,40192,0.161850588383413,0.00664352796330483,0.148829273575336,0.174871903191491,1.03047392787234e-128
NMR metabolomics,X23412.Phospholipids in VLDL,PLTP,Phospholipid transfer protein,40461,-0.0753952413721296,0.00309559910288732,-0.0814626156137888,-0.0693278671304705,1.09818714947172e-128
NMR metabolomics,X23412.Phospholipids in VLDL,DPY30,Protein dpy-30 homolog,40414,0.130830789921529,0.00538096408189656,0.120284100321011,0.141377479522046,2.99217030911939e-128
NMR metabolomics,X23412.Phospholipids in VLDL,ABL1,Tyrosine-protein kinase ABL1,40305,0.149218668430735,0.00615154887395717,0.137161632637779,0.161275704223691,1.16832566603607e-127
NMR metabolomics,X23412.Phospholipids in VLDL,FCN2,Ficolin-2,40291,0.0897899165529365,0.00371404629470554,0.0825103858153136,0.0970694472905593,7.86510786017491e-127
NMR metabolomics,X23412.Phospholipids in VLDL,NOMO1,Nodal modulator 1,40332,0.0518002810845938,0.00214361396523351,0.0475987977127361,0.0560017644564515,9.99607362486728e-127
NMR metabolomics,X23412.Phospholipids in VLDL,CD300LG,CMRF35-like molecule 9,40332,-0.0823969036941873,0.00341359665312483,-0.089087553134312,-0.0757062542540626,1.88023083583724e-126
NMR metabolomics,X23412.Phospholipids in VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,0.193654572275955,0.00805295249228898,0.177870785391069,0.209438359160841,1.60055222363636e-125
NMR metabolomics,X23412.Phospholipids in VLDL,COL4A1,Collagen alpha-1(IV) chain,40359,-0.0862016183115415,0.00358947708603247,-0.0932369934001651,-0.0791662432229178,3.24416304795531e-125
NMR metabolomics,X23412.Phospholipids in VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,37920,0.181029865563941,0.00752873833902218,0.166273538419458,0.195786192708425,3.99243064001122e-125
NMR metabolomics,X23412.Phospholipids in VLDL,BPIFB1,BPI fold-containing family B member 1,40261,-0.133937859998659,0.00557919110470434,-0.144873074563879,-0.123002645433438,4.06748735290384e-125
NMR metabolomics,X23412.Phospholipids in VLDL,MLN,Promotilin,40341,0.191423082095963,0.00803947558283362,0.175665709953609,0.207180454238317,3.70767752724662e-123
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,40497,-0.136917146363858,0.00575268141050849,-0.148192401928454,-0.125641890799261,4.43441013191816e-123
NMR metabolomics,X23412.Phospholipids in VLDL,YES1,Tyrosine-protein kinase Yes,40305,0.24428100898743,0.0102821615935683,0.224127972264036,0.264434045710824,1.25851782740877e-122
NMR metabolomics,X23412.Phospholipids in VLDL,CDHR2,Cadherin-related family member 2,40305,0.165027168901797,0.00696418005029397,0.151377376003221,0.178676961800373,5.12567484120936e-122
NMR metabolomics,X23412.Phospholipids in VLDL,CPB2,Carboxypeptidase B2,37981,0.0479350655251196,0.00202326913415864,0.0439694580221687,0.0519006730280705,1.28847229815874e-121
NMR metabolomics,X23412.Phospholipids in VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,0.0888938559225817,0.00376218279157931,0.0815199776510863,0.0962677341940772,2.44860516796027e-121
NMR metabolomics,X23412.Phospholipids in VLDL,MYH9,Myosin-9,37998,0.2405690083013,0.0101711611764479,0.220633532395462,0.260504484207138,3.16851907693373e-121
NMR metabolomics,X23412.Phospholipids in VLDL,CCL16,C-C motif chemokine 16,40536,0.113124744724963,0.00479146361421188,0.103733476041107,0.122516013408818,3.50335279228975e-121
NMR metabolomics,X23412.Phospholipids in VLDL,YTHDF3,YTH domain-containing family protein 3,40044,0.180778582327963,0.00767706332129215,0.16573153821823,0.195825626437695,1.65831300696744e-120
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RN,Interleukin-1 receptor antagonist protein,40313,0.117466258798573,0.00499249941825165,0.107680959938799,0.127251557658346,2.37789574159895e-120
NMR metabolomics,X23412.Phospholipids in VLDL,HEG1,Protein HEG homolog 1,37671,0.0562380642341658,0.00239275000737965,0.0515482742197017,0.0609278542486299,1.05214730007824e-119
NMR metabolomics,X23412.Phospholipids in VLDL,MAPK9,Mitogen-activated protein kinase 9,40341,0.0912820846460503,0.00389155722741238,0.083654632480322,0.0989095368117785,1.21592585456349e-119
NMR metabolomics,X23412.Phospholipids in VLDL,IL18R1,Interleukin-18 receptor 1,40516,0.0691214074171547,0.00295100680840789,0.0633374340726752,0.0749053807616342,2.47250758325574e-119
NMR metabolomics,X23412.Phospholipids in VLDL,FYB1,FYN-binding protein 1,40311,0.193930876534001,0.00828431889369907,0.17769361150235,0.210168141565651,3.56680638156581e-119
NMR metabolomics,X23412.Phospholipids in VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,0.0450865630221519,0.00192444818915464,0.0413146445714088,0.048858481472895,5.7454958337969e-119
NMR metabolomics,X23412.Phospholipids in VLDL,CCL17,C-C motif chemokine 17,40333,0.190884111127575,0.00820456273280739,0.174803168171272,0.206965054083877,9.14426488585749e-118
NMR metabolomics,X23412.Phospholipids in VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,40536,-0.0728756621152903,0.00313571362331363,-0.079021660816985,-0.0667296634135956,1.52146605484725e-117
NMR metabolomics,X23412.Phospholipids in VLDL,CANT1,Soluble calcium-activated nucleotidase 1,40312,0.0428462087338681,0.00184369600894594,0.039232564556334,0.0464598529114021,1.66349725614579e-117
NMR metabolomics,X23412.Phospholipids in VLDL,DKK1,Dickkopf-related protein 1,40471,0.125385230146772,0.00540853184106194,0.11478450773829,0.135985952555253,5.6685740363514e-117
NMR metabolomics,X23412.Phospholipids in VLDL,F11R,Junctional adhesion molecule A,40332,0.118381733296507,0.00512487124155651,0.108336985663057,0.128426480929958,3.82214823818093e-116
NMR metabolomics,X23412.Phospholipids in VLDL,FAM20A,Pseudokinase FAM20A,37990,0.0591672463810534,0.00256420942313042,0.0541413959117178,0.064193096850389,1.40603609513682e-115
NMR metabolomics,X23412.Phospholipids in VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,0.0840372883797683,0.00364200187100914,0.0768989647125904,0.0911756120469462,1.42447692016395e-115
NMR metabolomics,X23412.Phospholipids in VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,0.142492565497553,0.00617458776924282,0.130390373469837,0.154594757525269,1.54810391871304e-115
NMR metabolomics,X23412.Phospholipids in VLDL,EHBP1,EH domain-binding protein 1,37990,0.156065205489168,0.00676605368716254,0.14280374026233,0.169326670716007,1.69300188898491e-115
NMR metabolomics,X23412.Phospholipids in VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,0.062377502948041,0.00271329703360674,0.0570594407621718,0.0676955651339102,9.52779161516983e-115
NMR metabolomics,X23412.Phospholipids in VLDL,FGF21,Fibroblast growth factor 21,40453,0.243786169631007,0.0106230851975184,0.222964922643871,0.264607416618143,1.07113798051081e-114
NMR metabolomics,X23412.Phospholipids in VLDL,ADH1B,All-trans-retinol dehydrogenase,37671,0.153631046595128,0.00669882287541543,0.140501353759313,0.166760739430942,3.54683264143977e-114
NMR metabolomics,X23412.Phospholipids in VLDL,TJAP1,Tight junction-associated protein 1,40411,0.171240244847026,0.00748427578515768,0.156571064308117,0.185909425385935,4.98767245183211e-114
NMR metabolomics,X23412.Phospholipids in VLDL,SELPLG,P-selectin glycoprotein ligand 1,40341,0.0573143822304222,0.00250963627673745,0.0523954951280168,0.0622332693328276,1.29692208918193e-113
NMR metabolomics,X23412.Phospholipids in VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,0.0502354356657169,0.00220003530142485,0.0459233664749242,0.0545475048565096,1.3856627804854e-113
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,0.0602042111947539,0.00263324241610523,0.0550430560591877,0.0653653663303202,1.50924351003358e-113
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,0.174613578251217,0.00765103789409668,0.159617543978787,0.189609612523646,4.24224308412506e-113
NMR metabolomics,X23412.Phospholipids in VLDL,CES2,Cocaine esterase,40305,0.110159460536115,0.00485885105203518,0.100636112474126,0.119682808598104,5.09064661631266e-112
NMR metabolomics,X23412.Phospholipids in VLDL,FN1,Fibronectin,38013,0.0539213496080559,0.0023776897957483,0.0492610776083892,0.0585816216077225,8.7442719446192e-112
NMR metabolomics,X23412.Phospholipids in VLDL,SARG,Specifically androgen-regulated gene protein,37931,0.223377112300201,0.00985134764380886,0.204068470918336,0.242685753682066,9.66188770452264e-112
NMR metabolomics,X23412.Phospholipids in VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,0.149243487492588,0.006587832424976,0.136331335939636,0.162155639045541,1.47800671774304e-111
NMR metabolomics,X23412.Phospholipids in VLDL,MTSS1,Protein MTSS 1,37901,0.226103143433689,0.0100422892518248,0.206420256500112,0.245786030367265,3.17782062006356e-110
NMR metabolomics,X23412.Phospholipids in VLDL,SCLY,Selenocysteine lyase,40434,0.0968846573552063,0.00432788275905514,0.0884020071474582,0.105367307562954,2.55807984481691e-109
NMR metabolomics,X23412.Phospholipids in VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,0.193106246002401,0.00864558220616708,0.176160904878313,0.210051587126488,7.80373679972114e-109
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,37628,0.14666968051294,0.00656188314507105,0.133808389548601,0.159530971477279,1.19944466634339e-108
NMR metabolomics,X23412.Phospholipids in VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,0.0578266474046426,0.00259612159269455,0.0527382490829613,0.0629150457263239,2.833062831083e-108
NMR metabolomics,X23412.Phospholipids in VLDL,SORD,Sorbitol dehydrogenase,40417,0.134764800957425,0.00607094038867526,0.122865757795621,0.146663844119228,1.50183756616614e-107
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJA2,DnaJ homolog subfamily A member 2,40471,0.16521893542717,0.00745257856169745,0.150611881446243,0.179825989408097,2.7710190928335e-107
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,0.168660524482763,0.00760500471706834,0.153754715237309,0.183566333728217,4.61237968153704e-107
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,0.0692940253447132,0.00313556867853452,0.0631483107347856,0.0754397399546409,1.26739649506703e-106
NMR metabolomics,X23412.Phospholipids in VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,0.0415466828901988,0.00188305959631315,0.0378558860814251,0.0452374796989726,2.9388146367024e-106
NMR metabolomics,X23412.Phospholipids in VLDL,DAB2,Disabled homolog 2,40489,0.220660817473722,0.0100105819075306,0.201040076934962,0.240281558012482,4.19604641551337e-106
NMR metabolomics,X23412.Phospholipids in VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,0.108331609972458,0.00493342145461987,0.0986621039214033,0.118001116023513,2.68545105594432e-105
NMR metabolomics,X23412.Phospholipids in VLDL,ELN,Elastin,37990,0.0701984254031053,0.00319290847977014,0.0639403247827558,0.0764565260234548,2.71609959277216e-105
NMR metabolomics,X23412.Phospholipids in VLDL,NUCB2,Nucleobindin-2,40447,0.073970850638888,0.00337415437098763,0.0673575080717522,0.0805841932060237,5.50788673491127e-105
NMR metabolomics,X23412.Phospholipids in VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,37900,0.101904184874464,0.00464176774003279,0.0928063201039993,0.111002049644928,5.51035732995417e-105
NMR metabolomics,X23412.Phospholipids in VLDL,CD63,CD63 antigen,40203,0.103876488135065,0.0047387791321571,0.0945884810360375,0.113164495234093,6.10088406292254e-105
NMR metabolomics,X23412.Phospholipids in VLDL,TXLNA,Alpha-taxilin,40228,0.177549389821063,0.00810042986152252,0.161672547292478,0.193426232349647,6.33134682089169e-105
NMR metabolomics,X23412.Phospholipids in VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,0.0536976397759677,0.00244789270054357,0.0488997700829023,0.0584955094690331,7.98270607766033e-105
NMR metabolomics,X23412.Phospholipids in VLDL,MXRA8,Matrix remodeling-associated protein 8,37671,-0.0607219019567714,0.00276928778953484,-0.0661497060242597,-0.0552940978892831,1.04614553825131e-104
NMR metabolomics,X23412.Phospholipids in VLDL,BTD,Biotinidase,38013,0.0410710398823733,0.00187619176662071,0.0373937040197967,0.0447483757449499,2.03067046043423e-104
NMR metabolomics,X23412.Phospholipids in VLDL,TARBP2,RISC-loading complex subunit TARBP2,39961,0.156551587423483,0.00716762178241762,0.142503048729944,0.170600126117021,3.46165960958953e-104
NMR metabolomics,X23412.Phospholipids in VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.0514048749196089,0.00235738999285115,0.0467843905336207,0.0560253593055972,1.37154780028132e-103
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.0407775867043911,0.00187803658828957,0.0370966349913435,0.0444585384174386,4.89189794001593e-103
NMR metabolomics,X23412.Phospholipids in VLDL,CEP20,Centrosomal protein 20,39980,0.144898116898715,0.0066878359883792,0.131789958361491,0.158006275435938,1.41416738893919e-102
NMR metabolomics,X23412.Phospholipids in VLDL,C9,Complement component C9,37987,-0.0958973995915556,0.00442485149437516,-0.104570108520531,-0.0872246906625803,2.03822956528439e-102
NMR metabolomics,X23412.Phospholipids in VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,0.16353202467699,0.00754501881144388,0.14874378780656,0.17832026154742,2.1587823509633e-102
NMR metabolomics,X23412.Phospholipids in VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,0.191136468796482,0.00883222208471206,0.173825313510446,0.208447624082518,2.23772605102104e-102
NMR metabolomics,X23412.Phospholipids in VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,0.121115469603232,0.00559933751056188,0.11014076808253,0.132090171123933,2.99273990802673e-102
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,0.0893522994856884,0.00413173200101491,0.0812541047636992,0.0974504942076776,3.06525034771981e-102
NMR metabolomics,X23412.Phospholipids in VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,0.112481790485998,0.0051957419248758,0.102298136313242,0.122665444658755,3.71929467324296e-102
NMR metabolomics,X23412.Phospholipids in VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,0.219009519595453,0.0101371347180119,0.19914073554815,0.238878303642756,9.13559292849629e-102
NMR metabolomics,X23412.Phospholipids in VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,0.187914039759742,0.00869973254117134,0.170862563979046,0.204965515540438,9.38406520273281e-102
NMR metabolomics,X23412.Phospholipids in VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,0.210264981778898,0.00974559144819403,0.191163622540438,0.229366341017358,1.57679246548958e-101
NMR metabolomics,X23412.Phospholipids in VLDL,KHK,Ketohexokinase,37628,0.125954950079259,0.00585376121899028,0.114481578090038,0.13742832206848,5.8515138565426e-101
NMR metabolomics,X23412.Phospholipids in VLDL,AXIN1,Axin-1,40341,0.182968803078427,0.00854084180591722,0.166228753138829,0.199708853018025,2.14578013528619e-100
NMR metabolomics,X23412.Phospholipids in VLDL,OTUD7B,OTU domain-containing protein 7B,37959,0.123150725129682,0.00574150785504347,0.111897369733797,0.134404080525567,2.17820033380615e-100
NMR metabolomics,X23412.Phospholipids in VLDL,GGT1,Glutathione hydrolase 1 proenzyme,40303,0.0942122374614019,0.00440317967961789,0.0855820052893508,0.102842469633453,3.74956132257074e-100
NMR metabolomics,X23412.Phospholipids in VLDL,BECN1,Beclin-1,37628,0.118468343595657,0.0055402128196911,0.107609526469062,0.129327160722251,9.37958075586169e-100
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFC,Vascular endothelial growth factor C,40411,0.108155543390367,0.0050761528678644,0.0982062837693525,0.118104803011381,2.37708510724965e-99
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL5,C-X-C motif chemokine 5,40309,0.222245082283861,0.0104321274873514,0.201798112408653,0.24269205215907,2.56455848761116e-99
NMR metabolomics,X23412.Phospholipids in VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,0.0595539158244891,0.0027973826073142,0.0540710459141533,0.065036785734825,3.48568873224682e-99
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC1B,C-type lectin domain family 1 member B,40471,0.186134003530527,0.00875450928358908,0.168975165334692,0.203292841726361,5.98744228117235e-99
NMR metabolomics,X23412.Phospholipids in VLDL,HBEGF,Proheparin-binding EGF-like growth factor,40434,0.139936011452733,0.00658192028294596,0.127035447698159,0.152836575207307,6.13551354608632e-99
NMR metabolomics,X23412.Phospholipids in VLDL,CD6,T-cell differentiation antigen CD6,40502,0.10260037637887,0.00483052840201642,0.093132540710918,0.112068212046822,9.29318126781569e-99
NMR metabolomics,X23412.Phospholipids in VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,0.129162960371114,0.00608727669409314,0.117231898050692,0.141094022691537,1.60617238892078e-98
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA3F,Semaphorin-3F,40359,0.0498789498556642,0.00235154399620812,0.0452699236230963,0.0544879760882321,1.7348265616156e-98
NMR metabolomics,X23412.Phospholipids in VLDL,AGRN,Agrin,40422,0.0639670165083416,0.00301584992876795,0.0580559506479565,0.0698780823687268,1.74500861466836e-98
NMR metabolomics,X23412.Phospholipids in VLDL,NPPC,C-type natriuretic peptide,40341,0.0830097207376399,0.00392032808449993,0.0753258776920201,0.0906935637832598,3.73623451181381e-98
NMR metabolomics,X23412.Phospholipids in VLDL,PLIN1,Perilipin-1,39961,0.0682328195473755,0.00322505161170285,0.0619117183884379,0.0745539207063131,5.72370229025229e-98
NMR metabolomics,X23412.Phospholipids in VLDL,ATG16L1,Autophagy-related protein 16-1,37901,0.162724169233315,0.00769354153809005,0.147644827818659,0.177803510647972,1.05116973926785e-97
NMR metabolomics,X23412.Phospholipids in VLDL,AP3S2,AP-3 complex subunit sigma-2,37942,0.0895771956192915,0.00423664274645169,0.0812733758362462,0.0978810154023368,1.20804905664208e-97
NMR metabolomics,X23412.Phospholipids in VLDL,CTBS,Di-N-acetylchitobiase,37819,0.0520560349254549,0.00246383760600168,0.0472269132176916,0.0568851566332182,1.7119229893015e-97
NMR metabolomics,X23412.Phospholipids in VLDL,TPD52L2,Tumor protein D54,37671,0.207290816766733,0.00981258934267643,0.188058141655088,0.226523491878379,1.89659977060385e-97
NMR metabolomics,X23412.Phospholipids in VLDL,SELP,P-selectin,40403,0.110423706711352,0.00523822649023391,0.100156782790493,0.12069063063221,2.54978520363869e-97
NMR metabolomics,X23412.Phospholipids in VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,0.161258636716905,0.00764327093851229,0.146277825677421,0.176239447756389,3.04402963832229e-97
NMR metabolomics,X23412.Phospholipids in VLDL,EZR,Ezrin,40471,0.0453460452320723,0.00215226730970052,0.0411276013050593,0.0495644891590853,3.18195643179467e-97
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP4,Metalloproteinase inhibitor 4,40332,-0.0778457467377905,0.00369741045092602,-0.0850926712216055,-0.0705988222539755,4.42948837118687e-97
NMR metabolomics,X23412.Phospholipids in VLDL,KAZN,Kazrin,37901,0.198856659408583,0.0094367036585377,0.180360720237849,0.217352598579316,5.20035445983616e-97
NMR metabolomics,X23412.Phospholipids in VLDL,ARF6,ADP-ribosylation factor 6,37901,0.20103366307004,0.00955263319226306,0.182310502013205,0.219756824126876,9.18485469174162e-97
NMR metabolomics,X23412.Phospholipids in VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,40341,0.20214505819053,0.00963896145505812,0.183252693738616,0.221037422642444,2.39583233159554e-96
NMR metabolomics,X23412.Phospholipids in VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,0.206702981699213,0.00984810656517834,0.187400692831463,0.226005270566962,2.89286764526776e-96
NMR metabolomics,X23412.Phospholipids in VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,0.133392063225989,0.00636362591369822,0.120919356435141,0.145864770016838,3.14870240281282e-96
NMR metabolomics,X23412.Phospholipids in VLDL,MINK1,Misshapen-like kinase 1,37942,0.176660354336423,0.00841954388753484,0.160158048316855,0.193162660355991,3.26182422973407e-96
NMR metabolomics,X23412.Phospholipids in VLDL,PDLIM7,PDZ and LIM domain protein 7,40422,0.237178070347444,0.0113602429603656,0.214911994145127,0.25944414654976,1.60009898199541e-95
NMR metabolomics,X23412.Phospholipids in VLDL,MTSS2,Protein MTSS 2,37900,0.186850480434524,0.00894375321708483,0.169320724129037,0.20438023674001,2.07206649226285e-95
NMR metabolomics,X23412.Phospholipids in VLDL,PHACTR2,Phosphatase and actin regulator 2,37959,0.215824112538199,0.0103676385400609,0.19550354099968,0.236144684076718,9.25380134334912e-95
NMR metabolomics,X23412.Phospholipids in VLDL,DCTN1,Dynactin subunit 1,40489,0.124354993443731,0.00598126194311679,0.112631720035222,0.13607826685224,9.2979117918638e-95
NMR metabolomics,X23412.Phospholipids in VLDL,RAB11FIP3,Rab11 family-interacting protein 3,37990,0.202475110705447,0.00974000970600409,0.183384691681679,0.221565529729216,1.65378089299774e-94
NMR metabolomics,X23412.Phospholipids in VLDL,TCTN3,Tectonic-3,37990,0.0551639760131826,0.00265630662951116,0.0499576150193407,0.0603703370070244,2.51678020997549e-94
NMR metabolomics,X23412.Phospholipids in VLDL,PLXNA4,Plexin-A4,40341,0.155728949808098,0.00750876805246817,0.14101176442526,0.170446135190936,2.69105475409605e-94
NMR metabolomics,X23412.Phospholipids in VLDL,CES3,Carboxylesterase 3,40305,0.12935905526611,0.0062445418234735,0.117119753292102,0.141598357240118,4.40744602905929e-94
NMR metabolomics,X23412.Phospholipids in VLDL,NT5E,5'-nucleotidase,40411,0.109023601145642,0.00526534458277123,0.0987035257634106,0.119343676527874,5.25847045807475e-94
NMR metabolomics,X23412.Phospholipids in VLDL,AAMDC,Mth938 domain-containing protein,37628,0.101066791391153,0.00488165890742812,0.0914987399325941,0.110634842849712,9.95379141169948e-94
NMR metabolomics,X23412.Phospholipids in VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,0.0855601793286827,0.00413802215249084,0.0774496559098007,0.0936707027475648,1.68953826435143e-93
NMR metabolomics,X23412.Phospholipids in VLDL,THOP1,Thimet oligopeptidase,40288,0.0562342470230449,0.00272506705283374,0.0508931155994907,0.061575378446599,2.20456799618858e-93
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,40500,-0.219912338806879,0.0106663194880454,-0.240818325003448,-0.19900635261031,3.08224016774577e-93
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,0.193402319583775,0.00943188305006387,0.17491582880565,0.2118888103619,3.01812077797881e-92
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,0.0502900621114154,0.00245952138324345,0.0454694002002583,0.0551107240225726,9.75111174107676e-92
NMR metabolomics,X23412.Phospholipids in VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,37628,0.191442707842184,0.00935473765257926,0.173107422043128,0.209777993641239,1.17279657038571e-91
NMR metabolomics,X23412.Phospholipids in VLDL,PAXX,Protein PAXX,37671,0.0842410090425577,0.00412485934542425,0.0761562847255261,0.0923257333595892,2.67460792464824e-91
NMR metabolomics,X23412.Phospholipids in VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,0.090250474685664,0.00441962160194141,0.0815880163458589,0.0989129330254692,2.80237546659532e-91
NMR metabolomics,X23412.Phospholipids in VLDL,LEFTY2,Left-right determination factor 2,40453,0.0963920320494561,0.00472819543097761,0.08712476900474,0.105659295094172,3.15936409164056e-91
NMR metabolomics,X23412.Phospholipids in VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,0.138944327513419,0.00680982043097108,0.125597079468715,0.152291575558122,3.9578290636933e-91
NMR metabolomics,X23412.Phospholipids in VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,39980,0.0918732164481959,0.00451385521001504,0.0830260602365664,0.100720372659825,6.60114707548591e-91
NMR metabolomics,X23412.Phospholipids in VLDL,HJV,Hemojuvelin,37959,0.085451242709923,0.00419502331309817,0.0772289970162506,0.0936734884035954,7.16432467246056e-91
NMR metabolomics,X23412.Phospholipids in VLDL,ERBIN,Erbin,40305,0.189679752375026,0.00932448817768577,0.171403755546761,0.20795574920329,7.85182084122006e-91
NMR metabolomics,X23412.Phospholipids in VLDL,CRHBP,Corticotropin-releasing factor-binding protein,40357,0.0518699809939099,0.00255279943169784,0.0468664941077821,0.0568734678800376,1.23532135747343e-90
NMR metabolomics,X23412.Phospholipids in VLDL,SHBG,Sex hormone-binding globulin,37987,-0.0997806873263525,0.00491070932735521,-0.109405677607969,-0.0901556970447363,1.94041951368217e-90
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R9B,Neurabin-2,40516,0.173084574616048,0.00854139144713659,0.156343447379661,0.189825701852436,3.55872487327913e-90
NMR metabolomics,X23412.Phospholipids in VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,40341,0.0696131170665345,0.00343620161910472,0.0628781618930893,0.0763480722399798,4.07889851930827e-90
NMR metabolomics,X23412.Phospholipids in VLDL,CD99L2,CD99 antigen-like protein 2,40332,0.0438458458707503,0.0021650702381165,0.0396023082040419,0.0480893835374586,4.71747680890689e-90
NMR metabolomics,X23412.Phospholipids in VLDL,STC1,Stanniocalcin-1,40471,0.0763130276219907,0.00376936368466182,0.0689250748000535,0.0837009804439278,5.18128758134467e-90
NMR metabolomics,X23412.Phospholipids in VLDL,S100A4,Protein S100-A4,40411,0.106360827017249,0.00525496109399932,0.0960611032730105,0.116660550761488,5.83486545811463e-90
NMR metabolomics,X23412.Phospholipids in VLDL,TNIP1,TNFAIP3-interacting protein 1,37942,0.163389086604519,0.00806543403810527,0.147580835889833,0.179197337319205,6.54041135900211e-90
NMR metabolomics,X23412.Phospholipids in VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,37990,0.120183636142601,0.00594247793316444,0.108536379393599,0.131830892891603,1.25026730252108e-89
NMR metabolomics,X23412.Phospholipids in VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,0.126863053937604,0.00628010046109671,0.114554057033855,0.139172050841354,1.34605868711921e-89
NMR metabolomics,X23412.Phospholipids in VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,0.0421634949560647,0.00208800844759252,0.0380709983987833,0.046255991513346,1.49317253453661e-89
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA1,Ephrin type-A receptor 1,40400,0.0627156760865367,0.0031062756534204,0.0566273758058327,0.0688039763672407,1.57250823906169e-89
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4B,Eukaryotic translation initiation factor 4B,40228,0.108843176731976,0.00539660126615993,0.0982658382503025,0.119420515213649,2.45317594233621e-89
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL3,Angiopoietin-related protein 3,40355,0.0665970477540979,0.00330281891848247,0.0601235226738723,0.0730705728343236,2.6600098764565e-89
NMR metabolomics,X23412.Phospholipids in VLDL,THPO,Thrombopoietin,40042,0.0700299284281936,0.00347564327013505,0.0632176676187289,0.0768421892376583,3.75485490923179e-89
NMR metabolomics,X23412.Phospholipids in VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,0.191181885546862,0.00949069112959501,0.172580130932856,0.209783640160869,3.95861378266436e-89
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINH1,Serpin H1,37714,0.236288695540141,0.0117202775940583,0.213316951455787,0.259260439624495,4.65909680314742e-89
NMR metabolomics,X23412.Phospholipids in VLDL,FABP5,Fatty acid-binding protein 5,40432,0.126532580255515,0.00629421846107799,0.114195912071802,0.138869248439228,8.68179841730692e-89
NMR metabolomics,X23412.Phospholipids in VLDL,NHLRC3,NHL repeat-containing protein 3,37370,0.0584977587496711,0.00290842567752709,0.052797244421718,0.0641982730776242,1.27803997945344e-88
NMR metabolomics,X23412.Phospholipids in VLDL,NPL,N-acetylneuraminate lyase,37990,0.0788937335770332,0.00392828508373964,0.0711942948129035,0.0865931723411629,1.98642676940059e-88
NMR metabolomics,X23412.Phospholipids in VLDL,DOK2,Docking protein 2,40359,0.220310346838496,0.0109857480108429,0.198778280737244,0.241842412939748,2.28827107837968e-88
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,0.182373678636153,0.00910150623579783,0.164534726413989,0.200212630858317,3.08371538510294e-88
NMR metabolomics,X23412.Phospholipids in VLDL,USO1,General vesicular transport factor p115,40305,0.165320183490619,0.00825363828435768,0.149143052453278,0.18149731452796,3.70913488006384e-88
NMR metabolomics,X23412.Phospholipids in VLDL,NCK2,Cytoplasmic protein NCK2,40422,0.190396668987246,0.00950638306756567,0.171764158174817,0.209029179799674,3.76448344118326e-88
NMR metabolomics,X23412.Phospholipids in VLDL,BCR,Breakpoint cluster region protein,40341,0.165637354477018,0.00828854319758083,0.149391809809759,0.181882899144276,9.08656574580278e-88
NMR metabolomics,X23412.Phospholipids in VLDL,CD2AP,CD2-associated protein,40359,0.11633262492663,0.00582162579827651,0.104922238362008,0.127743011491252,9.24953650135587e-88
NMR metabolomics,X23412.Phospholipids in VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,0.165587367336704,0.0082795158315461,0.149359516306874,0.181815218366534,1.03974746931181e-87
NMR metabolomics,X23412.Phospholipids in VLDL,CIRBP,Cold-inducible RNA-binding protein,37901,0.173270878392828,0.00867807448751315,0.156261852397303,0.190279904388354,1.98092437279929e-87
NMR metabolomics,X23412.Phospholipids in VLDL,SUGP1,SURP and G-patch domain-containing protein 1,37901,0.0719816399519273,0.00360807223724301,0.064909818366931,0.0790534615369236,2.72157288470042e-87
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL10,C-X-C motif chemokine 10,40422,0.122433432674265,0.00614509722880438,0.110389042105808,0.134477823242721,2.90221562754618e-87
NMR metabolomics,X23412.Phospholipids in VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,40283,0.0584132577847155,0.00293382407206645,0.0526629626034653,0.0641635529659658,3.85391258416705e-87
NMR metabolomics,X23412.Phospholipids in VLDL,CEP85,Centrosomal protein of 85 kDa,39980,0.114092745491777,0.0057354451808526,0.102851272937305,0.125334218046248,5.70137108009592e-87
NMR metabolomics,X23412.Phospholipids in VLDL,CCN2,CCN family member 2,40358,0.1042283870222,0.00524147084352823,0.0939551041688847,0.114501669875515,6.19211752065405e-87
NMR metabolomics,X23412.Phospholipids in VLDL,TGFB1,Transforming growth factor beta-1 proprotein,40502,0.0684713582445606,0.00345097023345527,0.0617074565869883,0.0752352599021329,1.42925218628298e-86
NMR metabolomics,X23412.Phospholipids in VLDL,CMIP,C-Maf-inducing protein,37900,0.148599643663955,0.00748086403628104,0.133937150152844,0.163262137175066,1.44751909222383e-86
NMR metabolomics,X23412.Phospholipids in VLDL,GHRL,Appetite-regulating hormone,40359,0.142462934799462,0.00718451474497884,0.128381285899303,0.15654458369962,1.84339803529458e-86
NMR metabolomics,X23412.Phospholipids in VLDL,SLA2,Src-like-adapter 2,37959,0.186040329110596,0.00939067730462498,0.167634601593531,0.204446056627661,3.96647541299467e-86
NMR metabolomics,X23412.Phospholipids in VLDL,CCL5,C-C motif chemokine 5,40403,0.180228447415416,0.00911725915169093,0.162358619478102,0.19809827535273,6.00919763427525e-86
NMR metabolomics,X23412.Phospholipids in VLDL,BID,BH3-interacting domain death agonist,40341,0.120550434214224,0.00610034484376315,0.108593758320448,0.132507110107999,6.88736354765627e-86
NMR metabolomics,X23412.Phospholipids in VLDL,DCXR,L-xylulose reductase,40411,0.0939750082842766,0.00476048330662184,0.0846444610032978,0.103305555565255,1.01524115126508e-85
NMR metabolomics,X23412.Phospholipids in VLDL,FETUB,Fetuin-B,40372,0.0606397552762983,0.00307590915896533,0.0546109733247262,0.0666685372278703,1.69409491623819e-85
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,0.17045290815189,0.00868184890036548,0.153436484307174,0.187469331996606,8.04111004243673e-85
NMR metabolomics,X23412.Phospholipids in VLDL,C1S,Complement C1s subcomponent,38013,0.0371526361765787,0.00189088561273713,0.0334465003756139,0.0408587719775435,8.99420292796924e-85
NMR metabolomics,X23412.Phospholipids in VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,0.147115929990016,0.00750183012955664,0.132412342936085,0.161819517043947,1.32085532591704e-84
NMR metabolomics,X23412.Phospholipids in VLDL,SRPK2,SRSF protein kinase 2,40341,0.147623126539206,0.0075326468248085,0.132859138762581,0.16238711431583,1.60496767713575e-84
NMR metabolomics,X23412.Phospholipids in VLDL,CTSD,Cathepsin D,39243,0.0712819976866701,0.00363935396659786,0.0641488639121383,0.0784151314612019,2.35764962909002e-84
NMR metabolomics,X23412.Phospholipids in VLDL,STAT5B,Signal transducer and activator of transcription 5B,40305,0.245632941822666,0.0125473012000079,0.22104023147065,0.270225652174681,2.4232602925383e-84
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS9,Galectin-9,40350,0.0572987281527805,0.00292907469318947,0.0515577417541292,0.0630397145514319,3.17876674869213e-84
NMR metabolomics,X23412.Phospholipids in VLDL,PLSCR3,Phospholipid scramblase 3,37919,0.106558614419311,0.00545441283615731,0.0958679652604426,0.117249263578179,7.78810269820101e-84
NMR metabolomics,X23412.Phospholipids in VLDL,MASP1,Mannan-binding lectin serine protease 1,40192,0.0423264661555174,0.00216953048764681,0.0380741863997297,0.0465787459113052,8.88145345195883e-84
NMR metabolomics,X23412.Phospholipids in VLDL,MME,Neprilysin,40305,0.144591219477517,0.00741253525668647,0.130062650374412,0.159119788580623,9.2905494137095e-84
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA5,Integrin alpha-5,40332,0.0442333400030185,0.00226902598342422,0.0397860490755071,0.04868063093053,1.16152087330618e-83
NMR metabolomics,X23412.Phospholipids in VLDL,HCLS1,Hematopoietic lineage cell-specific protein,40516,0.0992591385977018,0.00509574031216484,0.0892714875858587,0.109246789609545,1.5243575520861e-83
NMR metabolomics,X23412.Phospholipids in VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,0.13193524012175,0.0067671374704086,0.118671650679749,0.14519882956375,1.78122057646218e-83
NMR metabolomics,X23412.Phospholipids in VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,0.0974067597653519,0.00500202056228442,0.0876027994632745,0.107210720067429,1.84568384744899e-83
NMR metabolomics,X23412.Phospholipids in VLDL,MVK,Mevalonate kinase,40044,0.135516507947418,0.00698188324057398,0.121832016795893,0.149200999098943,6.06822125098578e-83
NMR metabolomics,X23412.Phospholipids in VLDL,PCBP2,Poly(rC)-binding protein 2,37959,0.126909412395154,0.00654097870171278,0.114089094139797,0.139729730650511,9.84406922546106e-83
NMR metabolomics,X23412.Phospholipids in VLDL,CRELD2,Protein disulfide isomerase CRELD2,40396,0.091384502484242,0.00471560951626564,0.0821419078323613,0.100627097136123,1.03313342205058e-82
NMR metabolomics,X23412.Phospholipids in VLDL,COL18A1,Collagen alpha-1(XVIII) chain,40391,0.0408810572502567,0.00210963280633132,0.0367461769498473,0.0450159375506661,1.0510214068582e-82
NMR metabolomics,X23412.Phospholipids in VLDL,CKB,Creatine kinase B-type,37998,-0.106995985635358,0.00552321702565198,-0.117821491005636,-0.09617048026508,1.72890337837164e-82
NMR metabolomics,X23412.Phospholipids in VLDL,IKBKG,NF-kappa-B essential modulator,40341,0.162036324535543,0.0083787155242615,0.145614042107991,0.178458606963096,2.22696777461125e-82
NMR metabolomics,X23412.Phospholipids in VLDL,RTBDN,Retbindin,40305,0.0515451205123002,0.00266909227016022,0.0463136996627861,0.0567765413618142,3.74412634715803e-82
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,0.191800371381756,0.00992196082748736,0.172353328159881,0.211247414603631,3.82821247438635e-82
NMR metabolomics,X23412.Phospholipids in VLDL,FABP4,"Fatty acid-binding protein, adipocyte",40536,0.0862564064311175,0.00446995326215025,0.077495298037303,0.095017514824932,4.81469718270642e-82
NMR metabolomics,X23412.Phospholipids in VLDL,NFX1,Transcriptional repressor NF-X1,37562,0.119722167000646,0.00619789432199726,0.107574294129531,0.13187003987176,5.3491668877007e-82
NMR metabolomics,X23412.Phospholipids in VLDL,PLXNB3,Plexin-B3,40310,0.0820232571846054,0.00425238887178477,0.0736885749959072,0.0903579393733035,5.79153924601234e-82
NMR metabolomics,X23412.Phospholipids in VLDL,FUOM,Fucose mutarotase,37671,0.109708853607693,0.00568813803039384,0.0985601030681214,0.120857604147265,9.08763994019177e-82
NMR metabolomics,X23412.Phospholipids in VLDL,IDUA,Alpha-L-iduronidase,40489,0.0793789651744772,0.00412202242653194,0.0712998012184746,0.0874581291304798,1.02458831074054e-81
NMR metabolomics,X23412.Phospholipids in VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,40341,0.195949985434908,0.0101844752725371,0.175988413900735,0.21591155696908,1.44560246320707e-81
NMR metabolomics,X23412.Phospholipids in VLDL,SNAP23,Synaptosomal-associated protein 23,40359,0.152342953453284,0.00792222862499799,0.136815385348288,0.167870521558281,1.74973853907652e-81
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,-0.0657223123541979,0.0034207041222578,-0.0724268924338232,-0.0590177322745726,2.38346334620101e-81
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB6,DnaJ homolog subfamily B member 6,37557,0.148180914204965,0.00770566409177508,0.133077812585086,0.163284015824845,2.71851979508866e-81
NMR metabolomics,X23412.Phospholipids in VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,0.087863238755593,0.00458221839299557,0.0788820907053217,0.0968443868058643,5.19302221456229e-81
NMR metabolomics,X23412.Phospholipids in VLDL,RTN4R,Reticulon-4 receptor,40489,0.0591538569182245,0.00308743985346791,0.0531024748054274,0.0652052390310216,6.4558614220406e-81
NMR metabolomics,X23412.Phospholipids in VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,0.112882140784191,0.00588788976644662,0.101341876841956,0.124422404726427,7.46493321248068e-81
NMR metabolomics,X23412.Phospholipids in VLDL,PON2,Serum paraoxonase/arylesterase 2,40042,0.0599723243751953,0.00313333742311833,0.0538309830258834,0.0661136657245072,9.85914643784998e-81
NMR metabolomics,X23412.Phospholipids in VLDL,CCL13,C-C motif chemokine 13,40483,0.121441242662717,0.00635338786512617,0.108988602447069,0.133893882878364,1.50598905857958e-80
NMR metabolomics,X23412.Phospholipids in VLDL,FOXO1,Forkhead box protein O1,40341,0.147173486154751,0.00771145379739206,0.132059036711863,0.16228793559764,2.65703839452848e-80
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD5,Programmed cell death protein 5,40471,0.10142075674921,0.00531730238849692,0.0909988440677562,0.111842669430664,3.23028160737359e-80
NMR metabolomics,X23412.Phospholipids in VLDL,CMC1,COX assembly mitochondrial protein homolog,37990,0.156682903616939,0.0082112622236021,0.140588829658679,0.172776977575199,4.04216404601125e-80
NMR metabolomics,X23412.Phospholipids in VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,0.164546633946518,0.00863596399509576,0.147620144516131,0.181473123376906,4.84864473082512e-80
NMR metabolomics,X23412.Phospholipids in VLDL,FKBPL,FK506-binding protein-like,37901,0.102499980118222,0.00537624644305742,0.0919625370898295,0.113037423146615,5.54396671300348e-80
NMR metabolomics,X23412.Phospholipids in VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,40419,0.0552086125144198,0.00290280551768672,0.0495191136997539,0.0608981113290858,9.02563767906137e-80
NMR metabolomics,X23412.Phospholipids in VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,37900,0.198298667328236,0.0104181528828079,0.177879087677933,0.21871824697854,9.9410120422022e-80
NMR metabolomics,X23412.Phospholipids in VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,40305,0.14788700415068,0.00777830402186388,0.132641528267827,0.163132480033533,1.02967160650985e-79
NMR metabolomics,X23412.Phospholipids in VLDL,OGFR,Opioid growth factor receptor,40305,0.0572793442316154,0.00301314680945599,0.0513735764850816,0.0631851119781491,1.08783914072819e-79
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFC,Platelet-derived growth factor C,39980,0.0513834178564886,0.00270816234360358,0.0460754196630256,0.0566914160499517,2.2284811777974e-79
NMR metabolomics,X23412.Phospholipids in VLDL,STK11,Serine/threonine-protein kinase STK11,40042,0.125827619616327,0.00664850696138189,0.112796545972018,0.138858693260635,5.37543776623935e-79
NMR metabolomics,X23412.Phospholipids in VLDL,HGF,Hepatocyte growth factor,40516,0.0590087214997524,0.00312247927937908,0.0528886621121694,0.0651287808873354,8.46332772736729e-79
NMR metabolomics,X23412.Phospholipids in VLDL,BACH1,Transcription regulator protein BACH1,40341,0.124944679185456,0.00661993568076224,0.111969605251162,0.13791975311975,1.34939526579257e-78
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.0500530977903056,0.00265368398514934,0.0448518771794129,0.0552543184011983,1.6576280504017e-78
NMR metabolomics,X23412.Phospholipids in VLDL,HMOX2,Heme oxygenase 2,39961,0.0784761048419002,0.00416188268428765,0.0703188147806964,0.086633394903104,1.97762478646533e-78
NMR metabolomics,X23412.Phospholipids in VLDL,GIGYF2,GRB10-interacting GYF protein 2,37959,0.130145392461775,0.00691197748477453,0.116597916591617,0.143692868331933,4.3583151858125e-78
NMR metabolomics,X23412.Phospholipids in VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,0.122154826749585,0.00649855835452349,0.109417652374719,0.134892001124451,8.2040643031863e-78
NMR metabolomics,X23412.Phospholipids in VLDL,DAG1,Dystroglycan,40422,0.0809567417318564,0.00431380303784471,0.0725016877776807,0.089411795686032,9.65175125685841e-78
NMR metabolomics,X23412.Phospholipids in VLDL,CLUL1,Clusterin-like protein 1,40338,-0.0777654484928745,0.00415056666738373,-0.0859005591609466,-0.0696303378248024,1.71820985088602e-77
NMR metabolomics,X23412.Phospholipids in VLDL,VAMP8,Vesicle-associated membrane protein 8,37598,0.151915389873333,0.00810115735651099,0.136037121454572,0.167793658292095,1.89323776833601e-77
NMR metabolomics,X23412.Phospholipids in VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,0.074808227253679,0.00399999491412097,0.0669682372220019,0.0826482172853561,3.22233892479107e-77
NMR metabolomics,X23412.Phospholipids in VLDL,RGCC,Regulator of cell cycle RGCC,37959,0.127831760293019,0.00683081125666582,0.114443370229954,0.141220150356084,3.59221455969631e-77
NMR metabolomics,X23412.Phospholipids in VLDL,TANK,TRAF family member-associated NF-kappa-B activator,40044,0.118709850305037,0.00635443572942978,0.106255156275355,0.131164544334719,4.85755316306104e-77
NMR metabolomics,X23412.Phospholipids in VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,0.131389925686434,0.00703195820397983,0.117607287606633,0.145172563766234,6.10732643437842e-77
NMR metabolomics,X23412.Phospholipids in VLDL,LEP,Leptin,40359,0.108713038773319,0.00582572575038566,0.0972946163025629,0.120131461244075,6.81706088053797e-77
NMR metabolomics,X23412.Phospholipids in VLDL,CCL7,C-C motif chemokine 7,40341,0.103530830851893,0.00554928516837262,0.0926542319218831,0.114407429781904,7.38444536661495e-77
NMR metabolomics,X23412.Phospholipids in VLDL,YOD1,Ubiquitin thioesterase OTU1,37562,0.108393878592741,0.00580937494632251,0.0970075036979493,0.119780253487534,1.05864728836424e-76
NMR metabolomics,X23412.Phospholipids in VLDL,KLK10,Kallikrein-10,40354,0.0667493607794918,0.00358486202985202,0.0597230312009818,0.0737756903580018,1.44600688091241e-76
NMR metabolomics,X23412.Phospholipids in VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,0.117143444955712,0.00629009541162606,0.104814857948925,0.129472031962499,1.87939083708366e-76
NMR metabolomics,X23412.Phospholipids in VLDL,NIT2,Omega-amidase NIT2,37936,0.128182343100266,0.00689638935153264,0.114665419971262,0.14169926622927,3.66091067582986e-76
NMR metabolomics,X23412.Phospholipids in VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,40357,0.0851622826660116,0.00458797653191325,0.0761698486634616,0.0941547166685615,4.14486335240048e-76
NMR metabolomics,X23412.Phospholipids in VLDL,ASAH2,Neutral ceramidase,40228,0.0890179123389489,0.00479713863941877,0.0796155206056881,0.0984203040722097,4.65867796746849e-76
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFB,Platelet-derived growth factor subunit B,40422,0.144948880593681,0.00781178555808274,0.129637780899839,0.160259980287524,4.66563583848447e-76
NMR metabolomics,X23412.Phospholipids in VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,0.17382749809151,0.00936216357708133,0.155477657480431,0.192177338702589,5.28023034261951e-76
NMR metabolomics,X23412.Phospholipids in VLDL,HYOU1,Hypoxia up-regulated protein 1,40536,0.0365952515792416,0.00197376833303805,0.032726665646487,0.0404638375119962,5.98168072479419e-76
NMR metabolomics,X23412.Phospholipids in VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,0.13021126267633,0.00701669223621594,0.116458545893346,0.143963979459313,6.23508593316878e-76
NMR metabolomics,X23412.Phospholipids in VLDL,AP3B1,AP-3 complex subunit beta-1,37901,0.129149897479743,0.00696737731695829,0.115493837938504,0.142805957020981,9.20729017545414e-76
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS1,Galectin-1,40359,0.0568426495043413,0.00306994156394295,0.0508255640390131,0.0628597349696695,9.60376125432287e-76
NMR metabolomics,X23412.Phospholipids in VLDL,CTSO,Cathepsin O,40516,0.050805031820066,0.00274401167405629,0.0454267689389156,0.0561832947012163,9.60864888268675e-76
NMR metabolomics,X23412.Phospholipids in VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,0.162791067548204,0.0087987914447071,0.145545436316579,0.18003669877983,1.29289038628275e-75
NMR metabolomics,X23412.Phospholipids in VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,0.0528380314688393,0.00285539006302148,0.0472414669453172,0.0584345959923614,1.70853873551042e-75
NMR metabolomics,X23412.Phospholipids in VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,0.0897065898888295,0.00484896683178282,0.0802026148985351,0.0992105648791238,1.77444023058286e-75
NMR metabolomics,X23412.Phospholipids in VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,0.0744739431701752,0.00403575470234168,0.0665638639535855,0.0823840223867649,2.99512924991127e-75
NMR metabolomics,X23412.Phospholipids in VLDL,CEP43,Centrosomal protein 43,39934,0.116124174224318,0.00629216312678578,0.103791534495818,0.128456813952818,3.02427386564877e-75
NMR metabolomics,X23412.Phospholipids in VLDL,HEXIM1,Protein HEXIM1,40341,0.137352020109026,0.00745226242292342,0.122745585760097,0.151958454457956,4.49313128239426e-75
NMR metabolomics,X23412.Phospholipids in VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,0.187916015577997,0.0101958105201772,0.16793222695845,0.207899804197544,4.58640641739355e-75
NMR metabolomics,X23412.Phospholipids in VLDL,AHSG,Alpha-2-HS-glycoprotein,37987,0.0455635280201456,0.00247085647609417,0.0407206493270011,0.0504064067132902,5.15482103194269e-75
NMR metabolomics,X23412.Phospholipids in VLDL,LSP1,Lymphocyte-specific protein 1,40341,0.0671323241720235,0.00364573214452068,0.059986689168763,0.0742779591752841,6.1072974984186e-75
NMR metabolomics,X23412.Phospholipids in VLDL,LBR,Delta(14)-sterol reductase LBR,40471,0.110117657557104,0.00598283676913663,0.0983912974895966,0.121844017624612,7.00208009300862e-75
NMR metabolomics,X23412.Phospholipids in VLDL,SEC31A,Protein transport protein Sec31A,37628,0.128658043138468,0.00698274955337292,0.114971854013857,0.142344232263078,7.18076662641589e-75
NMR metabolomics,X23412.Phospholipids in VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,0.150176032757915,0.00815873784555646,0.134184906580625,0.166167158935206,9.57240223538999e-75
NMR metabolomics,X23412.Phospholipids in VLDL,LAT,Linker for activation of T-cells family member 1,40516,0.126659359730564,0.00689059890178105,0.113153785883074,0.140164933578055,1.07732727148975e-74
NMR metabolomics,X23412.Phospholipids in VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,0.17840282980666,0.00969651585818359,0.15939765872462,0.1974080008887,1.14076928729411e-74
NMR metabolomics,X23412.Phospholipids in VLDL,GFRA1,GDNF family receptor alpha-1,40453,0.0466956100536097,0.00254113807039915,0.0417149794356274,0.0516762406715921,1.20029426166928e-74
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP45,Rho GTPase-activating protein 45,37671,0.138084950840323,0.00750984909750992,0.123365646609204,0.152804255071443,1.41183111599104e-74
NMR metabolomics,X23412.Phospholipids in VLDL,F13B,Coagulation factor XIII B chain,37934,0.0433113317725761,0.00235748510798351,0.0386906609609284,0.0479320025842237,1.78565278149016e-74
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,0.152292035926842,0.00830579119511093,0.136012685184424,0.168571386669259,3.41629259203147e-74
NMR metabolomics,X23412.Phospholipids in VLDL,SIAE,Sialate O-acetylesterase,40374,0.0782645087839927,0.00427324545217184,0.0698889476977358,0.0866400698702495,3.62497190349442e-74
NMR metabolomics,X23412.Phospholipids in VLDL,AKT1S1,Proline-rich AKT1 substrate 1,39961,0.112970496841057,0.00616736481602006,0.100882461801658,0.125058531880457,3.63130038714033e-74
NMR metabolomics,X23412.Phospholipids in VLDL,METAP2,Methionine aminopeptidase 2,40453,0.0981741582153061,0.0053713167912479,0.0876463773044602,0.108701939126152,7.05485703774373e-74
NMR metabolomics,X23412.Phospholipids in VLDL,MYDGF,Myeloid-derived growth factor,37990,0.16766940854826,0.00916810058467633,0.149699931402294,0.185638885694225,7.91692998874138e-74
NMR metabolomics,X23412.Phospholipids in VLDL,DNMBP,Dynamin-binding protein,40228,0.102801086652921,0.00562628200607378,0.0917735739210163,0.113828599384826,8.03611226557524e-74
NMR metabolomics,X23412.Phospholipids in VLDL,CD36,Platelet glycoprotein 4,37598,0.0741423168390021,0.00405609005135438,0.0661923803383476,0.0820922533396567,9.88982912135934e-74
NMR metabolomics,X23412.Phospholipids in VLDL,EGLN1,Egl nine homolog 1,40341,0.0883940034788944,0.0048429225082667,0.0789018753626917,0.0978861315950972,1.12386501891909e-73
NMR metabolomics,X23412.Phospholipids in VLDL,SDC4,Syndecan-4,40359,0.075354009994202,0.00412891310265625,0.0672613403129957,0.0834466796754082,1.16008244875042e-73
NMR metabolomics,X23412.Phospholipids in VLDL,IST1,IST1 homolog,37812,0.166810301729511,0.00914031069569839,0.148895292765942,0.18472531069308,1.6152172985152e-73
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL3,C-X-C motif chemokine 3,40350,0.154689125180622,0.00849054858127858,0.138047649961316,0.171330600399928,2.03607516083017e-73
NMR metabolomics,X23412.Phospholipids in VLDL,CDH2,Cadherin-2,40359,0.0585805270391536,0.00321701531250529,0.0522751770266432,0.0648858770516639,2.40632317390119e-73
NMR metabolomics,X23412.Phospholipids in VLDL,FGF19,Fibroblast growth factor 19,40422,0.127284786999182,0.00699024421478151,0.11358390833821,0.140985665660154,2.41917622085699e-73
NMR metabolomics,X23412.Phospholipids in VLDL,APOM,Apolipoprotein M,40372,0.0444065470215249,0.00243987851675235,0.0396243851286903,0.0491887089143595,2.83682073011404e-73
NMR metabolomics,X23412.Phospholipids in VLDL,RABEP1,Rab GTPase-binding effector protein 1,37671,0.131219683075513,0.00720727359507194,0.117093426829172,0.145345939321854,3.57860598311711e-73
NMR metabolomics,X23412.Phospholipids in VLDL,TBCC,Tubulin-specific chaperone C,40228,0.13494947313249,0.00742045555893738,0.120405380236973,0.149493566028008,3.71090748611759e-73
NMR metabolomics,X23412.Phospholipids in VLDL,GLB1,Beta-galactosidase,40228,0.0677622776329868,0.00372711002139233,0.0604571419910578,0.0750674132749158,4.07410671283981e-73
NMR metabolomics,X23412.Phospholipids in VLDL,PAK4,Serine/threonine-protein kinase PAK 4,39961,0.101488645432327,0.00558444778703499,0.0905431277697383,0.112434163094915,4.79335428793904e-73
NMR metabolomics,X23412.Phospholipids in VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,0.171764555841586,0.00946388999679467,0.153215331447868,0.190313780235303,6.99702731130677e-73
NMR metabolomics,X23412.Phospholipids in VLDL,GOLM2,Protein GOLM2,40471,0.0371117588171742,0.00204833106124403,0.0330970299371359,0.0411264876972125,1.21871000272717e-72
NMR metabolomics,X23412.Phospholipids in VLDL,ACE2,Angiotensin-converting enzyme 2,40042,0.0808074095196224,0.00446138138648348,0.0720631020021148,0.08955171703713,1.40390675689675e-72
NMR metabolomics,X23412.Phospholipids in VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,0.1258050807936,0.00694819273140162,0.112186623040053,0.139423538547147,1.53208954194768e-72
NMR metabolomics,X23412.Phospholipids in VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,0.0872384393197302,0.00481345152613869,0.0778040743284983,0.096672804310962,1.54598589811861e-72
NMR metabolomics,X23412.Phospholipids in VLDL,PPY,Pancreatic prohormone,40337,0.166571408968297,0.00920825466569759,0.14852322982353,0.184619588113064,2.05879235670959e-72
NMR metabolomics,X23412.Phospholipids in VLDL,APOC1,Apolipoprotein C-I,37981,0.0598417011544564,0.00330899449446154,0.0533560719453117,0.066327330363601,2.98563219566325e-72
NMR metabolomics,X23412.Phospholipids in VLDL,TOP2B,DNA topoisomerase 2-beta,37598,0.130613457386168,0.0072264854366966,0.116449545930243,0.144777368842094,3.78830195052292e-72
NMR metabolomics,X23412.Phospholipids in VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,39980,0.105719856678351,0.00585563684964934,0.0942428084530385,0.117196904903664,3.97936009537452e-72
NMR metabolomics,X23412.Phospholipids in VLDL,MITD1,MIT domain-containing protein 1,40228,0.159290032598229,0.00882600631192537,0.141991060226856,0.176589004969603,4.35508456502401e-72
NMR metabolomics,X23412.Phospholipids in VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,0.119145875286792,0.00660407144336826,0.10620189525779,0.132089855315794,6.49485618923696e-72
NMR metabolomics,X23412.Phospholipids in VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,0.190654662331204,0.0105845276140615,0.169908988207644,0.211400336454765,8.06525514177637e-72
NMR metabolomics,X23412.Phospholipids in VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,0.102400888127596,0.00569157740767129,0.0912453964085601,0.113556379846631,1.54981917625925e-71
NMR metabolomics,X23412.Phospholipids in VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,0.0522903939116219,0.00290838504047104,0.0465899592322986,0.0579908285909451,1.93054450886501e-71
NMR metabolomics,X23412.Phospholipids in VLDL,RILPL2,RILP-like protein 2,37990,0.159671726356333,0.00888844074504701,0.142250382496041,0.177093070216625,2.50657479244581e-71
NMR metabolomics,X23412.Phospholipids in VLDL,SNCG,Gamma-synuclein,40228,0.109739493116292,0.0061155733934106,0.0977529692652068,0.121726016967376,2.71856726968553e-71
NMR metabolomics,X23412.Phospholipids in VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,-0.160571227745978,0.00896055538557314,-0.178133916301701,-0.143008539190255,4.13101192428656e-71
NMR metabolomics,X23412.Phospholipids in VLDL,GPC5,Glypican-5,40228,0.0916700551627274,0.00511823715824602,0.0816383103325652,0.10170179999289,4.93174072339763e-71
NMR metabolomics,X23412.Phospholipids in VLDL,GIT1,ARF GTPase-activating protein GIT1,37598,0.160250247847811,0.00893876246722519,0.142730273412049,0.177770222283572,5.02562005435657e-71
NMR metabolomics,X23412.Phospholipids in VLDL,SYTL4,Synaptotagmin-like protein 4,37990,0.119858200023373,0.00669019960666249,0.106745408794315,0.132970991252432,5.87766675174742e-71
NMR metabolomics,X23412.Phospholipids in VLDL,ARSB,Arylsulfatase B,40305,0.08972052738879,0.00501552911401563,0.0798900903253194,0.0995509644522606,7.19827997923894e-71
NMR metabolomics,X23412.Phospholipids in VLDL,EREG,Proepiregulin,40192,0.131195579649596,0.00733408088996839,0.116820781105258,0.145570378193934,7.28870900257126e-71
NMR metabolomics,X23412.Phospholipids in VLDL,STAMBP,STAM-binding protein,40192,0.105664263956337,0.0059091326715605,0.0940823639200781,0.117246163992595,8.23822160323922e-71
NMR metabolomics,X23412.Phospholipids in VLDL,F2,Prothrombin,38013,0.0240567982934925,0.00134470498734911,0.0214211765182883,0.0266924200686968,9.16002601783527e-71
NMR metabolomics,X23412.Phospholipids in VLDL,SNX15,Sorting nexin-15,37671,0.088523414050784,0.0049516507857412,0.0788181785107312,0.0982286495908367,1.19507051123241e-70
NMR metabolomics,X23412.Phospholipids in VLDL,SKAP2,Src kinase-associated phosphoprotein 2,40422,0.170049980698948,0.00952537782706576,0.151380240157899,0.188719721239997,1.34520070805298e-70
NMR metabolomics,X23412.Phospholipids in VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,0.163744785713279,0.00917580316963799,0.145760211500789,0.18172935992577,1.53393005103674e-70
NMR metabolomics,X23412.Phospholipids in VLDL,SH2D1A,SH2 domain-containing protein 1A,40341,0.0891165313511065,0.00500479648670448,0.0793071302371657,0.0989259324650473,3.0420237034209e-70
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,0.0453068739388926,0.00254508036568766,0.0403185164221448,0.0502952314556404,3.28444698471494e-70
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,0.106791222298033,0.00599622191433127,0.095038627345944,0.118543817250123,3.75747202389285e-70
NMR metabolomics,X23412.Phospholipids in VLDL,QDPR,Dihydropteridine reductase,40290,0.0711290184345146,0.0039989959298817,0.0632909864119465,0.0789670504570827,4.30124671471448e-70
NMR metabolomics,X23412.Phospholipids in VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,0.149586554494475,0.00840937583491528,0.133104177858041,0.166068931130909,4.30568717854242e-70
NMR metabolomics,X23412.Phospholipids in VLDL,ORM1,Alpha-1-acid glycoprotein 1,37950,0.0322493063995983,0.00181287984775661,0.0286960618979953,0.0358025509012012,5.40384075014451e-70
NMR metabolomics,X23412.Phospholipids in VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,0.117815038943359,0.0066434108603615,0.104793953657051,0.130836124229668,1.06562489448158e-69
NMR metabolomics,X23412.Phospholipids in VLDL,VNN1,Pantetheinase,37987,0.117307129136251,0.00661562789331187,0.104340498465359,0.130273759807142,1.45495160460868e-69
NMR metabolomics,X23412.Phospholipids in VLDL,DTNB,Dystrobrevin beta,37878,0.0676661772142488,0.00381597507337078,0.060186866070442,0.0751454883580555,1.46283039411911e-69
NMR metabolomics,X23412.Phospholipids in VLDL,COMMD1,COMM domain-containing protein 1,37628,0.099542883386821,0.00562392043335828,0.0885199993374388,0.110565767436203,2.65765118711364e-69
NMR metabolomics,X23412.Phospholipids in VLDL,KRT18,"Keratin, type I cytoskeletal 18",40305,0.124256530222848,0.00703314325261308,0.110471569447726,0.138041490997969,3.44705080450304e-69
NMR metabolomics,X23412.Phospholipids in VLDL,CNPY4,Protein canopy homolog 4,40305,0.120651902992724,0.00682972439883132,0.107265643171015,0.134038162814434,3.5428233913241e-69
NMR metabolomics,X23412.Phospholipids in VLDL,FAM13A,Protein FAM13A,37901,0.108774949268259,0.0061532884455021,0.096714503915075,0.120835394621443,3.77587792076559e-69
NMR metabolomics,X23412.Phospholipids in VLDL,TBC1D23,TBC1 domain family member 23,40305,0.144258577215929,0.00818709165059216,0.128211877580769,0.16030527685109,7.79919881695938e-69
NMR metabolomics,X23412.Phospholipids in VLDL,CDC27,Cell division cycle protein 27 homolog,39980,0.0978853269131487,0.00555881228620052,0.0869900548321956,0.108780598994102,9.77122474710562e-69
NMR metabolomics,X23412.Phospholipids in VLDL,AZI2,5-azacytidine-induced protein 2,37959,0.0885285624986848,0.00503279199698466,0.0786642901845949,0.0983928348127747,1.69220021048733e-68
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFA,Vascular endothelial growth factor A,40456,0.0941365219385991,0.00536402535306205,0.0836230322465975,0.104650011630601,2.61165405932718e-68
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINE1,Plasminogen activator inhibitor 1,40536,0.107809463082192,0.0061622987314845,0.0957313575684822,0.119887568595901,6.64940754732734e-68
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL7,Angiopoietin-related protein 7,40489,0.0591563233236466,0.00338153114032644,0.0525285222886068,0.0657841243586864,6.80051932729794e-68
NMR metabolomics,X23412.Phospholipids in VLDL,WASHC3,WASH complex subunit 3,37942,0.119923669133085,0.00685003245318581,0.106497605524841,0.133349732741329,7.11671632919888e-68
NMR metabolomics,X23412.Phospholipids in VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,0.101263588341002,0.00578945995183414,0.0899162468354074,0.112610929846597,7.49492883764425e-68
NMR metabolomics,X23412.Phospholipids in VLDL,PLG,Plasminogen,37705,0.0358660433405919,0.00204907492361103,0.0318498564903143,0.0398822301908695,7.78967873122892e-68
NMR metabolomics,X23412.Phospholipids in VLDL,DLK1,Protein delta homolog 1,40536,0.0845803819250659,0.00483889100757672,0.0750961555502155,0.0940646082999162,8.71566440768956e-68
NMR metabolomics,X23412.Phospholipids in VLDL,MTDH,Protein LYRIC,37598,0.146367179520853,0.00837147062214786,0.129959097101443,0.162775261940263,1.10345516163241e-67
NMR metabolomics,X23412.Phospholipids in VLDL,CRKL,Crk-like protein,40374,0.16947422870046,0.00971987370871148,0.150423276231385,0.188525181169534,1.86568842882704e-67
NMR metabolomics,X23412.Phospholipids in VLDL,STAT2,Signal transducer and activator of transcription 2,37598,0.122623235576761,0.00702982107527814,0.108844786269216,0.136401684884306,2.21723268668694e-67
NMR metabolomics,X23412.Phospholipids in VLDL,ISM1,Isthmin-1,40341,0.062048157607366,0.00356330839019371,0.0550640731625863,0.0690322420521457,2.76544584487484e-67
NMR metabolomics,X23412.Phospholipids in VLDL,TIA1,Nucleolysin TIA-1 isoform p40,39836,0.191560086543923,0.0110003145685049,0.169999469989654,0.213120703098193,2.84910136181944e-67
NMR metabolomics,X23412.Phospholipids in VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,0.171480523409094,0.00984310604910021,0.152188035552858,0.190773011265331,3.0804337024776e-67
NMR metabolomics,X23412.Phospholipids in VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,0.0735335936510105,0.00422115890661278,0.0652601221940494,0.0818070651079716,3.27550853251789e-67
NMR metabolomics,X23412.Phospholipids in VLDL,GH1,Somatotropin,40330,-0.277897528440788,0.0159916208329252,-0.309241105273322,-0.246553951608255,5.07381649874413e-67
NMR metabolomics,X23412.Phospholipids in VLDL,LYN,Tyrosine-protein kinase Lyn,40305,0.132923318573117,0.00766691794826483,0.117896159394518,0.147950477751716,1.0149626454817e-66
NMR metabolomics,X23412.Phospholipids in VLDL,PSIP1,PC4 and SFRS1-interacting protein,40341,0.0981523267525638,0.00566426041147247,0.0870503763460778,0.10925427715905,1.17769987264802e-66
NMR metabolomics,X23412.Phospholipids in VLDL,PON3,Serum paraoxonase/lactonase 3,40422,-0.0433410471704534,0.00250138153283875,-0.0482437549748174,-0.0384383393660895,1.19999764641008e-66
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,0.126725053399088,0.00731958855655015,0.11237865982825,0.141071446969926,1.52672440235222e-66
NMR metabolomics,X23412.Phospholipids in VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,0.0880846046348136,0.00508733980956296,0.0781134186080702,0.098055790661557,1.53239490779026e-66
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP3,Metalloproteinase inhibitor 3,40422,0.208484238173088,0.0120441055753802,0.184877791245343,0.232090685100834,1.59760888550703e-66
NMR metabolomics,X23412.Phospholipids in VLDL,CDNF,Cerebral dopamine neurotrophic factor,40305,0.0512315230201037,0.00296095803754188,0.0454280452665216,0.0570350007736858,1.84081104414499e-66
NMR metabolomics,X23412.Phospholipids in VLDL,PDLIM5,PDZ and LIM domain protein 5,37959,0.186946902823802,0.0108166478014715,0.165746273132918,0.208147532514686,3.23738874252304e-66
NMR metabolomics,X23412.Phospholipids in VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,0.125126121512666,0.00724130533576385,0.110933163054569,0.139319079970764,3.45054183789851e-66
NMR metabolomics,X23412.Phospholipids in VLDL,NAGK,N-acetyl-D-glucosamine kinase,37608,0.0894201040269485,0.0051748597356047,0.0792773789451633,0.0995628291087337,3.58900284489589e-66
NMR metabolomics,X23412.Phospholipids in VLDL,MPHOSPH8,M-phase phosphoprotein 8,40042,0.117844266492489,0.00682605218626069,0.104465204207418,0.131223328777559,3.62483836101321e-66
NMR metabolomics,X23412.Phospholipids in VLDL,GAS6,Growth arrest-specific protein 6,40429,-0.0405187803413835,0.00234811233814275,-0.0451210805241433,-0.0359164801586237,4.01475503474054e-66
NMR metabolomics,X23412.Phospholipids in VLDL,SH2B3,SH2B adapter protein 3,39980,0.153882158875678,0.00892151642958911,0.136395986673683,0.171368331077673,4.74050099724481e-66
NMR metabolomics,X23412.Phospholipids in VLDL,GORASP2,Golgi reassembly-stacking protein 2,37901,0.0738276600564997,0.00428326467259061,0.0654324612982221,0.0822228588147773,7.22232941349731e-66
NMR metabolomics,X23412.Phospholipids in VLDL,CSNK2A1,Casein kinase II subunit alpha,37959,-0.0713783792753236,0.0041413086889553,-0.079495344305676,-0.0632614142449713,7.24591440042566e-66
NMR metabolomics,X23412.Phospholipids in VLDL,FLT4,Vascular endothelial growth factor receptor 3,40411,0.0523262720215304,0.00303867240490725,0.0463704741079122,0.0582820699351486,7.38264817736394e-66
NMR metabolomics,X23412.Phospholipids in VLDL,APPL2,DCC-interacting protein 13-beta,37671,0.175746851350494,0.0102051063127131,0.155744842977576,0.195748859723411,9.5452823991534e-66
NMR metabolomics,X23412.Phospholipids in VLDL,BAG4,BAG family molecular chaperone regulator 4,37598,0.0766683357255948,0.00445334675076143,0.0679397760941024,0.0853968953570872,1.05823438894052e-65
NMR metabolomics,X23412.Phospholipids in VLDL,CD22,B-cell receptor CD22,40516,0.064378561275654,0.00374458401826944,0.0570391765998459,0.0717179459514621,1.16956573906913e-65
NMR metabolomics,X23412.Phospholipids in VLDL,CNST,Consortin,40359,0.169338544746058,0.00984915620108474,0.150034198591932,0.188642890900184,1.17000080425883e-65
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RL2,Interleukin-1 receptor-like 2,40044,0.0636447424218619,0.00370148165452075,0.0563898383790013,0.0708996464647226,1.17827948925831e-65
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,0.131677003100358,0.00766958536764267,0.116644615779779,0.146709390420938,1.77054918138439e-65
NMR metabolomics,X23412.Phospholipids in VLDL,DDHD2,Phospholipase DDHD2,37959,0.103753288385002,0.00604909024936633,0.0918970714962441,0.11560950527376,2.98308586307914e-65
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA4D,Semaphorin-4D,40471,0.0466945450973995,0.0027268690049371,0.0413498818477228,0.0520392083470763,3.74241703649976e-65
NMR metabolomics,X23412.Phospholipids in VLDL,HS1BP3,HCLS1-binding protein 3,37628,0.140131272127325,0.00817547289224078,0.124107345258533,0.156155198996117,3.76120443993541e-65
NMR metabolomics,X23412.Phospholipids in VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,0.230900832569808,0.0134775040935445,0.204484924546461,0.257316740593155,4.17496740780098e-65
NMR metabolomics,X23412.Phospholipids in VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,0.133958858426725,0.00781920355459923,0.11863321945971,0.149284497393739,4.32570617522919e-65
NMR metabolomics,X23412.Phospholipids in VLDL,OPHN1,Oligophrenin-1,37942,0.167303450408806,0.00976802948610382,0.148158112616042,0.186448788201569,4.49380560509879e-65
NMR metabolomics,X23412.Phospholipids in VLDL,DBNL,Drebrin-like protein,40422,0.144139163970914,0.0084277933680091,0.127620688969616,0.160657638972211,5.35714760529847e-65
NMR metabolomics,X23412.Phospholipids in VLDL,CASC3,Protein CASC3,37572,0.0642018769647237,0.00375035109523825,0.0568511888180568,0.0715525651113907,5.44053160114438e-65
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE4,Ribonuclease 4,37575,0.0427070199715014,0.00250061639809729,0.0378058118312307,0.0476082281117721,1.0696042805355e-64
NMR metabolomics,X23412.Phospholipids in VLDL,TWF2,Twinfilin-2,37998,0.129152781565122,0.007579876602201,0.114296223424808,0.144009339705436,1.97967859649072e-64
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF3,Immunoglobulin superfamily member 3,40305,0.0537219756930546,0.00315696190484012,0.047534330359568,0.0599096210265413,2.29023588101231e-64
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA11,Annexin A11,40312,0.104723955887238,0.00615524229011301,0.0926596809986166,0.11678823077586,2.41520820660646e-64
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,0.0430033970026259,0.00253182363427341,0.03804102267945,0.0479657713258018,3.90430110368268e-64
NMR metabolomics,X23412.Phospholipids in VLDL,HAO1,Hydroxyacid oxidase 1,40489,0.202324268285954,0.0119161684782194,0.178968578068644,0.225679958503264,4.26598990070304e-64
NMR metabolomics,X23412.Phospholipids in VLDL,TAX1BP1,Tax1-binding protein 1,37942,0.099546965408598,0.00586281569480646,0.0880558466467773,0.111038084170419,5.38632163493085e-64
NMR metabolomics,X23412.Phospholipids in VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,0.108660132159977,0.00640718718866026,0.0961020452702031,0.121218219049751,7.82782566772628e-64
NMR metabolomics,X23412.Phospholipids in VLDL,TXNDC5,Thioredoxin domain-containing protein 5,40471,0.103737957188264,0.00612564027560657,0.091731702248075,0.115744212128453,8.90342876840425e-64
NMR metabolomics,X23412.Phospholipids in VLDL,BRAP,BRCA1-associated protein,37778,0.16959285144197,0.0100067020888619,0.149979715347801,0.18920598753614,9.26717442301611e-64
NMR metabolomics,X23412.Phospholipids in VLDL,SPART,Spartin,37671,0.119504683637845,0.00705853044585352,0.105669963963972,0.133339403311718,1.25297723574789e-63
NMR metabolomics,X23412.Phospholipids in VLDL,CHMP1A,Charged multivesicular body protein 1a,40228,0.122918004209234,0.00726676277922581,0.108675149161951,0.137160859256516,1.26608193298993e-63
NMR metabolomics,X23412.Phospholipids in VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,37598,0.139052358845306,0.0082270007868358,0.122927437303108,0.155177280387504,2.03159383500115e-63
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM5,Tripartite motif-containing protein 5,40341,0.131377833452168,0.00778089239572847,0.11612728435654,0.146628382547796,2.08275150788506e-63
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD1,Sushi domain-containing protein 1,40042,0.0759451765269226,0.00450052907320399,0.0671241395434427,0.0847662135104024,2.5177284730304e-63
NMR metabolomics,X23412.Phospholipids in VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,0.0786489867400807,0.00465882198321608,0.0695176956529772,0.0877802778271842,2.74608963270958e-63
NMR metabolomics,X23412.Phospholipids in VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,39961,0.0412352309767883,0.00244510483629831,0.0364428254976436,0.046027636455933,3.00892757593299e-63
NMR metabolomics,X23412.Phospholipids in VLDL,CST3,Cystatin-C,40372,0.0431946868963059,0.00256396970752694,0.0381693062695531,0.0482200675230587,3.90002287267518e-63
NMR metabolomics,X23412.Phospholipids in VLDL,COCH,Cochlin,37990,0.0718782400854175,0.0042668755588939,0.0635151639899854,0.0802413161808495,4.94663044594511e-63
NMR metabolomics,X23412.Phospholipids in VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,0.0684333689981735,0.00406746730275634,0.060461133084771,0.0764056049115759,5.82005926376434e-63
NMR metabolomics,X23412.Phospholipids in VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,0.0940410868400122,0.0055918669782079,0.0830810275627247,0.1050011461173,6.36421075429812e-63
NMR metabolomics,X23412.Phospholipids in VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,0.0901857461252517,0.00535887908701947,0.0796823431146935,0.10068914913581,6.72245430866816e-63
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,0.126888095662535,0.00754339366772389,0.112103044073796,0.141673147251273,7.49761507754795e-63
NMR metabolomics,X23412.Phospholipids in VLDL,OGA,Protein O-GlcNAcase,37901,0.107931249990975,0.00642112646981842,0.0953458421101311,0.120516657871819,9.1892542477e-63
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R2,Protein phosphatase inhibitor 2,40359,0.121672819591179,0.00724521609022184,0.107472196054345,0.135873443128014,9.44328620667121e-63
NMR metabolomics,X23412.Phospholipids in VLDL,A1BG,Alpha-1B-glycoprotein,38013,0.0269102278129356,0.00160265271838244,0.023769028484906,0.0300514271409652,1.21660582141409e-62
NMR metabolomics,X23412.Phospholipids in VLDL,GTPBP2,GTP-binding protein 2,37572,0.122722338845203,0.00731125887992219,0.108392271440555,0.13705240624985,1.40172295093851e-62
NMR metabolomics,X23412.Phospholipids in VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,0.110277603100219,0.00658882329992301,0.0973635094323702,0.123191696768068,2.40523449177659e-62
NMR metabolomics,X23412.Phospholipids in VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,40350,0.0755212286434335,0.0045138179463541,0.0666741454685794,0.0843683118182875,2.65161982793718e-62
NMR metabolomics,X23412.Phospholipids in VLDL,NSFL1C,NSFL1 cofactor p47,40471,0.101940707734262,0.00609465344827224,0.0899951869756481,0.113886228492875,2.84719062769929e-62
NMR metabolomics,X23412.Phospholipids in VLDL,C3,Complement C3,37360,0.0720053824132559,0.00430589960459564,0.0635658191882485,0.0804449456382634,4.04306251922132e-62
NMR metabolomics,X23412.Phospholipids in VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,40470,0.0932381253283604,0.00559148050856559,0.0822788235315719,0.104197427125149,6.62027519442718e-62
NMR metabolomics,X23412.Phospholipids in VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,37863,0.066267425805073,0.00397202357733634,0.0584822595934938,0.0740525920166522,7.24991787409053e-62
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT5,ADP-sugar pyrophosphatase,40332,0.0794952281878754,0.00477004393377122,0.0701459420776838,0.088844514298067,7.82246922695571e-62
NMR metabolomics,X23412.Phospholipids in VLDL,CRADD,Death domain-containing protein CRADD,40192,0.116719742823341,0.00700718937159744,0.10298565165501,0.130453833991672,9.07192597416822e-62
NMR metabolomics,X23412.Phospholipids in VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,0.0946592051224,0.0056827212600168,0.0835210714527671,0.105797338792033,1.14985049008515e-61
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,0.0666790433558632,0.00401054749376685,0.0588183702680802,0.0745397164436462,1.53164777879293e-61
NMR metabolomics,X23412.Phospholipids in VLDL,SH3GLB2,Endophilin-B2,37942,0.101771266805395,0.00612519963735323,0.0897658755161827,0.113776658094607,2.20221898095886e-61
NMR metabolomics,X23412.Phospholipids in VLDL,CCL11,Eotaxin,40516,0.0570569126279631,0.00344069210196105,0.0503131561081194,0.0638006691478068,2.98763750708144e-61
NMR metabolomics,X23412.Phospholipids in VLDL,RBM17,Splicing factor 45,37959,0.115848590496801,0.00698072153203527,0.102166376294012,0.12953080469959,3.03131188076758e-61
NMR metabolomics,X23412.Phospholipids in VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,0.16737357414101,0.0100982082518261,0.14758108596743,0.187166062314589,3.45080447255207e-61
NMR metabolomics,X23412.Phospholipids in VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,0.0584792803219932,0.00352847418221035,0.0515634709248609,0.0653950897191255,3.54077980831624e-61
NMR metabolomics,X23412.Phospholipids in VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,37959,0.10357958637695,0.0062485083948142,0.0913325099231138,0.115826662830785,4.1202673870096e-61
NMR metabolomics,X23412.Phospholipids in VLDL,DGKA,Diacylglycerol kinase alpha,37598,0.0824435033225079,0.00497658096733942,0.0726894046265227,0.0921976020184932,5.06776543792764e-61
NMR metabolomics,X23412.Phospholipids in VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,0.0874898300950075,0.00528497283451612,0.077131283339356,0.0978483768506591,5.95451075891312e-61
NMR metabolomics,X23412.Phospholipids in VLDL,UBXN1,UBX domain-containing protein 1,37671,0.104634437579621,0.00632394981245485,0.092239495947209,0.117029379212032,7.02667595467827e-61
NMR metabolomics,X23412.Phospholipids in VLDL,MAX,Protein max,39961,0.157941228714953,0.00955426484745378,0.139214869613944,0.176667587815962,7.28023889450442e-61
NMR metabolomics,X23412.Phospholipids in VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,0.135252356730213,0.00818265617788185,0.119214350621565,0.151290362838862,7.30865217173097e-61
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS8,Galectin-8,40471,0.0911940599080759,0.00552319087012979,0.0803686058026215,0.10201951401353,9.68920554109196e-61
NMR metabolomics,X23412.Phospholipids in VLDL,MUC13,Mucin-13,39961,0.0757357088479839,0.0045925879512762,0.0667342364634826,0.0847371812324853,1.39899709791956e-60
NMR metabolomics,X23412.Phospholipids in VLDL,ST13,Hsc70-interacting protein,37671,0.0860608790948345,0.00521508927714625,0.0758393041116278,0.0962824540780411,1.42370054437834e-60
NMR metabolomics,X23412.Phospholipids in VLDL,ICA1,Islet cell autoantigen 1,40044,0.119491821095308,0.0072478644574533,0.105286006758699,0.133697635431916,1.49269688217258e-60
NMR metabolomics,X23412.Phospholipids in VLDL,IFNLR1,Interferon lambda receptor 1,40341,0.0564064930569338,0.00342221609472977,0.0496989495112634,0.0631140366026041,1.55971979019472e-60
NMR metabolomics,X23412.Phospholipids in VLDL,RWDD1,RWD domain-containing protein 1,40471,0.0970602246623676,0.00588970734275345,0.0855163982705708,0.108604051054164,1.61762415376325e-60
NMR metabolomics,X23412.Phospholipids in VLDL,MAMDC4,Apical endosomal glycoprotein,37900,0.082405997213604,0.00499761839909669,0.0726106651513745,0.0922013292758335,1.72378382354527e-60
NMR metabolomics,X23412.Phospholipids in VLDL,PGF,Placenta growth factor,40516,0.0395186804817272,0.00240101920491783,0.0348126828400883,0.0442246781233662,2.25045676442614e-60
NMR metabolomics,X23412.Phospholipids in VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,0.0952530060604161,0.00578504177837307,0.0839143241748049,0.106591687946027,2.58887216814591e-60
NMR metabolomics,X23412.Phospholipids in VLDL,PRKG1,cGMP-dependent protein kinase 1,37671,0.188658231901287,0.0114580100060246,0.166200532289479,0.211115931513095,2.59783265727505e-60
NMR metabolomics,X23412.Phospholipids in VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,0.131143957854901,0.00797324022815971,0.115516407007707,0.146771508702094,2.71849273867526e-60
NMR metabolomics,X23412.Phospholipids in VLDL,MAP2,Microtubule-associated protein 2,37942,0.0689819349223136,0.00419472389709228,0.0607602760840127,0.0772035937606145,3.50860828544271e-60
NMR metabolomics,X23412.Phospholipids in VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,0.117268471034477,0.00713623493370498,0.103281450564416,0.131255491504539,3.52038553276826e-60
NMR metabolomics,X23412.Phospholipids in VLDL,TALDO1,Transaldolase,37966,0.0671930932100497,0.0040861690412904,0.0591842018891205,0.0752019845309788,3.55150178496266e-60
NMR metabolomics,X23412.Phospholipids in VLDL,DOK1,Docking protein 1,37942,0.204901390885767,0.0124698719571983,0.180460441849658,0.229342339921876,4.34460105850868e-60
NMR metabolomics,X23412.Phospholipids in VLDL,KIFBP,KIF-binding protein,40305,0.123688912595575,0.00753421200212811,0.108921857071404,0.138455968119746,4.52682582970741e-60
NMR metabolomics,X23412.Phospholipids in VLDL,MMP10,Stromelysin-2,40341,-0.0898456204755662,0.00547875008114575,-0.100583970634612,-0.0791072703165205,6.04733326561064e-60
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,0.132836976374003,0.00810077275183309,0.116959461780411,0.148714490967596,6.354141646265e-60
NMR metabolomics,X23412.Phospholipids in VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,0.0849286831048129,0.00518043938534775,0.0747750219095314,0.0950823443000945,6.53823619386886e-60
NMR metabolomics,X23412.Phospholipids in VLDL,TRAF2,TNF receptor-associated factor 2,40341,0.106490588326976,0.00651080641077977,0.0937294077618479,0.119251768892105,1.21088179269479e-59
NMR metabolomics,X23412.Phospholipids in VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,0.0738349135070171,0.00451614535911113,0.0649832686031593,0.0826865584108749,1.70995273493429e-59
NMR metabolomics,X23412.Phospholipids in VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,0.136596428915773,0.00839003550611097,0.120151959323795,0.15304089850775,4.15109513043582e-59
NMR metabolomics,X23412.Phospholipids in VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,0.116572478878619,0.00716545569389579,0.102528185718584,0.130616772038655,5.06530965685487e-59
NMR metabolomics,X23412.Phospholipids in VLDL,VWA1,von Willebrand factor A domain-containing protein 1,40453,0.0624202220624816,0.00383867391179905,0.0548964211953555,0.0699440229296078,5.5552636230495e-59
NMR metabolomics,X23412.Phospholipids in VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,0.125570293060161,0.00773512698781247,0.110409444164048,0.140731141956273,8.86624195572815e-59
NMR metabolomics,X23412.Phospholipids in VLDL,PARP1,Poly [ADP-ribose] polymerase 1,40341,0.0802128967742062,0.00495187091168967,0.0705072297872944,0.0899185637611179,1.52101270110753e-58
NMR metabolomics,X23412.Phospholipids in VLDL,GMPR2,GMP reductase 2,37671,0.100644603597892,0.00620825913923918,0.0884764156849834,0.112812791510801,1.53547760615444e-58
NMR metabolomics,X23412.Phospholipids in VLDL,RAB27B,Ras-related protein Rab-27B,37990,0.121441392146419,0.00751001932018282,0.106721754278861,0.136161030013978,2.85612949524048e-58
NMR metabolomics,X23412.Phospholipids in VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,0.051887187861846,0.00320872119542187,0.0455980943188191,0.0581762814048729,3.0204030429687e-58
NMR metabolomics,X23412.Phospholipids in VLDL,TDRKH,Tudor and KH domain-containing protein,39961,0.12570308801651,0.00778170885271988,0.110450938665179,0.140955237367841,3.19496270329097e-58
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS8,Prostasin,40293,0.0595321503053794,0.00369186261305871,0.0522960995837844,0.0667682010269745,4.91350859266442e-58
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINC1,Antithrombin-III,37981,0.0216745905737764,0.00134829974471923,0.0190319230741267,0.0243172580734261,1.29382261138987e-57
NMR metabolomics,X23412.Phospholipids in VLDL,AMN,Protein amnionless,40044,0.0699990169324247,0.00435732419517027,0.0614586615098909,0.0785393723549584,1.30810087104062e-57
NMR metabolomics,X23412.Phospholipids in VLDL,NUB1,NEDD8 ultimate buster 1,40341,0.12264880326227,0.00763771783132377,0.107678876312876,0.137618730211665,1.41910554263782e-57
NMR metabolomics,X23412.Phospholipids in VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,0.111205573860923,0.00692690990572581,0.0976288304457,0.124782317276145,1.5220810231903e-57
NMR metabolomics,X23412.Phospholipids in VLDL,GMPR,GMP reductase 1,40516,0.0749022672112795,0.00466822661866057,0.0657525430387047,0.0840519913838542,1.72953139922478e-57
NMR metabolomics,X23412.Phospholipids in VLDL,TP53,Cellular tumor antigen p53,39980,0.0631746762087755,0.0039418853119917,0.0554485809972718,0.0709007714202793,2.4052509045526e-57
NMR metabolomics,X23412.Phospholipids in VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,0.0670456182136567,0.00418729622627007,0.0588385176101674,0.0752527188171461,2.97213727388347e-57
NMR metabolomics,X23412.Phospholipids in VLDL,MMP7,Matrilysin,40015,0.0706720897368977,0.00441620055246918,0.0620163366540581,0.0793278428197373,3.48510516886308e-57
NMR metabolomics,X23412.Phospholipids in VLDL,MAVS,Mitochondrial antiviral-signaling protein,39980,0.135616035953027,0.00848561397276641,0.118984232566405,0.152247839339649,4.87028743349535e-57
NMR metabolomics,X23412.Phospholipids in VLDL,MOCS2,Molybdopterin synthase catalytic subunit,37671,0.0985069059294459,0.00615929181515039,0.0864346939717512,0.110579117887141,4.88000627265695e-57
NMR metabolomics,X23412.Phospholipids in VLDL,YJU2,Splicing factor YJU2,37900,0.0468613809590074,0.00293228293017513,0.0411141064158642,0.0526086555021507,5.77680667726669e-57
NMR metabolomics,X23412.Phospholipids in VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,40305,0.0820222964822146,0.00513683950246207,0.0719540910573889,0.0920905019070402,5.98582764356805e-57
NMR metabolomics,X23412.Phospholipids in VLDL,PSME1,Proteasome activator complex subunit 1,40216,0.0550866987743742,0.00345115583159552,0.048322433344447,0.0618509642043014,6.58138104791674e-57
NMR metabolomics,X23412.Phospholipids in VLDL,CETN3,Centrin-3,37901,0.112193799001349,0.00702837285566576,0.0984181882042441,0.125969409798454,7.69301156738367e-57
NMR metabolomics,X23412.Phospholipids in VLDL,CRELD1,Protein disulfide isomerase CRELD1,37671,0.0549611312401361,0.00344582630990147,0.0482073116727292,0.061714950807543,9.62224633109789e-57
NMR metabolomics,X23412.Phospholipids in VLDL,NUDC,Nuclear migration protein nudC,40516,0.0920924385928753,0.00578456000268234,0.080754700987618,0.103430176198133,1.24021246094704e-56
NMR metabolomics,X23412.Phospholipids in VLDL,MPI,Mannose-6-phosphate isomerase,40305,0.125076047564591,0.00785676554094795,0.109676787104333,0.140475308024849,1.27359569910576e-56
NMR metabolomics,X23412.Phospholipids in VLDL,PYY,Peptide YY,37562,0.138790613210794,0.00871274197056801,0.121713638948481,0.155867587473107,1.33968134200497e-56
NMR metabolomics,X23412.Phospholipids in VLDL,SPRY2,Protein sprouty homolog 2,40044,0.133996838250416,0.00842337093653701,0.117487031214804,0.150506645286029,1.55877981867829e-56
NMR metabolomics,X23412.Phospholipids in VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,0.0387751607964436,0.00243804999344996,0.0339965828092817,0.0435537387836055,1.61412822891345e-56
NMR metabolomics,X23412.Phospholipids in VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,0.11132820298598,0.00700344357254325,0.0976014535837952,0.125054952388165,1.87628518508697e-56
NMR metabolomics,X23412.Phospholipids in VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,0.140704479088316,0.00884812924971716,0.12336214575887,0.158046812417762,1.99135295571314e-56
NMR metabolomics,X23412.Phospholipids in VLDL,OTUD6B,Deubiquitinase OTUD6B,37901,0.0856646107932535,0.00539080085858276,0.0750986411104313,0.0962305804760757,2.38486346974335e-56
NMR metabolomics,X23412.Phospholipids in VLDL,BPIFB2,BPI fold-containing family B member 2,37951,0.0988514355010502,0.00622240825137789,0.0866555153283495,0.111047355673751,2.54893248554715e-56
NMR metabolomics,X23412.Phospholipids in VLDL,SELE,E-selectin,40536,0.0725324150399537,0.00456958050218955,0.0635760372556622,0.0814887928242452,2.61291273136753e-56
NMR metabolomics,X23412.Phospholipids in VLDL,ATOX1,Copper transport protein ATOX1,40411,0.104120637413614,0.00656174538198086,0.0912596164649312,0.116981658362296,2.8502354393928e-56
NMR metabolomics,X23412.Phospholipids in VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,0.0717331173668831,0.00451725025282105,0.0628793068713538,0.0805869278624123,2.88289218600616e-56
NMR metabolomics,X23412.Phospholipids in VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,0.122174873275787,0.00769411472837576,0.107094408408171,0.137255338143404,2.93113632861162e-56
NMR metabolomics,X23412.Phospholipids in VLDL,PXN,Paxillin,39961,0.0750793973839272,0.00473606299180955,0.0657967139199805,0.084362080847874,3.71661225867831e-56
NMR metabolomics,X23412.Phospholipids in VLDL,GYS1,"Glycogen [starch] synthase, muscle",40042,0.134868137306278,0.00851279882929719,0.118183051600855,0.1515532230117,4.30494345209098e-56
NMR metabolomics,X23412.Phospholipids in VLDL,C2,Complement C2,40372,0.0347335542188593,0.00219260849006792,0.0304360415783262,0.0390310668593924,4.33620349924401e-56
NMR metabolomics,X23412.Phospholipids in VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,0.151202670037577,0.00956723911505377,0.132450881372072,0.169954458703083,7.74773015354245e-56
NMR metabolomics,X23412.Phospholipids in VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,0.111832282921966,0.0070861177527163,0.0979434921266424,0.12572107371729,1.09847480426796e-55
NMR metabolomics,X23412.Phospholipids in VLDL,DLG4,Disks large homolog 4,37942,0.101302987680835,0.00641827975526725,0.0887231593605111,0.113882816001159,1.2701379564588e-55
NMR metabolomics,X23412.Phospholipids in VLDL,GOLGA3,Golgin subfamily A member 3,37959,0.113178519186027,0.00717423995382197,0.0991170088765357,0.127240029495518,1.43261707247572e-55
NMR metabolomics,X23412.Phospholipids in VLDL,VASP,Vasodilator-stimulated phosphoprotein,37987,0.104221877053908,0.00660958430419969,0.0912670918176762,0.117176662290139,1.60320879745992e-55
NMR metabolomics,X23412.Phospholipids in VLDL,GP1BB,Platelet glycoprotein Ib beta chain,37562,0.0977942309781729,0.0062065360840703,0.0856294202533951,0.109959041702951,1.99220526195312e-55
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4G,C-type lectin domain family 4 member G,40341,0.0474058040148171,0.00301412205223906,0.0414981247924286,0.0533134832372057,2.54510784166575e-55
NMR metabolomics,X23412.Phospholipids in VLDL,PALM2,Paralemmin-2,37942,0.0532082188090755,0.00338481095854027,0.0465739893303366,0.0598424482878145,3.42127538549346e-55
NMR metabolomics,X23412.Phospholipids in VLDL,PF4,Platelet factor 4,37934,0.139678329638142,0.0089123434158498,0.122210136543076,0.157146522733207,7.11238308772779e-55
NMR metabolomics,X23412.Phospholipids in VLDL,CD244,Natural killer cell receptor 2B4,40516,0.0381551597546581,0.00243710876485698,0.0333784265755384,0.0429318929337778,7.69709114503056e-55
NMR metabolomics,X23412.Phospholipids in VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,0.0903610943819478,0.00577348576643364,0.0790450622797379,0.101677126484158,8.31210508654367e-55
NMR metabolomics,X23412.Phospholipids in VLDL,GRAP2,GRB2-related adapter protein 2,40359,0.181474135663332,0.0116058201593587,0.158726728150989,0.204221543175675,1.04923812272313e-54
NMR metabolomics,X23412.Phospholipids in VLDL,STIP1,Stress-induced-phosphoprotein 1,40307,0.0935869527171188,0.0059928726806914,0.0818409222629637,0.105332983171274,1.43577185488064e-54
NMR metabolomics,X23412.Phospholipids in VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,0.0831721529507661,0.00533046005601658,0.0727244512409736,0.0936198546605586,1.74915585439087e-54
NMR metabolomics,X23412.Phospholipids in VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,0.12219023479158,0.00783706081171706,0.106829595600614,0.137550873982545,2.15434996744502e-54
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,0.114362235574997,0.00733462473079628,0.0999863711026363,0.128738100047358,2.4498116282238e-54
NMR metabolomics,X23412.Phospholipids in VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,37598,0.082248765961173,0.00527791870848668,0.0719040452925392,0.0925934866298069,2.87737008146206e-54
NMR metabolomics,X23412.Phospholipids in VLDL,CD5,T-cell surface glycoprotein CD5,40470,0.0476080623991478,0.00305901377741625,0.0416123953954119,0.0536037294028836,3.22883479800796e-54
NMR metabolomics,X23412.Phospholipids in VLDL,PKD2,Polycystin-2,37562,0.0850708638990412,0.00546797490218319,0.0743536330907622,0.0957880947073203,4.27150968853769e-54
NMR metabolomics,X23412.Phospholipids in VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,0.0679845076195822,0.00437057982658971,0.0594181711594663,0.076550844079698,4.35003517159749e-54
NMR metabolomics,X23412.Phospholipids in VLDL,FST,Follistatin,40396,0.0738854649078097,0.00475451221256589,0.0645666209711805,0.0832043088444388,4.62818744324263e-54
NMR metabolomics,X23412.Phospholipids in VLDL,FAM172A,Cotranscriptional regulator FAM172A,37628,0.0879171305594499,0.00566041766604194,0.0768227119340077,0.0990115491848921,6.33810185625535e-54
NMR metabolomics,X23412.Phospholipids in VLDL,TMED8,Protein TMED8,37901,0.14603730446985,0.0094047808857227,0.127603933933834,0.164470675005867,6.58448922580767e-54
NMR metabolomics,X23412.Phospholipids in VLDL,CACYBP,Calcyclin-binding protein,37642,0.145812316226435,0.0093926139377629,0.12740279290842,0.16422183954445,7.13053888972662e-54
NMR metabolomics,X23412.Phospholipids in VLDL,ELOA,Elongin-A,40305,0.0723905794981693,0.00467018429399922,0.0632370182819308,0.0815441407144078,8.52971167022446e-54
NMR metabolomics,X23412.Phospholipids in VLDL,HSPA1A,Heat shock 70 kDa protein 1A,40400,0.100875215211567,0.00652129460605387,0.0880934777837011,0.113656952639432,1.38504288491697e-53
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,0.0420682933808863,0.00272063328891955,0.036735852134604,0.0474007346271686,1.51773468583002e-53
NMR metabolomics,X23412.Phospholipids in VLDL,CD69,Early activation antigen CD69,40288,0.124127095766266,0.00804683150673782,0.10835530601306,0.139898885519472,2.68881967792727e-53
NMR metabolomics,X23412.Phospholipids in VLDL,RRAS,Ras-related protein R-Ras,37572,0.184200504316076,0.0119581768038614,0.160762477780508,0.207638530851645,4.49954965107917e-53
NMR metabolomics,X23412.Phospholipids in VLDL,SRP14,Signal recognition particle 14 kDa protein,40305,0.0834820446076799,0.00543272159289633,0.0728339102856031,0.0941301789297567,6.60510298888573e-53
NMR metabolomics,X23412.Phospholipids in VLDL,YWHAQ,14-3-3 protein theta,37671,0.103904612864485,0.00676129105547055,0.0906524823957627,0.117156743333207,7.72827752028446e-53
NMR metabolomics,X23412.Phospholipids in VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,0.120260318909512,0.00782835790833882,0.104916737409168,0.135603900409856,8.20785102478662e-53
NMR metabolomics,X23412.Phospholipids in VLDL,IGBP1,Immunoglobulin-binding protein 1,37959,0.0861432267171019,0.00561009562084065,0.0751474393002542,0.0971390141339496,9.1407023949839e-53
NMR metabolomics,X23412.Phospholipids in VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,0.095933908022564,0.0062523352084273,0.0836793310140465,0.108188485031082,1.11832871966641e-52
NMR metabolomics,X23412.Phospholipids in VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,0.135214886403079,0.00882070850522917,0.11792629773283,0.152503475073328,1.16102657241856e-52
NMR metabolomics,X23412.Phospholipids in VLDL,TBCB,Tubulin-folding cofactor B,40228,0.142007824112623,0.00926365620729555,0.123851057946323,0.160164590278922,1.16269856171346e-52
NMR metabolomics,X23412.Phospholipids in VLDL,NIT1,Deaminated glutathione amidase,37628,0.0696767010578633,0.0045455048884632,0.0607675114764754,0.0785858906392512,1.39681220320082e-52
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH9,Protocadherin-9,37901,0.0475091619997799,0.00309983337163013,0.0414334885913849,0.053584835408175,1.4172373338046e-52
NMR metabolomics,X23412.Phospholipids in VLDL,LPP,Lipoma-preferred partner,37562,0.0943454866745726,0.00616175741622362,0.0822684421387743,0.106422531210371,1.82223130567114e-52
NMR metabolomics,X23412.Phospholipids in VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",40411,0.0859128147333194,0.00561991077080553,0.0748977896225405,0.0969278398440982,2.18666129803604e-52
NMR metabolomics,X23412.Phospholipids in VLDL,MSR1,Macrophage scavenger receptor types I and II,40471,0.0625236532210346,0.00409481509923066,0.0544978156265425,0.0705494908155267,2.87208063756487e-52
NMR metabolomics,X23412.Phospholipids in VLDL,BAG6,Large proline-rich protein BAG6,40042,0.050190370731545,0.00328762121050765,0.04374663315895,0.05663410830414,3.05278616298668e-52
NMR metabolomics,X23412.Phospholipids in VLDL,SPARC,SPARC,40411,0.0988141614208199,0.0064801591164103,0.0861130495526558,0.111515273288984,3.9123257891846e-52
NMR metabolomics,X23412.Phospholipids in VLDL,KRT5,"Keratin, type II cytoskeletal 5",39961,0.0682211921874803,0.00447641492997619,0.059447418924727,0.0769949654502337,4.56271014468073e-52
NMR metabolomics,X23412.Phospholipids in VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,0.0661539467768099,0.00433917081116311,0.0576491719869302,0.0746587215666896,4.76189790827542e-52
NMR metabolomics,X23412.Phospholipids in VLDL,ERP29,Endoplasmic reticulum resident protein 29,37671,0.165482423686588,0.0108576335598379,0.144201461909306,0.186763385463871,5.21735233154916e-52
NMR metabolomics,X23412.Phospholipids in VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,40044,0.0838727526628554,0.00550791760578663,0.0730772341555136,0.0946682711701971,5.48119754243822e-52
NMR metabolomics,X23412.Phospholipids in VLDL,DFFA,DNA fragmentation factor subunit alpha,40516,0.0944999302360406,0.00621486917631405,0.0823187866504651,0.106681073821616,7.46993359483044e-52
NMR metabolomics,X23412.Phospholipids in VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,0.0861857349020618,0.00566474024579373,0.0750828440203061,0.0972886257838175,7.61132113426229e-52
NMR metabolomics,X23412.Phospholipids in VLDL,GPI,Glucose-6-phosphate isomerase,37987,0.0651793964778275,0.0042926728487898,0.0567657576941995,0.0735930352614555,1.20409421515566e-51
NMR metabolomics,X23412.Phospholipids in VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,0.130456096019417,0.00861115712163583,0.113578228061011,0.147333963977823,1.74350367217419e-51
NMR metabolomics,X23412.Phospholipids in VLDL,CDCP1,CUB domain-containing protein 1,40228,0.067350125955487,0.00445030242040404,0.0586275332114951,0.0760727186994789,2.2230221560346e-51
NMR metabolomics,X23412.Phospholipids in VLDL,VAV3,Guanine nucleotide exchange factor VAV3,37541,0.138255867755357,0.00913829220000333,0.12034481504335,0.156166920467363,2.81577301632521e-51
NMR metabolomics,X23412.Phospholipids in VLDL,CTSZ,Cathepsin Z,40345,0.0429903509509139,0.00284375568238161,0.0374165898134459,0.0485641120883818,2.82368748144386e-51
NMR metabolomics,X23412.Phospholipids in VLDL,GZMA,Granzyme A,40516,0.0486967886729743,0.00322278860902506,0.0423801229992852,0.0550134543466635,3.12324476294106e-51
NMR metabolomics,X23412.Phospholipids in VLDL,MGLL,Monoglyceride lipase,40396,0.119236548577278,0.00789322286037628,0.10376583177094,0.134707265383615,3.33331856918218e-51
NMR metabolomics,X23412.Phospholipids in VLDL,NACC1,Nucleus accumbens-associated protein 1,37900,0.0761390405635658,0.00503931481750513,0.0662619835212558,0.0860160976058759,3.71262339557495e-51
NMR metabolomics,X23412.Phospholipids in VLDL,LACTB2,Endoribonuclease LACTB2,40359,0.0912631381043588,0.00604459930994987,0.0794157234568571,0.103110552751861,3.75829542384713e-51
NMR metabolomics,X23412.Phospholipids in VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,0.107642805979601,0.00712917144917697,0.0936696299392138,0.121615982019988,3.79815866559691e-51
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA4,Protein disulfide-isomerase A4,37998,0.0837322908433632,0.00554372108103729,0.0728665975245301,0.0945979841621963,3.97379286442661e-51
NMR metabolomics,X23412.Phospholipids in VLDL,NEXN,Nexilin,37987,0.0942469164599764,0.00626281401775219,0.0819718009851821,0.106522031934771,9.06589725678374e-51
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,0.0752991601595447,0.00500657772174888,0.0654862678249169,0.0851120524941725,9.10859518614374e-51
NMR metabolomics,X23412.Phospholipids in VLDL,FIS1,Mitochondrial fission 1 protein,40354,0.106265687325422,0.00706723861400776,0.0924138996419665,0.120117475008877,9.46860143627259e-51
NMR metabolomics,X23412.Phospholipids in VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,0.135995199694446,0.00904951297282598,0.118258154267707,0.153732245121185,1.09495768384078e-50
NMR metabolomics,X23412.Phospholipids in VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,0.0726665602179898,0.00483824319262953,0.0631836035604359,0.0821495168755437,1.24619783311687e-50
NMR metabolomics,X23412.Phospholipids in VLDL,EGF,Pro-epidermal growth factor,40324,0.14106069614256,0.00940261342722652,0.122631573825196,0.159489818459924,1.57462223579452e-50
NMR metabolomics,X23412.Phospholipids in VLDL,STX4,Syntaxin-4,40305,0.0820480879632422,0.00547183301951117,0.0713232952450003,0.0927728806814841,1.76605323990487e-50
NMR metabolomics,X23412.Phospholipids in VLDL,ESM1,Endothelial cell-specific molecule 1,40357,-0.0464508588434318,0.00310071696961922,-0.0525282641038855,-0.0403734535829781,2.16653613528588e-50
NMR metabolomics,X23412.Phospholipids in VLDL,PENK,Proenkephalin-A,37671,0.0423818024419523,0.00282876011978819,0.0368374326071674,0.0479261722767371,2.47376245148754e-50
NMR metabolomics,X23412.Phospholipids in VLDL,ESYT2,Extended synaptotagmin-2,37942,0.111906761599741,0.00747459545962546,0.0972565544988753,0.126556968700607,2.8502949918043e-50
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.0309362206186287,0.00206831986890215,0.0268823136755805,0.0349901275616769,3.0670089220446e-50
NMR metabolomics,X23412.Phospholipids in VLDL,DIABLO,"Diablo homolog, mitochondrial",40314,0.149953931082746,0.0100256347513019,0.130303686970195,0.169604175195298,3.08211929538527e-50
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,0.118910016536147,0.00794813438081937,0.103331673149741,0.134488359922553,3.35684360860303e-50
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM40,E3 ubiquitin ligase TRIM40,37572,0.0987270477237079,0.00659862729157128,0.0857937382322282,0.111660357215188,3.38398540890298e-50
NMR metabolomics,X23412.Phospholipids in VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,40422,0.0524046701118372,0.00350691856641719,0.0455311097216595,0.0592782305020149,3.76256295749912e-50
NMR metabolomics,X23412.Phospholipids in VLDL,PPBP,Platelet basic protein,37934,0.115031013862637,0.00769343735367722,0.0999518766494295,0.130110151075844,3.82035393722497e-50
NMR metabolomics,X23412.Phospholipids in VLDL,GLOD4,Glyoxalase domain-containing protein 4,40328,0.0497159120771814,0.00332745529330247,0.0431940997023085,0.0562377244520542,3.89933102532164e-50
NMR metabolomics,X23412.Phospholipids in VLDL,STX8,Syntaxin-8,40341,0.0667715316172528,0.00447453243748988,0.0580014480397726,0.075541615194733,5.12701575628916e-50
NMR metabolomics,X23412.Phospholipids in VLDL,IL1R2,Interleukin-1 receptor type 2,40330,0.0266644955139763,0.00178724140826036,0.023161502353786,0.0301674886741666,5.37925838036144e-50
NMR metabolomics,X23412.Phospholipids in VLDL,MESD,LRP chaperone MESD,40332,0.16529869223649,0.0110799618428273,0.143581967024548,0.187015417448431,5.43086916060359e-50
NMR metabolomics,X23412.Phospholipids in VLDL,F11,Coagulation factor XI,37810,0.0414240463653751,0.00277696117235543,0.0359812024675585,0.0468668902631918,6.4378915055689e-50
NMR metabolomics,X23412.Phospholipids in VLDL,AP2B1,AP-2 complex subunit beta,37572,0.0669207289039845,0.00448894138707516,0.0581224037853172,0.0757190540226518,7.48809535324735e-50
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.0828885169567995,0.00556750065024939,0.0719762156823107,0.0938008182312883,8.55173321606934e-50
NMR metabolomics,X23412.Phospholipids in VLDL,CASP7,Caspase-7,37942,0.114255428142062,0.00767382389513908,0.0992147333075896,0.129296122976535,9.64545028503492e-50
NMR metabolomics,X23412.Phospholipids in VLDL,CTF1,Cardiotrophin-1,40042,0.115179710556229,0.00774240741085261,0.100004592030958,0.1303548290815,1.02736296890599e-49
NMR metabolomics,X23412.Phospholipids in VLDL,STXBP1,Syntaxin-binding protein 1,37959,0.105513948605752,0.00709045965512504,0.0916166476817067,0.119411249529797,1.08165645773909e-49
NMR metabolomics,X23412.Phospholipids in VLDL,STK24,Serine/threonine-protein kinase 24,39961,0.0840965018396259,0.00565941624358596,0.0730040460021974,0.0951889576770544,1.32301901796243e-49
NMR metabolomics,X23412.Phospholipids in VLDL,CCL3,C-C motif chemokine 3,40341,0.0837400245880815,0.00563689000196443,0.0726917201842312,0.0947883289919318,1.37449767728649e-49
NMR metabolomics,X23412.Phospholipids in VLDL,GASK1A,Golgi-associated kinase 1A,37562,0.0590922930492365,0.00398193697044209,0.05128769658717,0.066896889511303,2.02975424598144e-49
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN2L,Ataxin-2-like protein,37959,0.0656411147867226,0.00442447741374027,0.0569691390557916,0.0743130905176535,2.10108890739493e-49
NMR metabolomics,X23412.Phospholipids in VLDL,HSPB1,Heat shock protein beta-1,40116,0.0920073495809517,0.00621129175056236,0.0798332177498495,0.104181481412054,2.60615601718257e-49
NMR metabolomics,X23412.Phospholipids in VLDL,CD226,CD226 antigen,37598,0.0569962348027968,0.00384763855675752,0.049454863231552,0.0645376063740415,2.9974843394617e-49
NMR metabolomics,X23412.Phospholipids in VLDL,PMVK,Phosphomevalonate kinase,39951,0.150243020892298,0.0101492208716484,0.130350547983867,0.170135493800729,3.02075458445113e-49
NMR metabolomics,X23412.Phospholipids in VLDL,GP5,Platelet glycoprotein V,37671,0.0486646661068524,0.00329306147711583,0.0422102656117053,0.0551190666019994,5.00179292121005e-49
NMR metabolomics,X23412.Phospholipids in VLDL,F2R,Proteinase-activated receptor 1,40396,0.0776352135887452,0.00525919200994764,0.0673271972492478,0.0879432299282426,5.43762690014692e-49
NMR metabolomics,X23412.Phospholipids in VLDL,CD207,C-type lectin domain family 4 member K,40029,0.0519886687480401,0.00352409089031842,0.045081450603016,0.0588958868930642,6.35277918257538e-49
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT16,U8 snoRNA-decapping enzyme,37880,0.11845361564249,0.00802702213501231,0.102720652257866,0.134186579027114,6.71067390784047e-49
NMR metabolomics,X23412.Phospholipids in VLDL,FUS,RNA-binding protein FUS,39960,0.0532568322562725,0.00361241564896257,0.0461764975843059,0.0603371669282391,7.33846155497147e-49
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL16,C-X-C motif chemokine 16,40517,0.0320641008917587,0.00217523950311284,0.0278006314656576,0.0363275703178599,7.38546499283739e-49
NMR metabolomics,X23412.Phospholipids in VLDL,EHD3,EH domain-containing protein 3,37628,0.158244564995025,0.0107397369411973,0.137194680590278,0.179294449399771,9.45257563063848e-49
NMR metabolomics,X23412.Phospholipids in VLDL,SUGT1,Protein SGT1 homolog,39980,0.109738300379332,0.00745762608653945,0.0951213532497152,0.12435524750895,1.1000704271807e-48
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB14,DnaJ homolog subfamily B member 14,37901,0.0867573236460678,0.00589320017978887,0.0752066512936817,0.098307995998454,1.12020451108138e-48
NMR metabolomics,X23412.Phospholipids in VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,0.135371105447308,0.00921540062259239,0.117308920227027,0.153433290667589,1.56253468682632e-48
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH1A1,Retinal dehydrogenase 1,40332,0.0710231477278627,0.004837735449173,0.0615411862474836,0.0805051092082418,1.77129406047638e-48
NMR metabolomics,X23412.Phospholipids in VLDL,PPP3R1,Calcineurin subunit B type 1,40228,0.0555874740078351,0.00378851205740529,0.0481619903753208,0.0630129576403495,2.01204849007219e-48
NMR metabolomics,X23412.Phospholipids in VLDL,IL7,Interleukin-7,40341,0.0866060270121051,0.00590274755053751,0.0750366418130516,0.0981754122111586,2.01582871856146e-48
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB6,Serpin B6,40433,0.080180135098727,0.0054725816118317,0.0694538751395369,0.0909063950579171,2.7203681866255e-48
NMR metabolomics,X23412.Phospholipids in VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,0.123203862870612,0.00841809217821171,0.106704402201317,0.139703323539907,3.42787904436393e-48
NMR metabolomics,X23412.Phospholipids in VLDL,THTPA,Thiamine-triphosphatase,37884,0.118940218335975,0.00812273762492306,0.103019652591126,0.134860784080824,3.51636333725698e-48
NMR metabolomics,X23412.Phospholipids in VLDL,GDF2,Growth/differentiation factor 2,40359,0.0479052685979799,0.00327405629160219,0.0414881182664396,0.0543224189295202,3.62050748900881e-48
NMR metabolomics,X23412.Phospholipids in VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,0.120557122908349,0.00823772054135832,0.104411190647287,0.136703055169411,3.92811772464865e-48
NMR metabolomics,X23412.Phospholipids in VLDL,SULT2A1,Bile salt sulfotransferase,40341,0.0713640873548912,0.00487951102108685,0.061800245753561,0.0809279289562215,3.98304411522082e-48
NMR metabolomics,X23412.Phospholipids in VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,0.139325068025826,0.00952363426005666,0.120658744876115,0.157991391175537,4.33179278793382e-48
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFA,Platelet-derived growth factor subunit A,40536,0.0961236642318315,0.00657917797505696,0.0832284754007199,0.109018853062943,4.90540516528905e-48
NMR metabolomics,X23412.Phospholipids in VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,0.0517586677381761,0.00354093084709722,0.0448184432778655,0.0586988921984866,5.08931132698385e-48
NMR metabolomics,X23412.Phospholipids in VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,0.130594330375207,0.00895053916769803,0.113051273606519,0.148137387143895,7.60083125047388e-48
NMR metabolomics,X23412.Phospholipids in VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,0.0636218735366459,0.00436745304379326,0.0550616655708111,0.0721820815024807,1.0431045769701e-47
NMR metabolomics,X23412.Phospholipids in VLDL,CERT,Ceramide transfer protein,39961,0.082064213877697,0.00563881644637959,0.071012133642793,0.093116294112601,1.14475964916136e-47
NMR metabolomics,X23412.Phospholipids in VLDL,DNM3,Dynamin-3,37959,0.0731926035105641,0.00502884763444185,0.0633360621470581,0.0830491448740701,1.25289401166604e-47
NMR metabolomics,X23412.Phospholipids in VLDL,CIAPIN1,Anamorsin,40411,0.0850047038639634,0.00584525270713551,0.0735480085579779,0.096461399169949,1.31336168889628e-47
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINE2,Glia-derived nexin,37990,0.0857034849643675,0.00589113025783159,0.0741568696590176,0.0972501002697174,1.37641606399034e-47
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,0.0766919402132595,0.00527617842714201,0.0663506304960612,0.0870332499304579,1.46477667819172e-47
NMR metabolomics,X23412.Phospholipids in VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,0.076883257922895,0.0052866193850535,0.0665214839281901,0.0872450319175998,1.48492838379115e-47
NMR metabolomics,X23412.Phospholipids in VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,0.0976472422598611,0.00671845817271194,0.0844790642413456,0.110815420278376,1.70515746197577e-47
NMR metabolomics,X23412.Phospholipids in VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,0.149474076804383,0.0102930326055106,0.129299732897582,0.169648420711184,1.80435261002142e-47
NMR metabolomics,X23412.Phospholipids in VLDL,OCLN,Occludin,37959,0.0580844974364287,0.00399898714537415,0.0502464826314953,0.065922512241362,1.92183069668563e-47
NMR metabolomics,X23412.Phospholipids in VLDL,RFC4,Replication factor C subunit 4,37900,0.0273730418058976,0.00188454298885403,0.0236793375477437,0.0310667460640515,1.92243398813762e-47
NMR metabolomics,X23412.Phospholipids in VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,0.103243596796996,0.00711084200126956,0.0893063464745077,0.117180847119484,2.1264859839131e-47
NMR metabolomics,X23412.Phospholipids in VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,40359,0.0902420949568948,0.00622109736819838,0.078048744115226,0.102435445798564,2.23322381247126e-47
NMR metabolomics,X23412.Phospholipids in VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,0.03966898171177,0.00273611075313282,0.0343062046356296,0.0450317587879103,2.50713016885758e-47
NMR metabolomics,X23412.Phospholipids in VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,40359,0.046905224574401,0.00323565246185854,0.0405633457491582,0.0532471033996437,2.55802312459802e-47
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS2,Trypsin-2,40403,0.0665157078399547,0.00459452207577759,0.0575104445714307,0.0755209711084788,3.36393248792579e-47
NMR metabolomics,X23412.Phospholipids in VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,0.100006343106619,0.00690721941936028,0.086468193044673,0.113544493168565,3.36434589392309e-47
NMR metabolomics,X23412.Phospholipids in VLDL,IL18,Interleukin-18,40292,0.0627561172210829,0.00433834652077072,0.0542529580403723,0.0712592764017935,3.99975456687839e-47
NMR metabolomics,X23412.Phospholipids in VLDL,VSNL1,Visinin-like protein 1,37942,0.04971688557242,0.00343577970284971,0.0429827573548345,0.0564510137900054,4.20169475874039e-47
NMR metabolomics,X23412.Phospholipids in VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,0.125211468307315,0.00865902638324693,0.108239776596151,0.142183160018479,4.30834112760238e-47
NMR metabolomics,X23412.Phospholipids in VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,0.076684047680563,0.00530792234661165,0.0662805198812042,0.0870875754799218,5.27531706278224e-47
NMR metabolomics,X23412.Phospholipids in VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,0.0879912215737673,0.00609726214030757,0.0760405877787644,0.0999418553687701,7.44654992752535e-47
NMR metabolomics,X23412.Phospholipids in VLDL,JPT2,Jupiter microtubule associated homolog 2,37901,0.116045709589697,0.00804203177353833,0.100283327313562,0.131808091865832,7.50855156324912e-47
NMR metabolomics,X23412.Phospholipids in VLDL,CCL8,C-C motif chemokine 8,40470,0.0796740881898919,0.00553202872110668,0.0688313118965228,0.090516864483261,9.79860839214528e-47
NMR metabolomics,X23412.Phospholipids in VLDL,IMPACT,Protein IMPACT,37942,0.0751758292505089,0.00521683692673085,0.0649508288741165,0.0854008296269014,9.9170291471215e-47
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC59,Leucine-rich repeat-containing protein 59,37990,0.0620821857266085,0.00431261156035149,0.0536294670683196,0.0705349043848975,1.22004388124772e-46
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,0.122539944095283,0.0085125311969781,0.105855382949206,0.13922450524136,1.22669184992636e-46
NMR metabolomics,X23412.Phospholipids in VLDL,UROD,Uroporphyrinogen decarboxylase,37671,0.0928433548664612,0.00645549884019316,0.0801905771396826,0.10549613259324,1.50549528949199e-46
NMR metabolomics,X23412.Phospholipids in VLDL,BIN2,Bridging integrator 2,40332,0.119447631274808,0.00831241861935719,0.103155290780868,0.135739971768748,1.56808356262247e-46
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4E,Eukaryotic translation initiation factor 4E,37598,0.120379422118907,0.00837643810452958,0.103961603434029,0.136797240803785,1.76483131842521e-46
NMR metabolomics,X23412.Phospholipids in VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,0.115707193968159,0.0080585655932705,0.0999124054053492,0.13150198253097,1.84104150613519e-46
NMR metabolomics,X23412.Phospholipids in VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,0.075356893159454,0.00525006532299273,0.0650667651263883,0.0856470211925198,1.96561667599493e-46
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD3,Mothers against decapentaplegic homolog 3,37900,0.0668115570781219,0.00465303133648113,0.0576916156586189,0.0759314984976249,2.069742514145e-46
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,0.144563328899615,0.0100804025680679,0.124805739866202,0.164320917933028,2.35512500935992e-46
NMR metabolomics,X23412.Phospholipids in VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,37671,0.114894812970458,0.00801103699205943,0.0991931804660213,0.130596445474894,2.65750144186418e-46
NMR metabolomics,X23412.Phospholipids in VLDL,FOXJ3,Forkhead box protein J3,37598,0.0575390693887155,0.0040129914124896,0.0496736062202359,0.0654045325571952,2.81969603433554e-46
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,0.130011662379721,0.00908216944843375,0.11221061026079,0.147812714498651,3.83323436942771e-46
NMR metabolomics,X23412.Phospholipids in VLDL,CD274,Programmed cell death 1 ligand 1,40228,0.0455427106740472,0.00318795801454837,0.0392943129655324,0.051791108382562,5.19125069786645e-46
NMR metabolomics,X23412.Phospholipids in VLDL,TMSB10,Thymosin beta-10,40332,0.0993438665181113,0.00695518466624711,0.085711704572267,0.112976028463956,5.35015716968996e-46
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB1,Leukocyte elastase inhibitor,40287,0.116315471203245,0.00815112017335022,0.100339275663479,0.132291666743012,6.49413821112636e-46
NMR metabolomics,X23412.Phospholipids in VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,0.0973603709987092,0.00681968860292673,0.0839937813369728,0.110726960660446,6.61475981377157e-46
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2L1,Bcl-2-like protein 1,37942,0.130429177801267,0.00915046768360511,0.112494261141401,0.148364094461133,9.11844522253137e-46
NMR metabolomics,X23412.Phospholipids in VLDL,LAP3,Cytosol aminopeptidase,40044,0.0641077393544915,0.00450293206787062,0.0552819925014651,0.072933486207518,1.04586369834819e-45
NMR metabolomics,X23412.Phospholipids in VLDL,KLK13,Kallikrein-13,40032,0.0565671883373364,0.00397851515490723,0.0487692986337182,0.0643650780409546,1.36286058505641e-45
NMR metabolomics,X23412.Phospholipids in VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,0.123097580731516,0.00866054855887344,0.106122905556124,0.140072255906908,1.61106693173919e-45
NMR metabolomics,X23412.Phospholipids in VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,0.0420761394468841,0.00296288210230203,0.0362688905263721,0.0478833883673961,1.71466011035962e-45
NMR metabolomics,X23412.Phospholipids in VLDL,MIF,Macrophage migration inhibitory factor,40307,0.0896950915844916,0.00631616910751937,0.0773154001337536,0.10207478303523,1.7197338473987e-45
NMR metabolomics,X23412.Phospholipids in VLDL,RP2,Protein XRP2,40305,0.0537808809083044,0.0037880240653026,0.0463563537403113,0.0612054080762975,1.80074327957218e-45
NMR metabolomics,X23412.Phospholipids in VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,0.140647870018913,0.00990012740367032,0.121243620307719,0.160052119730107,1.84774563670221e-45
NMR metabolomics,X23412.Phospholipids in VLDL,F12,Coagulation factor XII,38013,0.0543823949317844,0.00383313038025152,0.0468694593864915,0.0618953304770774,2.31212697221682e-45
NMR metabolomics,X23412.Phospholipids in VLDL,DYNLT1,Dynein light chain Tctex-type 1,37572,0.105572537927932,0.00744111836530875,0.0909879459319269,0.120157129923937,2.36161800461358e-45
NMR metabolomics,X23412.Phospholipids in VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,37628,0.0954992688972244,0.00673668991309502,0.0822953566675581,0.108703181126891,2.7753603550242e-45
NMR metabolomics,X23412.Phospholipids in VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,0.0758820153750404,0.0053599770137551,0.0653764604280804,0.0863875703220004,3.17809978282883e-45
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN3,Ataxin-3,37942,0.0809568602989366,0.00571750174871076,0.0697505568714636,0.0921631637264097,3.43755486445003e-45
NMR metabolomics,X23412.Phospholipids in VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,0.0706335224394169,0.0049967449405143,0.0608399023560089,0.0804271425228249,4.28719240667964e-45
NMR metabolomics,X23412.Phospholipids in VLDL,TMEM106A,Transmembrane protein 106A,37900,0.0909472957063278,0.00643103346034811,0.0783424701240455,0.10355212128861,4.40545171517976e-45
NMR metabolomics,X23412.Phospholipids in VLDL,TBC1D5,TBC1 domain family member 5,40341,0.101292952909815,0.00718268980626957,0.0872148808895265,0.115371024930103,6.84951937953376e-45
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM24,Transcription intermediary factor 1-alpha,37687,0.0832406498963066,0.00590016016469579,0.0716763359735029,0.0948049638191104,7.14571869993568e-45
NMR metabolomics,X23412.Phospholipids in VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,37628,0.120549358230672,0.00855695338245401,0.103777729601062,0.137320986860281,9.52037546289629e-45
NMR metabolomics,X23412.Phospholipids in VLDL,MEP1A,Meprin A subunit alpha,37901,0.088472183221415,0.00628053978666365,0.0761623252395543,0.100782041203276,9.53229117652582e-45
NMR metabolomics,X23412.Phospholipids in VLDL,CASP2,Caspase-2,40341,0.0871985224910063,0.00619518841228905,0.0750559532029197,0.0993410917790928,1.00154192884499e-44
NMR metabolomics,X23412.Phospholipids in VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,0.0745350025884617,0.0053004065213503,0.0641462058066151,0.0849237993703083,1.22134333172613e-44
NMR metabolomics,X23412.Phospholipids in VLDL,MICALL2,MICAL-like protein 2,37572,0.088444934244547,0.00628635011823654,0.0761236880128034,0.100766180476291,1.23634964422681e-44
NMR metabolomics,X23412.Phospholipids in VLDL,C4BPB,C4b-binding protein beta chain,40411,0.0531713655422982,0.00378254265809109,0.0457575819324397,0.0605851491521568,1.28710399993692e-44
NMR metabolomics,X23412.Phospholipids in VLDL,DCTD,Deoxycytidylate deaminase,37671,0.121895710035088,0.00866907278374176,0.104904327378954,0.138887092691222,1.38165049205793e-44
NMR metabolomics,X23412.Phospholipids in VLDL,TP53I3,Quinone oxidoreductase PIG3,37419,0.0692195742857157,0.00492364001825818,0.0595692398499297,0.0788699087215017,1.44840093914743e-44
NMR metabolomics,X23412.Phospholipids in VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,0.15282655489161,0.0108791649542972,0.131503391581188,0.174149718202033,1.46697441192229e-44
NMR metabolomics,X23412.Phospholipids in VLDL,JAM3,Junctional adhesion molecule C,37671,0.0653167482643978,0.00464759943590383,0.0562074533700263,0.0744260431587693,1.52555796340524e-44
NMR metabolomics,X23412.Phospholipids in VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,0.0544436976544805,0.00387538021862711,0.0468479524259713,0.0620394428829896,1.63733403121011e-44
NMR metabolomics,X23412.Phospholipids in VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,0.0787579444684245,0.00560783744922263,0.0677665830679482,0.0897493058689009,1.74364860570114e-44
NMR metabolomics,X23412.Phospholipids in VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,0.103668414886152,0.00738350060699657,0.0891967536964389,0.118140076075865,1.84243392964507e-44
NMR metabolomics,X23412.Phospholipids in VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,0.126183778723868,0.00898862745298286,0.108566068916022,0.143801488531715,1.86584131686646e-44
NMR metabolomics,X23412.Phospholipids in VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,0.131775482257765,0.00939979598503817,0.11335188212709,0.150199082388439,2.48372085329082e-44
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,0.0578615677147553,0.00413051668712188,0.0497657550079964,0.0659573804215142,2.55546611985649e-44
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,0.121830300441516,0.00870546591341702,0.104767587251219,0.138893013631814,3.08814829250797e-44
NMR metabolomics,X23412.Phospholipids in VLDL,GMFG,Glia maturation factor gamma,37990,0.0921498096352443,0.00658393336339276,0.0792453002429945,0.105054319027494,3.34298490389317e-44
NMR metabolomics,X23412.Phospholipids in VLDL,SPON2,Spondin-2,40267,-0.044287863272423,0.00316606472198114,-0.050493350127506,-0.0380823764173399,3.36977659769611e-44
NMR metabolomics,X23412.Phospholipids in VLDL,PARK7,Parkinson disease protein 7,40332,0.0686173108496546,0.00490605839194703,0.0590014364014384,0.0782331852978707,3.45903602532376e-44
NMR metabolomics,X23412.Phospholipids in VLDL,CASP3,Caspase-3,40536,0.112483393756767,0.00806322230205585,0.0966794780447371,0.128287309468796,5.66096244398085e-44
NMR metabolomics,X23412.Phospholipids in VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,0.103517548212643,0.0074249903676236,0.0889645670921003,0.118070529333185,6.4054093422743e-44
NMR metabolomics,X23412.Phospholipids in VLDL,DBI,Acyl-CoA-binding protein,40270,0.100742860086724,0.00723023267238877,0.0865716040488424,0.114914116124606,7.1960026760731e-44
NMR metabolomics,X23412.Phospholipids in VLDL,SCARF1,Scavenger receptor class F member 1,40536,0.053967251617533,0.00387926561177566,0.0463638910184527,0.0615706122166132,9.63781804942542e-44
NMR metabolomics,X23412.Phospholipids in VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,0.0601481492862972,0.00432571955870387,0.0516697389512376,0.0686265596213568,1.06331699872664e-43
NMR metabolomics,X23412.Phospholipids in VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,0.0737482692526563,0.00530382495942498,0.0633527723321833,0.0841437661731293,1.08359828624267e-43
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB9,Serpin B9,40228,0.0427832945798932,0.00307952583029095,0.0367474239525229,0.0488191652072634,1.26529929895268e-43
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,0.057716123202415,0.00415416992191246,0.0495739501554666,0.0658582962493634,1.40637608371266e-43
NMR metabolomics,X23412.Phospholipids in VLDL,MYO9B,Unconventional myosin-IXb,40044,0.0843390654211634,0.00607958088528046,0.0724230868860137,0.0962550439563131,1.68559761052828e-43
NMR metabolomics,X23412.Phospholipids in VLDL,SDHB,Succinate dehydrogenase,37901,0.0906093251431595,0.0065324912090119,0.0778056423734962,0.103413007912823,1.90193528982332e-43
NMR metabolomics,X23412.Phospholipids in VLDL,MCEMP1,Mast cell-expressed membrane protein 1,37598,0.117791947750922,0.0084917039041947,0.1011482080987,0.134435687403143,1.90956272430433e-43
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP25,Rho GTPase-activating protein 25,39980,0.0754460055849374,0.00544342758616855,0.0647768875160471,0.0861151236538278,2.00686101959499e-43
NMR metabolomics,X23412.Phospholipids in VLDL,CETN2,Centrin-2,39961,0.0852415299825862,0.00616165976323017,0.0731646768466551,0.0973183831185174,2.86477760337174e-43
NMR metabolomics,X23412.Phospholipids in VLDL,DXO,Decapping and exoribonuclease protein,37942,0.0581343234085607,0.00420431423286143,0.0498938675121523,0.0663747793049691,3.43683934910324e-43
NMR metabolomics,X23412.Phospholipids in VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,0.137009321803428,0.00991137062488203,0.117583035378659,0.156435608228197,3.63080321929823e-43
NMR metabolomics,X23412.Phospholipids in VLDL,CRYBB1,Beta-crystallin B1,37990,0.082262317042425,0.00595122715538138,0.0705979118178775,0.0939267222669724,3.64941997274901e-43
NMR metabolomics,X23412.Phospholipids in VLDL,TXNDC9,Thioredoxin domain-containing protein 9,37942,0.0673824555073131,0.00487609240470459,0.0578253143940921,0.0769395966205341,3.85373779390373e-43
NMR metabolomics,X23412.Phospholipids in VLDL,CCL18,C-C motif chemokine 18,40172,0.0889068612777034,0.00643960039974918,0.076285244494195,0.101528478061212,4.16919844860668e-43
NMR metabolomics,X23412.Phospholipids in VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,0.0521146239684453,0.00377581564953255,0.0447140252953615,0.0595152226415291,4.85558574768572e-43
NMR metabolomics,X23412.Phospholipids in VLDL,CASP10,Caspase-10,39961,0.0907586787214643,0.0065821955639887,0.0778575754160464,0.103659782026882,5.35937952833831e-43
NMR metabolomics,X23412.Phospholipids in VLDL,RAB33A,Ras-related protein Rab-33A,37562,0.0845881545189717,0.00613264271079114,0.072568174805821,0.0966081342321223,5.59571550646374e-43
NMR metabolomics,X23412.Phospholipids in VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,0.0461272918827533,0.00334513429724204,0.0395708286601589,0.0526837551053477,5.85529308355948e-43
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN9,Septin-9,40305,0.0355695526168014,0.00258287264069341,0.0305071222410423,0.0406319829925604,6.69697951569176e-43
NMR metabolomics,X23412.Phospholipids in VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,0.112032685725365,0.00813192797270234,0.0960941068988687,0.127971264551862,6.83365219978482e-43
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6AP2,Renin receptor,39980,0.0526095496018024,0.00382445822760156,0.0451136114757033,0.0601054877279014,8.34547890393956e-43
NMR metabolomics,X23412.Phospholipids in VLDL,SCARB2,Lysosome membrane protein 2,40011,0.0389648856554528,0.00283323086252629,0.0334117531649013,0.0445180181460044,8.71664097751243e-43
NMR metabolomics,X23412.Phospholipids in VLDL,GGCT,Gamma-glutamylcyclotransferase,37978,0.0610613602485033,0.00444096337317459,0.0523570720370811,0.0697656484599254,9.92584979226879e-43
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL11,C-X-C motif chemokine 11,40471,0.100106494970276,0.00728844509442235,0.085821142585208,0.114391847355344,1.09415534442887e-42
NMR metabolomics,X23412.Phospholipids in VLDL,SNAP25,Synaptosomal-associated protein 25,37541,0.0590891514759333,0.00429939080659634,0.0506623454950045,0.0675159574568622,1.10041325329491e-42
NMR metabolomics,X23412.Phospholipids in VLDL,COMT,Catechol O-methyltransferase,39877,0.106854503564612,0.00779429664185351,0.0915776821465793,0.122131324982645,1.58513363309148e-42
NMR metabolomics,X23412.Phospholipids in VLDL,GP6,Platelet glycoprotein VI,40311,0.110548726946215,0.00806670711581804,0.0947379809992114,0.126359472893218,1.6705990565621e-42
NMR metabolomics,X23412.Phospholipids in VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,0.050434012817102,0.00367964352289097,0.0432219115122357,0.0576461141219683,1.78966831978873e-42
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB3A2,Secretoglobin family 3A member 2,40396,-0.106238793564163,0.007771003681498,-0.121469960779899,-0.0910076263484265,2.6141100336588e-42
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB2,DnaJ homolog subfamily B member 2,37671,0.0683610480702913,0.00500499862974805,0.0585512507559851,0.0781708453845974,3.46991947064234e-42
NMR metabolomics,X23412.Phospholipids in VLDL,RILP,Rab-interacting lysosomal protein,40434,0.0753683502850086,0.00552370191587944,0.0645418945298849,0.0861948060401323,3.74807265787138e-42
NMR metabolomics,X23412.Phospholipids in VLDL,REEP4,Receptor expression-enhancing protein 4,37959,0.0778268730691664,0.00570387128819897,0.0666472853442965,0.0890064607940364,4.13512388125666e-42
NMR metabolomics,X23412.Phospholipids in VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,0.0957175551018428,0.00701892311300403,0.0819604658003549,0.109474644403331,4.15251488861672e-42
NMR metabolomics,X23412.Phospholipids in VLDL,SMTN,Smoothelin,37905,0.120583658991416,0.00883894838331812,0.103259320160112,0.137907997822719,4.27453588263753e-42
NMR metabolomics,X23412.Phospholipids in VLDL,SFRP1,Secreted frizzled-related protein 1,40178,0.0544953435365914,0.00400112994151209,0.0466531288512277,0.0623375582219551,5.27256891620791e-42
NMR metabolomics,X23412.Phospholipids in VLDL,CEP170,Centrosomal protein of 170 kDa,37628,0.0967035634691414,0.00709644063762342,0.0827945398193995,0.110612587118883,5.32450058523553e-42
NMR metabolomics,X23412.Phospholipids in VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,0.0765648943952986,0.00562129394256462,0.0655471582678719,0.0875826305227252,5.83239440189504e-42
NMR metabolomics,X23412.Phospholipids in VLDL,SLMAP,Sarcolemmal membrane-associated protein,37901,0.104034320338467,0.00764143556452883,0.0890571066319903,0.119011534044943,6.2256913600339e-42
NMR metabolomics,X23412.Phospholipids in VLDL,MCAM,Cell surface glycoprotein MUC18,40403,-0.0424008739075347,0.00311677593983373,-0.0485097547496088,-0.0362919930654606,6.4884289559341e-42
NMR metabolomics,X23412.Phospholipids in VLDL,MARCO,Macrophage receptor MARCO,40359,0.0331219873270168,0.0024370116199607,0.0283454445518938,0.0378985301021398,7.73035425190573e-42
NMR metabolomics,X23412.Phospholipids in VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.0511153268961925,0.00376183938055977,0.0437421217102953,0.0584885320820896,8.13967794570027e-42
NMR metabolomics,X23412.Phospholipids in VLDL,FMNL1,Formin-like protein 1,39961,0.0746931431900208,0.00549758210283422,0.0639178822684658,0.0854684041115759,8.3488311411802e-42
NMR metabolomics,X23412.Phospholipids in VLDL,CTSL,Cathepsin L1,40359,0.0301777813880866,0.00222304114837946,0.0258206207372628,0.0345349420389103,9.62412868320323e-42
NMR metabolomics,X23412.Phospholipids in VLDL,FADD,FAS-associated death domain protein,40359,0.0950095601091202,0.0070004178510873,0.0812887411209891,0.108730379097251,1.00236191061253e-41
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,0.0336199089960786,0.00247833151999722,0.0287623792168841,0.0384774387752732,1.19815221862748e-41
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPT1,Angiopoietin-1,40263,0.105177212627971,0.00777345437388928,0.0899412420551477,0.120413183200794,1.76279122404638e-41
NMR metabolomics,X23412.Phospholipids in VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,0.0992020956500732,0.00732766258768556,0.0848398769782095,0.113564314321937,1.76836169361906e-41
NMR metabolomics,X23412.Phospholipids in VLDL,NRGN,Neurogranin,37987,0.11248310180509,0.00831858160059008,0.0961786818679334,0.128787521742247,2.15580145230712e-41
NMR metabolomics,X23412.Phospholipids in VLDL,AKT2,RAC-beta serine/threonine-protein kinase,37959,0.15576945881977,0.0115270680292546,0.133176405482431,0.178362512157109,2.42061824236263e-41
NMR metabolomics,X23412.Phospholipids in VLDL,HPSE,Heparanase,37848,0.11514185265225,0.00853048614058671,0.0984220998167001,0.1318616054878,3.00138807070026e-41
NMR metabolomics,X23412.Phospholipids in VLDL,CTSS,Cathepsin S,37057,0.0306079228395672,0.00226767199480371,0.026163285729752,0.0350525599493825,3.12697621146388e-41
NMR metabolomics,X23412.Phospholipids in VLDL,TADA3,Transcriptional adapter 3,37900,0.0482334102283853,0.00357475115018147,0.0412268979740296,0.0552399224827409,3.19671236991803e-41
NMR metabolomics,X23412.Phospholipids in VLDL,ADD1,Alpha-adducin,37671,0.0867755870099527,0.00644639134262505,0.0741406599784076,0.0994105140414978,4.93490084527254e-41
NMR metabolomics,X23412.Phospholipids in VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,0.0441380681240257,0.00328267201431541,0.0377040309759675,0.0505721052720839,6.082826613126e-41
NMR metabolomics,X23412.Phospholipids in VLDL,CDC26,Anaphase-promoting complex subunit CDC26,37879,0.086964085969738,0.00647024532656678,0.0742824051296671,0.0996457668098089,6.42544783190075e-41
NMR metabolomics,X23412.Phospholipids in VLDL,CD72,B-cell differentiation antigen CD72,37671,0.0522920059010584,0.00389163841191004,0.0446643946137147,0.0599196171884021,6.80571365964565e-41
NMR metabolomics,X23412.Phospholipids in VLDL,CCL26,C-C motif chemokine 26,40341,0.109330654613299,0.00815162856125578,0.0933534626332381,0.125307846593361,8.55876700447744e-41
NMR metabolomics,X23412.Phospholipids in VLDL,TBCA,Tubulin-specific chaperone A,37671,0.107298851015415,0.00800257703852257,0.0916138000199111,0.12298390201092,1.00101671761126e-40
NMR metabolomics,X23412.Phospholipids in VLDL,APP,Amyloid-beta precursor protein,40309,0.0822692835461185,0.00614235189564839,0.0702302738306476,0.0943082932615893,1.09406748784883e-40
NMR metabolomics,X23412.Phospholipids in VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,39897,0.0703178525242585,0.00525448019497029,0.0600190713421168,0.0806166337064003,1.28918788870776e-40
NMR metabolomics,X23412.Phospholipids in VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,37746,0.0684324865051478,0.00511321946991901,0.0584105763441065,0.078454396666189,1.38325576616691e-40
NMR metabolomics,X23412.Phospholipids in VLDL,BGLAP,Osteocalcin,37998,0.111957523754708,0.00838601106819698,0.0955209420610415,0.128394105448374,2.11740828669819e-40
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS3,Galectin-3,40374,0.0361996907131343,0.00271328710559069,0.0308816479861765,0.0415177334400921,2.18343105178587e-40
NMR metabolomics,X23412.Phospholipids in VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,0.0830526609961545,0.00622618452583438,0.0708493393255191,0.0952559826667899,2.28202561747237e-40
NMR metabolomics,X23412.Phospholipids in VLDL,SUOX,"Sulfite oxidase, mitochondrial",37959,0.0755802047505179,0.00566457444775659,0.064477638832915,0.0866827706681208,2.35495991775625e-40
NMR metabolomics,X23412.Phospholipids in VLDL,CPA1,Carboxypeptidase A1,40536,0.0698259931140424,0.00524377997353249,0.0595481843659187,0.0801038018621661,3.05327999022772e-40
NMR metabolomics,X23412.Phospholipids in VLDL,BLMH,Bleomycin hydrolase,40536,0.0394297971668016,0.00296116349546356,0.033625916715693,0.0452336776179101,3.06633187670805e-40
NMR metabolomics,X23412.Phospholipids in VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,39980,0.0607458344826301,0.00456414174263012,0.0518001166670751,0.0696915522981851,3.39056392021582e-40
NMR metabolomics,X23412.Phospholipids in VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,0.149485875210666,0.0112407375573542,0.127454029598252,0.17151772082308,3.86608244378549e-40
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA3,Annexin A3,40442,0.0852746393026664,0.00641852514253217,0.0726943300233034,0.0978549485820295,4.56936367704575e-40
NMR metabolomics,X23412.Phospholipids in VLDL,PTX3,Pentraxin-related protein PTX3,40341,-0.0598202283034161,0.00451011165528792,-0.0686600471477804,-0.0509804094590518,6.13850413064126e-40
NMR metabolomics,X23412.Phospholipids in VLDL,NPDC1,Neural proliferation differentiation and control protein 1,40359,0.0376885085662612,0.00284392435046667,0.0321144168393465,0.0432626002931759,7.12011002975147e-40
NMR metabolomics,X23412.Phospholipids in VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",37928,0.0495570578864797,0.00373920400046509,0.0422282180455681,0.0568858977273913,7.65788905819544e-40
NMR metabolomics,X23412.Phospholipids in VLDL,CPB1,Carboxypeptidase B,40536,0.0683639428062665,0.00516353806377134,0.0582434082012747,0.0784844774112583,8.35502374724678e-40
NMR metabolomics,X23412.Phospholipids in VLDL,GIPC3,PDZ domain-containing protein GIPC3,37901,0.118959472796956,0.00898455049625964,0.101349753824287,0.136569191769625,9.08674779555378e-40
NMR metabolomics,X23412.Phospholipids in VLDL,TSC22D1,TSC22 domain family protein 1,37959,0.0817976299752999,0.00617959608189691,0.0696856216547819,0.0939096382958178,9.51884345295019e-40
NMR metabolomics,X23412.Phospholipids in VLDL,C1RL,Complement C1r subcomponent-like protein,37993,0.0235826093191367,0.00178216798269167,0.020089560073061,0.0270756585652123,1.00429995302742e-39
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G4A,Cytosolic phospholipase A2,40422,0.105422780130585,0.00798024167890595,0.0897815064399297,0.121064053821241,1.23218764890154e-39
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,0.083945660422718,0.00635981091274203,0.0714804310337436,0.0964108898116924,1.42127827118788e-39
NMR metabolomics,X23412.Phospholipids in VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,0.0797156654517581,0.00604914605701644,0.0678593391800059,0.0915719917235103,1.88433571276744e-39
NMR metabolomics,X23412.Phospholipids in VLDL,CCL24,C-C motif chemokine 24,40396,0.100054852455791,0.00760006347227257,0.0851587280501369,0.114950976861445,2.23926115739722e-39
NMR metabolomics,X23412.Phospholipids in VLDL,RASSF2,Ras association domain-containing protein 2,39980,0.0664228633818864,0.00504532244698182,0.0565340313858021,0.0763116953779708,2.26066001366334e-39
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,40042,0.133278075056329,0.010138084549575,0.113407429339162,0.153148720773496,2.89165122930589e-39
NMR metabolomics,X23412.Phospholipids in VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,40490,0.0386165028498643,0.00293826312227525,0.0328575071302048,0.0443754985695238,2.99278937005771e-39
NMR metabolomics,X23412.Phospholipids in VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,0.0466729973898097,0.00355304959581151,0.0397090201820192,0.0536369745976003,3.55970631905194e-39
NMR metabolomics,X23412.Phospholipids in VLDL,INPP1,Inositol polyphosphate 1-phosphatase,40305,0.0648080612062759,0.00493904113454715,0.0551275405825634,0.0744885818299883,3.961138646257e-39
NMR metabolomics,X23412.Phospholipids in VLDL,CDC37,Hsp90 co-chaperone Cdc37,40411,0.100622794932156,0.00767573225329539,0.085578359715697,0.115667230148615,4.6410927459201e-39
NMR metabolomics,X23412.Phospholipids in VLDL,RBKS,Ribokinase,39991,0.0598260363775375,0.00456388465621247,0.050880822451361,0.0687712503037139,4.73830408107448e-39
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF6,SLAM family member 6,39980,0.045686172876935,0.0034886422987936,0.0388484339712995,0.0525239117825704,5.60694044724292e-39
NMR metabolomics,X23412.Phospholipids in VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,0.0569111889261664,0.00434941586787036,0.0483863338251405,0.0654360440271923,7.02744381349075e-39
NMR metabolomics,X23412.Phospholipids in VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,0.0806983831512302,0.00617267348247465,0.0685999431255799,0.0927968231768805,8.16071731082845e-39
NMR metabolomics,X23412.Phospholipids in VLDL,MENT,Protein MENT,37671,-0.0260390056233668,0.001992573079499,-0.0299444488591848,-0.0221335623875488,8.71999003542526e-39
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH7,Protocadherin-7,37901,0.0418723065921789,0.00320518201270046,0.035590149847286,0.0481544633370718,9.10945081857038e-39
NMR metabolomics,X23412.Phospholipids in VLDL,ABHD14B,Protein ABHD14B,40171,0.0699690268879298,0.00537359201640084,0.0594367865357842,0.0805012672400755,1.47308561326908e-38
NMR metabolomics,X23412.Phospholipids in VLDL,BDNF,Brain-derived neurotrophic factor,37998,0.0989824533997534,0.00760043989983516,0.0840855911960765,0.11387931560343,1.53731655809054e-38
NMR metabolomics,X23412.Phospholipids in VLDL,GGACT,Gamma-glutamylaminecyclotransferase,37990,0.0846263678464821,0.00651103025543078,0.0718647485458378,0.0973879871471264,2.14832300189926e-38
NMR metabolomics,X23412.Phospholipids in VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,0.0883812490934378,0.00680392752967692,0.075045551135271,0.101716947051605,2.37115405661644e-38
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA2,Integrin alpha-2,37671,0.0404200189316776,0.00311169051847824,0.0343211055154603,0.046518932347895,2.40159531721395e-38
NMR metabolomics,X23412.Phospholipids in VLDL,CALB2,Calretinin,39961,0.03752804527932,0.00289218423984339,0.031859364169227,0.0431967263894131,2.66043741763591e-38
NMR metabolomics,X23412.Phospholipids in VLDL,CCL4,C-C motif chemokine 4,40376,0.0804861390692481,0.00620489316405577,0.0683245484676988,0.0926477296707974,2.77833217298882e-38
NMR metabolomics,X23412.Phospholipids in VLDL,C1R,Complement C1r subcomponent,38013,0.0237281287545462,0.00182998980553366,0.0201413487357002,0.0273149087733922,3.20657529248895e-38
NMR metabolomics,X23412.Phospholipids in VLDL,MIA,Melanoma-derived growth regulatory protein,40411,0.0439394416925062,0.00339442654989548,0.0372863656547111,0.0505925177303014,3.92251339840229e-38
NMR metabolomics,X23412.Phospholipids in VLDL,AIF1,Allograft inflammatory factor 1,39980,0.0625573194266444,0.00484190150927063,0.053067192468474,0.0720474463848149,5.44908231241477e-38
NMR metabolomics,X23412.Phospholipids in VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,0.0725026046563233,0.00561277154776504,0.0615015724227039,0.0835036368899428,5.57421457716528e-38
NMR metabolomics,X23412.Phospholipids in VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,0.105218115147903,0.0081515460726966,0.0892410848454174,0.121195145450388,6.31818209838192e-38
NMR metabolomics,X23412.Phospholipids in VLDL,FNDC1,Fibronectin type III domain-containing protein 1,37942,0.0544172129883975,0.0042147447422793,0.0461563132935301,0.0626781126832649,6.52998074638396e-38
NMR metabolomics,X23412.Phospholipids in VLDL,PNMA1,Paraneoplastic antigen Ma1,37628,0.0663167649353744,0.0051389255952708,0.0562444707686436,0.0763890591021052,7.17197897352985e-38
NMR metabolomics,X23412.Phospholipids in VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,0.0416212648810218,0.00322874161733515,0.0352929313110449,0.0479495984509987,8.48331975334538e-38
NMR metabolomics,X23412.Phospholipids in VLDL,SCRN1,Secernin-1,40341,0.0664009490151632,0.00516161281764847,0.0562841878925722,0.0765177101377542,1.10122454498942e-37
NMR metabolomics,X23412.Phospholipids in VLDL,BLNK,B-cell linker protein,37598,0.0454145104887262,0.00352859747950514,0.0384984594288962,0.0523305615485563,1.11506659720528e-37
NMR metabolomics,X23412.Phospholipids in VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,0.0765918765513012,0.00597184031182373,0.0648870695401267,0.0882966835624757,1.95540477136829e-37
NMR metabolomics,X23412.Phospholipids in VLDL,TREML2,Trem-like transcript 2 protein,40332,0.0394261328820705,0.00307680340542605,0.0333955982074355,0.0454566675567056,2.09762368759086e-37
NMR metabolomics,X23412.Phospholipids in VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,40044,0.0778573936890566,0.0060777574501748,0.065944989086714,0.0897697982913992,2.2183684049326e-37
NMR metabolomics,X23412.Phospholipids in VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,0.0487105549419068,0.00380403541648915,0.041254645525588,0.0561664643582255,2.56213362650706e-37
NMR metabolomics,X23412.Phospholipids in VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,37562,0.0819538259029227,0.00640353149435617,0.0694029041739846,0.0945047476318608,2.8034508958816e-37
NMR metabolomics,X23412.Phospholipids in VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,0.102540565019051,0.00802185104029547,0.0868177369800716,0.11826339305803,3.37337203086425e-37
NMR metabolomics,X23412.Phospholipids in VLDL,CA13,Carbonic anhydrase 13,40173,0.121402391923771,0.00950593442656922,0.102770760447695,0.140034023399846,3.63230216914137e-37
NMR metabolomics,X23412.Phospholipids in VLDL,CALCA,Calcitonin,40192,0.0644962652027854,0.00505393491687812,0.0545905527657043,0.0744019776398665,4.1030926682343e-37
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJC9,DnaJ homolog subfamily C member 9,37901,0.0902556661472845,0.00707182842333189,0.076394882437554,0.104116449857015,4.34577615827814e-37
NMR metabolomics,X23412.Phospholipids in VLDL,CCT5,T-complex protein 1 subunit epsilon,39980,0.0531607587160406,0.0041724137824751,0.0449828277023894,0.0613386897296918,5.35930797525927e-37
NMR metabolomics,X23412.Phospholipids in VLDL,GGH,Gamma-glutamyl hydrolase,40077,0.0400310945564784,0.00314309689482409,0.0338706246426232,0.0461915644703336,5.68175947583869e-37
NMR metabolomics,X23412.Phospholipids in VLDL,APOL1,Apolipoprotein L1,37987,0.0762171643502171,0.00598294075335229,0.0644906004736466,0.0879437282267876,5.8448398069853e-37
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,37990,0.0349958558485321,0.00274729022363287,0.0296111670102117,0.0403805446868526,5.90094463962266e-37
NMR metabolomics,X23412.Phospholipids in VLDL,CTRB1,Chymotrypsinogen B,40332,0.0621885852967238,0.00488548366605854,0.0526130373112491,0.0717641332821986,6.16240503188217e-37
NMR metabolomics,X23412.Phospholipids in VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,0.0617499308226413,0.00485031009645868,0.0522433230335823,0.0712565386117003,6.54947780154724e-37
NMR metabolomics,X23412.Phospholipids in VLDL,LARP1,La-related protein 1,37900,0.0742429501166551,0.00583523150998593,0.0628058963570827,0.0856800038762275,7.1663392403133e-37
NMR metabolomics,X23412.Phospholipids in VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,0.0451921206881255,0.00355193581692467,0.0382303264869532,0.0521539148892979,7.24647867448076e-37
NMR metabolomics,X23412.Phospholipids in VLDL,DBN1,Drebrin,37598,0.0605891498058269,0.00476238354509511,0.0512548780574404,0.0699234215542133,7.31854613650197e-37
NMR metabolomics,X23412.Phospholipids in VLDL,RAB2B,Ras-related protein Rab-2B,37900,0.0717860590833868,0.00564427455788183,0.0607232809499384,0.0828488372168352,7.61842149878212e-37
NMR metabolomics,X23412.Phospholipids in VLDL,LONP1,"Lon protease homolog, mitochondrial",37628,0.100944015628266,0.00796779883432814,0.085327129912983,0.116560901343549,1.43496055554329e-36
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA6,Integrin alpha-6,40341,0.0615553978126266,0.00487918798781049,0.051992189356518,0.0711186062687352,2.57651840097537e-36
NMR metabolomics,X23412.Phospholipids in VLDL,DDT,D-dopachrome decarboxylase,37998,0.0474383029108462,0.00376209728205012,0.0400645922380279,0.0548120135836644,2.98977265228764e-36
NMR metabolomics,X23412.Phospholipids in VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,0.0277003571145074,0.00219847437023305,0.0233913473488507,0.0320093668801642,3.1568656214413e-36
NMR metabolomics,X23412.Phospholipids in VLDL,SERPING1,Plasma protease C1 inhibitor,37981,0.0215559441591593,0.00171054980450807,0.0182032665423235,0.0249086217759952,3.29771311866653e-36
NMR metabolomics,X23412.Phospholipids in VLDL,CD83,CD83 antigen,40341,0.0388858567422536,0.00308731993996343,0.0328347096599253,0.0449370038245819,3.33581774354542e-36
NMR metabolomics,X23412.Phospholipids in VLDL,MZT1,Mitotic-spindle organizing protein 1,39980,0.0609698897434732,0.00484102471432041,0.0514814813034051,0.0704582981835412,3.40597249022087e-36
NMR metabolomics,X23412.Phospholipids in VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,0.11934092662836,0.00947822796479372,0.100763599817365,0.137918253439356,3.78138348121272e-36
NMR metabolomics,X23412.Phospholipids in VLDL,SCRG1,Scrapie-responsive protein 1,37990,0.0317576444767739,0.00252474208382366,0.0268091499924795,0.0367061389610683,4.40769773955636e-36
NMR metabolomics,X23412.Phospholipids in VLDL,HNMT,Histamine N-methyltransferase,40147,0.0535427259537956,0.00426170894597266,0.0451897764196892,0.061895675487902,4.9852066096595e-36
NMR metabolomics,X23412.Phospholipids in VLDL,IFT20,Intraflagellar transport protein 20 homolog,37572,0.0498331190687095,0.00396838319236184,0.0420550880116803,0.0576111501257387,5.81745411884293e-36
NMR metabolomics,X23412.Phospholipids in VLDL,TST,Thiosulfate sulfurtransferase,39923,0.0873760867841232,0.0069652256209569,0.0737242445670477,0.101027929001199,6.3632894547722e-36
NMR metabolomics,X23412.Phospholipids in VLDL,HSPB6,Heat shock protein beta-6,40489,0.0419360607766094,0.00334915869343749,0.0353717097374719,0.0485004118157468,8.38756885557456e-36
NMR metabolomics,X23412.Phospholipids in VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,40291,0.0495173765806799,0.0039607618701826,0.041754283315122,0.0572804698462378,1.07324113038611e-35
NMR metabolomics,X23412.Phospholipids in VLDL,TPP1,Tripeptidyl-peptidase 1,40255,0.0512600538757648,0.00410133105717388,0.043221445003704,0.0592986627478256,1.12328282689223e-35
NMR metabolomics,X23412.Phospholipids in VLDL,BAG3,BAG family molecular chaperone regulator 3,40203,0.0454853857774656,0.0036447112880111,0.0383417516529638,0.0526290199019673,1.41699081068559e-35
NMR metabolomics,X23412.Phospholipids in VLDL,AGXT,Serine--pyruvate aminotransferase,40359,0.088011936809683,0.00705264683708782,0.0741887490089909,0.101835124610375,1.42142740814696e-35
NMR metabolomics,X23412.Phospholipids in VLDL,KLRD1,Natural killer cells antigen CD94,40516,0.0522032566968149,0.00418595278121215,0.0439987892456391,0.0604077241479908,1.5685416719841e-35
NMR metabolomics,X23412.Phospholipids in VLDL,TTF2,Transcription termination factor 2,37572,0.0558399508734146,0.00447706162023519,0.0470649100977536,0.0646149916490756,1.67723790022413e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,0.0329539910245991,0.00264506237586625,0.0277696687679013,0.038138313281297,1.98274075191436e-35
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP5,Microfibrillar-associated protein 5,40536,0.046751982222994,0.00376197811913316,0.039378505109493,0.054125459336495,2.69172832257069e-35
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS3BP,Galectin-3-binding protein,38013,0.0338031784591778,0.00272291621743775,0.0284662626729998,0.0391400942453557,3.3935374977864e-35
NMR metabolomics,X23412.Phospholipids in VLDL,ATG4A,Cysteine protease ATG4A,39980,0.067818230588316,0.00546534366038098,0.0571061570139693,0.0785303041626628,3.43888451634388e-35
NMR metabolomics,X23412.Phospholipids in VLDL,OXT,Oxytocin-neurophysin 1,40471,0.150550321756444,0.0121349915473973,0.126765738323545,0.174334905189343,3.50471069574963e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CFB,Complement factor B,37770,0.0374121481094506,0.00301546722342662,0.0315018323515344,0.0433224638673668,3.75627027810728e-35
NMR metabolomics,X23412.Phospholipids in VLDL,SCARA5,Scavenger receptor class A member 5,40471,0.0333634748545062,0.00269086950795406,0.0280893706189162,0.0386375790900961,3.84651545803716e-35
NMR metabolomics,X23412.Phospholipids in VLDL,AK2,"Adenylate kinase 2, mitochondrial",37942,0.120135557090991,0.00969569400948532,0.1011319968324,0.139139117349582,4.55810808842589e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CCL2,C-C motif chemokine 2,40203,0.0601840053625828,0.00486037252178712,0.05065767521988,0.0697103355052855,4.72688135844533e-35
NMR metabolomics,X23412.Phospholipids in VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,0.0745591213400462,0.00602203717395799,0.0627559284790885,0.0863623142010038,4.84373243206199e-35
NMR metabolomics,X23412.Phospholipids in VLDL,ANG,Angiogenin,40309,0.0391295779266385,0.00316237859531882,0.0329313158798136,0.0453278399734633,5.27714423607117e-35
NMR metabolomics,X23412.Phospholipids in VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,0.135476130762895,0.0109512314685255,0.114011717084585,0.156940544441205,5.44544891972216e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CEMIP2,Cell surface hyaluronidase,37598,0.0384583914533463,0.00311098543932934,0.0323608599922608,0.0445559229144318,6.54713618955612e-35
NMR metabolomics,X23412.Phospholipids in VLDL,TPK1,Thiamin pyrophosphokinase 1,37990,0.0307953515776179,0.0024927417797023,0.0259095776894013,0.0356811254658344,7.14227929266852e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CD74,HLA class II histocompatibility antigen gamma chain,40471,0.0393809189076252,0.00319133503117043,0.0331259022465312,0.0456359355687193,7.94463175957499e-35
NMR metabolomics,X23412.Phospholipids in VLDL,FOXO3,Forkhead box protein O3,39980,0.109842263905892,0.00890261058263882,0.0923931471639203,0.127291380647864,8.2102054657721e-35
NMR metabolomics,X23412.Phospholipids in VLDL,ACRBP,Acrosin-binding protein,37900,0.0428787206282556,0.00348236836078319,0.0360532786411205,0.0497041626153907,1.18359507977513e-34
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM1,Intercellular adhesion molecule 1,40291,0.0322048100500449,0.00261811971458652,0.0270732954094553,0.0373363246906345,1.29129757803997e-34
NMR metabolomics,X23412.Phospholipids in VLDL,CD164,Sialomucin core protein 24,40332,0.0299456144311677,0.00243663311909055,0.0251698135177503,0.0347214153445852,1.47613401907207e-34
NMR metabolomics,X23412.Phospholipids in VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,37959,0.0443514739370526,0.00361225560606857,0.0372714529491582,0.051431494924947,1.81393465799979e-34
NMR metabolomics,X23412.Phospholipids in VLDL,FAP,Prolyl endopeptidase FAP,40536,0.0304121147805348,0.00248228278301387,0.0255468405258276,0.035277389035242,2.34157793520001e-34
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL1,Growth-regulated alpha protein,40329,0.109331604774926,0.00892563295142003,0.0918373641901428,0.126825845359709,2.42527852545998e-34
NMR metabolomics,X23412.Phospholipids in VLDL,NID1,Nidogen-1,40355,0.0444566181829819,0.00362940891608863,0.0373429767074482,0.0515702596585156,2.42903694919455e-34
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAL,Integrin alpha-L,37598,0.049213551322714,0.00401659458100507,0.0413410259439441,0.0570860767014839,2.5049544331744e-34
NMR metabolomics,X23412.Phospholipids in VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,-0.0508496295421142,0.00415447328198009,-0.0589923971747951,-0.0427068619094332,2.71309292085847e-34
NMR metabolomics,X23412.Phospholipids in VLDL,ASGR2,Asialoglycoprotein receptor 2,37987,0.0291119144435415,0.00237827626640684,0.0244504929613841,0.0337733359256989,2.85698750849985e-34
NMR metabolomics,X23412.Phospholipids in VLDL,ITPA,Inosine triphosphate pyrophosphatase,37562,0.0765552919551583,0.00625737429084609,0.0642908383451,0.0888197455652167,3.12844392385196e-34
NMR metabolomics,X23412.Phospholipids in VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,0.0673500832598256,0.00550863074186724,0.0565531670057658,0.0781469995138854,3.20841701503922e-34
NMR metabolomics,X23412.Phospholipids in VLDL,CEBPB,CCAAT/enhancer-binding protein beta,40042,0.0424323733081929,0.00347196663436193,0.0356273187048436,0.0492374279115423,3.42454292644728e-34
NMR metabolomics,X23412.Phospholipids in VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,0.0549976335890103,0.00449874327975313,0.0461800967606942,0.0638151704173265,3.49935857905553e-34
NMR metabolomics,X23412.Phospholipids in VLDL,MDK,Midkine,40352,0.0567174840875068,0.0046549276296922,0.0475938259333101,0.0658411422417035,5.33663043683519e-34
NMR metabolomics,X23412.Phospholipids in VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.0269809051821851,0.00221621870084195,0.0226371165285348,0.0313246938358353,6.03578972578435e-34
NMR metabolomics,X23412.Phospholipids in VLDL,FRMD4B,FERM domain-containing protein 4B,37562,0.0789221961317456,0.00648947546737846,0.0662028242156838,0.0916415680478074,7.57563814359158e-34
NMR metabolomics,X23412.Phospholipids in VLDL,CD40LG,CD40 ligand,40516,0.0853292983233252,0.00702565820078483,0.0715590082497869,0.0990995883968635,8.53752747721953e-34
NMR metabolomics,X23412.Phospholipids in VLDL,RGS10,Regulator of G-protein signaling 10,37959,0.0669372647327958,0.00550906448839483,0.0561394983355419,0.0777350311300496,8.56800867608232e-34
NMR metabolomics,X23412.Phospholipids in VLDL,PSAP,Prosaposin,37901,0.0317529098607838,0.0026166759067103,0.0266242250836317,0.036881594637936,1.03595654368578e-33
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,37671,0.0407135479875488,0.00335822559692818,0.0341314258175695,0.047295670157528,1.19573258752278e-33
NMR metabolomics,X23412.Phospholipids in VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,0.101095082243783,0.00834975174427027,0.0847295688250129,0.117460595662552,1.43734939485973e-33
NMR metabolomics,X23412.Phospholipids in VLDL,BTC,Probetacellulin,39980,0.0837637348300247,0.00692154741470224,0.0701975018972083,0.0973299677628411,1.4616222583555e-33
NMR metabolomics,X23412.Phospholipids in VLDL,IL10RB,Interleukin-10 receptor subunit beta,40422,0.0315900895210525,0.00261330017139141,0.0264680211851253,0.0367121578569796,1.70755953696932e-33
NMR metabolomics,X23412.Phospholipids in VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,0.0631162853550672,0.00521888051085618,0.052887279553789,0.0733452911563453,1.71429759027497e-33
NMR metabolomics,X23412.Phospholipids in VLDL,AFP,Alpha-fetoprotein,40182,0.0772626601364582,0.00639213333480303,0.0647340788002443,0.0897912414726721,1.73817071603955e-33
NMR metabolomics,X23412.Phospholipids in VLDL,PKN3,Serine/threonine-protein kinase N3,37714,0.0855242214512691,0.0071003383894345,0.0716075582079775,0.0994408846945607,3.0689206127152e-33
NMR metabolomics,X23412.Phospholipids in VLDL,ARFIP1,Arfaptin-1,37959,0.0759584688195818,0.00631676888133216,0.0635776018121708,0.0883393358269929,3.88171198982425e-33
NMR metabolomics,X23412.Phospholipids in VLDL,C19orf12,Protein C19orf12,39961,0.0685721968423932,0.00570850385046165,0.0573835292954884,0.079760864389298,4.29481318102823e-33
NMR metabolomics,X23412.Phospholipids in VLDL,CPXM1,Probable carboxypeptidase X1,40411,0.0757597174211203,0.00631134020464743,0.0633894906200114,0.0881299442222293,4.71289393931068e-33
NMR metabolomics,X23412.Phospholipids in VLDL,PARD3,Partitioning defective 3 homolog,37714,0.0820188621444289,0.00683057761579821,0.0686309300174644,0.0954067942713934,4.80833277741861e-33
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,0.0605094442264627,0.00504904060704308,0.0506133246366582,0.0704055638162671,5.96699360967012e-33
NMR metabolomics,X23412.Phospholipids in VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,0.0746291975377248,0.00622640431538658,0.0624254450795671,0.0868329499958825,6.25840666949072e-33
NMR metabolomics,X23412.Phospholipids in VLDL,CD84,SLAM family member 5,40341,0.0338549921473264,0.00282889093222297,0.0283103659201694,0.0393996183744834,7.27326625937511e-33
NMR metabolomics,X23412.Phospholipids in VLDL,IMMT,MICOS complex subunit MIC60,37900,0.0489323135474612,0.00408888703516211,0.0409180949585434,0.0569465321363789,7.7527949278158e-33
NMR metabolomics,X23412.Phospholipids in VLDL,ACYP1,Acylphosphatase-1,37622,0.0727478348433751,0.0060852794438201,0.0608206871334877,0.0846749825532625,9.06220400008533e-33
NMR metabolomics,X23412.Phospholipids in VLDL,WDR46,WD repeat-containing protein 46,37900,0.0391380071334319,0.00327414000880865,0.0327206927161669,0.0455553215506968,9.10283226575139e-33
NMR metabolomics,X23412.Phospholipids in VLDL,ASAH1,Acid ceramidase,37882,0.0507347804718441,0.00424642113121454,0.0424117950546636,0.0590577658890246,9.78412556880921e-33
NMR metabolomics,X23412.Phospholipids in VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,0.0584201288144558,0.0048916507555895,0.0488324933335004,0.0680077642954113,1.04483075593154e-32
NMR metabolomics,X23412.Phospholipids in VLDL,GET3,ATPase GET3,37990,0.0617222013841433,0.00516873811207092,0.0515914746844843,0.0718529280838023,1.0503017960834e-32
NMR metabolomics,X23412.Phospholipids in VLDL,BMPER,BMP-binding endothelial regulator protein,37671,0.0246767343976888,0.00206746860597699,0.0206244959299739,0.0287289728654037,1.13448320817409e-32
NMR metabolomics,X23412.Phospholipids in VLDL,RNASEH2A,Ribonuclease H2 subunit A,37959,0.0542802729284123,0.00455040264417936,0.0453614837458208,0.0631990621110039,1.22361069147235e-32
NMR metabolomics,X23412.Phospholipids in VLDL,RAB10,Ras-related protein Rab-10,37990,0.0588725874853692,0.0049370751853888,0.0491959201220072,0.0685492548487312,1.28340446418812e-32
NMR metabolomics,X23412.Phospholipids in VLDL,ARAF,Serine/threonine-protein kinase A-Raf,37714,0.0735600417944228,0.00618290972139143,0.0614415387404956,0.08567854484835,1.78764017893398e-32
NMR metabolomics,X23412.Phospholipids in VLDL,NFAT5,Nuclear factor of activated T-cells 5,37598,0.0958443088249417,0.00806859318834708,0.0800298661757814,0.111658751474102,2.23638666607533e-32
NMR metabolomics,X23412.Phospholipids in VLDL,CORO1A,Coronin-1A,39990,0.0980589407603391,0.00826762203831867,0.0818544015652345,0.114263479955444,2.61382009850653e-32
NMR metabolomics,X23412.Phospholipids in VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,0.0838525227844389,0.00708104529640917,0.0699736740034769,0.0977313715654009,3.42813204829005e-32
NMR metabolomics,X23412.Phospholipids in VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,0.129996207565464,0.0109910644027299,0.108453721336114,0.151538693794815,3.83771423509181e-32
NMR metabolomics,X23412.Phospholipids in VLDL,APOA2,Apolipoprotein A-II,37987,-0.0517793960316428,0.00437739962596657,-0.0603590992985372,-0.0431996927647483,3.98824329153194e-32
NMR metabolomics,X23412.Phospholipids in VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,0.0693863701913639,0.00588009858391972,0.0578613769668813,0.0809113634158466,5.33600743512809e-32
NMR metabolomics,X23412.Phospholipids in VLDL,SLC27A4,Long-chain fatty acid transport protein 4,39961,0.0720641748741494,0.00611015268710189,0.0600882756074297,0.0840400741408691,5.72906500795371e-32
NMR metabolomics,X23412.Phospholipids in VLDL,SPOCK1,Testican-1,40228,0.0272802040208017,0.00231378579924918,0.0227451838542733,0.0318152241873301,5.96515530800169e-32
NMR metabolomics,X23412.Phospholipids in VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,39980,0.0830623512528725,0.00705443032555119,0.0692356678147921,0.0968890346909528,7.21815627052456e-32
NMR metabolomics,X23412.Phospholipids in VLDL,CD1C,T-cell surface glycoprotein CD1c,40411,0.0258835264571775,0.00219914101107166,0.0215732100754771,0.0301938428388779,7.56089659147218e-32
NMR metabolomics,X23412.Phospholipids in VLDL,EGFL7,Epidermal growth factor-like protein 7,39980,0.0434925156032693,0.00370828156282265,0.0362242837401369,0.0507607474664016,1.23835442611661e-31
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G15,Phospholipase A2 group XV,40411,0.0276975449948628,0.00236312845719391,0.0230658132187628,0.0323292767709629,1.3451752195856e-31
NMR metabolomics,X23412.Phospholipids in VLDL,GBP1,Guanylate-binding protein 1,37931,0.0694363632770254,0.00592198586509981,0.0578292709814298,0.0810434555726211,1.3481891006269e-31
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP1,Metalloproteinase inhibitor 1,40167,0.0302689605511161,0.00258368938278543,0.0252049293608567,0.0353329917413756,1.43797494973643e-31
NMR metabolomics,X23412.Phospholipids in VLDL,SWAP70,Switch-associated protein 70,37901,0.0378998150005463,0.00323593717315512,0.0315573781411623,0.0442422518599303,1.57095842520268e-31
NMR metabolomics,X23412.Phospholipids in VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,0.0885099901546551,0.00756588696401458,0.0736808517051866,0.103339128604124,1.74512335250391e-31
NMR metabolomics,X23412.Phospholipids in VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,0.0439713412736574,0.00376078128853509,0.0366002099481287,0.0513424725991862,2.00372825494056e-31
NMR metabolomics,X23412.Phospholipids in VLDL,DPP4,Dipeptidyl peptidase 4,40068,0.0320462989373732,0.00274622349732211,0.0266637008826219,0.0374288969921245,2.4700496750702e-31
NMR metabolomics,X23412.Phospholipids in VLDL,SNX9,Sorting nexin-9,40359,0.0735878092903897,0.00630717309139273,0.0612257500312599,0.0859498685495195,2.51175354783911e-31
NMR metabolomics,X23412.Phospholipids in VLDL,FGF2,Fibroblast growth factor 2,40341,0.0708839759295739,0.00608227857921884,0.058962709914305,0.0828052419448429,2.92802375501839e-31
NMR metabolomics,X23412.Phospholipids in VLDL,ARSA,Arylsulfatase A,40332,0.0476956686108505,0.00409311506708986,0.0396731630793544,0.0557181741423466,2.98089348887263e-31
NMR metabolomics,X23412.Phospholipids in VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,0.0488168892083399,0.00418953531968549,0.0406053999817564,0.0570283784349235,3.16221922930967e-31
NMR metabolomics,X23412.Phospholipids in VLDL,PALM,Paralemmin-1,37824,0.0314153560161299,0.00269652896574207,0.0261301592432754,0.0367005527889843,3.23568637193587e-31
NMR metabolomics,X23412.Phospholipids in VLDL,BAP18,Chromatin complexes subunit BAP18,37942,0.0692991613585386,0.00595914752388611,0.0576192322117218,0.0809790905053553,4.12863339218253e-31
NMR metabolomics,X23412.Phospholipids in VLDL,NBN,Nibrin,40044,0.0543629886322025,0.00467882100361803,0.0451924994651112,0.0635334777992939,4.43384861262709e-31
NMR metabolomics,X23412.Phospholipids in VLDL,GSR,"Glutathione reductase, mitochondrial",37944,0.0236872011562133,0.00203805638422198,0.0196926106431382,0.0276817916692883,4.4563830141433e-31
NMR metabolomics,X23412.Phospholipids in VLDL,FGL1,Fibrinogen-like protein 1,37987,-0.0671641783288871,0.00577891921008543,-0.0784908599806545,-0.0558374966771197,4.46053572454362e-31
NMR metabolomics,X23412.Phospholipids in VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,0.0936920967516139,0.00806767982608159,0.077879444292494,0.109504749210734,4.73635601623908e-31
NMR metabolomics,X23412.Phospholipids in VLDL,RAD23B,UV excision repair protein RAD23 homolog B,39980,0.050759599671871,0.00437801185197096,0.0421786964420079,0.0593405029017341,5.91333812488792e-31
NMR metabolomics,X23412.Phospholipids in VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,0.052684412783999,0.00454681951133353,0.0437726465417853,0.0615961790262127,6.81617578879241e-31
NMR metabolomics,X23412.Phospholipids in VLDL,ZNRD2,Protein ZNRD2,37901,0.0724094201436291,0.00625979674397817,0.0601402185254319,0.0846786217618263,8.43403891450826e-31
NMR metabolomics,X23412.Phospholipids in VLDL,VWC2,Brorin,40167,0.0412882573695926,0.00357553100847957,0.0342802165929727,0.0482962981462126,1.01170533580256e-30
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC134,Coiled-coil domain-containing protein 134,37900,0.0522240436836409,0.00452204705320446,0.0433608314593601,0.0610872559079216,1.04530825338978e-30
NMR metabolomics,X23412.Phospholipids in VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,0.0944589423692744,0.00818376751656028,0.0784187580368162,0.110499126701733,1.13341875529546e-30
NMR metabolomics,X23412.Phospholipids in VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,0.0573955092301048,0.0049811092918505,0.0476325350180778,0.0671584834421318,1.35111470373472e-30
NMR metabolomics,X23412.Phospholipids in VLDL,DPT,Dermatopontin,40536,0.0279756129281447,0.00243165778655592,0.0232095636664951,0.0327416621897944,1.6435521388759e-30
NMR metabolomics,X23412.Phospholipids in VLDL,NPC2,NPC intracellular cholesterol transporter 2,37815,0.0328164328278347,0.00285363731693278,0.0272233036866465,0.038409561969023,1.83777967777833e-30
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJC21,DnaJ homolog subfamily C member 21,37942,0.0397756593683905,0.00346068796462157,0.0329927109577322,0.0465586077790487,1.96920753947733e-30
NMR metabolomics,X23412.Phospholipids in VLDL,CSTB,Cystatin-B,40097,0.0441141033282955,0.00384681375747418,0.0365743483636461,0.0516538582929449,2.53371569502775e-30
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC80,Coiled-coil domain-containing protein 80,40359,0.0369952852053916,0.00322870396639475,0.0306670254312579,0.0433235449795253,2.81058952628834e-30
NMR metabolomics,X23412.Phospholipids in VLDL,KLF4,Krueppel-like factor 4,37541,0.0412801576085978,0.00360106183945968,0.0342220764032569,0.0483382388139388,2.81168625103409e-30
NMR metabolomics,X23412.Phospholipids in VLDL,IMPA1,Inositol monophosphatase 1,40228,0.064194431445837,0.00560248819756327,0.053213554578613,0.075175308313061,2.81843136665014e-30
NMR metabolomics,X23412.Phospholipids in VLDL,DNM1,Dynamin-1,37901,0.119553165509383,0.0104391702384079,0.0990923918421038,0.140013939176663,3.15916967657955e-30
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,0.0255650336732675,0.00223911800915233,0.0211763623753289,0.0299537049712061,4.48261168527363e-30
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA4,Annexin A4,40279,0.075176163852852,0.006589695243084,0.0622603611764074,0.0880919665292967,4.98900662660209e-30
NMR metabolomics,X23412.Phospholipids in VLDL,CBLN4,Cerebellin-4,40489,0.0329960127035391,0.00289478975248823,0.0273222247886621,0.038669800618416,5.55423923422245e-30
NMR metabolomics,X23412.Phospholipids in VLDL,FCN1,Ficolin-1,37967,0.0591839634823305,0.0051927131952301,0.0490062456196795,0.0693616813449815,5.89559491021965e-30
NMR metabolomics,X23412.Phospholipids in VLDL,FXN,"Frataxin, mitochondrial",40489,0.0773295550342047,0.00679457733339632,0.064012183460748,0.0906469266076615,6.76673894776493e-30
NMR metabolomics,X23412.Phospholipids in VLDL,IL12A_IL12B,Interleukin-12,40305,0.0819911418969581,0.00720452920196407,0.0678702646611085,0.0961120191328077,6.83152284397944e-30
NMR metabolomics,X23412.Phospholipids in VLDL,MATN2,Matrilin-2,40379,0.0309443418705621,0.00272493351745135,0.0256034721763575,0.0362852115647668,9.01335957901888e-30
NMR metabolomics,X23412.Phospholipids in VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,0.0726612374878845,0.00639885930150103,0.0601194732569425,0.0852030017188265,9.0919024529172e-30
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,0.043709272450637,0.00384958317926538,0.0361640894192769,0.0512544554819972,9.24208212127563e-30
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX6,Peroxiredoxin-6,40489,-0.0623837330553189,0.00549601117146206,-0.0731559149513846,-0.0516115511592533,9.55167572327472e-30
NMR metabolomics,X23412.Phospholipids in VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,0.0796240610946163,0.00701870640849442,0.0658673965339672,0.0933807256552653,1.07590574400002e-29
NMR metabolomics,X23412.Phospholipids in VLDL,FAM3C,Protein FAM3C,40330,0.0308769493472838,0.00272640480381782,0.0255331959318009,0.0362207027627667,1.27966400814676e-29
NMR metabolomics,X23412.Phospholipids in VLDL,PPM1F,Protein phosphatase 1F,37990,0.0544829725904473,0.0048159106750351,0.0450437876673785,0.0639221575135161,1.53341693325721e-29
NMR metabolomics,X23412.Phospholipids in VLDL,PDZD2,PDZ domain-containing protein 2,37562,0.0640485845057612,0.00566401852112161,0.0529471082043628,0.0751500608071595,1.64125189754644e-29
NMR metabolomics,X23412.Phospholipids in VLDL,FAM3B,Protein FAM3B,40305,0.0374448714014335,0.00331893896064579,0.0309397510385677,0.0439499917642992,2.08041150563158e-29
NMR metabolomics,X23412.Phospholipids in VLDL,EFNA4,Ephrin-A4,40203,0.0305349050357769,0.00270859521427483,0.0252260584157983,0.0358437516557556,2.3023887842468e-29
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4A,C-type lectin domain family 4 member A,40341,-0.0355847458133326,0.00316174893365844,-0.0417817737233032,-0.0293877179033621,2.83158347724497e-29
NMR metabolomics,X23412.Phospholipids in VLDL,CCN4,CCN family member 4,40489,0.0421629932075408,0.00376131547895598,0.0347908148687871,0.0495351715462945,4.68951891411894e-29
NMR metabolomics,X23412.Phospholipids in VLDL,WAS,Wiskott-Aldrich syndrome protein,40044,0.0702526844965004,0.00627122003781256,0.0579610932223878,0.082544275770613,5.12209452472814e-29
NMR metabolomics,X23412.Phospholipids in VLDL,MRI1,Methylthioribose-1-phosphate isomerase,37572,0.0710844019484271,0.00634679251244971,0.0586446886240256,0.0835241152728285,5.51539987144205e-29
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,0.0657923919611055,0.00588198208653403,0.0542637070714988,0.0773210768507122,6.16348339727606e-29
NMR metabolomics,X23412.Phospholipids in VLDL,TSNAX,Translin-associated protein X,37562,0.0406120444488551,0.00363956628539736,0.0334784945294762,0.0477455943682339,8.77315768330786e-29
NMR metabolomics,X23412.Phospholipids in VLDL,DKK4,Dickkopf-related protein 4,40203,0.0466750428143489,0.0041937373500001,0.0384553176083487,0.0548947680203491,1.15039518495952e-28
NMR metabolomics,X23412.Phospholipids in VLDL,SPINT2,Kunitz-type protease inhibitor 2,40422,0.0428406246565687,0.00385224198798651,0.0352902303601152,0.0503910189530223,1.2636771867468e-28
NMR metabolomics,X23412.Phospholipids in VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,40422,-0.0210409815179599,0.00189293827191061,-0.0247511405309047,-0.0173308225050151,1.34256029920701e-28
NMR metabolomics,X23412.Phospholipids in VLDL,TNF,Tumor necrosis factor,40014,0.0406395983264356,0.00365893358619262,0.0334680884974981,0.0478111081553732,1.48589822763316e-28
NMR metabolomics,X23412.Phospholipids in VLDL,IGF1R,Insulin-like growth factor 1 receptor,40305,0.0224123306657362,0.00201998411073392,0.0184531618086978,0.0263714995227747,1.68349925729407e-28
NMR metabolomics,X23412.Phospholipids in VLDL,LGMN,Legumain,40422,0.0361689679099787,0.00326017404776732,0.0297790267763548,0.0425589090436026,1.70150582988031e-28
NMR metabolomics,X23412.Phospholipids in VLDL,PECAM1,Platelet endothelial cell adhesion molecule,40332,0.0305106276599503,0.00275081904258221,0.0251190223364892,0.0359022329834114,1.75587290083993e-28
NMR metabolomics,X23412.Phospholipids in VLDL,HPCAL1,Hippocalcin-like protein 1,40516,0.0746792980306722,0.00673666285483811,0.0614754388351895,0.0878831572261549,1.87088071001933e-28
NMR metabolomics,X23412.Phospholipids in VLDL,POMC,Pro-opiomelanocortin,37628,0.0696319329427376,0.00627950612548989,0.0573241009367774,0.0819397649486977,1.90050357304963e-28
NMR metabolomics,X23412.Phospholipids in VLDL,BOLA2_BOLA2B,BolA-like protein 2,37628,0.0571042901863294,0.00515958653239787,0.0469915005828296,0.0672170797898292,2.40156040945722e-28
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL1,Fc receptor-like protein 1,40359,0.0457586874313246,0.00413866037285067,0.0376469131005373,0.0538704617621119,2.58839904407109e-28
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS27,Serine protease 27,40314,0.0411082656687867,0.00371965587771876,0.0338177401484579,0.0483987911891155,2.73040009828865e-28
NMR metabolomics,X23412.Phospholipids in VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,0.0401927460780158,0.00363668122459499,0.0330648508778096,0.047320641278222,2.83343799603104e-28
NMR metabolomics,X23412.Phospholipids in VLDL,EPCAM,Epithelial cell adhesion molecule,40358,-0.101135798845983,0.0091683434038553,-0.119105751917539,-0.0831658457744267,3.42780871797973e-28
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,40063,0.0430356527951244,0.00390130714981116,0.0353890907814946,0.0506822148087543,3.43894409624838e-28
NMR metabolomics,X23412.Phospholipids in VLDL,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.0380987069670274,0.00345621469708682,0.0313245261607372,0.0448728877733175,3.75430345278414e-28
NMR metabolomics,X23412.Phospholipids in VLDL,ESAM,Endothelial cell-selective adhesion molecule,40536,0.0316460564827539,0.00287460160512019,0.0260118373367183,0.0372802756287894,4.36371162440747e-28
NMR metabolomics,X23412.Phospholipids in VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,0.0317150998512597,0.00288013865497249,0.0260700280875137,0.0373601716150058,4.42886659527779e-28
NMR metabolomics,X23412.Phospholipids in VLDL,CD46,Membrane cofactor protein,40250,0.0289752467134684,0.00263412047038268,0.0238123705915183,0.0341381228354184,4.83189190144114e-28
NMR metabolomics,X23412.Phospholipids in VLDL,ENAH,Protein enabled homolog,40044,0.0478135256819081,0.00434956155881347,0.0392883850266337,0.0563386663371825,5.2490143017064e-28
NMR metabolomics,X23412.Phospholipids in VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,0.0682119347529191,0.00620594729152753,0.0560482780615252,0.0803755914443131,5.55678451989277e-28
NMR metabolomics,X23412.Phospholipids in VLDL,ING1,Inhibitor of growth protein 1,39925,0.0450994030439688,0.00410499760666168,0.0370536077349119,0.0531451983530257,5.63318088797999e-28
NMR metabolomics,X23412.Phospholipids in VLDL,GRK5,G protein-coupled receptor kinase 5,40042,0.0531097823163949,0.00483762206228874,0.043628043074309,0.0625915215584809,6.1380090191629e-28
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC3B,Tetranectin,37681,0.0212944355593607,0.00194021928863826,0.0174916057536298,0.0250972653650917,6.62978068773389e-28
NMR metabolomics,X23412.Phospholipids in VLDL,DMD,Dystrophin,37628,0.0525477591477294,0.00478869216844677,0.0431619224975737,0.0619335957978851,6.78218015996982e-28
NMR metabolomics,X23412.Phospholipids in VLDL,OPLAH,5-oxoprolinase,37628,0.0686864328079007,0.00626795379658503,0.056401243366594,0.0809716222492073,7.98919244898581e-28
NMR metabolomics,X23412.Phospholipids in VLDL,BPIFA2,BPI fold-containing family A member 2,37150,-0.112019965734837,0.0102249452039587,-0.132060858334596,-0.0919790731350777,8.32284429502879e-28
NMR metabolomics,X23412.Phospholipids in VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,0.0281950199725637,0.00258255188401829,0.0231332182798878,0.0332568216652395,1.25015014124398e-27
NMR metabolomics,X23412.Phospholipids in VLDL,PTGDS,Prostaglandin-H2 D-isomerase,40234,0.0296303101256349,0.00271569842680377,0.0243075412090995,0.0349530790421703,1.28516826747664e-27
NMR metabolomics,X23412.Phospholipids in VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,0.0743744976309445,0.00681846653526581,0.0610103032218235,0.0877386920400655,1.32798964253321e-27
NMR metabolomics,X23412.Phospholipids in VLDL,ENO2,Gamma-enolase,40471,0.0658862109528408,0.00604387643412318,0.0540402131419593,0.0777322087637222,1.41981519247051e-27
NMR metabolomics,X23412.Phospholipids in VLDL,AMOT,Angiomotin,37671,0.0418683201401752,0.00384181654698455,0.0343383597080855,0.0493982805722649,1.54192379305001e-27
NMR metabolomics,X23412.Phospholipids in VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,0.0941433676473698,0.00866893459558843,0.0771522558400165,0.111134479454723,2.23808707069009e-27
NMR metabolomics,X23412.Phospholipids in VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,39980,0.0358922047512105,0.00330688174392494,0.0294107165331176,0.0423736929693034,2.39853141096712e-27
NMR metabolomics,X23412.Phospholipids in VLDL,CCS,Copper chaperone for superoxide dismutase,40228,0.0481783151876832,0.00444222185346392,0.0394715603548939,0.0568850700204725,2.6139831325012e-27
NMR metabolomics,X23412.Phospholipids in VLDL,EPPK1,Epiplakin,37628,0.0734572136342637,0.00677301499925799,0.0601821042357181,0.0867323230328094,2.72949016814467e-27
NMR metabolomics,X23412.Phospholipids in VLDL,GIP,Gastric inhibitory polypeptide,37628,0.0515578291032645,0.00475880440874213,0.0422305724621299,0.060885085744399,3.08739552996226e-27
NMR metabolomics,X23412.Phospholipids in VLDL,DYNLT3,Dynein light chain Tctex-type 3,37900,0.0434081665448298,0.0040085276420719,0.0355514523663688,0.0512648807232907,3.25040782747592e-27
NMR metabolomics,X23412.Phospholipids in VLDL,GNAS,Neuroendocrine secretory protein 55,37959,0.0898033815857329,0.00830784491982295,0.0735200055428799,0.106086757628586,4.00860118070954e-27
NMR metabolomics,X23412.Phospholipids in VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,0.0284844366293401,0.00263992627815231,0.0233101811241616,0.0336586921345186,4.98594801785663e-27
NMR metabolomics,X23412.Phospholipids in VLDL,SOD1,Superoxide dismutase [Cu-Zn],39978,0.0485190064867303,0.00450710462990053,0.0396850814121253,0.0573529315613353,6.26799275034536e-27
NMR metabolomics,X23412.Phospholipids in VLDL,DSCAM,Down syndrome cell adhesion molecule,37959,0.0349184015653759,0.00324309034853633,0.0285619444822447,0.0412748586485072,6.33670843840216e-27
NMR metabolomics,X23412.Phospholipids in VLDL,PQBP1,Polyglutamine-binding protein 1,39980,0.0545109833775333,0.00507295645183656,0.0445679887319337,0.064453978023133,7.74022984838661e-27
NMR metabolomics,X23412.Phospholipids in VLDL,DCTN6,Dynactin subunit 6,39961,0.0699149603791158,0.00650839042778517,0.0571585151406569,0.0826714056175747,8.00701651784184e-27
NMR metabolomics,X23412.Phospholipids in VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,0.0299806929719913,0.00279198137016242,0.024508409486473,0.0354529764575097,8.31632332151602e-27
NMR metabolomics,X23412.Phospholipids in VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,0.0614074978615377,0.00571785736640663,0.0502004974233807,0.0726144982996947,8.50313084226689e-27
NMR metabolomics,X23412.Phospholipids in VLDL,SH3BP1,SH3 domain-binding protein 1,37901,0.0461476358619725,0.00430316609616059,0.0377134303134977,0.0545818414104472,1.00585048152646e-26
NMR metabolomics,X23412.Phospholipids in VLDL,LAMA4,Laminin subunit alpha-4,40422,0.0322478610028884,0.00301357544791864,0.0263412531249678,0.0381544688808089,1.24128368428245e-26
NMR metabolomics,X23412.Phospholipids in VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,0.0442825852412483,0.00413759154347178,0.0361729058160436,0.052392264666453,1.27507161758098e-26
NMR metabolomics,X23412.Phospholipids in VLDL,PTGES2,Prostaglandin E synthase 2,37484,0.0538975923099637,0.00504123067001946,0.0440167801967255,0.0637784044232018,1.43966566095479e-26
NMR metabolomics,X23412.Phospholipids in VLDL,TREML1,Trem-like transcript 1 protein,37987,0.0519223667907196,0.00485795736428318,0.0424007703567246,0.0614439632247147,1.47665834516671e-26
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,0.0706672114406168,0.00662037606859187,0.0576912743461767,0.0836431485350568,1.6594830017408e-26
NMR metabolomics,X23412.Phospholipids in VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,37990,0.058467681803953,0.00549165258703982,0.047704042733355,0.069231320874551,2.29815331638845e-26
NMR metabolomics,X23412.Phospholipids in VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,0.0267324465531845,0.00251336078120772,0.0218062594220174,0.0316586336843516,2.48153897454521e-26
NMR metabolomics,X23412.Phospholipids in VLDL,ALCAM,CD166 antigen,40536,0.0189510829291494,0.00178225911660727,0.0154578550605991,0.0224443107976996,2.55431163500139e-26
NMR metabolomics,X23412.Phospholipids in VLDL,THBD,Thrombomodulin,40359,0.0270653573497035,0.00255153723737985,0.022064344364439,0.032066370334968,3.36522571271109e-26
NMR metabolomics,X23412.Phospholipids in VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,0.0600176126097846,0.00566345178465506,0.0489172471118607,0.0711179781077085,3.76519198874399e-26
NMR metabolomics,X23412.Phospholipids in VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,0.0435129248038913,0.00410662699376883,0.0354639358961044,0.0515619137116782,3.97086380137526e-26
NMR metabolomics,X23412.Phospholipids in VLDL,KITLG,Kit ligand,40359,-0.0353524823276335,0.00334630305010148,-0.0419112363058324,-0.0287937283494346,5.29995489472451e-26
NMR metabolomics,X23412.Phospholipids in VLDL,AMOTL2,Angiomotin-like protein 2,37855,0.0467339089278028,0.00443341424022253,0.0380444170169667,0.055423400838639,7.03617944337926e-26
NMR metabolomics,X23412.Phospholipids in VLDL,XCL1,Lymphotactin,40489,0.0545575920641037,0.00518323339013719,0.0443984546194348,0.0647167295087726,7.97736370050103e-26
NMR metabolomics,X23412.Phospholipids in VLDL,SF3B4,Splicing factor 3B subunit 4,40305,0.0710027350115444,0.00674700147169955,0.0577786121270133,0.0842268578960755,8.18158644631585e-26
NMR metabolomics,X23412.Phospholipids in VLDL,MMP12,Macrophage metalloelastase,40346,0.0500059342758432,0.00476101535954168,0.0406743441711415,0.0593375243805449,1.01367738773875e-25
NMR metabolomics,X23412.Phospholipids in VLDL,PTN,Pleiotrophin,40042,0.0483168720828351,0.00461712644855592,0.0392673042436655,0.0573664399220047,1.52463694961603e-25
NMR metabolomics,X23412.Phospholipids in VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,0.0563650261003554,0.00539366009145504,0.0457934523211035,0.0669365998796073,1.77019451396467e-25
NMR metabolomics,X23412.Phospholipids in VLDL,NPPB,Natriuretic peptides B,40042,-0.123343541717135,0.0118097748253205,-0.146490700374763,-0.100196383059507,1.89014827233734e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CFHR5,Complement factor H-related protein 5,37785,0.0402052018789029,0.00385166062024122,0.0326559470632301,0.0477544566945757,2.074363891237e-25
NMR metabolomics,X23412.Phospholipids in VLDL,BOLA1,BolA-like protein 1,37541,0.0527140971930037,0.00505282037843953,0.0428105692512622,0.0626176251347452,2.2130858425154e-25
NMR metabolomics,X23412.Phospholipids in VLDL,UNC79,Protein unc-79 homolog,37482,0.0544020892470938,0.00521671991820233,0.0441773182074173,0.0646268602867704,2.31463550512884e-25
NMR metabolomics,X23412.Phospholipids in VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,37990,0.0310638452133922,0.0029822718299201,0.0252185924267488,0.0369090980000355,2.60747107978825e-25
NMR metabolomics,X23412.Phospholipids in VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,0.0486817623768618,0.00467685774800279,0.0395151211907764,0.0578484035629473,2.71312532212112e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CASP8,Caspase-8,40434,0.05914575145408,0.00568938472793693,0.0479945573873236,0.0702969455208364,3.11805655273734e-25
NMR metabolomics,X23412.Phospholipids in VLDL,NGRN,Neugrin,37942,0.0210907755747909,0.00202840544687135,0.0171151008989231,0.0250664502506588,3.16271909335194e-25
NMR metabolomics,X23412.Phospholipids in VLDL,ROBO2,Roundabout homolog 2,40471,0.0222518450554077,0.00214168275762072,0.0180541468504711,0.0264495432603443,3.31496939879405e-25
NMR metabolomics,X23412.Phospholipids in VLDL,IL6R,Interleukin-6 receptor subunit alpha,40273,0.0321065811571561,0.00309464350001737,0.026041079897122,0.0381720824171901,3.88389037932196e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CR1,Complement receptor type 1,37959,0.0346153696442899,0.00333927436477613,0.0280703918893286,0.0411603473992511,4.39010311318968e-25
NMR metabolomics,X23412.Phospholipids in VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,0.0388390639135132,0.00374717040095341,0.0314946099276445,0.0461835178993819,4.4728907370631e-25
NMR metabolomics,X23412.Phospholipids in VLDL,KIF22,Kinesin-like protein KIF22,37562,0.11692881882861,0.0112856042534631,0.0948090344918223,0.139048603165398,4.66628575428287e-25
NMR metabolomics,X23412.Phospholipids in VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,0.0871561705403747,0.00841255107826766,0.0706675704269701,0.103644770653779,4.69156408626647e-25
NMR metabolomics,X23412.Phospholipids in VLDL,TLR3,Toll-like receptor 3,40516,0.0577677129962005,0.0055987859015639,0.0467940926291353,0.0687413333632658,6.99459010974358e-25
NMR metabolomics,X23412.Phospholipids in VLDL,SCG2,Secretogranin-2,40392,0.0305530911670653,0.00296642795192673,0.0247388923812889,0.0363672899528416,8.46052784263233e-25
NMR metabolomics,X23412.Phospholipids in VLDL,NID2,Nidogen-2,40332,0.0698295757793909,0.00678427695987727,0.0565323929380315,0.0831267586207504,9.07895819102128e-25
NMR metabolomics,X23412.Phospholipids in VLDL,STXBP3,Syntaxin-binding protein 3,39980,0.0418373683329201,0.0040650393607231,0.0338698911859028,0.0498048454799374,9.19686823626773e-25
NMR metabolomics,X23412.Phospholipids in VLDL,APOD,Apolipoprotein D,37345,-0.0422443255150073,0.00410638279002876,-0.0502928357834637,-0.034195815246551,1.00004809190681e-24
NMR metabolomics,X23412.Phospholipids in VLDL,CCL25,C-C motif chemokine 25,40516,0.0460929821377782,0.00449249146991727,0.0372876988567403,0.054898265418816,1.2710276480599e-24
NMR metabolomics,X23412.Phospholipids in VLDL,CTSE,Cathepsin E,37671,0.0487352317645235,0.00475012092119663,0.0394249947589781,0.0580454687700689,1.32248081855677e-24
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA9,Serpin A9,40228,0.0679888905060873,0.00663407074655588,0.0549861118428378,0.0809916691693368,1.43602875047545e-24
NMR metabolomics,X23412.Phospholipids in VLDL,EGFR,Epidermal growth factor receptor,40536,0.0153777695807869,0.00150445671590548,0.0124290344176121,0.0183265047439616,1.88753598343167e-24
NMR metabolomics,X23412.Phospholipids in VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,0.109499566173418,0.01072154954502,0.0884853290651792,0.130513803281658,2.12807617869165e-24
NMR metabolomics,X23412.Phospholipids in VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,0.026201641066301,0.00256888749645776,0.0211666215732437,0.0312366605593582,2.3639645577016e-24
NMR metabolomics,X23412.Phospholipids in VLDL,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.0304492292297396,0.00298542544379835,0.0245977953598948,0.0363006630995843,2.37010775722073e-24
NMR metabolomics,X23412.Phospholipids in VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,37901,0.10617320111881,0.0104356010931392,0.0857194229762576,0.126626979261363,3.16591921963578e-24
NMR metabolomics,X23412.Phospholipids in VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,40453,0.0618906325294407,0.00608646442136214,0.0499611622635709,0.0738201027953105,3.24507946159659e-24
NMR metabolomics,X23412.Phospholipids in VLDL,BRK1,Protein BRICK1,39961,0.041339665947576,0.004067092217041,0.0333681652021757,0.0493111666929764,3.40318208750737e-24
NMR metabolomics,X23412.Phospholipids in VLDL,STK4,Serine/threonine-protein kinase 4,40359,0.0801434487347433,0.00790292063155099,0.0646537242969034,0.0956331731725833,4.30176918108242e-24
NMR metabolomics,X23412.Phospholipids in VLDL,PSMG3,Proteasome assembly chaperone 3,40341,0.0477782433392851,0.0047129153839053,0.0385409291868307,0.0570155574917395,4.44788306792132e-24
NMR metabolomics,X23412.Phospholipids in VLDL,PMM2,Phosphomannomutase 2,37562,0.0565330602910647,0.00558209491661624,0.0455921542544968,0.0674739663276325,5.10936463826972e-24
NMR metabolomics,X23412.Phospholipids in VLDL,ABCA2,ATP-binding cassette sub-family A member 2,37562,0.0345497173148125,0.00341715991277646,0.0278520838857706,0.0412473507438543,6.06521143021526e-24
NMR metabolomics,X23412.Phospholipids in VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,37942,0.028044405664644,0.00277686370292933,0.0226017528069025,0.0334870585223855,6.76499266904393e-24
NMR metabolomics,X23412.Phospholipids in VLDL,STX16,Syntaxin-16,39980,0.0547120833642792,0.00543599085883263,0.0440575412809672,0.0653666254475911,9.34972096148041e-24
NMR metabolomics,X23412.Phospholipids in VLDL,ASS1,Argininosuccinate synthase,37562,0.0744617213644579,0.00741345049841229,0.0599313583875699,0.088992084341346,1.18714476899895e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.0508797040324937,0.00507840104724206,0.0409260379798992,0.0608333700850881,1.47706507773616e-23
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,0.0304704858211821,0.00304226302591084,0.0245076502903968,0.0364333213519673,1.52618609175859e-23
NMR metabolomics,X23412.Phospholipids in VLDL,TGFA,Protransforming growth factor alpha,40341,0.0441193480394768,0.00440760554048589,0.0354804411801245,0.0527582548988292,1.62014162479834e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,0.0538821221092043,0.00538342307775659,0.0433306128768014,0.0644336313416072,1.68195952746617e-23
NMR metabolomics,X23412.Phospholipids in VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,0.0399243564548764,0.00398977334432554,0.0321044006999984,0.0477443122097545,1.72876648636716e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CD302,CD302 antigen,40305,0.0276576291611897,0.00276845863429538,0.0222314502379707,0.0330838080844086,1.97220576440322e-23
NMR metabolomics,X23412.Phospholipids in VLDL,EFCAB2,Dynein regulatory complex protein 8,37714,0.0319636468213774,0.00320394020636105,0.0256839240169097,0.038243369625845,2.33807861020521e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CCL20,C-C motif chemokine 20,40516,0.0813001975464163,0.00815567624946861,0.0653150720974578,0.0972853229953748,2.44639626800289e-23
NMR metabolomics,X23412.Phospholipids in VLDL,NAA10,N-alpha-acetyltransferase 10,37562,0.0471939857242768,0.00473965818873801,0.0379042556743503,0.0564837157742033,2.83578933341047e-23
NMR metabolomics,X23412.Phospholipids in VLDL,COLEC12,Collectin-12,40357,0.0232452042905225,0.00234893652486823,0.0186412887017807,0.0278491198792642,5.04705826631841e-23
NMR metabolomics,X23412.Phospholipids in VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,0.0491157798652775,0.00496269333243325,0.0393889009337084,0.0588426587968467,5.1643330688536e-23
NMR metabolomics,X23412.Phospholipids in VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,-0.0277780632851984,0.0028124008187694,-0.0332903688899864,-0.0222657576804104,6.09659278431063e-23
NMR metabolomics,X23412.Phospholipids in VLDL,IL12B,Interleukin-12 subunit beta,40516,0.0492195756926807,0.00498980856110318,0.0394395509129185,0.058999600472443,6.92431184369601e-23
NMR metabolomics,X23412.Phospholipids in VLDL,MAGED1,Melanoma-associated antigen D1,39980,0.0440265519775699,0.00447302360065706,0.035259425720282,0.0527936782348577,8.59552654075135e-23
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1F,V-type proton ATPase subunit F,39925,0.0598802949951477,0.00608384104236163,0.0479559665521189,0.0718046234381765,8.61448585690631e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,0.0863106700712861,0.00877085903358091,0.0691197863654675,0.103501553777105,8.75465479506149e-23
NMR metabolomics,X23412.Phospholipids in VLDL,ERI1,3'-5' exoribonuclease 1,37714,0.0304648272535599,0.00309897506323362,0.024390836129622,0.0365388183774978,9.93840510198006e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,0.0436758861296841,0.00444712790456468,0.0349595154367374,0.0523922568226309,1.05822540523942e-22
NMR metabolomics,X23412.Phospholipids in VLDL,TPMT,Thiopurine S-methyltransferase,39980,0.0668408246196975,0.00680924349885403,0.0534947073619435,0.0801869418774514,1.11637299753391e-22
NMR metabolomics,X23412.Phospholipids in VLDL,GLO1,Lactoylglutathione lyase,40042,0.0534397715621105,0.00544718221854905,0.0427632944137544,0.0641162487104667,1.17962200643326e-22
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,37671,0.0344000067690148,0.00350602134842486,0.0275282049261021,0.0412718086119275,1.19811443213172e-22
NMR metabolomics,X23412.Phospholipids in VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,0.0469771022980421,0.00479148779479569,0.0375857862202426,0.0563684183758417,1.25030420567603e-22
NMR metabolomics,X23412.Phospholipids in VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,0.0394835358158527,0.0040295392979213,0.0315856387919269,0.0473814328397784,1.32847164088324e-22
NMR metabolomics,X23412.Phospholipids in VLDL,IFNAR1,Interferon alpha/beta receptor 1,37901,0.0238513448220812,0.00243508151841873,0.0190785850459805,0.0286241045981819,1.40915562792259e-22
NMR metabolomics,X23412.Phospholipids in VLDL,CLSTN3,Calsyntenin-3,37942,0.027530984830327,0.00281702352303332,0.0220096187251817,0.0330523509354723,1.74458263763982e-22
NMR metabolomics,X23412.Phospholipids in VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,0.0614552347651905,0.00629493968633685,0.0491171529799703,0.0737933165504107,1.93199689130637e-22
NMR metabolomics,X23412.Phospholipids in VLDL,FRZB,Secreted frizzled-related protein 3,40176,0.0239185985607467,0.00245380472276919,0.0191091413041191,0.0287280558173743,2.18657892029096e-22
NMR metabolomics,X23412.Phospholipids in VLDL,STX6,Syntaxin-6,39980,0.0616942150577692,0.00633731384696923,0.0492730799177095,0.0741153501978289,2.47509418204487e-22
NMR metabolomics,X23412.Phospholipids in VLDL,RPE,Ribulose-phosphate 3-epimerase,37714,0.0627265870736652,0.00644392365753716,0.0500964967048924,0.0753566774424381,2.55894022525472e-22
NMR metabolomics,X23412.Phospholipids in VLDL,LAMB1,Laminin subunit beta-1,37628,0.0264205568698156,0.00272009252441207,0.021089175521968,0.0317519382176633,3.14764692711503e-22
NMR metabolomics,X23412.Phospholipids in VLDL,ERMAP,Erythroid membrane-associated protein,37598,0.0402075689094643,0.00414322184781298,0.0320868540877509,0.0483282837311777,3.42695186742955e-22
NMR metabolomics,X23412.Phospholipids in VLDL,MSTN,Growth/differentiation factor 8,40042,0.0456204465040118,0.00470535458134631,0.036397951524573,0.0548429414834506,3.64178963451824e-22
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,0.0310032360178829,0.00320050045840123,0.0247302551194165,0.0372762169163494,3.94678494355821e-22
NMR metabolomics,X23412.Phospholipids in VLDL,DENR,Density-regulated protein,37598,0.0514432220239618,0.00531548891615975,0.0410248637482887,0.0618615802996349,4.43134535318719e-22
NMR metabolomics,X23412.Phospholipids in VLDL,BMP6,Bone morphogenetic protein 6,40024,0.0376324450043166,0.00389400037285946,0.030000204273512,0.0452646857351211,4.93415214476551e-22
NMR metabolomics,X23412.Phospholipids in VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,0.0331139243035728,0.00343237741446266,0.026386464571226,0.0398413840359196,5.77638807034683e-22
NMR metabolomics,X23412.Phospholipids in VLDL,NADK,NAD kinase,40359,0.0474815580700761,0.00492448477418406,0.0378295679126753,0.0571335482274769,6.10578268998732e-22
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,0.0338112447268105,0.00350796544413768,0.0269356324563007,0.0406868569973204,6.30868330310049e-22
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS7_LGALS7B,Galectin-7,40270,0.0356353217275377,0.00369962315516401,0.0283840603434162,0.0428865831116591,6.71771913182116e-22
NMR metabolomics,X23412.Phospholipids in VLDL,LTA,Lymphotoxin-alpha,40341,0.0356116274255157,0.00370485960267573,0.0283501026042713,0.0428731522467601,8.14640421966629e-22
NMR metabolomics,X23412.Phospholipids in VLDL,C7orf50,Uncharacterized protein C7orf50,37942,0.0194382588722392,0.0020227039467176,0.0154737591366727,0.0234027586078057,8.5169706703658e-22
NMR metabolomics,X23412.Phospholipids in VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,37910,0.0363358514621523,0.00378263171842013,0.0289218932940488,0.0437498096302557,8.86088191511548e-22
NMR metabolomics,X23412.Phospholipids in VLDL,PZP,Pregnancy zone protein,38013,0.0577030461087751,0.0060093643589969,0.0459246919651412,0.0694814002524091,9.17885584218098e-22
NMR metabolomics,X23412.Phospholipids in VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,0.0772251545837717,0.00804298246947943,0.0614609089435921,0.0929894002239514,9.26793040131871e-22
NMR metabolomics,X23412.Phospholipids in VLDL,CPQ,Carboxypeptidase Q,37986,0.0323402789386446,0.00336895653483875,0.0257371241303607,0.0389434337469286,9.42323829798314e-22
NMR metabolomics,X23412.Phospholipids in VLDL,TXN,Thioredoxin,37819,0.0393852517089947,0.00410783316329918,0.0313338987089284,0.0474366047090611,1.05631970773898e-21
NMR metabolomics,X23412.Phospholipids in VLDL,STX7,Syntaxin-7,37598,0.0445266432516469,0.00464640508021651,0.0354196892944226,0.0536335972088713,1.10933088154141e-21
NMR metabolomics,X23412.Phospholipids in VLDL,FGA,Fibrinogen alpha chain,37698,0.0271801280145571,0.00283705651416167,0.0216194972468002,0.0327407587823139,1.13639474842651e-21
NMR metabolomics,X23412.Phospholipids in VLDL,CFHR4,Complement factor H-related protein 4,37973,0.0648286193101202,0.00676775327517655,0.0515638228907741,0.0780934157294662,1.14749427990423e-21
NMR metabolomics,X23412.Phospholipids in VLDL,GLRX,Glutaredoxin-1,40260,0.0498503103796232,0.00521000795092051,0.039638694795819,0.0600619259634274,1.24515708435758e-21
NMR metabolomics,X23412.Phospholipids in VLDL,C5,Complement C5,38013,0.0134864033404084,0.00140980204674546,0.0107231913287873,0.0162496153520295,1.29806027921797e-21
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.0313827339767244,0.00328856150034173,0.0249371534360546,0.0378283145173942,1.62247043010101e-21
NMR metabolomics,X23412.Phospholipids in VLDL,IL17RB,Interleukin-17 receptor B,40126,-0.0469085940763689,0.00491771621740972,-0.0565473178624919,-0.0372698702902458,1.65450147488759e-21
NMR metabolomics,X23412.Phospholipids in VLDL,DCTN2,Dynactin subunit 2,40305,0.0825405036455197,0.00865356378012461,0.0655795186364755,0.099501488654564,1.65786856902724e-21
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL1,Angiopoietin-related protein 1,40136,0.0258867195003105,0.00272019718716786,0.0205551330134615,0.0312183059871595,2.04635095713133e-21
NMR metabolomics,X23412.Phospholipids in VLDL,FGR,Tyrosine-protein kinase Fgr,39961,0.048414210073695,0.00508801096709287,0.038441708578193,0.0583867115691971,2.07178842916821e-21
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA3,Protein disulfide-isomerase A3,37671,0.0223904960754575,0.00235592410770889,0.0177728848243481,0.027008107326567,2.36509996951086e-21
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,0.0196116296028045,0.00206423046121564,0.0155657378988218,0.0236575213067871,2.42958395693211e-21
NMR metabolomics,X23412.Phospholipids in VLDL,S100P,Protein S100-P,40042,0.0467210333046721,0.00493267874218773,0.0370529829699842,0.0563890836393601,3.13886978151248e-21
NMR metabolomics,X23412.Phospholipids in VLDL,MMP1,Interstitial collagenase,39757,0.0809058520512872,0.00855248927196668,0.0641429730782325,0.0976687310243419,3.52095033731983e-21
NMR metabolomics,X23412.Phospholipids in VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,0.0300304432131938,0.00317736617602811,0.0238028055081787,0.0362580809182089,3.80218246489568e-21
NMR metabolomics,X23412.Phospholipids in VLDL,APLP1,Amyloid-like protein 1,40359,-0.0452106108481567,0.00478622366078409,-0.0545916092232935,-0.0358296124730199,3.99919388535606e-21
NMR metabolomics,X23412.Phospholipids in VLDL,HDGF,Hepatoma-derived growth factor,40471,0.0830044870802052,0.00878762190733032,0.0657807481418378,0.100228226018573,4.00984728576255e-21
NMR metabolomics,X23412.Phospholipids in VLDL,UMOD,Uromodulin,40502,-0.0468950480472096,0.0049835438950572,-0.0566627940815217,-0.0371273020128974,5.61977266805319e-21
NMR metabolomics,X23412.Phospholipids in VLDL,CGA,Glycoprotein hormones alpha chain,40332,0.0774760721969785,0.00824734503128462,0.0613112759356607,0.0936408684582964,6.54103872922813e-21
NMR metabolomics,X23412.Phospholipids in VLDL,LY75,Lymphocyte antigen 75,40341,0.0336288661664863,0.00358168771003971,0.0266087582548085,0.0406489740781642,6.85360140157201e-21
NMR metabolomics,X23412.Phospholipids in VLDL,SPAG1,Sperm-associated antigen 1,37959,0.0497679172314346,0.00530699540293131,0.0393662062416893,0.06016962822118,7.79373364095336e-21
NMR metabolomics,X23412.Phospholipids in VLDL,ADA,Adenosine deaminase,40516,0.0293146515583368,0.00312807521067107,0.0231836241454215,0.0354456789712521,8.08386204982605e-21
NMR metabolomics,X23412.Phospholipids in VLDL,APRT,Adenine phosphoribosyltransferase,40216,0.041826362613724,0.0044635046166092,0.03307789356517,0.0505748316622781,8.15791102921279e-21
NMR metabolomics,X23412.Phospholipids in VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,0.0322840421546378,0.00344527348564113,0.0255313061227812,0.0390367781864944,8.16637889195615e-21
NMR metabolomics,X23412.Phospholipids in VLDL,ENTR1,Endosome-associated-trafficking regulator 1,37628,0.0491115279676765,0.00525334591002415,0.0388149699840291,0.0594080859513238,1.02920884805432e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,0.0411597927992555,0.00440657432395475,0.0325229071243042,0.0497966784742068,1.08590318185805e-20
NMR metabolomics,X23412.Phospholipids in VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,37998,0.0428947603779533,0.00459353459773175,0.0338914325663991,0.0518980881895075,1.13176360404563e-20
NMR metabolomics,X23412.Phospholipids in VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,0.0411478820981945,0.00441050748350456,0.0325032874305255,0.0497924767658634,1.22709784437412e-20
NMR metabolomics,X23412.Phospholipids in VLDL,FEN1,Flap endonuclease 1,39980,0.0531840780780568,0.00570396531694481,0.042004306056845,0.0643638500992686,1.26762873481045e-20
NMR metabolomics,X23412.Phospholipids in VLDL,BRDT,Bromodomain testis-specific protein,37562,0.03204843139846,0.00343966198097375,0.0253066939157515,0.0387901688811686,1.38122474285108e-20
NMR metabolomics,X23412.Phospholipids in VLDL,MTUS1,Microtubule-associated tumor suppressor 1,37714,0.0475960819309733,0.00510873357615308,0.0375829641217132,0.0576091997402333,1.38810546146147e-20
NMR metabolomics,X23412.Phospholipids in VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,37959,0.0446496831195628,0.00479337717172916,0.0352546638629736,0.0540447023761519,1.40723287150561e-20
NMR metabolomics,X23412.Phospholipids in VLDL,BST2,Bone marrow stromal antigen 2,40471,0.0458164756842297,0.00492700488794511,0.0361595461038573,0.0554734052646021,1.59603191660868e-20
NMR metabolomics,X23412.Phospholipids in VLDL,C7,Complement component C7,37678,-0.0270285699238251,0.00290696938097574,-0.0327262299105376,-0.0213309099371127,1.65491467753228e-20
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB8,Serpin B8,40516,0.0465377538601154,0.00501646390049117,0.0367054846151527,0.0563700231050781,1.96048402867347e-20
NMR metabolomics,X23412.Phospholipids in VLDL,NEK7,Serine/threonine-protein kinase Nek7,37714,0.0648441568360977,0.00699522493696182,0.0511335159596525,0.0785547977125428,2.14959529844136e-20
NMR metabolomics,X23412.Phospholipids in VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,-0.0996502330981229,0.010761775790801,-0.120743313648093,-0.078557152548153,2.30978933310096e-20
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC25,Leucine-rich repeat-containing protein 25,40305,0.0330757088357244,0.00357630799558319,0.0260661451643814,0.0400852725070675,2.55936707376348e-20
NMR metabolomics,X23412.Phospholipids in VLDL,AK1,Adenylate kinase isoenzyme 1,40359,0.0542371237447566,0.00588212719045405,0.0427081544514667,0.0657660930380465,3.31531219236126e-20
NMR metabolomics,X23412.Phospholipids in VLDL,ADM,Pro-adrenomedullin,40489,0.0228473897959148,0.00247817496690942,0.0179901668607724,0.0277046127310573,3.35000846817568e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,37990,0.0213657193193853,0.00231892256536441,0.016820631091271,0.0259108075474995,3.61040779421558e-20
NMR metabolomics,X23412.Phospholipids in VLDL,FSHB,Follitropin subunit beta,37628,0.0593462799918717,0.0064444036397466,0.0467152488579684,0.071977311125775,3.78417892985753e-20
NMR metabolomics,X23412.Phospholipids in VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,0.0550371693902544,0.00597732575506654,0.043321610910324,0.0667527278701848,3.83020067988967e-20
NMR metabolomics,X23412.Phospholipids in VLDL,RGMB,RGM domain family member B,40471,0.0219905030083982,0.00238920485637519,0.0173076614899028,0.0266733445268936,3.86207123943127e-20
NMR metabolomics,X23412.Phospholipids in VLDL,FABP6,Gastrotropin,40017,0.0473223086035273,0.00514217985341774,0.0372436360908285,0.0574009811162261,3.92320051670486e-20
NMR metabolomics,X23412.Phospholipids in VLDL,XRCC4,DNA repair protein XRCC4,39961,0.0315475402126543,0.0034303964685666,0.0248239631342637,0.0382711172910448,4.16057015227419e-20
NMR metabolomics,X23412.Phospholipids in VLDL,SLIT2,Slit homolog 2 protein,39961,0.044414389109219,0.0048306103519833,0.0349463928193317,0.0538823853991063,4.24245567727684e-20
NMR metabolomics,X23412.Phospholipids in VLDL,KLK7,Kallikrein-7,37352,0.0328536300718651,0.0035766082963234,0.0258434778110712,0.039863782332659,4.7061613099924e-20
NMR metabolomics,X23412.Phospholipids in VLDL,LIPF,Gastric triacylglycerol lipase,37628,0.0505469681718006,0.00550985820905875,0.0397476460820454,0.0613462902615557,5.23116370988488e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CLTA,Clathrin light chain A,40042,0.0399893789191558,0.00436217414514036,0.0314395175946807,0.0485392402436309,5.44387040085807e-20
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP1,Rho GTPase-activating protein 1,39980,0.0386966759033653,0.00422227129554461,0.0304210241640979,0.0469723276426328,5.56872803294148e-20
NMR metabolomics,X23412.Phospholipids in VLDL,PNLIP,Pancreatic triacylglycerol lipase,37987,0.0509212138688449,0.00556370778871569,0.0400163466029622,0.0618260811347277,6.35555486898712e-20
NMR metabolomics,X23412.Phospholipids in VLDL,PIGR,Polymeric immunoglobulin receptor,40154,0.0295906229435574,0.00323814879810808,0.0232438512992655,0.0359373945878492,7.11625930541015e-20
NMR metabolomics,X23412.Phospholipids in VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,0.0456059110308892,0.00499288325993154,0.0358198598414234,0.055391962220355,7.51322844179005e-20
NMR metabolomics,X23412.Phospholipids in VLDL,TCOF1,Treacle protein,37990,0.0254554628688648,0.0027883913219137,0.019990215877914,0.0309207098598157,7.87327175446184e-20
NMR metabolomics,X23412.Phospholipids in VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,0.0460703771104104,0.00504821884178289,0.0361758681805159,0.0559648860403049,8.10158897542328e-20
NMR metabolomics,X23412.Phospholipids in VLDL,SV2A,Synaptic vesicle glycoprotein 2A,37572,0.0519800726116911,0.00569889797939181,0.0408102325720831,0.063149912651299,8.50893308278376e-20
NMR metabolomics,X23412.Phospholipids in VLDL,DDX58,Antiviral innate immune response receptor RIG-I,39980,0.0480149668281967,0.00526659644185004,0.0376924378021707,0.0583374958542228,8.66040320688626e-20
NMR metabolomics,X23412.Phospholipids in VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.0320397121560455,0.00351544053536934,0.0251494487067215,0.0389299756053694,8.86938438288063e-20
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA2,Annexin A2,37441,0.0599385550790444,0.00659500747564653,0.0470123404267772,0.0728647697313116,1.14831299747255e-19
NMR metabolomics,X23412.Phospholipids in VLDL,CA4,Carbonic anhydrase 4,40536,-0.0195129685067861,0.00214852482085956,-0.0237240771556709,-0.0153018598579014,1.18713450512332e-19
NMR metabolomics,X23412.Phospholipids in VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,0.0246327324945278,0.00271288185211793,0.0193154840643767,0.0299499809246789,1.21287786422896e-19
NMR metabolomics,X23412.Phospholipids in VLDL,RAB6A,Ras-related protein Rab-6A,40341,0.0399045185723247,0.0043966844515391,0.0312870170473081,0.0485220200973413,1.25550951056721e-19
NMR metabolomics,X23412.Phospholipids in VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,0.0316389209305055,0.00348692012032944,0.0248045574946598,0.0384732843663512,1.28397148440629e-19
NMR metabolomics,X23412.Phospholipids in VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,0.0239275160435162,0.00263670680646384,0.018759570702847,0.0290954613841853,1.29973135169837e-19
NMR metabolomics,X23412.Phospholipids in VLDL,HRG,Histidine-rich glycoprotein,37934,0.0263276714216479,0.00290627231679012,0.0206313776807393,0.0320239651625566,1.49656205595725e-19
NMR metabolomics,X23412.Phospholipids in VLDL,PER3,Period circadian protein homolog 3,37598,0.0985428183383585,0.0109036391099392,0.0771716856828777,0.119913950993839,1.82264279490923e-19
NMR metabolomics,X23412.Phospholipids in VLDL,MMP3,Stromelysin-1,40332,-0.0401946329693894,0.00444900275708245,-0.048914678373271,-0.0314745875655078,1.83329776194088e-19
NMR metabolomics,X23412.Phospholipids in VLDL,MEP1B,Meprin A subunit beta,40359,0.0984203420492472,0.0108944651128959,0.0770671904279711,0.119773493670523,1.84215671646104e-19
NMR metabolomics,X23412.Phospholipids in VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,37790,0.0466915742792803,0.00517381549334053,0.0365508959123328,0.0568322526462277,2.04759661286589e-19
NMR metabolomics,X23412.Phospholipids in VLDL,TREH,Trehalase,37998,0.0618464927385727,0.00686432168758185,0.0483924222309122,0.0753005632462331,2.33608011704542e-19
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,0.0298668163357184,0.00331571841004274,0.0233680082520346,0.0363656244194022,2.34027812541311e-19
NMR metabolomics,X23412.Phospholipids in VLDL,STAM,Signal transducing adapter molecule 1,37900,0.0311860657729003,0.0034635128921502,0.0243975805042859,0.0379745510415147,2.46157450791178e-19
NMR metabolomics,X23412.Phospholipids in VLDL,NECTIN2,Nectin-2,40330,0.0239347220857981,0.002659573550176,0.0187219579274531,0.029147486244143,2.52061804732951e-19
NMR metabolomics,X23412.Phospholipids in VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,37628,-0.0527541172205354,0.00586106947239798,-0.0642418133864354,-0.0412664210546353,2.54518494431917e-19
NMR metabolomics,X23412.Phospholipids in VLDL,BGN,Biglycan,39956,-0.100546820866333,0.0111911771341401,-0.122481528049247,-0.078612113683418,2.89422030780026e-19
NMR metabolomics,X23412.Phospholipids in VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,0.0351407743331482,0.00391737296059775,0.0274627233303767,0.0428188253359198,3.27422942405666e-19
NMR metabolomics,X23412.Phospholipids in VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,0.0271744881556086,0.00303143093491582,0.0212328835231736,0.0331160927880436,3.46185196432981e-19
NMR metabolomics,X23412.Phospholipids in VLDL,IL17D,Interleukin-17D,40044,0.0282723449813552,0.00315560687756699,0.0220873555013239,0.0344573344613865,3.62776438862285e-19
NMR metabolomics,X23412.Phospholipids in VLDL,ECI2,Enoyl-CoA delta isomerase 2,37562,0.0517955800599545,0.00579941907867633,0.0404287186657488,0.0631624414541601,4.77119525402823e-19
NMR metabolomics,X23412.Phospholipids in VLDL,CPA2,Carboxypeptidase A2,40398,0.0526450359629901,0.0058991887222653,0.0410826260673501,0.0642074458586301,4.97316869232919e-19
NMR metabolomics,X23412.Phospholipids in VLDL,HLA_E,,40341,0.0236752140935547,0.0026530020161014,0.018475330141996,0.0288750980451135,4.98306945619634e-19
NMR metabolomics,X23412.Phospholipids in VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,-0.0298362059521088,0.00335105416253832,-0.0364042721106839,-0.0232681397935337,6.11026591832899e-19
NMR metabolomics,X23412.Phospholipids in VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,0.0552277196943981,0.00620344922207065,0.0430689592191397,0.0673864801696566,6.15711868277355e-19
NMR metabolomics,X23412.Phospholipids in VLDL,ELOB,Elongin-B,37562,0.0330030781462903,0.00370974107533687,0.02573198563863,0.0402741706539505,6.52116169247325e-19
NMR metabolomics,X23412.Phospholipids in VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,0.0250585067165436,0.00281721829427991,0.019536758859755,0.0305802545733322,6.58752860783433e-19
NMR metabolomics,X23412.Phospholipids in VLDL,POSTN,Periostin,37998,-0.0310742302244032,0.00349399525837017,-0.0379224609308087,-0.0242259995179976,6.65579987518898e-19
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL2,Fc receptor-like protein 2,40442,0.0397978929235512,0.00447904533772849,0.0310189640616033,0.048576821785499,7.03907484216173e-19
NMR metabolomics,X23412.Phospholipids in VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,0.0835213832560831,0.00940009950844849,0.065097188219524,0.101945578292642,7.18457865032208e-19
NMR metabolomics,X23412.Phospholipids in VLDL,CAPG,Macrophage-capping protein,40185,0.0474275401096146,0.00534263728008731,0.0369559710406435,0.0578991091785857,7.58540084546722e-19
NMR metabolomics,X23412.Phospholipids in VLDL,COL15A1,Collagen alpha-1(XV) chain,37998,0.0212363752527239,0.00239176635291726,0.0165485132010061,0.0259242373044417,7.58823992435129e-19
NMR metabolomics,X23412.Phospholipids in VLDL,FGF23,Fibroblast growth factor 23,40469,0.0503744750815911,0.00567549074824458,0.0392505132150317,0.0614984369481505,7.66630431856702e-19
NMR metabolomics,X23412.Phospholipids in VLDL,INSR,Insulin receptor,37598,0.0138317038982536,0.00156086151620129,0.0107724153264991,0.0168909924700082,8.89231878084343e-19
NMR metabolomics,X23412.Phospholipids in VLDL,CHCHD6,MICOS complex subunit MIC25,37900,0.0236522616305163,0.00267558083428465,0.0184081231953184,0.0288964000657142,1.07442666980003e-18
NMR metabolomics,X23412.Phospholipids in VLDL,SMS,Spermine synthase,37541,0.0521299939066891,0.00589932083012142,0.0405673250796511,0.063692662733727,1.11130990523014e-18
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD1,Programmed cell death protein 1,40455,0.0355796837212873,0.0040299949153125,0.0276808936872748,0.0434784737552998,1.16671349494588e-18
NMR metabolomics,X23412.Phospholipids in VLDL,CCL19,C-C motif chemokine 19,40471,0.106422209384128,0.0120567723113538,0.0827909356538742,0.130053483114381,1.18710677186362e-18
NMR metabolomics,X23412.Phospholipids in VLDL,SCRIB,Protein scribble homolog,37628,0.0757603277260784,0.00858099834266625,0.0589415709744525,0.0925790844777042,1.18977307585734e-18
NMR metabolomics,X23412.Phospholipids in VLDL,CRYGD,Gamma-crystallin D,37942,0.0780447950746009,0.00884599295970292,0.0607066488735832,0.0953829412756186,1.25408302105334e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,0.0396257272967858,0.00449306964774918,0.0308193107871974,0.0484321438063742,1.26934784657297e-18
NMR metabolomics,X23412.Phospholipids in VLDL,TPR,Nucleoprotein TPR,37562,0.0381937048703517,0.00433865342355917,0.0296899441601757,0.0466974655805276,1.4957459171035e-18
NMR metabolomics,X23412.Phospholipids in VLDL,GRN,Progranulin,40262,0.0196511566040735,0.00223396496943494,0.015272585263981,0.024029727944166,1.55443845705015e-18
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL8,Interleukin-8,40209,0.0548586968854405,0.00624296506904955,0.0426224853501034,0.0670949084207776,1.68781328614326e-18
NMR metabolomics,X23412.Phospholipids in VLDL,HMOX1,Heme oxygenase 1,40184,-0.037932682032411,0.00431930196033265,-0.046398513874663,-0.029466850190159,1.76680972806633e-18
NMR metabolomics,X23412.Phospholipids in VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,0.0321342741106683,0.00366030210994923,0.0249600819751678,0.0393084662461688,1.84331898825281e-18
NMR metabolomics,X23412.Phospholipids in VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,0.0696452080253177,0.00794921071560412,0.0540647550227337,0.0852256610279018,2.1585067473747e-18
NMR metabolomics,X23412.Phospholipids in VLDL,AHCY,Adenosylhomocysteinase,40359,0.0545712676080342,0.0062385249758481,0.0423437586553719,0.0667987765606965,2.39735032479019e-18
NMR metabolomics,X23412.Phospholipids in VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,0.0564554241985935,0.00647604926382625,0.043762367641494,0.0691484807556929,3.18004327525873e-18
NMR metabolomics,X23412.Phospholipids in VLDL,EDF1,Endothelial differentiation-related factor 1,37959,0.0558810084849791,0.00641763059356748,0.0433024525215868,0.0684595644483714,3.46593738524436e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ROBO1,Roundabout homolog 1,40379,0.0192756965853331,0.00221490634275543,0.0149344801535325,0.0236169130171337,3.55305146913196e-18
NMR metabolomics,X23412.Phospholipids in VLDL,VCAM1,Vascular cell adhesion protein 1,40372,-0.0216311405790651,0.00248707552730145,-0.026505808612576,-0.0167564725455543,3.72206256868595e-18
NMR metabolomics,X23412.Phospholipids in VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",40359,0.0579480914706475,0.00666469648201208,0.0448852863659039,0.0710108965753912,3.80938744825344e-18
NMR metabolomics,X23412.Phospholipids in VLDL,TSHB,Thyrotropin subunit beta,40359,0.067081261839065,0.00772033446319952,0.051949406291194,0.0822131173869361,4.01070015033417e-18
NMR metabolomics,X23412.Phospholipids in VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,0.0534179070720986,0.00615428620365336,0.041355506112938,0.0654803080312592,4.41471778569328e-18
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,40489,0.0430901928918827,0.00497139866315496,0.033346251512099,0.0528341342716664,4.82819058434854e-18
NMR metabolomics,X23412.Phospholipids in VLDL,PVR,Poliovirus receptor,40471,0.0292633409169887,0.00338241889285691,0.0226337998869891,0.0358928819469882,5.55351419158598e-18
NMR metabolomics,X23412.Phospholipids in VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,39961,0.0419874194342901,0.00485371381590036,0.0324741403551254,0.0515006985134548,5.61988400092265e-18
NMR metabolomics,X23412.Phospholipids in VLDL,CCL14,C-C motif chemokine 14,40309,0.0310152945822701,0.00358809107732963,0.023982636070704,0.0380479530938362,5.94187177626629e-18
NMR metabolomics,X23412.Phospholipids in VLDL,PRG2,Bone marrow proteoglycan,37998,-0.041580110864158,0.00481779409597122,-0.0510229872922616,-0.0321372344360544,6.78127304219182e-18
NMR metabolomics,X23412.Phospholipids in VLDL,PPL,Periplakin,37598,0.0263069627084141,0.00304942325502906,0.0203300931285571,0.032283832288271,7.02298130297416e-18
NMR metabolomics,X23412.Phospholipids in VLDL,GRSF1,G-rich sequence factor 1,37402,0.0628870229792306,0.00729084348993833,0.0485969697389514,0.0771770762195097,7.1195807293365e-18
NMR metabolomics,X23412.Phospholipids in VLDL,CD28,T-cell-specific surface glycoprotein CD28,39980,0.0285448587334715,0.00331435095624079,0.0220487308592396,0.0350409866077034,7.82662887641631e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB6,Integrin beta-6,40044,0.0237737449150363,0.00277968557820539,0.0183255611817537,0.0292219286483188,1.31312750261512e-17
NMR metabolomics,X23412.Phospholipids in VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,0.0395952140549056,0.00463187852872477,0.0305167321386051,0.0486736959712062,1.38426813315167e-17
NMR metabolomics,X23412.Phospholipids in VLDL,AMIGO2,Amphoterin-induced protein 2,40305,0.0177302446701937,0.0020770948217272,0.0136591388196084,0.021801350520779,1.5128594990042e-17
NMR metabolomics,X23412.Phospholipids in VLDL,NFASC,Neurofascin,40516,0.0213866556003062,0.00250562551246921,0.0164756295958665,0.0262976816047458,1.51928865690879e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CSNK1D,Casein kinase I isoform delta,37598,0.0502593205987531,0.00588706185077348,0.0387206793712371,0.0617979618262691,1.52426775388232e-17
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.0179432043865632,0.00210580679687565,0.0138158230646869,0.0220705857084395,1.722953433524e-17
NMR metabolomics,X23412.Phospholipids in VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,-0.0247613492899483,0.00290613442818301,-0.030457372769187,-0.0190653258107096,1.72961292268211e-17
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,0.0374336712367212,0.00439475435411933,0.0288199527026473,0.0460473897707951,1.7740181714293e-17
NMR metabolomics,X23412.Phospholipids in VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.0121417830797199,0.00142816025138412,0.00934258898700705,0.0149409771724328,2.03049699051663e-17
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,0.0372055908318804,0.0043759353236585,0.0286287575975097,0.045782424066251,2.05189394352181e-17
NMR metabolomics,X23412.Phospholipids in VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,0.0379480504492663,0.00447502596866719,0.0291769995506787,0.046719101347854,2.44862209070669e-17
NMR metabolomics,X23412.Phospholipids in VLDL,RANBP1,Ran-specific GTPase-activating protein,37628,0.0415638962922839,0.00490052704045346,0.0319588632929952,0.0511689292915727,2.45788276334751e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CNDP1,Beta-Ala-His dipeptidase,40403,0.0356362171807121,0.00420412841737204,0.0273961254826629,0.0438763088787613,2.52168929644959e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CIT,Citron Rho-interacting kinase,37572,0.0352410383173111,0.00416198898137485,0.0270835399138164,0.0433985367208058,2.7751236808668e-17
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,0.0292388779541401,0.00345441259324177,0.0224682292713862,0.0360095266368939,2.80306563224216e-17
NMR metabolomics,X23412.Phospholipids in VLDL,PAEP,Glycodelin,40228,-0.102578930327816,0.01212254631371,-0.126339121102687,-0.0788187395529441,2.86063884303906e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CASP9,Caspase-9,37598,0.0488337004941188,0.00577074238445007,0.0375230454205967,0.060144355567641,2.89710503553514e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CLU,Clusterin,38013,0.0258036928685734,0.00305368791955019,0.0198184645462551,0.0317889211908918,3.20713730874865e-17
NMR metabolomics,X23412.Phospholipids in VLDL,VGF,Neurosecretory protein VGF,37959,0.0237563134212097,0.00281275561287167,0.0182433124199812,0.0292693144224381,3.322064283567e-17
NMR metabolomics,X23412.Phospholipids in VLDL,LEPR,Leptin receptor,40359,-0.0237878419303345,0.00282273322976341,-0.0293203990606708,-0.0182552847999983,3.83877395996738e-17
NMR metabolomics,X23412.Phospholipids in VLDL,PVALB,Parvalbumin alpha,40417,0.0875712628769294,0.0104030051068677,0.0671813728674687,0.10796115288639,4.15530200704629e-17
NMR metabolomics,X23412.Phospholipids in VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,0.0322306152040289,0.00382975017524105,0.0247243048605565,0.0397369255475014,4.29992620784947e-17
NMR metabolomics,X23412.Phospholipids in VLDL,PRL,Prolactin,40471,-0.0593598285019772,0.00706415968749631,-0.07320558148947,-0.0455140755144844,4.71526096901157e-17
NMR metabolomics,X23412.Phospholipids in VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,0.0302567343630255,0.00361953654728275,0.0231624427303513,0.0373510259956997,6.93998768690422e-17
NMR metabolomics,X23412.Phospholipids in VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.0296348729200266,0.00355036724498237,0.0226761531198612,0.0365935927201921,7.58440680405198e-17
NMR metabolomics,X23412.Phospholipids in VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,0.0185909194296041,0.0022306216536784,0.0142189009883945,0.0229629378708138,8.42484507748909e-17
NMR metabolomics,X23412.Phospholipids in VLDL,COL24A1,Collagen alpha-1(XXIV) chain,37901,0.0422866788362269,0.0050749930234239,0.032339692510316,0.0522336651621377,8.68689684481901e-17
NMR metabolomics,X23412.Phospholipids in VLDL,PTGR1,Prostaglandin reductase 1,37990,0.0610555057124635,0.00732962239100571,0.0466894458260923,0.0754215655988347,8.85826779649899e-17
NMR metabolomics,X23412.Phospholipids in VLDL,KLB,Beta-klotho,39961,-0.0562740799966582,0.00677830798113725,-0.0695595636396872,-0.0429885963536292,1.10661423046838e-16
NMR metabolomics,X23412.Phospholipids in VLDL,ACAN,Aggrecan core protein,40224,0.021641339022434,0.0026134609757808,0.0165189555099036,0.0267637225349643,1.32162093161678e-16
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTSL2,ADAMTS-like protein 2,37998,0.0236076904544064,0.00285176892678842,0.018018223357901,0.0291971575509117,1.36604534481651e-16
NMR metabolomics,X23412.Phospholipids in VLDL,BSG,Basigin,40502,0.0153819824915843,0.00185894468270878,0.0117384509134751,0.0190255140696935,1.38941767485698e-16
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTSL4,ADAMTS-like protein 4,37628,0.0179182749294735,0.00216845351425344,0.0136681060415368,0.0221684438174103,1.5534011563273e-16
NMR metabolomics,X23412.Phospholipids in VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,0.0532004177336043,0.00644384526400177,0.0405704810161608,0.0658303544510478,1.62451244330077e-16
NMR metabolomics,X23412.Phospholipids in VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,-0.0151095434131829,0.00183265801446138,-0.0187015531215273,-0.0115175337048386,1.78571847201256e-16
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,0.0432719249502178,0.00526111628325198,0.0329601370350439,0.0535837128653916,2.10451520352945e-16
NMR metabolomics,X23412.Phospholipids in VLDL,ASPN,Asporin,37990,0.0207053256130797,0.00251871548739029,0.0157686432577947,0.0256420079683646,2.20808127087806e-16
NMR metabolomics,X23412.Phospholipids in VLDL,TFPI2,Tissue factor pathway inhibitor 2,40357,0.0301314414480808,0.00366744879931848,0.0229432418014166,0.0373196410947451,2.26618967052668e-16
NMR metabolomics,X23412.Phospholipids in VLDL,C1QA,Complement C1q subcomponent subunit A,40442,-0.0171813692275276,0.00209280171691675,-0.0212832605926844,-0.0130794778623707,2.38424062431078e-16
NMR metabolomics,X23412.Phospholipids in VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,37879,0.0315409748151219,0.00384391581868431,0.0240068998105007,0.0390750498197431,2.50557798341721e-16
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,0.0311846162985901,0.00380450805075571,0.0237277805191089,0.0386414520780713,2.65572060645198e-16
NMR metabolomics,X23412.Phospholipids in VLDL,CD300E,CMRF35-like molecule 2,40436,0.0301100217732491,0.003678702202372,0.0228997654566,0.0373202780898982,2.92758614364136e-16
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINI2,Serpin I2,37901,0.042116667709395,0.00516320885612018,0.0319967783513994,0.0522365570673905,3.73499644077759e-16
NMR metabolomics,X23412.Phospholipids in VLDL,ECE1,Endothelin-converting enzyme 1,39961,0.0264318637955626,0.00325066112889212,0.020060567982934,0.0328031596081911,4.56865621128111e-16
NMR metabolomics,X23412.Phospholipids in VLDL,RPL14,60S ribosomal protein L14,37628,0.0310199812071651,0.00381550974143652,0.0235415821139495,0.0384983803003807,4.67537131839475e-16
NMR metabolomics,X23412.Phospholipids in VLDL,CBLIF,Cobalamin binding intrinsic factor,40330,0.0545904849503338,0.0067221652705437,0.0414150410200682,0.0677659288805995,4.96190289461738e-16
NMR metabolomics,X23412.Phospholipids in VLDL,SFRP4,Secreted frizzled-related protein 4,37671,0.0313060934995829,0.00386021523555288,0.0237400716378993,0.0388721153612665,5.50853958591746e-16
NMR metabolomics,X23412.Phospholipids in VLDL,SLITRK2,SLIT and NTRK-like protein 2,40489,0.0282472443905555,0.00349015434688013,0.0214065418706705,0.0350879469104406,6.21457319281149e-16
NMR metabolomics,X23412.Phospholipids in VLDL,COL2A1,Collagen alpha-1(II) chain,37628,0.061377716376375,0.00759229444669554,0.0464968192608518,0.0762586134918983,6.79979586271137e-16
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,0.0313987579102104,0.00388555500417224,0.0237830701020328,0.039014445718388,6.97472171650674e-16
NMR metabolomics,X23412.Phospholipids in VLDL,DAPK2,Death-associated protein kinase 2,37598,0.039102941072486,0.00483978690867295,0.0296169587314871,0.048588923413485,7.0691124821313e-16
NMR metabolomics,X23412.Phospholipids in VLDL,COL6A3,Collagen alpha-3(VI) chain,40536,0.0254873484321682,0.0031565913612121,0.0193004293641925,0.0316742675001439,7.26169804577912e-16
NMR metabolomics,X23412.Phospholipids in VLDL,CBS,Cystathionine beta-synthase,37628,0.0377356040152288,0.00468552213485755,0.028551980630908,0.0469192273995496,8.72207603341955e-16
NMR metabolomics,X23412.Phospholipids in VLDL,CST5,Cystatin-D,40070,0.0408122073089317,0.00508504141384778,0.03084552613779,0.0507788884800734,1.07876396461488e-15
NMR metabolomics,X23412.Phospholipids in VLDL,C8B,Complement component C8 beta chain,38013,0.0226258251440052,0.00281909839244035,0.0171003922948221,0.0281512579931883,1.0901879330443e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CRYM,Ketimine reductase mu-crystallin,37541,0.0568038245514628,0.00711697584943945,0.0428545518865615,0.0707530972163641,1.56611199020608e-15
NMR metabolomics,X23412.Phospholipids in VLDL,VAMP5,Vesicle-associated membrane protein 5,40042,0.0409745896092841,0.0051602154046053,0.0308605674162578,0.0510886118023105,2.15050630127221e-15
NMR metabolomics,X23412.Phospholipids in VLDL,TAFA5,Chemokine-like protein TAFA-5,40305,0.0262472551880959,0.00330641913646806,0.0197666736806185,0.0327278366955733,2.18660389988526e-15
NMR metabolomics,X23412.Phospholipids in VLDL,GDNF,Glial cell line-derived neurotrophic factor,39961,0.0280124162971025,0.00352967763002509,0.0210942481422533,0.0349305844519517,2.22549478450247e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CD300LF,CMRF35-like molecule 1,40489,0.0443691891573366,0.00559395927679344,0.0334050289748214,0.0553333493398517,2.30471819817299e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CD300A,CMRF35-like molecule 8,37671,0.0216592799050157,0.0027308517100161,0.0163068105533842,0.0270117492566473,2.34159904324099e-15
NMR metabolomics,X23412.Phospholipids in VLDL,WFDC1,WAP four-disulfide core domain protein 1,37653,0.0398674395190466,0.00503283816588991,0.0300030767139024,0.0497318023241908,2.53441991722085e-15
NMR metabolomics,X23412.Phospholipids in VLDL,SLITRK6,SLIT and NTRK-like protein 6,40042,-0.0248068025989335,0.00314587769564687,-0.0309727228824014,-0.0186408823154656,3.33935481260275e-15
NMR metabolomics,X23412.Phospholipids in VLDL,SNX2,Sorting nexin-2,37900,0.0567789908940023,0.00720050724512422,0.0426659966935588,0.0708919850944458,3.37550428071063e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CHRDL1,Chordin-like protein 1,40396,0.0221424457530912,0.00280856451444042,0.0166376593047879,0.0276472322013944,3.37729542618919e-15
NMR metabolomics,X23412.Phospholipids in VLDL,SPRR3,Small proline-rich protein 3,37942,0.051765557635063,0.00656846429108867,0.0388913676245292,0.0646397476455968,3.4977575165662e-15
NMR metabolomics,X23412.Phospholipids in VLDL,C2orf69,UPF0565 protein C2orf69,37572,0.043851233482891,0.00557151828293091,0.0329310576483464,0.0547714093174355,3.80497754592559e-15
NMR metabolomics,X23412.Phospholipids in VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,0.0291416553979225,0.00371531527836057,0.0218596374523358,0.0364236733435092,4.70235144788413e-15
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINI1,Neuroserpin,37642,0.0231035061028964,0.00294673700088658,0.0173279015811587,0.0288791106246341,4.83585482330401e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CD80,T-lymphocyte activation antigen CD80,37990,0.0245538447546903,0.00314236062200089,0.0183948179355685,0.030712871573812,5.95540297011243e-15
NMR metabolomics,X23412.Phospholipids in VLDL,SMARCA2,Probable global transcription activator SNF2L2,39961,0.0526444431371303,0.00674716233482308,0.039420004960877,0.0658688813133835,6.45664610708259e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,0.0393010469144785,0.00503970204697938,0.0294232309023989,0.0491788629265581,6.74745821860489e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CYTL1,Cytokine-like protein 1,37998,0.0165175831894115,0.00212346585023797,0.0123555901229451,0.0206795762558779,7.86179326807082e-15
NMR metabolomics,X23412.Phospholipids in VLDL,SNX5,Sorting nexin-5,37628,0.0214869434511276,0.00276711207952344,0.0160634037752617,0.0269104831269936,8.75768367881747e-15
NMR metabolomics,X23412.Phospholipids in VLDL,COPB2,Coatomer subunit beta',37562,0.0309677538845208,0.0039966035554416,0.0231344109158553,0.0388010968531863,9.97922062720842e-15
NMR metabolomics,X23412.Phospholipids in VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,0.0264320101738057,0.00341185414231723,0.0197447760548639,0.0331192442927474,1.00817590148035e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CCN5,CCN family member 5,40332,0.0279698372940588,0.00361480877448723,0.0208848120960638,0.0350548624920538,1.07402534345319e-14
NMR metabolomics,X23412.Phospholipids in VLDL,NPHS1,Nephrin,37598,0.0247662890076553,0.00320870129042872,0.018477234478415,0.0310553435368956,1.26204977121355e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CSDE1,Cold shock domain-containing protein E1,37562,0.0833155688923919,0.0108247014377941,0.0620991540743154,0.104531983710468,1.4947578111674e-14
NMR metabolomics,X23412.Phospholipids in VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,0.043138839814761,0.0056077795436193,0.0321475919092672,0.0541300877202549,1.54322809917422e-14
NMR metabolomics,X23412.Phospholipids in VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,0.0333619093806352,0.00434056628185741,0.0248543994681947,0.0418694192930758,1.60801697975846e-14
NMR metabolomics,X23412.Phospholipids in VLDL,S100A13,Protein S100-A13,37598,0.0247695830086969,0.00322259637379131,0.018453294116066,0.0310858719013279,1.62275111639372e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CDA,Cytidine deaminase,37970,0.032526831730389,0.00423246682964375,0.0242311967442873,0.0408224667164908,1.63417006504808e-14
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,0.0444643518383496,0.00580908910869035,0.0330785371853165,0.0558501664913827,2.05568065514966e-14
NMR metabolomics,X23412.Phospholipids in VLDL,YAP1,Transcriptional coactivator YAP1,37942,0.0187949434691993,0.00245808347266691,0.0139770998627722,0.0236127870756265,2.2101386623887e-14
NMR metabolomics,X23412.Phospholipids in VLDL,DPP7,Dipeptidyl peptidase 2,40251,0.0407434737121297,0.00534026542486679,0.0302765534793908,0.0512103939448686,2.49097048804343e-14
NMR metabolomics,X23412.Phospholipids in VLDL,PPME1,Protein phosphatase methylesterase 1,40305,0.0430509617289467,0.00564741017752801,0.0319820377809918,0.0541198856769016,2.6157409944161e-14
NMR metabolomics,X23412.Phospholipids in VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,0.0402500315270566,0.00528320515082898,0.0298949494314318,0.0506051136226814,2.71376281810934e-14
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE6,Ribonuclease K6,37917,0.0207361963225387,0.00272259567048469,0.0153999088083887,0.0260724838366887,2.78351974724051e-14
NMR metabolomics,X23412.Phospholipids in VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,38013,-0.0179734228698358,0.00236012984005316,-0.02259927735634,-0.0133475683833316,2.80152408259618e-14
NMR metabolomics,X23412.Phospholipids in VLDL,BAX,Apoptosis regulator BAX,39934,0.0626556545695716,0.00823013659180234,0.046524586849639,0.0787867222895042,2.83319396444703e-14
NMR metabolomics,X23412.Phospholipids in VLDL,GPR15L,Protein GPR15L,37901,0.0423455331628295,0.00556621454525474,0.0314357526541302,0.0532553136715288,2.97752516073937e-14
NMR metabolomics,X23412.Phospholipids in VLDL,IGHMBP2,DNA-binding protein SMUBP-2,37562,0.0390914408726567,0.00514351806875112,0.0290101454579045,0.0491727362874089,3.15880351881698e-14
NMR metabolomics,X23412.Phospholipids in VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,0.0586273175525191,0.00772035733193373,0.043495417181929,0.0737592179231092,3.28172038779628e-14
NMR metabolomics,X23412.Phospholipids in VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,37628,0.0212046858103354,0.00279704710844543,0.0157224734777823,0.0266868981428884,3.65529246579187e-14
NMR metabolomics,X23412.Phospholipids in VLDL,SCT,Secretin,37572,0.0321220291354279,0.00424785818154419,0.0237962270996013,0.0404478311712545,4.23482413023147e-14
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,0.0248444552576331,0.00328734691721472,0.0184012552998922,0.0312876552153739,4.37713813444997e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CLGN,Calmegin,37572,0.0310337668444696,0.00410726664251154,0.022983524225147,0.0390840094637923,4.43774965285817e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CDH5,Cadherin-5,40536,-0.0210686736277209,0.00279603617666621,-0.0265489045339867,-0.0155884427214551,5.1350462291178e-14
NMR metabolomics,X23412.Phospholipids in VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,0.0556481040395954,0.0073921933962667,0.0411594049829127,0.0701368030962781,5.43672743098154e-14
NMR metabolomics,X23412.Phospholipids in VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,0.0311235909949925,0.00413444620781453,0.0230200764276761,0.039227105562309,5.49283297109926e-14
NMR metabolomics,X23412.Phospholipids in VLDL,NCF2,Neutrophil cytosol factor 2,40324,0.0575582029380226,0.00765713777480932,0.0425502128993964,0.0725661929766489,5.90646060553884e-14
NMR metabolomics,X23412.Phospholipids in VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,0.0385024529104685,0.0051322767584073,0.0284431904639902,0.0485617153569468,6.61679496128105e-14
NMR metabolomics,X23412.Phospholipids in VLDL,MCTS1,Malignant T-cell-amplified sequence 1,37901,0.018027534358437,0.00240337038096415,0.0133169284117473,0.0227381403051267,6.73311105523318e-14
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,0.0221201427866754,0.00294944681692578,0.0163392270255009,0.02790105854785,6.73326739364262e-14
NMR metabolomics,X23412.Phospholipids in VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,39961,0.0445020821949071,0.00594394069281493,0.0328519584369898,0.0561522059528244,7.42696772235253e-14
NMR metabolomics,X23412.Phospholipids in VLDL,WFDC2,WAP four-disulfide core domain protein 2,39535,0.0262734085401493,0.00351039399587905,0.0193930363082264,0.0331537807720723,7.58060791738535e-14
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,40291,0.0199193077783103,0.00267078885071831,0.0146845616309024,0.0251540539257182,9.22442505281686e-14
NMR metabolomics,X23412.Phospholipids in VLDL,RARRES1,Retinoic acid receptor responder protein 1,39980,0.0240742594525779,0.00323193054899124,0.017739675576555,0.0304088433286007,9.90838030936072e-14
NMR metabolomics,X23412.Phospholipids in VLDL,MANSC1,MANSC domain-containing protein 1,40411,-0.0187877167441561,0.00252588157973177,-0.0237384446404304,-0.0138369888478818,1.07346817905845e-13
NMR metabolomics,X23412.Phospholipids in VLDL,PODXL,Podocalyxin,40305,0.0103741333930921,0.00140123482235651,0.00762771314127331,0.0131205536449108,1.39231622517757e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CD14,Monocyte differentiation antigen CD14,40048,0.0283385328801379,0.00382957868716353,0.0208325586532974,0.0358445071069784,1.43221055327589e-13
NMR metabolomics,X23412.Phospholipids in VLDL,NFIC,Nuclear factor 1 C-type,37959,0.0297578599805636,0.00402879015247313,0.0218614312817163,0.037654288679411,1.59815093615453e-13
NMR metabolomics,X23412.Phospholipids in VLDL,LBP,Lipopolysaccharide-binding protein,40403,-0.0394983516465356,0.00536063942974471,-0.0500052049288353,-0.028991498364236,1.81388176322173e-13
NMR metabolomics,X23412.Phospholipids in VLDL,S100A11,Protein S100-A11,40207,0.0305108239181718,0.00414190149054426,0.0223926969967051,0.0386289508396386,1.84002449705291e-13
NMR metabolomics,X23412.Phospholipids in VLDL,DGKZ,Diacylglycerol kinase zeta,40044,0.0237949617710339,0.00323032058315042,0.0174635334280591,0.0301263901140087,1.84440421203705e-13
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE3,Eosinophil cationic protein,40288,0.0737069731688114,0.0100087818176479,0.0540897608062215,0.0933241855314013,1.86936686716666e-13
NMR metabolomics,X23412.Phospholipids in VLDL,PKD1,Polycystin-1,37990,0.0175749276375549,0.00238990347495149,0.01289071682665,0.0222591384484598,2.03678005585969e-13
NMR metabolomics,X23412.Phospholipids in VLDL,REG4,Regenerating islet-derived protein 4,40379,0.0329163917258346,0.00447775256184278,0.0241399967046228,0.0416927867470464,2.06132599254878e-13
NMR metabolomics,X23412.Phospholipids in VLDL,DHPS,Deoxyhypusine synthase,37900,0.0279186403482853,0.00380309549586914,0.0204645731763818,0.0353727075201888,2.24125246603138e-13
NMR metabolomics,X23412.Phospholipids in VLDL,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.0174037615156868,0.0023748233629723,0.0127491077242611,0.0220584153071125,2.44019708451147e-13
NMR metabolomics,X23412.Phospholipids in VLDL,RNASET2,Ribonuclease T2,40465,0.0178002482984546,0.00243007280116982,0.0130373056081618,0.0225631909887475,2.50297990062129e-13
NMR metabolomics,X23412.Phospholipids in VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,0.0524625267096463,0.0071936111956117,0.0383630487662474,0.0665620046530453,3.20594987065205e-13
NMR metabolomics,X23412.Phospholipids in VLDL,HEPH,Hephaestin,37990,0.0168382787767108,0.00231451067002777,0.0123018378634564,0.0213747196899652,3.65219863548631e-13
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,0.0196425964366014,0.00271097949438374,0.0143290766276093,0.0249561162455936,4.50233846212389e-13
NMR metabolomics,X23412.Phospholipids in VLDL,KLK6,Kallikrein-6,40387,0.0203222902095759,0.00280508849735477,0.0148243167547605,0.0258202636643912,4.52919013084767e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CD276,CD276 antigen,40357,-0.0239695918207728,0.00331328039635215,-0.030463621397623,-0.0174755622439226,4.88917208701994e-13
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA7,Thyroxine-binding globulin,38013,0.0124650976964493,0.00172665268282906,0.00908085843810432,0.0158493369547942,5.50662245993058e-13
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,0.0207282154155332,0.00287394720128011,0.0150952789010242,0.0263611519300422,5.74064942328404e-13
NMR metabolomics,X23412.Phospholipids in VLDL,LACRT,Extracellular glycoprotein lacritin,37863,0.035401845511515,0.00491886111073264,0.025760877734479,0.045042813288551,6.47467649719114e-13
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL3,Fc receptor-like protein 3,40044,0.0362408459455574,0.00504626533600636,0.0263501658869849,0.0461315260041299,7.19524788079313e-13
NMR metabolomics,X23412.Phospholipids in VLDL,IFNGR2,Interferon gamma receptor 2,40228,0.0341592578147702,0.00475847102976481,0.0248326545964311,0.0434858610331092,7.3557074364252e-13
NMR metabolomics,X23412.Phospholipids in VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,0.0454348749063146,0.00633238544098843,0.0330233994419772,0.0578463503706519,7.61725491324246e-13
NMR metabolomics,X23412.Phospholipids in VLDL,ULBP2,UL16-binding protein 2,40228,0.0246076309071611,0.00343783471183672,0.0178694748719611,0.0313457869423611,8.55401207997562e-13
NMR metabolomics,X23412.Phospholipids in VLDL,LCP1,Plastin-2,37998,0.0311227987854563,0.00434988614348759,0.0225970219442206,0.039648575626692,8.80668187002303e-13
NMR metabolomics,X23412.Phospholipids in VLDL,MNDA,Myeloid cell nuclear differentiation antigen,40333,0.0638909069761578,0.00893342977473568,0.0463813846176759,0.0814004293346398,8.932429596725e-13
NMR metabolomics,X23412.Phospholipids in VLDL,IL32,Interleukin-32,40341,-0.0281094815123663,0.00393430281651424,-0.0358207150327342,-0.0203982479919984,9.40968297139577e-13
NMR metabolomics,X23412.Phospholipids in VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,0.0361568921270382,0.00506306189377606,0.0262332908152371,0.0460804934388393,9.64614097196509e-13
NMR metabolomics,X23412.Phospholipids in VLDL,XG,Glycoprotein Xg,40458,0.019686017319843,0.00275763836316377,0.014281046128042,0.025090988511644,9.82477513929445e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CTSF,Cathepsin F,40411,0.026302325105269,0.00368593428410162,0.0190778939084299,0.0335267563021082,1.00318002590368e-12
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB103A_DEFB103B,Beta-defensin 103,37539,0.0271526192041197,0.00381132828262618,0.0196824157701724,0.034622822638067,1.10174133871482e-12
NMR metabolomics,X23412.Phospholipids in VLDL,AGER,Advanced glycosylation end product-specific receptor,40311,0.0265777320091316,0.00373181142925542,0.0192633816077909,0.0338920824104722,1.10990116618759e-12
NMR metabolomics,X23412.Phospholipids in VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,0.0266976409465197,0.00375489101302642,0.0193380545609879,0.0340572273320515,1.20995487842926e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CD59,CD59 glycoprotein,39665,0.0147375197444963,0.00207934728219491,0.0106619990713943,0.0188130404175983,1.4248567020697e-12
NMR metabolomics,X23412.Phospholipids in VLDL,IDS,Iduronate 2-sulfatase,40516,0.00563435823125095,0.000796715669426018,0.00407279551917595,0.00719592094332594,1.59032013440385e-12
NMR metabolomics,X23412.Phospholipids in VLDL,SPTLC1,Serine palmitoyltransferase 1,37942,0.0234284591167194,0.00331499070289076,0.0169310773390535,0.0299258408943853,1.65584197501395e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CABP2,Calcium-binding protein 2,37572,0.0427008336764584,0.00604736129849484,0.0308480055314085,0.0545536618215083,1.73546949193138e-12
NMR metabolomics,X23412.Phospholipids in VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,0.0376721676092759,0.00534310522292324,0.0271996813723464,0.0481446538462055,1.85607983409964e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,37835,0.0381872059880309,0.00541889194211516,0.0275661777814852,0.0488082341945767,1.91695859794628e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CFHR2,Complement factor H-related protein 2,37911,0.03709635426523,0.00527943721047771,0.0267486573326937,0.0474440511977664,2.21849183353889e-12
NMR metabolomics,X23412.Phospholipids in VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,40422,0.0166828315651659,0.00237972111243862,0.0120185781847862,0.0213470849455456,2.47126171342326e-12
NMR metabolomics,X23412.Phospholipids in VLDL,DSG4,Desmoglein-4,40250,0.0328843482643836,0.00469357921374401,0.0236849330054453,0.0420837635233218,2.54691879078577e-12
NMR metabolomics,X23412.Phospholipids in VLDL,S100A12,Protein S100-A12,40139,0.0493923195199611,0.00705196071396367,0.0355704765205923,0.0632141625193298,2.58760253641334e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CTSC,Dipeptidyl peptidase 1,40349,0.0274546322887851,0.00392083171009815,0.0197698021369927,0.0351394624405775,2.61974187742703e-12
NMR metabolomics,X23412.Phospholipids in VLDL,TF,Serotransferrin,38013,0.0140911333372985,0.00201354719458263,0.0101445808359165,0.0180376858386805,2.71518801380812e-12
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB3A1,Secretoglobin family 3A member 1,37671,-0.0161070899103213,0.00231107592236907,-0.0206367987181647,-0.0115773811024779,3.33105179596273e-12
NMR metabolomics,X23412.Phospholipids in VLDL,HGFAC,Hepatocyte growth factor activator,37849,0.0186382743309546,0.00267446968848904,0.0133963137415161,0.0238802349203931,3.34221727711523e-12
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS22,Brain-specific serine protease 4,37598,0.0227740318509549,0.00327082300802411,0.0163632187552277,0.0291848449466822,3.49463293949091e-12
NMR metabolomics,X23412.Phospholipids in VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,0.0422385945013226,0.00606909412538711,0.0303431700155638,0.0541340189870813,3.56997674734282e-12
NMR metabolomics,X23412.Phospholipids in VLDL,MPO,Myeloperoxidase,40332,0.02995413888572,0.00430876239807264,0.0215089645854977,0.0383993131859424,3.74400372401092e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CD101,Immunoglobulin superfamily member 2,37901,0.0272888418387105,0.00392733421640494,0.0195912667745568,0.0349864169028642,3.86352133009373e-12
NMR metabolomics,X23412.Phospholipids in VLDL,GIMAP8,GTPase IMAP family member 8,37482,0.0332583576473019,0.00478787064057381,0.0238741311917773,0.0426425841028266,3.92581707366719e-12
NMR metabolomics,X23412.Phospholipids in VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,0.0243186252707299,0.00350690663661425,0.017445088262966,0.0311921622784939,4.23688571749858e-12
NMR metabolomics,X23412.Phospholipids in VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.0218754292131835,0.00315697492026361,0.0156877583694668,0.0280631000569002,4.42783916411747e-12
NMR metabolomics,X23412.Phospholipids in VLDL,GC,Vitamin D-binding protein,38013,0.0166190331758395,0.00239986243834627,0.0119153027966808,0.0213227635549982,4.55626581908328e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CD300C,CMRF35-like molecule 6,40471,0.0217384677673448,0.00314201036533084,0.0155801274512964,0.0278968080833933,4.73235949880079e-12
NMR metabolomics,X23412.Phospholipids in VLDL,THBS4,Thrombospondin-4,40355,0.0285752309554588,0.00415414391766563,0.0204331088768342,0.0367173530340835,6.2639918233136e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,0.0503022262196892,0.00732584748285047,0.0359435651533023,0.0646608872860762,6.87306139876182e-12
NMR metabolomics,X23412.Phospholipids in VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,0.0289896479812989,0.00422659158495869,0.0207055284747798,0.0372737674878179,7.25198917472777e-12
NMR metabolomics,X23412.Phospholipids in VLDL,FES,Tyrosine-protein kinase Fes/Fps,39980,0.0300411068349706,0.00438197124371113,0.0214524431972968,0.0386297704726444,7.36821714983643e-12
NMR metabolomics,X23412.Phospholipids in VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,0.0154742146559041,0.00226068059658267,0.0110432806866021,0.0199051486252062,7.93129157482698e-12
NMR metabolomics,X23412.Phospholipids in VLDL,RSPO3,R-spondin-3,40489,0.0180096252024848,0.00263405398040798,0.0128468794008852,0.0231723710040844,8.36537389256911e-12
NMR metabolomics,X23412.Phospholipids in VLDL,APOA1,Apolipoprotein A-I,38013,-0.0173709309485582,0.00254656337148134,-0.0223621951566617,-0.0123796667404548,9.40301082395335e-12
NMR metabolomics,X23412.Phospholipids in VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.0210132100516132,0.00308519613918063,0.0149662256188192,0.0270601944844073,1.01027616157439e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CXADR,Coxsackievirus and adenovirus receptor,40341,0.0332908503623067,0.00489095275797546,0.0237045829566748,0.0428771177679386,1.03493918083025e-11
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBR2,TGF-beta receptor type-2,40411,0.0197950170895625,0.00290822201132819,0.0140949019473592,0.0254951322317657,1.03512792627555e-11
NMR metabolomics,X23412.Phospholipids in VLDL,ENSA,Alpha-endosulfine,37900,0.0331075495319972,0.00487745529916167,0.0235477371456404,0.0426673619183541,1.18569354860181e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,-0.0189698091587551,0.00279649919790403,-0.024450947586647,-0.0134886707308632,1.22437664742115e-11
NMR metabolomics,X23412.Phospholipids in VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,37900,0.0256718073111118,0.00378750149128298,0.0182483043881972,0.0330953102340264,1.26901582674562e-11
NMR metabolomics,X23412.Phospholipids in VLDL,MYOM3,Myomesin-3,37671,-0.0564361173182184,0.00832680878323502,-0.0727566625333591,-0.0401155721030777,1.27334616514091e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CHAD,Chondroadherin,37671,0.0336450674061614,0.00496848398857399,0.0239068387885564,0.0433832960237664,1.32659499816072e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,0.0463823428779557,0.00685032134673049,0.032955713038364,0.0598089727175475,1.33438715835344e-11
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA12,Serpin A12,39903,0.0710536878563912,0.0105336320265076,0.0504077690844362,0.0916996066283462,1.5801115583596e-11
NMR metabolomics,X23412.Phospholipids in VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.045214320285519,0.00671170475146321,0.0320593789726511,0.0583692615983868,1.68855285233999e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CTSH,Pro-cathepsin H,40013,0.0448473079951473,0.00667076158311921,0.0317726152922336,0.0579220006980609,1.84255158417093e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CKAP4,Cytoskeleton-associated protein 4,40457,0.0161908449717272,0.00240961568917104,0.011467998220952,0.0209136917225025,1.88805117764998e-11
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,0.0209351747133101,0.00311942683340012,0.0148210981198458,0.0270492513067743,1.99517236973556e-11
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,0.0279177043950673,0.00416190882761099,0.0197603630929498,0.0360750456971848,2.04097527813318e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PLXNB2,Plexin-B2,40472,0.0143912922494101,0.00214733188728001,0.0101825217503413,0.0186000627484789,2.12528840374325e-11
NMR metabolomics,X23412.Phospholipids in VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,0.0227663080793822,0.00341382131998627,0.0160752182922091,0.0294573978665553,2.67863379233168e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,0.0313866850091112,0.00471682056209032,0.0221417167074142,0.0406316533108082,2.94369458814596e-11
NMR metabolomics,X23412.Phospholipids in VLDL,GM2A,Ganglioside GM2 activator,37714,0.0236156785346999,0.00355346310783532,0.0166508908433426,0.0305804662260571,3.13316736333882e-11
NMR metabolomics,X23412.Phospholipids in VLDL,KLRK1,NKG2-D type II integral membrane protein,37942,0.0282797495153691,0.00425795985420508,0.0199341482011271,0.036625350829611,3.22141947849556e-11
NMR metabolomics,X23412.Phospholipids in VLDL,APOB,Apolipoprotein B-100,37987,0.0136870506709862,0.00206359378918034,0.00964240684419272,0.0177316944977797,3.42285307961375e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC5A,C-type lectin domain family 5 member A,40314,-0.0172359947744141,0.00260411081860841,-0.0223400519788866,-0.0121319375699416,3.73827639371775e-11
NMR metabolomics,X23412.Phospholipids in VLDL,LMNB2,Lamin-B2,37942,0.0166930656718856,0.00252526053899504,0.0117435550154553,0.0216425763283159,3.97606508255717e-11
NMR metabolomics,X23412.Phospholipids in VLDL,ZBP1,Z-DNA-binding protein 1,37598,0.0246159018350157,0.0037256094580698,0.0173137072971989,0.0319180963728325,4.06705921479871e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CCL15,C-C motif chemokine 15,40536,0.0270128329329908,0.00409624226656296,0.0189841980905274,0.0350414677754542,4.39866889687112e-11
NMR metabolomics,X23412.Phospholipids in VLDL,DKK3,Dickkopf-related protein 3,40536,-0.0178765570642269,0.00271200957444254,-0.0231920958301342,-0.0125610182983195,4.48560552361902e-11
NMR metabolomics,X23412.Phospholipids in VLDL,MSLN,Mesothelin,40271,0.0329306826261081,0.00499600414530966,0.0231385145013011,0.042722850750915,4.49464370918535e-11
NMR metabolomics,X23412.Phospholipids in VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,37628,0.0306146807865889,0.0046510977085531,0.0214985292778248,0.039730832295353,4.80931723760418e-11
NMR metabolomics,X23412.Phospholipids in VLDL,SFTPD,Pulmonary surfactant-associated protein D,40359,0.0402177042926739,0.00612083593947014,0.0282208658513125,0.0522145427340354,5.16612772590123e-11
NMR metabolomics,X23412.Phospholipids in VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,39925,0.0265215100665451,0.00403995644074774,0.0186031954426795,0.0344398246904106,5.37606330768517e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,0.0172769385885693,0.00263958439797977,0.012103353168529,0.0224505240086097,6.15640392688537e-11
NMR metabolomics,X23412.Phospholipids in VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,-0.0157663138978734,0.00240927136415164,-0.0204884857716106,-0.0110441420241362,6.21033796091949e-11
NMR metabolomics,X23412.Phospholipids in VLDL,EFNA1,Ephrin-A1,40303,0.0164339954050748,0.00251654401913657,0.0115015691275671,0.0213664216825825,6.75972209043779e-11
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2,Apoptosis regulator Bcl-2,37901,0.0326029969890505,0.00499442027814446,0.0228139332438873,0.0423920607342136,6.90985579001374e-11
NMR metabolomics,X23412.Phospholipids in VLDL,GSTT2B,Glutathione S-transferase theta-2B,37942,0.143771864343969,0.0220447288389959,0.100564195819537,0.186979532868401,7.19321946944652e-11
NMR metabolomics,X23412.Phospholipids in VLDL,IL1B,Interleukin-1 beta,39946,0.033861249337791,0.00519641396833309,0.0236762779598581,0.0440462207157239,7.43002899444408e-11
NMR metabolomics,X23412.Phospholipids in VLDL,MRC1,Macrophage mannose receptor 1,37987,0.0170121123582654,0.00261124052001295,0.01189408093904,0.0221301437774908,7.52834713320256e-11
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN1,Tetraspanin-1,40042,0.018310728670166,0.00281440196691376,0.0127945008150151,0.023826956525317,7.94873311076142e-11
NMR metabolomics,X23412.Phospholipids in VLDL,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.0330694734020696,0.00508301513528435,-0.043032183067227,-0.0231067637369123,7.9550183567e-11
NMR metabolomics,X23412.Phospholipids in VLDL,LYZL2,Lysozyme-like protein 2,37482,0.021591717373549,0.00331970986661361,0.0150850860349863,0.0280983487121116,8.10152783225086e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CD93,Complement component C1q receptor,39725,-0.0188851684138178,0.0029069101857151,-0.0245827123778194,-0.0131876244498162,8.46711799497832e-11
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB8,DnaJ homolog subfamily B member 8,40042,0.035123932492136,0.00541491057752423,0.0245107077601885,0.0457371572240835,9.04863317446435e-11
NMR metabolomics,X23412.Phospholipids in VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,0.0399732058373156,0.00616374176853053,0.0278922719709958,0.0520541397036354,9.18022340440817e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,0.0251181673453319,0.00387457837290931,0.0175239937344297,0.0327123409562342,9.2678568624043e-11
NMR metabolomics,X23412.Phospholipids in VLDL,AFAP1,Actin filament-associated protein 1,37671,0.0505177023936286,0.00782605595817506,0.0351786327156055,0.0658567720716517,1.11949643498782e-10
NMR metabolomics,X23412.Phospholipids in VLDL,FOLR2,Folate receptor beta,40471,-0.017495397612469,0.00271488110575928,-0.0228165645797572,-0.0121742306451808,1.1948295709208e-10
NMR metabolomics,X23412.Phospholipids in VLDL,MDM1,Nuclear protein MDM1,37572,0.0186182810595688,0.00289326209906161,0.012947487345408,0.0242890747737295,1.27724267643616e-10
NMR metabolomics,X23412.Phospholipids in VLDL,GNLY,Granulysin,40332,0.0299870204957614,0.00468023478956553,0.0208137603082129,0.0391602806833098,1.52427323798499e-10
NMR metabolomics,X23412.Phospholipids in VLDL,RBP2,Retinol-binding protein 2,40305,-0.0448883404025541,0.00701881517447059,-0.0586452181445165,-0.0311314626605917,1.64578437745073e-10
NMR metabolomics,X23412.Phospholipids in VLDL,MST1,Hepatocyte growth factor-like protein,37787,0.0362236000739041,0.00568790109322359,0.0250753139311858,0.0473718862166223,1.97102422293693e-10
NMR metabolomics,X23412.Phospholipids in VLDL,HSPA2,Heat shock-related 70 kDa protein 2,37900,0.0195449021406078,0.00307062859421893,0.0135264700959387,0.0255633341852769,2.01478208253728e-10
NMR metabolomics,X23412.Phospholipids in VLDL,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.0238159508413874,0.00374904530065993,0.016467822052094,0.0311640796306809,2.18800443014301e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CLPS,Colipase,40311,0.0400211085199921,0.00632277535969052,0.0276284688149987,0.0524137482249855,2.52279310618646e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CA2,Carbonic anhydrase 2,40291,0.0411775475661487,0.00651432033289462,0.0284094797136753,0.0539456154186222,2.66688776164106e-10
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,0.0196975572127767,0.00311654764935253,0.0135891238200457,0.0258059906055076,2.67927051933847e-10
NMR metabolomics,X23412.Phospholipids in VLDL,LTB,Lymphotoxin-beta,37900,0.0205175378808555,0.00327689186352651,0.0140948298283435,0.0269402459333674,3.93441171106683e-10
NMR metabolomics,X23412.Phospholipids in VLDL,NCAM2,Neural cell adhesion molecule 2,40332,-0.0155728728663648,0.00248919938118537,-0.0204517036534881,-0.0106940420792414,4.04635023014143e-10
NMR metabolomics,X23412.Phospholipids in VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.0210192394332259,0.00336357728734285,0.0144266279500339,0.0276118509164179,4.23304649219564e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CILP,Cartilage intermediate layer protein 1,37998,0.031086663244361,0.00497482308567722,0.0213360099964337,0.0408373164922884,4.26011794074376e-10
NMR metabolomics,X23412.Phospholipids in VLDL,IL18BP,Interleukin-18-binding protein,40403,0.017548414970619,0.00280871710198798,0.0120433294507226,0.0230535004905155,4.26725387997938e-10
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,0.0160396524411983,0.0025688332962685,0.0110047391805121,0.0210745657018846,4.37442396725505e-10
NMR metabolomics,X23412.Phospholipids in VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,0.0509723249547838,0.00816752550046494,0.0349639749738725,0.0669806749356951,4.46187896868224e-10
NMR metabolomics,X23412.Phospholipids in VLDL,GBA,Lysosomal acid glucosylceramidase,37572,0.0305020518173262,0.00488840031446095,0.0209207872009827,0.0400833164336696,4.5195357571458e-10
NMR metabolomics,X23412.Phospholipids in VLDL,PPM1A,Protein phosphatase 1A,39980,0.0178622086135664,0.00286343312779613,0.012249879683086,0.0234745375440468,4.54567965413076e-10
NMR metabolomics,X23412.Phospholipids in VLDL,NAGA,Alpha-N-acetylgalactosaminidase,37567,0.0343394903028932,0.00550610785776511,0.0235475189016736,0.0451314617041128,4.60863282812026e-10
NMR metabolomics,X23412.Phospholipids in VLDL,SRPX,Sushi repeat-containing protein SRPX,37990,-0.0188122736916598,0.00302128200000326,-0.0247339864116662,-0.0128905609716534,4.90792676549224e-10
NMR metabolomics,X23412.Phospholipids in VLDL,NPTX1,Neuronal pentraxin-1,40332,0.0226456337027156,0.00363744114631956,0.0155162490559293,0.029775018349502,4.91443494908982e-10
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,40305,0.012124599242385,0.0019500962538075,0.00830241058492231,0.0159467878998477,5.17997068938681e-10
NMR metabolomics,X23412.Phospholipids in VLDL,NTRK3,NT-3 growth factor receptor,40471,-0.0124427449391086,0.00201107775853167,-0.0163844573458306,-0.00850103253238648,6.2769342774398e-10
NMR metabolomics,X23412.Phospholipids in VLDL,GAS2,Growth arrest-specific protein 2,37714,0.0305486611266455,0.00494578107143447,0.0208549302266339,0.040242392026657,6.73634936070869e-10
NMR metabolomics,X23412.Phospholipids in VLDL,APOBR,Apolipoprotein B receptor,37628,-0.0241618306920374,0.00391759942293374,-0.0318403255609875,-0.0164833358230872,7.14029593913641e-10
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB1A1,Uteroglobin,40384,0.032227759695814,0.00522692199678381,0.0219829925821177,0.0424725268095103,7.18526203506108e-10
NMR metabolomics,X23412.Phospholipids in VLDL,REN,Renin,40359,-0.0404439812533085,0.00657413300206753,-0.0533292819373609,-0.0275586805692562,7.83494618514015e-10
NMR metabolomics,X23412.Phospholipids in VLDL,MTPN,Myotrophin,40042,0.0187649718059441,0.00305563621009542,0.0127759248341571,0.0247540187777312,8.39389904519805e-10
NMR metabolomics,X23412.Phospholipids in VLDL,TEK,Angiopoietin-1 receptor,40411,0.0121819625999651,0.00198393483546904,0.00829345032244579,0.0160704748774844,8.43138991798887e-10
NMR metabolomics,X23412.Phospholipids in VLDL,DDC,Aromatic-L-amino-acid decarboxylase,40330,-0.0274803258514427,0.00448101693858658,-0.0362631190510724,-0.018697532651813,8.84965302916306e-10
NMR metabolomics,X23412.Phospholipids in VLDL,PRTG,Protogenin,40489,0.0142335587869808,0.00232106446072095,0.00968427244396778,0.0187828451299939,8.86250212599031e-10
NMR metabolomics,X23412.Phospholipids in VLDL,IL6,Interleukin-6,40305,0.0412237741576615,0.00672968904300142,0.0280335836333787,0.0544139646819442,9.24420313988178e-10
NMR metabolomics,X23412.Phospholipids in VLDL,RABEPK,Rab9 effector protein with kelch motifs,39980,0.033859918680722,0.00554600947421027,0.0229897401112699,0.0447300972501741,1.05065349285186e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ICOSLG,ICOS ligand,40305,0.0107626974160188,0.00176337824687407,0.00730647605214561,0.0142189187798919,1.06216879250291e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,40359,-0.0159899193610565,0.00262494381409774,-0.0211348092366881,-0.010845029485425,1.14412297721985e-09
NMR metabolomics,X23412.Phospholipids in VLDL,GBP4,Guanylate-binding protein 4,39961,0.0277014313158867,0.0045496852869404,0.0187840481534835,0.0366188144782899,1.1655242518629e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,0.0200112927457387,0.00330941966141734,0.0135248302093607,0.0264977552821167,1.51797943461727e-09
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.0140908651786937,0.0023337292489806,0.00951675585069172,0.0186649745066957,1.59557928393329e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA5,Protein disulfide-isomerase A5,37482,0.034314841996847,0.00568409591064971,0.0231740140119736,0.0454556699817205,1.61281189467537e-09
NMR metabolomics,X23412.Phospholipids in VLDL,DSG3,Desmoglein-3,40419,0.0186099735144717,0.00308702289363522,0.0125594086429467,0.0246605383859967,1.69179754190628e-09
NMR metabolomics,X23412.Phospholipids in VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,0.0323713981824756,0.00537151334944095,0.0218432320175714,0.0428995643473799,1.71250831662645e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ECM1,Extracellular matrix protein 1,37655,0.0205900653096831,0.00342326660056678,0.0138804627725723,0.027299667846794,1.84935932054346e-09
NMR metabolomics,X23412.Phospholipids in VLDL,IL1R1,Interleukin-1 receptor type 1,40303,-0.0123622841724505,0.0020587751535638,-0.0163974834734355,-0.00832708487146543,1.95895943700053e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CA6,Carbonic anhydrase 6,40295,-0.0352504676469602,0.00587765738878322,-0.0467706761289753,-0.0237302591649451,2.04902024236106e-09
NMR metabolomics,X23412.Phospholipids in VLDL,HSBP1,Heat shock factor-binding protein 1,37628,0.0529359035807951,0.00882697647718749,0.0356350296855076,0.0702367774760826,2.06182891293589e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,38484,-0.01730167910329,0.00288854341696318,-0.0229632242005378,-0.0116401340060421,2.15290392164309e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,0.0123135843817115,0.00206091669787981,0.0082741876538671,0.0163529811095559,2.3528379609379e-09
NMR metabolomics,X23412.Phospholipids in VLDL,VIT,Vitrin,37990,0.0203373467082058,0.00340750367742294,0.0136586395004569,0.0270160539159548,2.45579842680733e-09
NMR metabolomics,X23412.Phospholipids in VLDL,LY9,T-lymphocyte surface antigen Ly-9,40182,0.0157924971788413,0.00264745026292527,0.0106034946635078,0.0209814996941749,2.4961449353714e-09
NMR metabolomics,X23412.Phospholipids in VLDL,APOE,Apolipoprotein E,38013,0.0413156963320379,0.00692609556448357,0.0277405490256501,0.0548908436384257,2.5038564312902e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM5,Intercellular adhesion molecule 5,40359,0.0241826037977899,0.00406744162081912,0.0162104182209844,0.0321547893745954,2.81536843940702e-09
NMR metabolomics,X23412.Phospholipids in VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,0.0189856777556073,0.00319583452225167,0.0127218420919941,0.0252495134192206,2.89645670775819e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00808466870669806,0.00136186199476833,0.00541541919695214,0.010753918216444,2.9834781642745e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB1,Integrin beta-1,40333,0.0119755358685647,0.00201767129303097,0.00802090013422396,0.0159301716029054,2.99367706805682e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,0.0216128921019925,0.00364106723724096,0.0144764003170003,0.0287493838869848,2.99448720913657e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL9,C-X-C motif chemokine 9,40422,0.0370278067143243,0.00623912608579445,0.0247991195861672,0.0492564938424814,3.00338035564654e-09
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,0.031347314329696,0.00530559863896447,0.0209483409973256,0.0417462876620663,3.53915863457333e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.018017277782682,0.0030509369526669,0.0120374413554549,0.0239971142099091,3.60029912419427e-09
NMR metabolomics,X23412.Phospholipids in VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,0.0460143871578304,0.00782971516744466,0.0306681454296389,0.0613606288860219,4.28199327168577e-09
NMR metabolomics,X23412.Phospholipids in VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,0.0182727140830892,0.00311443160724311,0.0121684281328927,0.0243770000332857,4.52220260790022e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,-0.016397890218013,0.00279695742351334,-0.0218799267680992,-0.0109158536679269,4.64434903171936e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL4,Angiopoietin-related protein 4,40396,-0.0245609345067007,0.00420237972936986,-0.0327975987762656,-0.0163242702371358,5.17913848285518e-09
NMR metabolomics,X23412.Phospholipids in VLDL,GAST,Gastrin,37942,0.0702116595550441,0.0120199241876372,0.0466526081472752,0.0937707109628129,5.29974100891749e-09
NMR metabolomics,X23412.Phospholipids in VLDL,KIF1C,Kinesin-like protein KIF1C,37562,0.0203365024466793,0.00348250450882896,0.0135107936093746,0.0271622112839841,5.35599033231949e-09
NMR metabolomics,X23412.Phospholipids in VLDL,EGFLAM,Pikachurin,37901,0.0166035056235032,0.00284415340234312,0.0110289649549107,0.0221780462920957,5.41252502764269e-09
NMR metabolomics,X23412.Phospholipids in VLDL,NFYA,Nuclear transcription factor Y subunit alpha,37562,0.0207763518805829,0.00356006482204747,0.0137986248293699,0.027754078931796,5.47500179234892e-09
NMR metabolomics,X23412.Phospholipids in VLDL,IL6ST,Interleukin-6 receptor subunit beta,40359,0.00935606570046838,0.00161113884541215,0.00619823356346058,0.0125138978374762,6.47714451438725e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,37998,-0.0176746546678271,0.00304941600413787,-0.0236515100359373,-0.0116977992997169,6.93947235761696e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CFC1,Cryptic protein,39980,0.0246704267640362,0.00425744629440501,0.0163258320270023,0.03301502150107,6.97890275650541e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PI3,Elafin,40074,0.0285896386119945,0.00493465218367987,0.0189177203319819,0.038261556892007,7.0199348724372e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN2,Ataxin-2,37541,0.0615786843279603,0.0106553950959823,0.040694109939835,0.0824632587160856,7.68084394688855e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,0.0191945315250495,0.003333479814656,0.0126609110883237,0.0257281519617753,8.66640642682972e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,37598,0.0205142074796872,0.00356833804083571,0.0135202649196493,0.0275081500397252,9.17932777730382e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,39980,0.0310122930093745,0.00541371167062621,0.0204014181349471,0.0416231678838018,1.03216885052178e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PFDN2,Prefoldin subunit 2,39961,0.0296913801396376,0.00518352975359087,0.0195316618225995,0.0398510984566757,1.03491525780409e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,0.0253563121285776,0.00443439731011017,0.0166648934007617,0.0340477308563936,1.10014398478615e-08
NMR metabolomics,X23412.Phospholipids in VLDL,RHOC,Rho-related GTP-binding protein RhoC,40152,0.0611980282742454,0.0107105064281276,0.0402054356751154,0.0821906208733754,1.12463908499331e-08
NMR metabolomics,X23412.Phospholipids in VLDL,REG3G,Regenerating islet-derived protein 3-gamma,37900,0.0213194065326898,0.00373137324553577,0.0140059149714397,0.0286328980939399,1.12985391711207e-08
NMR metabolomics,X23412.Phospholipids in VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,0.0195776193365055,0.00343094795932453,0.0128529613362295,0.0263022773367816,1.17601628205926e-08
NMR metabolomics,X23412.Phospholipids in VLDL,DGCR6,Protein DGCR6,37541,0.023964246908431,0.00420391774508056,0.0157245681280731,0.0322039256887889,1.22067232708127e-08
NMR metabolomics,X23412.Phospholipids in VLDL,GFAP,Glial fibrillary acidic protein,39959,0.0246151184724914,0.00432230231471227,0.0161434059356554,0.0330868310093275,1.25675383527707e-08
NMR metabolomics,X23412.Phospholipids in VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,0.0227124080836769,0.00398886675392334,0.0148942292459871,0.0305305869213666,1.26789710090895e-08
NMR metabolomics,X23412.Phospholipids in VLDL,RCOR1,REST corepressor 1,40042,0.0234678708762324,0.00413081665544952,0.0153714702315514,0.0315642715209135,1.36165930135706e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CD86,T-lymphocyte activation antigen CD86,37901,0.0153505673390112,0.00270225802713757,0.0100541416058215,0.0206469930722008,1.36968648983425e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CA7,Carbonic anhydrase 7,37714,-0.0184803087688934,0.00325347546330861,-0.0248571206769783,-0.0121034968608085,1.37384249856615e-08
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS11D,Transmembrane protease serine 11D,37921,0.0202610463549898,0.00356737749215576,0.0132689864703645,0.027253106239615,1.37853505735554e-08
NMR metabolomics,X23412.Phospholipids in VLDL,GGT5,Glutathione hydrolase 5 proenzyme,40228,0.011779954741147,0.00209136112601069,0.007680886934166,0.0158790225481279,1.80465165476967e-08
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,0.0378025824954498,0.0067125622029842,0.0246459605776007,0.0509592044132988,1.82087555672815e-08
NMR metabolomics,X23412.Phospholipids in VLDL,COMP,Cartilage oligomeric matrix protein,40198,0.0175603402205054,0.00311948056419818,0.011446158314677,0.0236745221263338,1.84080885750352e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,37562,0.0527861226203552,0.00938302902762778,0.0343953857262048,0.0711768595145057,1.88536704345551e-08
NMR metabolomics,X23412.Phospholipids in VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.0170887064229585,0.00304258957117628,-0.023052181982464,-0.011125230863453,1.98725487357274e-08
NMR metabolomics,X23412.Phospholipids in VLDL,EPHB4,Ephrin type-B receptor 4,40536,-0.0127430668106089,0.00226921823327538,-0.0171907345478287,-0.00829539907338917,1.99098327119751e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ALPP,"Alkaline phosphatase, placental type",40305,0.0533738083004079,0.00950507946575329,0.0347438525475314,0.0720037640532844,1.99521604856413e-08
NMR metabolomics,X23412.Phospholipids in VLDL,DUSP3,Dual specificity protein phosphatase 3,39961,0.0439569890264263,0.00782916465155897,0.0286118263093707,0.0593021517434819,2.00489705364289e-08
NMR metabolomics,X23412.Phospholipids in VLDL,FABP2,"Fatty acid-binding protein, intestinal",40359,-0.0399979838695647,0.00712596747673299,-0.0539648801239613,-0.026031087615168,2.02179962660358e-08
NMR metabolomics,X23412.Phospholipids in VLDL,AGT,Angiotensinogen,37987,0.0125426029785278,0.00223889003497385,0.00815437850997906,0.0169308274470765,2.15833775567623e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,0.0156427736120301,0.00279680586518642,0.0101610341162647,0.0211245131077955,2.26837191069924e-08
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,0.0152616365690457,0.00273132226641133,0.00990824492687949,0.0206150282112119,2.33956243261326e-08
NMR metabolomics,X23412.Phospholipids in VLDL,LUZP2,Leucine zipper protein 2,37900,0.0230337019403831,0.00413180484155241,0.0149353644509404,0.0311320394298259,2.52684319370623e-08
NMR metabolomics,X23412.Phospholipids in VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,0.0535180654198978,0.00961100671568466,0.0346804922571559,0.0723556385826397,2.6211895004354e-08
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,0.0209374272760763,0.00377396233105829,0.013540461107202,0.0283343934449505,2.9383258503788e-08
NMR metabolomics,X23412.Phospholipids in VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.0356267333458934,0.00643061875317768,0.0230227205896652,0.0482307461021217,3.07008383605944e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,39980,0.0212263127121005,0.00383205044579095,0.0137154938383502,0.0287371315858507,3.08874826722503e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CA12,Carbonic anhydrase 12,40305,-0.0164798364511651,0.00297990070004629,-0.0223204418232558,-0.0106392310790744,3.2468002111855e-08
NMR metabolomics,X23412.Phospholipids in VLDL,QPCT,Glutaminyl-peptide cyclotransferase,40373,0.0137020596679133,0.0024778711263122,0.0088454322603414,0.0185586870754852,3.25694076365118e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PSME2,Proteasome activator complex subunit 2,40152,0.0189040442374917,0.00341901310836346,0.0122027785450993,0.0256053099298841,3.27022805012167e-08
NMR metabolomics,X23412.Phospholipids in VLDL,FABP3,"Fatty acid-binding protein, heart",37990,0.0242931712393394,0.00439366515786953,0.0156815875299151,0.0329047549487636,3.27770727668098e-08
NMR metabolomics,X23412.Phospholipids in VLDL,NPTX2,Neuronal pentraxin-2,37998,-0.016669308740567,0.00302023576588886,-0.0225889708417091,-0.0107496466394248,3.46788583057059e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,37598,0.0160113773602456,0.00290629270261318,0.0103150436631237,0.0217077110573674,3.672253499425e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CCL28,C-C motif chemokine 28,40278,0.0301636293567263,0.00549918268502484,0.0193852312940776,0.0409420274193749,4.19545473303591e-08
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,0.013347758479695,0.00243366792790369,0.00857776934100374,0.0181177476183862,4.20638993925596e-08
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFB,Vascular endothelial growth factor B,37598,0.0144718325233807,0.0026415939678943,0.00929430834630782,0.0196493567004535,4.36968852086054e-08
NMR metabolomics,X23412.Phospholipids in VLDL,HEPACAM2,HEPACAM family member 2,37942,-0.0205697447145207,0.0037616921735646,-0.0279426613747073,-0.0131968280543341,4.62677084382783e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PREB,Prolactin regulatory element-binding protein,40044,0.0149501625528496,0.00273557474663689,0.00958843604944129,0.0203118890562579,4.69771614355487e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,0.0108448390377991,0.0019855084193144,0.00695324253594285,0.0147364355396553,4.79176750865116e-08
NMR metabolomics,X23412.Phospholipids in VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,37959,0.0188630755296628,0.00346318192055939,0.0120752389653664,0.0256509120939592,5.21971230736734e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PGA4,Pepsin A-4,37987,0.0341035991194417,0.00628762873449479,0.0217798467998319,0.0464273514390515,5.93074606604486e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,-0.0121720418084083,0.00224471623615889,-0.0165716856312797,-0.00777239798553691,5.96156402235478e-08
NMR metabolomics,X23412.Phospholipids in VLDL,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.0132452940250435,0.00245094322332263,0.00844144530733115,0.0180491427427559,6.6049583975725e-08
NMR metabolomics,X23412.Phospholipids in VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.0172802586224675,0.0032151864233896,0.0109784932326239,0.0235820240123111,7.78506297627403e-08
NMR metabolomics,X23412.Phospholipids in VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,0.0293441949926804,0.00546388905693329,0.0186349724410912,0.0400534175442697,7.96053587106176e-08
NMR metabolomics,X23412.Phospholipids in VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,0.0215631323300517,0.00402844623581429,0.0136673777078557,0.0294588869522477,8.78694244820244e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PRELP,Prolargin,40357,0.0114417267770814,0.00213833397512838,0.00725059218582979,0.015632861368333,8.87953669886666e-08
NMR metabolomics,X23412.Phospholipids in VLDL,GPC1,Glypican-1,40489,0.014457677350327,0.00270743550743119,0.00915110375576188,0.0197642509448922,9.42187796003298e-08
NMR metabolomics,X23412.Phospholipids in VLDL,MUC16,Mucin-16,40305,0.0923166885255914,0.0172892037957783,0.0584298490858659,0.126203527965317,9.44582816018275e-08
NMR metabolomics,X23412.Phospholipids in VLDL,NXPH3,Neurexophilin-3,37598,0.0149926557061474,0.00280862750517159,0.00948774579601108,0.0204975656162837,9.55017962119786e-08
NMR metabolomics,X23412.Phospholipids in VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,0.0180114081795432,0.00337938107982207,0.011387821263092,0.0246349950959945,9.99446176063351e-08
NMR metabolomics,X23412.Phospholipids in VLDL,FSTL3,Follistatin-related protein 3,40293,0.0153346359875907,0.00287835183342536,0.00969306639407699,0.0209762055811044,1.00893564403759e-07
NMR metabolomics,X23412.Phospholipids in VLDL,JAM2,Junctional adhesion molecule B,40471,0.0128213554264934,0.00240723660632932,0.00810317167808794,0.0175395391748989,1.01659188564487e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4D,C-type lectin domain family 4 member D,40341,0.0300271816469787,0.0056436284816684,0.0189656698229086,0.0410886934710487,1.04859759783085e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAV,Integrin alpha-V,40489,0.00799735464329532,0.00150985515473712,0.00503803854001056,0.0109566707465801,1.1942576709194e-07
NMR metabolomics,X23412.Phospholipids in VLDL,GBP2,Guanylate-binding protein 2,40044,0.0290798082508514,0.00549090868052539,0.0183176272370216,0.0398419892646812,1.19979021341308e-07
NMR metabolomics,X23412.Phospholipids in VLDL,FGF16,Fibroblast growth factor 16,37598,0.0241091453594118,0.00455417709559038,0.0151829582520546,0.0330353324667689,1.21692913780912e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SEL1L,Protein sel-1 homolog 1,37628,0.0158786801308724,0.00300089317356342,0.00999692951068811,0.0217604307510567,1.23384164301681e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CDH17,Cadherin-17,40359,-0.0328925444155995,0.00624488643374489,-0.0451325218257394,-0.0206525670054595,1.40388336557219e-07
NMR metabolomics,X23412.Phospholipids in VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,0.0132733544055785,0.00252539504462395,0.00832358011811553,0.0182231286930414,1.49155716193131e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CRH,Corticoliberin,39947,0.0420704079622097,0.00801708744083358,0.0263569165781759,0.0577838993462435,1.56130952042427e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NXPH1,Neurexophilin-1,39961,0.0182656838744558,0.00348107782720927,0.0114427713331256,0.025088596415786,1.5651683327961e-07
NMR metabolomics,X23412.Phospholipids in VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,37714,0.0208598633591204,0.00397966065018352,0.0130597284847607,0.0286599982334801,1.6161690736412e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CAT,Catalase,37786,0.0263655258050225,0.00503575386295711,0.0164954482336265,0.0362356033764184,1.66888988510969e-07
NMR metabolomics,X23412.Phospholipids in VLDL,MILR1,Allergin-1,40044,-0.0240552439554838,0.0046076444491412,-0.0330862270758005,-0.015024260835167,1.80512580103656e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PRKD2,Serine/threonine-protein kinase D2,37562,0.022948250977449,0.00439648328203173,0.0143311437446668,0.0315653582102312,1.81966826090006e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NEFL,Neurofilament light polypeptide,39903,0.0205715805613145,0.00394259789727259,0.0128440886826602,0.0282990724399688,1.83428640472001e-07
NMR metabolomics,X23412.Phospholipids in VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,0.0298562356374885,0.00575739933487914,0.0185717329411253,0.0411407383338516,2.183005427392e-07
NMR metabolomics,X23412.Phospholipids in VLDL,C1QL2,Complement C1q-like protein 2,37598,0.0206350465772556,0.00398041848256166,0.0128334263514348,0.0284366668030765,2.20232777087141e-07
NMR metabolomics,X23412.Phospholipids in VLDL,GFRA2,GDNF family receptor alpha-2,40305,0.010082898479059,0.00195941845807201,0.00624243830123787,0.0139233586568801,2.69473186921458e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ANPEP,Aminopeptidase N,40370,0.0134036108035621,0.00260681217967879,0.00829425893139163,0.0185129626757325,2.75398070433375e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CSF1,Macrophage colony-stimulating factor 1,40422,0.0128077732238056,0.00249426443260754,0.00791901493589484,0.0176965315117164,2.85627154273994e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CREBZF,CREB/ATF bZIP transcription factor,37482,-0.0125669275416882,0.00244714446581961,-0.0173633306946946,-0.00777052438868172,2.85691573589406e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PRUNE2,Protein prune homolog 2,37714,0.0140353490805145,0.00273465256219593,0.00867543005861052,0.0193952681024186,2.90105377738921e-07
NMR metabolomics,X23412.Phospholipids in VLDL,BRD1,Bromodomain-containing protein 1,37714,-0.0147135787459366,0.00286988972213142,-0.0203385626013142,-0.00908859489055902,2.98731865493256e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PCDHB15,Protocadherin beta-15,37900,-0.019095817742831,0.00372841410008264,-0.026403509378993,-0.0117881261066691,3.06981413409828e-07
NMR metabolomics,X23412.Phospholipids in VLDL,INSL5,Insulin-like peptide INSL5,37901,0.0444299179518958,0.00868020099627956,0.0274167239991878,0.0614431119046037,3.12165157661943e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,0.0164269938981964,0.00321629100162622,0.010123063535009,0.0227309242613838,3.30300020378166e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CTRC,Chymotrypsin-C,40360,0.0295098338312864,0.00578013276538831,0.0181807736111253,0.0408388940514475,3.33921188225781e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TPM3,Tropomyosin alpha-3 chain,37562,-0.0200605381918728,0.00393634488557284,-0.0277757741675955,-0.01234530221615,3.51296994458638e-07
NMR metabolomics,X23412.Phospholipids in VLDL,FLT1,Vascular endothelial growth factor receptor 1,40272,0.0108861965778399,0.00213687353978627,0.00669792443985884,0.015074468715821,3.53778404758456e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS53,Serine protease 53,37942,0.0172674171116066,0.00339478725047751,0.0106136341006706,0.0239212001225425,3.69723730708067e-07
NMR metabolomics,X23412.Phospholipids in VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,0.0166863911039065,0.00328103415341017,0.0102555641632226,0.0231172180445905,3.70429001512191e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ODAM,Odontogenic ameloblast-associated protein,39934,0.0251349537444607,0.00494771524395189,0.015437431866315,0.0348324756226064,3.8159710798383e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,0.0177420591128936,0.0034987060399229,0.0108845952746447,0.0245995229511425,4.00066449906927e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CX3CL1,Fractalkine,40228,-0.0159950549876534,0.00315517028423994,-0.0221791887447637,-0.00981092123054314,4.0343166889417e-07
NMR metabolomics,X23412.Phospholipids in VLDL,LHB,Lutropin subunit beta,39980,0.0397057577140842,0.00783417747963693,0.0243507698539958,0.0550607455741725,4.06052466010785e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,0.0134934926965464,0.00266711074906795,0.0082659556283732,0.0187210297647196,4.25678302162259e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA6,Corticosteroid-binding globulin,38013,0.00835275577301931,0.0016517402413807,0.00511534489991313,0.0115901666461255,4.31592241925045e-07
NMR metabolomics,X23412.Phospholipids in VLDL,RPS10,40S ribosomal protein S10,37562,-0.0198066542733356,0.00392137458225561,-0.0274925484545566,-0.0121207600921146,4.45535331910223e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,37482,0.0278263637358207,0.00551139819655892,0.0170240232705652,0.0386287042010762,4.50419549487379e-07
NMR metabolomics,X23412.Phospholipids in VLDL,IL7R,Interleukin-7 receptor subunit alpha,40332,-0.0244345124226631,0.00486077754915091,-0.0339616364189988,-0.0149073884263273,5.03967826171803e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0320780711193268,0.00638892716240084,-0.0446003683576325,-0.0195557738810212,5.19919797276062e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CALCB,Calcitonin gene-related peptide 2,37942,0.0185060759254257,0.00368911895269682,0.0112754027781399,0.0257367490727114,5.33198185928579e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD2,Sushi domain-containing protein 2,40332,-0.0131895949081551,0.00264130107732397,-0.01836654501971,-0.00801264479660007,5.98934379572031e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CD248,Endosialin,37998,-0.0184747461021089,0.00370402698997133,-0.0257346390024527,-0.0112148532017651,6.18445245897695e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CCN3,CCN family member 3,40522,0.0155043774409014,0.00311156594009745,0.00940570819831044,0.0216030466834925,6.33151113148484e-07
NMR metabolomics,X23412.Phospholipids in VLDL,MYL3,Myosin light chain 3,37628,-0.0314596588990028,0.006322516761701,-0.0438517917519368,-0.0190675260460689,6.57944233948174e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CSF3,Granulocyte colony-stimulating factor,40044,0.0223697965074815,0.00450631987712321,0.0135374095483201,0.031202183466643,6.97512389046033e-07
NMR metabolomics,X23412.Phospholipids in VLDL,LIF,Leukemia inhibitory factor,39961,0.0241188212443482,0.00486078155135642,0.0145916894036896,0.0336459530850068,7.05385708889345e-07
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,0.0121523855340106,0.0024493738348765,0.00735161281765262,0.0169531582503685,7.08275274897815e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,40305,0.0141323295414489,0.00285831865019325,0.00853002498707013,0.0197346340958277,7.72069934622679e-07
NMR metabolomics,X23412.Phospholipids in VLDL,DLL4,Delta-like protein 4,37628,0.0385677988259857,0.0078008091054504,0.0232782129793029,0.0538573846726685,7.74473979038587e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CRISP3,Cysteine-rich secretory protein 3,37875,-0.0123447061360636,0.00249903186874371,-0.0172428085988012,-0.00744660367332588,7.9146365654928e-07
NMR metabolomics,X23412.Phospholipids in VLDL,GPNMB,Transmembrane glycoprotein NMB,39957,0.0128477781188805,0.00260727091886918,0.00773752711789691,0.0179580291198641,8.40735867168727e-07
NMR metabolomics,X23412.Phospholipids in VLDL,RAB37,Ras-related protein Rab-37,40044,0.0378777975555706,0.00769081028067319,0.0228038094054512,0.05295178570569,8.5192766900566e-07
NMR metabolomics,X23412.Phospholipids in VLDL,KLK11,Kallikrein-11,40260,0.0134885613430893,0.00274104160293181,0.00811611980134291,0.0188610028848356,8.6986970693353e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SPON1,Spondin-1,40379,0.0149119718327509,0.00303197601769413,0.00896929883807039,0.0208546448274314,8.81986307863129e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,0.0205562858268775,0.00418982531937167,0.012344228200909,0.0287683434528459,9.39260910128068e-07
NMR metabolomics,X23412.Phospholipids in VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,39980,0.0183894506815007,0.00374866168409711,0.0110420737806704,0.025736827582331,9.40834234494236e-07
NMR metabolomics,X23412.Phospholipids in VLDL,FSTL1,Follistatin-related protein 1,37628,-0.0102016039954831,0.00207988170529633,-0.014278172137864,-0.00612503585310233,9.45925745995488e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH1,Protocadherin-1,40475,0.00984824998154805,0.00200844737104642,0.00591169313429706,0.013784806828799,9.51076161056473e-07
NMR metabolomics,X23412.Phospholipids in VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,40471,0.0103956190688199,0.00212444355516665,0.00623170970069322,0.0145595284369465,1.00103997918321e-06
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,0.0161280632495112,0.0032975361095093,0.00966489247487297,0.0225912340241494,1.01514426969764e-06
NMR metabolomics,X23412.Phospholipids in VLDL,EPHB6,Ephrin type-B receptor 6,40192,0.0140505005729969,0.00288221019679874,0.00840136858727135,0.0196996325587224,1.09922382568549e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN10,Ataxin-10,39961,0.0325922840847233,0.00668576998567681,0.0194881749127968,0.0456963932566498,1.09955612896185e-06
NMR metabolomics,X23412.Phospholipids in VLDL,LMOD1,Leiomodin-1,37959,-0.0162173984832069,0.00335110348007803,-0.0227855613041598,-0.00964923566225394,1.31657708976797e-06
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,0.0187557041216921,0.00387947170563679,0.011151939578644,0.0263594686647403,1.34683679963701e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NME3,Nucleoside diphosphate kinase 3,40379,0.0106690231440926,0.0022081244059337,0.00634109930846255,0.0149969469797226,1.36623639239298e-06
NMR metabolomics,X23412.Phospholipids in VLDL,TPSAB1,Tryptase alpha/beta-1,40498,0.0234656186491495,0.00486049102419415,0.013939056241729,0.03299218105657,1.39301229932818e-06
NMR metabolomics,X23412.Phospholipids in VLDL,GZMH,Granzyme H,40042,0.0331463275451798,0.00688253807890085,0.0196565529105342,0.0466361021798255,1.47837720346033e-06
NMR metabolomics,X23412.Phospholipids in VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,39980,0.0239086234281883,0.00496476050361296,0.0141776928411069,0.0336395540152697,1.48093725297966e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX1,Peroxiredoxin-1,39953,-0.0394672515424715,0.00823309176773632,-0.0556041114072347,-0.0233303916777083,1.65224524794948e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ITM2A,Integral membrane protein 2A,40341,-0.0261326128717293,0.00545547757672141,-0.0368253489221033,-0.0154398768213554,1.68152263518931e-06
NMR metabolomics,X23412.Phospholipids in VLDL,KLK8,Kallikrein-8,39801,0.0156963880978103,0.00327891275609584,0.00926971909586241,0.0221230570997581,1.70810588048435e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA1,Annexin A1,37608,0.0183414953027839,0.00383439430422211,0.0108260824665085,0.0258569081390592,1.74212672475167e-06
NMR metabolomics,X23412.Phospholipids in VLDL,FOSB,Protein fosB,39961,0.0172544048946853,0.00361101103261207,0.0101768232707656,0.0243319865186049,1.78424761506793e-06
NMR metabolomics,X23412.Phospholipids in VLDL,RALY,RNA-binding protein Raly,37900,0.0211733241590671,0.00446385075567651,0.0124241766779412,0.0299224716401931,2.1243875045568e-06
NMR metabolomics,X23412.Phospholipids in VLDL,LXN,Latexin,40183,-0.0290430081251326,0.00612344107772016,-0.0410449526374641,-0.0170410636128011,2.12505214958692e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PROCR,Endothelial protein C receptor,37562,-0.0162486241245544,0.00342706246195254,-0.0229656665499814,-0.00953158169912745,2.14618910888397e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CASP1,Caspase-1,39961,0.0293687899468753,0.00620930019048404,0.0171985615735266,0.041539018320224,2.26712893537548e-06
NMR metabolomics,X23412.Phospholipids in VLDL,FCRLB,Fc receptor-like B,39980,0.0265799159907326,0.00563250246519349,0.0155402111589533,0.0376196208225118,2.39044773604009e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SLC16A1,Monocarboxylate transporter 1,39961,0.0261746411605093,0.00554668221539034,0.0153031440183442,0.0370461383026743,2.39108025984085e-06
NMR metabolomics,X23412.Phospholipids in VLDL,VWF,von Willebrand factor,40536,-0.0310244596579532,0.00658936346186085,-0.0439396120432004,-0.0181093072727059,2.51920371426625e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PEPD,Xaa-Pro dipeptidase,37987,0.0111930985279025,0.00238726385139089,0.00651406137917633,0.0158721356766286,2.77667402570749e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,0.0126629396162936,0.00270582144751778,0.00735952957915872,0.0179663496534284,2.89372165159571e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SCN4B,Sodium channel subunit beta-4,37628,0.018143091799399,0.00387685435405295,0.0105444572654552,0.0257417263333428,2.8994511991184e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,0.0170313874511302,0.00364386660113578,0.0098894089129041,0.0241733659893563,2.98274569604127e-06
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,0.0118792032545476,0.00254886603003492,0.00688342583567917,0.0168749806734161,3.179376736794e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CRLF1,Cytokine receptor-like factor 1,40422,0.0112771160871992,0.00242283598667312,0.00652835755331993,0.0160258746210786,3.27361710478808e-06
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,0.0116653016266283,0.00250690315787495,0.00675177143719337,0.0165788318160632,3.29317495472271e-06
NMR metabolomics,X23412.Phospholipids in VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,39961,0.0611190558923919,0.0131459859883722,0.0353529233551824,0.0868851884296013,3.35880391359791e-06
NMR metabolomics,X23412.Phospholipids in VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,0.010884269704464,0.00235452528266543,0.0062694001504398,0.0154991392584883,3.8177527837642e-06
NMR metabolomics,X23412.Phospholipids in VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,0.020910752527696,0.00452979136584265,0.0120323614506444,0.0297891436047476,3.94402380340833e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CNPY2,Protein canopy homolog 2,40042,0.0259881945227695,0.0056399925554742,0.0149338091140401,0.037042579931499,4.10093154896658e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SCARF2,Scavenger receptor class F member 2,40471,-0.0126174303313927,0.0027416347184184,-0.0179910343794928,-0.00724382628329267,4.21348603505713e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM4,Intercellular adhesion molecule 4,40341,-0.0223955877672153,0.00486813987806778,-0.0319371419282281,-0.0128540336062024,4.24855420987875e-06
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA1549L,UPF0606 protein KIAA1549L,37714,-0.0123664348193642,0.0026901350566281,-0.0176390995303553,-0.00709377010837312,4.32665001684329e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CENPF,Centromere protein F,37714,0.0231908707008129,0.00505033482712846,0.0132922144396411,0.0330895269619847,4.43167499183395e-06
NMR metabolomics,X23412.Phospholipids in VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.0119547147874335,0.00260455830530586,0.006849780509034,0.017059649065833,4.46807108607745e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,0.0112036880811989,0.00244486376104807,0.00641175510954466,0.0159956210528531,4.62840412099978e-06
NMR metabolomics,X23412.Phospholipids in VLDL,FABP9,Fatty acid-binding protein 9,40341,0.0236022560003905,0.00515565833920324,0.0134971656555522,0.0337073463452289,4.73154073749143e-06
NMR metabolomics,X23412.Phospholipids in VLDL,AGR2,Anterior gradient protein 2 homolog,39839,0.042769070364905,0.00935132387985609,0.024440475560387,0.0610976651694229,4.83190025630539e-06
NMR metabolomics,X23412.Phospholipids in VLDL,GLYR1,Putative oxidoreductase GLYR1,37900,0.0255096892194444,0.00560764692023371,0.0145187012557863,0.0365006771831025,5.43497115417893e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF7,SLAM family member 7,40341,-0.0242044913804445,0.00532431950120291,-0.0346401576028022,-0.0137688251580868,5.50719071665489e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,0.0204344180953211,0.00450539436155604,0.0116038451466713,0.029264991043971,5.7883328574902e-06
NMR metabolomics,X23412.Phospholipids in VLDL,EPHX2,Bifunctional epoxide hydrolase 2,40042,0.0262198197644423,0.00578296921009196,0.0148852001126621,0.0375544394162226,5.83157252339158e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SYT1,Synaptotagmin-1,37942,0.0164004739593831,0.0036184023137384,0.00930840542445588,0.0234925424943104,5.87858054374836e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CHI3L1,Chitinase-3-like protein 1,40054,0.0309246594967237,0.00685618810115576,0.0174865308184584,0.044362788174989,6.51545958928286e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CHRM1,Muscarinic acetylcholine receptor M1,37572,-0.0157132379955553,0.00348756042442825,-0.0225488564274347,-0.00887761956367598,6.67858735995492e-06
NMR metabolomics,X23412.Phospholipids in VLDL,FAM171B,Protein FAM171B,37900,0.0115235534326854,0.00256331416347522,0.00649945767227402,0.0165476491930969,6.99643478249273e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,37714,0.0285228302607535,0.0063483056262838,0.0160801512332372,0.0409655092882697,7.08262813069182e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,0.0257320740952779,0.00573186158497728,0.0144976253887224,0.0369665228018334,7.20663498023608e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,39980,0.0213594426038244,0.00475889944571472,0.0120319996902235,0.0306868855174252,7.23047262389925e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SBSN,Suprabasin,37977,-0.0139459766908688,0.00310720321240044,-0.0200360949871736,-0.00785585839456391,7.23958188306011e-06
NMR metabolomics,X23412.Phospholipids in VLDL,LTA4H,Leukotriene A-4 hydrolase,40489,0.023982584366796,0.00534495149876297,0.0135064794292205,0.0344586893043714,7.27489615020659e-06
NMR metabolomics,X23412.Phospholipids in VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,0.0111480952077997,0.00248641849709259,0.00627471495349827,0.0160214754621012,7.40001987767445e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CALB1,Calbindin,40305,0.0175336533011778,0.00391403119907509,0.00986215215099061,0.025205154451365,7.52734922792003e-06
NMR metabolomics,X23412.Phospholipids in VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,0.0163599385745525,0.0036589146409047,0.0091884658783793,0.0235314112707257,7.83138111468978e-06
NMR metabolomics,X23412.Phospholipids in VLDL,IL34,Interleukin-34,39934,0.0148053739866747,0.00331426658232221,0.00830941148532312,0.0213013364880262,7.98245653580807e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SDC1,Syndecan-1,40359,0.0164795567067409,0.003690718663417,0.00924574812644359,0.0237133652870382,8.05689059492299e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CLASP1,CLIP-associating protein 1,37482,0.0295122011294585,0.00661989758186057,0.0165372018690118,0.0424872003899053,8.33780341927359e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN8,Septin-8,37921,0.0131000454251682,0.00294430230028908,0.00732921291660157,0.0188708779337348,8.68468638764014e-06
NMR metabolomics,X23412.Phospholipids in VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,40311,0.0359217615228026,0.0080892810556619,0.0200667706537053,0.0517767523919,9.02886921179963e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CD48,CD48 antigen,40396,0.0119795112091089,0.00270395620059333,0.00667975705594594,0.0172792653622718,9.47007319785854e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CCL21,C-C motif chemokine 21,40422,0.0173522373643801,0.00391785723760563,0.00967323717867312,0.0250312375500872,9.52945930192713e-06
NMR metabolomics,X23412.Phospholipids in VLDL,BCAM,Basal cell adhesion molecule,40332,-0.009641688886492,0.00218545847382003,-0.0139251874951793,-0.00535819027780474,1.03215020735416e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF8,SLAM family member 8,39980,0.0217314303403013,0.00493993060206301,0.0120491663602578,0.0314136943203448,1.09405948244636e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1D,V-type proton ATPase subunit D,40305,0.01068042023582,0.00242809914539117,0.00592134591085329,0.0154394945607867,1.09623509818954e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN2,Contactin-2,40489,0.0181594811842193,0.00413694175539013,0.0100510753436547,0.026267887024784,1.14290201690641e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CLSTN2,Calsyntenin-2,40516,-0.0157793771618445,0.00360022149644766,-0.0228358112948819,-0.00872294302880712,1.17857993538625e-05
NMR metabolomics,X23412.Phospholipids in VLDL,LYAR,Cell growth-regulating nucleolar protein,39980,0.0212642908965105,0.00485217965342902,0.0117540187757897,0.0307745630172314,1.18138228255165e-05
NMR metabolomics,X23412.Phospholipids in VLDL,B2M,Beta-2-microglobulin,38013,0.0128144049396194,0.0029326963092325,0.00706632017352366,0.0185624897057151,1.25459102591193e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA7A,Semaphorin-7A,40490,0.0107917522845607,0.00248010734958908,0.00593074187936613,0.0156527626897553,1.3615403358009e-05
NMR metabolomics,X23412.Phospholipids in VLDL,UROS,Uroporphyrinogen-III synthase,37572,0.0282525232033781,0.00649943293279323,0.0155136346551034,0.0409914117516529,1.39101567952387e-05
NMR metabolomics,X23412.Phospholipids in VLDL,EP300,Histone acetyltransferase p300,37598,0.0119573594511805,0.00276540707410607,0.00653716158593261,0.0173775573164284,1.54419890107119e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NINJ1,Ninjurin-1,39980,0.0224851566650713,0.00520147793029392,0.0122902599216952,0.0326800534084474,1.54992652449371e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CR2,Complement receptor type 2,40403,0.0184763596867642,0.00428561036655064,0.010076563368325,0.0268761560052035,1.6330441562109e-05
NMR metabolomics,X23412.Phospholipids in VLDL,MYOM2,Myomesin-2,37562,-0.0186658518053013,0.00435755180006192,-0.0272066533334226,-0.0101250502771799,1.85233798192773e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CD34,Hematopoietic progenitor cell antigen CD34,40408,0.00957835091028595,0.00223815651060935,0.00519156414949163,0.0139651376710803,1.88345358521922e-05
NMR metabolomics,X23412.Phospholipids in VLDL,GZMB,Granzyme B,40341,0.0248364741337596,0.00580614801576789,0.0134564240228546,0.0362165242446647,1.90009437044072e-05
NMR metabolomics,X23412.Phospholipids in VLDL,MYOM1,Myomesin-1,37541,0.0184987704410728,0.00433823261348149,0.00999583451864908,0.0270017063634965,2.02093863407964e-05
NMR metabolomics,X23412.Phospholipids in VLDL,IFNG,Interferon gamma,40044,0.0447191003390395,0.0104886535442677,0.0241613393922749,0.0652768612858041,2.0237070997788e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CD7,T-cell antigen CD7,37567,0.0169289107611447,0.00397616998570773,0.00913561758915758,0.0247222039331319,2.08078456059241e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CRTAP,Cartilage-associated protein,37572,0.0190893458540636,0.00448682028246579,0.0102951781004306,0.0278835136076965,2.10934743742049e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ENO1,Alpha-enolase,40299,0.031016031265706,0.00731063071112523,0.0166871950719006,0.0453448674595115,2.22206885985635e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ACRV1,Acrosomal protein SP-10,37598,0.013863538420753,0.00326857750633027,0.00745712650834563,0.0202699503331603,2.23590838958726e-05
NMR metabolomics,X23412.Phospholipids in VLDL,OLFM4,Olfactomedin-4,37177,0.0482242167425664,0.0114015013712524,0.0258772740549116,0.0705711594302212,2.3570562590166e-05
NMR metabolomics,X23412.Phospholipids in VLDL,EFHD1,EF-hand domain-containing protein D1,37959,0.0135259970432773,0.0032100549442153,0.00723428935261536,0.0198177047339393,2.5292631002884e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CST1,Cystatin-SN,36179,0.0406649547225855,0.00967078259278443,0.021710220840728,0.059619688604443,2.63103026448132e-05
NMR metabolomics,X23412.Phospholipids in VLDL,AZU1,Azurocidin,39809,0.0301047592878557,0.00717848653170079,0.0160349256857221,0.0441745928899892,2.75922397634597e-05
NMR metabolomics,X23412.Phospholipids in VLDL,EIF5,Eukaryotic translation initiation factor 5,37562,0.0176536826716156,0.00421365421223835,0.00939492041562848,0.0259124449276028,2.81230145946661e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NEDD9,Enhancer of filamentation 1,37598,0.0127959745669348,0.00306284497538928,0.00679279841517184,0.0187991507186978,2.96234785745122e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SAA4,Serum amyloid A-4 protein,38013,0.0126040639049068,0.00301950908241305,0.00668582610337721,0.0185223017064364,3.00888515696031e-05
NMR metabolomics,X23412.Phospholipids in VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,0.0116269737910879,0.00278869706580033,0.00616112754211924,0.0170928200400565,3.07165435480188e-05
NMR metabolomics,X23412.Phospholipids in VLDL,AHNAK2,Protein AHNAK2,37628,0.0110308692988053,0.00264818635162703,0.00584042404961631,0.0162213145479943,3.12728810503978e-05
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.0120777559695075,0.00290102971020892,-0.017763774201517,-0.00639173773749803,3.15717411558265e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,0.0139592869237307,0.00335375258290826,0.00738593186123054,0.0205326419862309,3.17080070046385e-05
NMR metabolomics,X23412.Phospholipids in VLDL,DNPEP,Aspartyl aminopeptidase,37942,0.0228650554774624,0.00549495708070133,0.0120949395992878,0.033635171355637,3.18684388673846e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,0.0142258907913392,0.00342028753931099,0.00752212721428964,0.0209296543683887,3.20947764711879e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TDO2,"Tryptophan 2,3-dioxygenase",37572,0.0149342881539473,0.00359604307460589,0.00788604372771976,0.0219825325801749,3.30252563385322e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SHISA5,Protein shisa-5,37998,0.00954964335910239,0.00230031949620485,0.00504101714654087,0.0140582695716639,3.32408418557359e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,0.0123524739665222,0.0029784440393424,0.00651472364941114,0.0181902242836333,3.38199671741372e-05
NMR metabolomics,X23412.Phospholipids in VLDL,EXTL1,Exostosin-like 1,37562,0.0183094227352449,0.00442792330436597,0.00963069305868762,0.0269881524118022,3.57179449081961e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,0.0136767764397306,0.00330851551010004,0.00719208603993453,0.0201614668395267,3.59017349077125e-05
NMR metabolomics,X23412.Phospholipids in VLDL,RPA2,Replication protein A 32 kDa subunit,37598,0.0124999487883966,0.00302506587618557,0.00657081967107293,0.0184290779057204,3.61652190344048e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TBC1D17,TBC1 domain family member 17,39961,0.0175377687864554,0.00424722375934226,0.00921321021814455,0.0258623273547662,3.65883744224202e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC1,Sialoadhesin,40422,0.0164854184179821,0.00399272737606734,0.00865967276089013,0.0243111640750741,3.66416581157455e-05
NMR metabolomics,X23412.Phospholipids in VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,0.0171203694456881,0.00415110263950252,0.00898420827226318,0.025256530619113,3.73768788635328e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.0681954334504959,0.0165786096871381,0.0357013584637052,0.100689508437287,3.91743726985322e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CRTAC1,Cartilage acidic protein 1,40536,0.0110943328500863,0.00269940279778723,0.00580350336642331,0.0163851623337492,3.97756621912482e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,0.0127326314541786,0.00309903310687517,0.00665852656470323,0.0188067363436539,4.00091674337855e-05
NMR metabolomics,X23412.Phospholipids in VLDL,FUCA1,Tissue alpha-L-fucosidase,40437,0.0306585677005547,0.00748145939347514,0.0159949072893434,0.0453222281117659,4.18900998819143e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TGFB2,Transforming growth factor beta-2 proprotein,37900,0.0200413660916107,0.00490063122990061,0.0104361288810055,0.0296466033022159,4.34730894601823e-05
NMR metabolomics,X23412.Phospholipids in VLDL,EBI3_IL27,Interleukin-27,40453,-0.011740958618915,0.00287714296702917,-0.0173801588342922,-0.00610175840353785,4.51045109959696e-05
NMR metabolomics,X23412.Phospholipids in VLDL,RAB39B,Ras-related protein Rab-39B,37562,0.0334959781586041,0.00826366900100473,0.0172991869166348,0.0496927694005734,5.0769441637251e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CA1,Carbonic anhydrase 1,40003,0.0233258931153345,0.00576844967551644,0.0120197317513222,0.0346320544793467,5.28674084481578e-05
NMR metabolomics,X23412.Phospholipids in VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,40042,0.0206274656713679,0.00511648516288968,0.0105991547521041,0.0306557765906317,5.56690567788309e-05
NMR metabolomics,X23412.Phospholipids in VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,0.0129875312776395,0.00323026470608276,0.00665621245371734,0.0193188501015618,5.83287291947991e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ARTN,Artemin,40044,0.016486421230939,0.0041123638829746,0.00842618802030877,0.0245466544415692,6.12630872208678e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NELL2,Protein kinase C-binding protein NELL2,40422,0.0104135593512311,0.00260476163540935,0.00530822654582881,0.0155188921566335,6.41960746013789e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NECTIN1,Nectin-1,37598,0.0118187943164082,0.00296053978905598,0.00601613632985847,0.0176214523029579,6.58444336493682e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TCN1,Transcobalamin-1,37766,0.0122064621531284,0.00305864927344664,0.006211509577173,0.0182014147290838,6.62032545172305e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,0.0131818372114347,0.00330627395020394,0.00670154026903497,0.0196621341538344,6.7288903725624e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TNC,Tenascin,40403,-0.0173123970659595,0.0043572422025287,-0.0258525917829157,-0.00877220234900319,7.12114019565859e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SLC13A1,Solute carrier family 13 member 1,37900,0.0227844385919509,0.00574916205350683,0.0115160809670775,0.0340527962168243,7.43685960437262e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAM,Integrin alpha-M,40332,-0.0115774997555945,0.00292279683959024,-0.0173061815611913,-0.0058488179499976,7.49300303600432e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NPTXR,Neuronal pentraxin receptor,40359,0.0123779925929386,0.00313226443236002,0.00623875430551293,0.0185172308803642,7.79099922326632e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.0126760140318735,0.00321016704130241,0.00638408663092078,0.0189679414328262,7.89086598715755e-05
NMR metabolomics,X23412.Phospholipids in VLDL,DIPK2B,Divergent protein kinase domain 2B,37671,0.00975617789323051,0.00247156687102155,0.00491190682602827,0.0146004489604327,7.94250214740561e-05
NMR metabolomics,X23412.Phospholipids in VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,-0.00707744072268198,0.00180991571144428,-0.0106248755171128,-0.0035300059282512,9.26035595936848e-05
NMR metabolomics,X23412.Phospholipids in VLDL,FOLR1,Folate receptor alpha,40299,0.0102343304719559,0.00261816781598222,0.00510272155263076,0.0153659393912811,9.30775022723196e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.0136755125164589,0.00349923982600478,-0.0205340225754283,-0.00681700245748952,9.34639772479493e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,39961,0.0147779775277121,0.00378328742078635,0.0073627341829709,0.0221932208724534,9.41873589067489e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CST6,Cystatin-M,39992,0.017220054781337,0.00440927466816839,0.00857787643172692,0.025862233130947,9.44609654837335e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ROBO4,Roundabout homolog 4,37628,-0.00645620697113703,0.00165404806959364,-0.00969814118754057,-0.00321427275473349,9.5371662073965e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SLC4A1,Band 3 anion transport protein,37998,-0.0166632670494099,0.00427518603910427,-0.0250426316860542,-0.00828390241276551,9.75901595235597e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CA9,Carbonic anhydrase 9,40489,-0.0161836871975228,0.00415309917248673,-0.0243237615755968,-0.00804361281944883,9.78788002222248e-05
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF21,Immunoglobulin superfamily member 21,37628,0.0140897281666576,0.00361780298907651,0.00699883430806768,0.0211806220252476,9.88653620699073e-05
NMR metabolomics,X23412.Phospholipids in VLDL,GIMAP7,GTPase IMAP family member 7,37671,-0.0116712006661786,0.0030006227145383,-0.0175524211866736,-0.00578998014568349,0.000100904271118311
NMR metabolomics,X23412.Phospholipids in VLDL,HYAL1,Hyaluronidase-1,40214,0.00823212355908579,0.0021193264697207,0.00407824367843323,0.0123860034397384,0.000103039582250735
NMR metabolomics,X23412.Phospholipids in VLDL,ELAVL4,ELAV-like protein 4,37541,0.0313460189924004,0.00807227337550841,0.0155243631764039,0.0471676748083969,0.000103609695961695
NMR metabolomics,X23412.Phospholipids in VLDL,NRP2,Neuropilin-2,40332,-0.0104042504584433,0.00268054153548152,-0.0156581118679871,-0.00515038904889949,0.000104277297950211
NMR metabolomics,X23412.Phospholipids in VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,0.0158102171124374,0.00407682627140437,0.00781963762048486,0.02380079660439,0.00010578964006698
NMR metabolomics,X23412.Phospholipids in VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,0.0257742383096682,0.00666078419117823,0.0127191012949588,0.0388293753243775,0.000109468341050889
NMR metabolomics,X23412.Phospholipids in VLDL,IL10RA,Interleukin-10 receptor subunit alpha,40044,0.0215104224555416,0.00556088042556405,0.0106110968214361,0.0324097480896471,0.000110101631200975
NMR metabolomics,X23412.Phospholipids in VLDL,PADI4,Protein-arginine deiminase type-4,39934,0.024806459210244,0.00641436828204951,0.012234297377427,0.0373786210430611,0.000110484965181685
NMR metabolomics,X23412.Phospholipids in VLDL,INHBB,Inhibin beta B chain,37671,0.0183951033295707,0.00476719453750777,0.00905140203605548,0.0277388046230859,0.00011454030761537
NMR metabolomics,X23412.Phospholipids in VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,-0.0157531597205529,0.00408401700627334,-0.0237578330528487,-0.00774848638825716,0.000115110843257435
NMR metabolomics,X23412.Phospholipids in VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,40009,0.0183980863045414,0.00477010556060664,0.00904867940575237,0.0277474932033304,0.000115270550923604
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL5,Fc receptor-like protein 5,40332,-0.0199173709015375,0.00516424040365386,-0.030039282092699,-0.0097954597103759,0.000115341039883151
NMR metabolomics,X23412.Phospholipids in VLDL,ERC2,ERC protein 2,37572,0.0274575436943,0.00712915970824825,0.0134843906661334,0.0414306967224666,0.00011798263289326
NMR metabolomics,X23412.Phospholipids in VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,37541,-0.0118565206738402,0.00308086760515292,-0.0178950211799399,-0.00581802016774045,0.000119439280986307
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,0.0131240517205777,0.00341210895900456,0.0064363181609288,0.0198117852802267,0.000120471470842558
NMR metabolomics,X23412.Phospholipids in VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,0.0135878086495335,0.00353859995559326,0.00665215273657068,0.0205234645624962,0.000123570221453608
NMR metabolomics,X23412.Phospholipids in VLDL,NUP50,Nuclear pore complex protein Nup50,37562,-0.0126564087119644,0.00329754216681788,-0.0191195913589275,-0.00619322606500135,0.000124554939429268
NMR metabolomics,X23412.Phospholipids in VLDL,IFNGR1,Interferon gamma receptor 1,40422,0.0072445903186046,0.00188855318085154,0.00354302608413557,0.0109461545530736,0.000125508182811887
NMR metabolomics,X23412.Phospholipids in VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,0.0175314700953882,0.00457356150501674,0.00856728954555539,0.026495650645221,0.000126975906654324
NMR metabolomics,X23412.Phospholipids in VLDL,STX5,Syntaxin-5,37598,0.0148641327069527,0.00388378451997434,0.00725191504780298,0.0224763503661024,0.000130194297824636
NMR metabolomics,X23412.Phospholipids in VLDL,OBP2B,Odorant-binding protein 2b,40184,-0.0233755089367838,0.00611593877020813,-0.0353627489263917,-0.0113882689471759,0.000132848930565488
NMR metabolomics,X23412.Phospholipids in VLDL,SNX18,Sorting nexin-18,37901,0.0160678619267042,0.00420639710088021,0.00782332360897895,0.0243124002444294,0.000134125883958448
NMR metabolomics,X23412.Phospholipids in VLDL,SSH3,Protein phosphatase Slingshot homolog 3,37482,0.010277195611246,0.00270758222291119,0.00497033445434003,0.0155840567681519,0.000147888759936528
NMR metabolomics,X23412.Phospholipids in VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,0.0250362133180773,0.00664211159259649,0.0120176745965881,0.0380547520395664,0.000164405630522655
NMR metabolomics,X23412.Phospholipids in VLDL,DSC2,Desmocollin-2,40177,-0.0116932717521643,0.00311087566786138,-0.0177905880611726,-0.00559595544315599,0.000171323119134062
NMR metabolomics,X23412.Phospholipids in VLDL,CAPS,Calcyphosin,37942,0.0329835897122116,0.00877858175899388,0.0157775694645836,0.0501896099598396,0.000172493579500342
NMR metabolomics,X23412.Phospholipids in VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,37998,0.0203358666025653,0.00545070296451762,0.00965248879211075,0.0310192444130198,0.000191598571917696
NMR metabolomics,X23412.Phospholipids in VLDL,PSPN,Persephin,40341,0.0342132651359778,0.00917212429403905,0.0162359015196612,0.0521906287522943,0.000192042571156537
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,0.0224210917284368,0.00601387755607687,0.0106338917185261,0.0342082917383474,0.000193527775688775
NMR metabolomics,X23412.Phospholipids in VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,0.0186667589457592,0.00501283875785442,0.00884159498036455,0.0284919229111539,0.000197053201834473
NMR metabolomics,X23412.Phospholipids in VLDL,COL9A2,Collagen alpha-2(IX) chain,37714,0.015986108038727,0.00429541535622302,0.00756709394052991,0.0244051221369241,0.000198729352890999
NMR metabolomics,X23412.Phospholipids in VLDL,CYB5A,Cytochrome b5,37482,0.0253353158363473,0.00680977948101206,0.0119881480535637,0.0386824836191309,0.000199718458392838
NMR metabolomics,X23412.Phospholipids in VLDL,SPINT1,Kunitz-type protease inhibitor 1,40278,0.00877924001557727,0.00236254099713752,0.00414865966118774,0.0134098203699668,0.000203085553936346
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,-0.00912629199648942,0.00246831942026736,-0.0139641980602134,-0.00428838593276539,0.000218728182844218
NMR metabolomics,X23412.Phospholipids in VLDL,PMS1,PMS1 protein homolog 1,37572,0.0178015479466372,0.00481881103156544,0.0083566783247689,0.0272464175685054,0.00022149502557225
NMR metabolomics,X23412.Phospholipids in VLDL,GIPC2,PDZ domain-containing protein GIPC2,37942,0.00986831087658927,0.00269473833954397,0.00458662373108309,0.0151499980220954,0.000251145526697128
NMR metabolomics,X23412.Phospholipids in VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,0.0192232256076666,0.00525716833551483,0.00891917567005756,0.0295272755452757,0.00025645267360148
NMR metabolomics,X23412.Phospholipids in VLDL,OMD,Osteomodulin,40422,-0.0149172160177488,0.00408616601589583,-0.0229261014089046,-0.00690833062659294,0.000262398803581527
NMR metabolomics,X23412.Phospholipids in VLDL,RBM19,Probable RNA-binding protein 19,37562,-0.0162029563211723,0.00444273970438864,-0.024910726141774,-0.00749518650057053,0.000266281474437668
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPT2,Angiopoietin-2,40489,-0.0130100362834105,0.00357341038872423,-0.02001392064531,-0.00600615192151098,0.0002726580242639
NMR metabolomics,X23412.Phospholipids in VLDL,SDK2,Protein sidekick-2,37671,0.0128493780262725,0.00353099608860328,0.00592862569261004,0.0197701303599349,0.000274716603630092
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,0.0105760508630645,0.00290734463954255,0.00487765536956107,0.0162744463565679,0.000275953684484224
NMR metabolomics,X23412.Phospholipids in VLDL,MELTF,Melanotransferrin,37990,0.00981077686893645,0.00270220922260138,0.00451444679263774,0.0151071069452352,0.000283750777297031
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE1,Ribonuclease pancreatic,37987,0.00810793047640763,0.00223441664560964,0.00372847385101274,0.0124873871018025,0.000285948999846219
NMR metabolomics,X23412.Phospholipids in VLDL,PLAU,Urokinase-type plasminogen activator,40332,0.00981756683561369,0.00271001397004413,0.00450593945432721,0.0151291942169002,0.000292453347819115
NMR metabolomics,X23412.Phospholipids in VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,-0.0115991471284862,0.00320373657872981,-0.0178784708227966,-0.00531982343417575,0.000294937839799187
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2L15,Bcl-2-like protein 15,37598,0.0189339774097528,0.00523327646701393,0.00867675553440554,0.0291911992851001,0.000298005254976206
NMR metabolomics,X23412.Phospholipids in VLDL,EDN1,Endothelin-1,37628,0.00972235029102145,0.00269176992699106,0.00444648123411897,0.0149982193479239,0.000305115063012858
NMR metabolomics,X23412.Phospholipids in VLDL,NME1,Nucleoside diphosphate kinase A,37598,-0.00734995308637129,0.00203704033932177,-0.011342552151442,-0.00335735402130063,0.000309529199597342
NMR metabolomics,X23412.Phospholipids in VLDL,NTF3,Neurotrophin-3,40341,0.0116333923607525,0.00322509488000067,0.00531220639595116,0.0179545783255538,0.00031053131414249
NMR metabolomics,X23412.Phospholipids in VLDL,CD5L,CD5 antigen-like,37934,0.0155534224155189,0.0043119082427863,0.00710208225965779,0.0240047625713801,0.000310774755574656
NMR metabolomics,X23412.Phospholipids in VLDL,NMRK2,Nicotinamide riboside kinase 2,37482,-0.0145925308698475,0.00404674760211941,-0.0225241561700015,-0.00666090556969344,0.000312127021043106
NMR metabolomics,X23412.Phospholipids in VLDL,CDH1,Cadherin-1,39806,0.0133504239094539,0.00370453322718861,0.0060895387841642,0.0206113090347435,0.000314581377912847
NMR metabolomics,X23412.Phospholipids in VLDL,S100A14,Protein S100-A14,37959,0.0178855392537356,0.00497412207837826,0.00813625998011424,0.027634818527357,0.000324651802910171
NMR metabolomics,X23412.Phospholipids in VLDL,RAB44,Ras-related protein Rab-44,37900,0.0132382206675056,0.00368788925355935,0.00600995773052923,0.0204664836044819,0.000332304389038292
NMR metabolomics,X23412.Phospholipids in VLDL,DPP10,Inactive dipeptidyl peptidase 10,40341,0.0112756887455122,0.00314219182204158,0.00511699277431075,0.0174343847167137,0.000333613436257496
NMR metabolomics,X23412.Phospholipids in VLDL,ACTN2,Alpha-actinin-2,37562,-0.0181912342921843,0.00507120971295515,-0.0281308053295763,-0.00825166325479217,0.000335518005089029
NMR metabolomics,X23412.Phospholipids in VLDL,DDX25,ATP-dependent RNA helicase DDX25,37572,-0.0130352392081429,0.00363585276786385,-0.020161510633156,-0.00590896778312972,0.000338050077019258
NMR metabolomics,X23412.Phospholipids in VLDL,GLP1R,Glucagon-like peptide 1 receptor,37541,-0.0127581422937609,0.00355975971376861,-0.0197352713327474,-0.0057810132547744,0.000339615347546417
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC14A,C-type lectin domain family 14 member A,40332,-0.0103511837661687,0.0029025700094798,-0.0160402209847491,-0.0046621465475883,0.000363241470121721
NMR metabolomics,X23412.Phospholipids in VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,37714,0.0195329304535519,0.0054779014566884,0.00879624359844265,0.0302696173086612,0.000364067866882138
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,0.0169690394264393,0.00478813773212638,0.00758428947147157,0.026353789381407,0.000395479897789611
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP5,Rho GTPase-activating protein 5,37482,0.0254093376779141,0.00717196951608061,0.0113522774263961,0.0394663979294322,0.000397185617333925
NMR metabolomics,X23412.Phospholipids in VLDL,MANSC4,MANSC domain-containing protein 4,37562,0.0215864420219636,0.00609872119034334,0.00963294848889063,0.0335399355550365,0.00040226955077029
NMR metabolomics,X23412.Phospholipids in VLDL,PTK7,Inactive tyrosine-protein kinase 7,39961,0.0125303874816533,0.00356315523095418,0.00554660322898313,0.0195141717343235,0.00043827008920646
NMR metabolomics,X23412.Phospholipids in VLDL,NPR1,Atrial natriuretic peptide receptor 1,37562,-0.0131433477336531,0.00373924001434659,-0.0204722581617724,-0.00581443730553379,0.000441273857236713
NMR metabolomics,X23412.Phospholipids in VLDL,CHGA,Chromogranin-A,37998,-0.0293511862637655,0.00835454570991215,-0.0457260958551933,-0.0129762766723376,0.000444187955510222
NMR metabolomics,X23412.Phospholipids in VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,-0.0106368079804958,0.00302832948559911,-0.01657233377227,-0.00470128218872154,0.000445257467357493
NMR metabolomics,X23412.Phospholipids in VLDL,CST7,Cystatin-F,40376,0.0297132704610043,0.00848683273086517,0.0130790783085085,0.0463474626135,0.000464605859874077
NMR metabolomics,X23412.Phospholipids in VLDL,NRCAM,Neuronal cell adhesion molecule,40359,0.00902208630511074,0.00258120742859606,0.00396291974506246,0.014081252865159,0.000474824071192039
NMR metabolomics,X23412.Phospholipids in VLDL,ITGBL1,Integrin beta-like protein 1,37998,0.0112851427592772,0.00323015355347599,0.00495404179446427,0.0176162437240902,0.00047792158357303
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA1549,UPF0606 protein KIAA1549,37714,0.0228516243084459,0.00656496469093999,0.00998429351420349,0.0357189551026882,0.000501442358134761
NMR metabolomics,X23412.Phospholipids in VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,-0.00831415242920843,0.00239591907786275,-0.0130101538218194,-0.00361815103659743,0.000521824417789208
NMR metabolomics,X23412.Phospholipids in VLDL,KIT,Mast/stem cell growth factor receptor Kit,40372,-0.00948126689174522,0.00273291490687524,-0.0148377801092207,-0.00412475367426975,0.000523221878450643
NMR metabolomics,X23412.Phospholipids in VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,0.0112928924968541,0.0032594604472108,0.00490435002032088,0.0176814349733872,0.000532613238194128
NMR metabolomics,X23412.Phospholipids in VLDL,KIRREL2,Kin of IRRE-like protein 2,39961,0.0128397290528195,0.00370864087634458,0.00557079293518416,0.0201086651704549,0.000537399112282621
NMR metabolomics,X23412.Phospholipids in VLDL,IL11,Interleukin-11,40044,0.0203768438840628,0.00589887543021167,0.0088150480408479,0.0319386397272776,0.000553065373890562
NMR metabolomics,X23412.Phospholipids in VLDL,GSAP,Gamma-secretase-activating protein,39980,0.0285150602558866,0.00825485546491784,0.0123355435446477,0.0446945769671256,0.000553118257716948
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA2,Ephrin type-A receptor 2,39759,0.00981017039128681,0.00284642332871082,0.0042311806670136,0.01538916011556,0.000569443888711388
NMR metabolomics,X23412.Phospholipids in VLDL,SIRPB1,Signal-regulatory protein beta-1,40335,0.014270978530045,0.00414075990021762,0.00615508912561849,0.0223868679344716,0.000569444634935018
NMR metabolomics,X23412.Phospholipids in VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,0.0161885145712543,0.00471850110130398,0.00694025241269853,0.0254367767298101,0.000603480124486004
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFD,Vascular endothelial growth factor D,40483,-0.0104917112569795,0.00307128125348055,-0.0165114225138014,-0.00447200000015762,0.000636895429240136
NMR metabolomics,X23412.Phospholipids in VLDL,CDH3,Cadherin-3,40471,0.0111502104560442,0.00327020203138193,0.00474061447453565,0.0175598064375528,0.000652091166774908
NMR metabolomics,X23412.Phospholipids in VLDL,NMI,N-myc-interactor,37857,0.0225808856306801,0.00662395868388925,0.00959792661025716,0.035563844651103,0.000654002924357102
NMR metabolomics,X23412.Phospholipids in VLDL,PRKCQ,Protein kinase C theta type,40044,0.013968957539677,0.00409838107116722,0.00593613064018925,0.0220017844391648,0.00065508221503623
NMR metabolomics,X23412.Phospholipids in VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,0.0120344152138301,0.00353643403351503,0.00510300450814062,0.0189658259195195,0.000668491506127888
NMR metabolomics,X23412.Phospholipids in VLDL,CD109,CD109 antigen,40332,-0.0104592688431333,0.00308392279460554,-0.0165037575205601,-0.00441478016570643,0.00069668696227145
NMR metabolomics,X23412.Phospholipids in VLDL,FOLH1,Glutamate carboxypeptidase 2,37598,0.0337882848651079,0.00998777390725043,0.0142122480068971,0.0533643217233187,0.000719171201769078
NMR metabolomics,X23412.Phospholipids in VLDL,NEO1,Neogenin,37959,0.00665524507268456,0.0019735748065628,0.00278703845182146,0.0105234516935477,0.000747855753841673
NMR metabolomics,X23412.Phospholipids in VLDL,SATB1,DNA-binding protein SATB1,37959,0.00938719073646353,0.00278691338258947,0.00392484050658817,0.0148495409663389,0.000758415895621649
NMR metabolomics,X23412.Phospholipids in VLDL,SNU13,NHP2-like protein 1,37562,0.0193680227184118,0.00578546138380468,0.00802851840615465,0.030707527030669,0.000817127618925972
NMR metabolomics,X23412.Phospholipids in VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,0.0187518987344361,0.00560311908682415,0.0077697853242608,0.0297340121446115,0.000819738272674245
NMR metabolomics,X23412.Phospholipids in VLDL,DCTPP1,dCTP pyrophosphatase 1,40359,0.00973970897469483,0.00292651616758086,0.00400373728623634,0.0154756806631533,0.000876420399838544
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC38,Leucine-rich repeat-containing protein 38,37572,0.0152525598070726,0.0045833719196671,0.00626915084452511,0.0242359687696201,0.000877744303876378
NMR metabolomics,X23412.Phospholipids in VLDL,RCC1,Regulator of chromosome condensation,37900,0.015740955284642,0.00473045364406637,0.00646926614227189,0.0250126444270121,0.000878393506120291
NMR metabolomics,X23412.Phospholipids in VLDL,CD55,Complement decay-accelerating factor,39802,0.00807107064072689,0.00242585543963452,0.00331639397904323,0.0128257473024106,0.000879600778882677
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN1,Contactin-1,40536,-0.00841895345829104,0.0025455468701451,-0.0134082253237754,-0.00342968159280664,0.000943977068151593
NMR metabolomics,X23412.Phospholipids in VLDL,CDKL5,Cyclin-dependent kinase-like 5,37541,-0.0166278883704744,0.00503153211907047,-0.0264896913238525,-0.00676608541709625,0.000953211170066881
NMR metabolomics,X23412.Phospholipids in VLDL,OSM,Oncostatin-M,40268,0.022060827168882,0.00669259030159689,0.00894335017775206,0.0351783041600119,0.000981809116245156
NMR metabolomics,X23412.Phospholipids in VLDL,FCAR,Immunoglobulin alpha Fc receptor,40341,0.0142904603016316,0.00434160858562385,0.00578090747380889,0.0228000131294544,0.000998673510660467
NMR metabolomics,X23412.Phospholipids in VLDL,NCR1,Natural cytotoxicity triggering receptor 1,40306,0.0109288314635729,0.00332424726700852,0.00441330682023621,0.0174443561069096,0.00101261220954603
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA3G,Semaphorin-3G,37671,0.0131535023840615,0.00400090527096349,0.00531172805297311,0.02099527671515,0.00101297642675642
NMR metabolomics,X23412.Phospholipids in VLDL,PDRG1,p53 and DNA damage-regulated protein 1,37572,0.0163978406178332,0.00498984138638988,0.00661775150050901,0.0261779297351573,0.00101799260736805
NMR metabolomics,X23412.Phospholipids in VLDL,CTRL,Chymotrypsin-like protease CTRL-1,37942,-0.019936870032422,0.00606981522976768,-0.0318337078827666,-0.00804003218207732,0.00102390217339501
NMR metabolomics,X23412.Phospholipids in VLDL,TSC1,Hamartin,37598,0.0232175429288312,0.00707493291337433,0.00935067441861755,0.0370844114390449,0.00103465990024593
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,0.00950904003827209,0.00291208148578722,0.00380136032612913,0.0152167197504151,0.00109598737711527
NMR metabolomics,X23412.Phospholipids in VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,0.0314407235179571,0.00965115379991124,0.012524462070131,0.0503569849657831,0.00112549925693147
NMR metabolomics,X23412.Phospholipids in VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,0.01003121086792,0.00307955196230558,0.00399528902180107,0.016067132714039,0.00112688870204656
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB7,Integrin beta-7,40489,0.0136355393747411,0.00420099014280421,0.00540159869484483,0.0218694800546373,0.00117364720926563
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,0.00760131919157893,0.00234537978079723,0.00300437482121636,0.0121982635619415,0.00119420931062358
NMR metabolomics,X23412.Phospholipids in VLDL,LMNB1,Lamin-B1,37874,0.0170693096959286,0.00526942908970734,0.00674122868010222,0.027397390711755,0.00120111185697538
NMR metabolomics,X23412.Phospholipids in VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,0.0109480056227545,0.00338674433720245,0.00430998672183769,0.0175860245236713,0.0012297020451872
NMR metabolomics,X23412.Phospholipids in VLDL,CHL1,Neural cell adhesion molecule L1-like protein,40379,-0.00943475447960728,0.00292024086102111,-0.0151584265672087,-0.0037110823920059,0.0012368896573632
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,-0.0155981570175978,0.00483380779853438,-0.0250724203027252,-0.00612389373247045,0.00125451740314604
NMR metabolomics,X23412.Phospholipids in VLDL,IL15RA,Interleukin-15 receptor subunit alpha,40044,0.0105810191140973,0.00328945609679641,0.00413368516437636,0.0170283530638183,0.00129962752714693
NMR metabolomics,X23412.Phospholipids in VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,0.0130170388791608,0.00405446933433749,0.0050702789838593,0.0209637987744623,0.00132803973618021
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB2A2,Mammaglobin-A,37562,-0.00953511029101372,0.00297503603517883,-0.0153661809199642,-0.00370403966206322,0.00135367050284254
NMR metabolomics,X23412.Phospholipids in VLDL,TEF,Thyrotroph embryonic factor,37562,0.012806587580866,0.00399749167665857,0.00497150389461517,0.0206416712671168,0.0013601908175349
NMR metabolomics,X23412.Phospholipids in VLDL,RGMA,Repulsive guidance molecule A,40471,-0.00912657860505895,0.00285469011772188,-0.0147217712357938,-0.00353138597432407,0.00139111921825277
NMR metabolomics,X23412.Phospholipids in VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,0.0260082258687006,0.00814124271453347,0.010051390148215,0.0419650615891862,0.00140342594860813
NMR metabolomics,X23412.Phospholipids in VLDL,CDH15,Cadherin-15,40435,0.0130475352984153,0.0040879399390148,0.00503517301794631,0.0210598975788843,0.00141704878067381
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,37942,0.00911829084260982,0.00286979158922877,0.00349349932772143,0.0147430823574982,0.0014897004162436
NMR metabolomics,X23412.Phospholipids in VLDL,JUN,Transcription factor AP-1,40044,0.0151669225618515,0.00478789623711598,0.00578264593710415,0.0245511991865988,0.00153912763073723
NMR metabolomics,X23412.Phospholipids in VLDL,CTSB,Cathepsin B,40353,-0.0157525137349494,0.00497748797852517,-0.0255083901728587,-0.00599663729704006,0.00155507854270318
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.0204153545538412,0.00646951783980742,0.00773509958781862,0.0330956095198637,0.00160451371966727
NMR metabolomics,X23412.Phospholipids in VLDL,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.011795994462421,0.0037422418236641,-0.0191307884368026,-0.00446120048803936,0.00162454914453597
NMR metabolomics,X23412.Phospholipids in VLDL,CPA4,Carboxypeptidase A4,37410,0.0128118913892942,0.00406609949829191,0.00484233637264208,0.0207814464059464,0.00163136121763294
NMR metabolomics,X23412.Phospholipids in VLDL,QSOX1,Sulfhydryl oxidase 1,37761,0.0130824167304516,0.00415210108717901,0.00494429859958075,0.0212205348613225,0.00163187842170815
NMR metabolomics,X23412.Phospholipids in VLDL,BRD3,Bromodomain-containing protein 3,37562,0.0141412865217672,0.00449277137315331,0.00533545463038668,0.0229471184131476,0.00165005839365913
NMR metabolomics,X23412.Phospholipids in VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,0.0193346177287711,0.00616230680026271,0.00725649640025624,0.0314127390572861,0.00170732389183924
NMR metabolomics,X23412.Phospholipids in VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,-0.0200392086922563,0.00639494629406026,-0.0325733034286144,-0.00750511395589817,0.00173046662252462
NMR metabolomics,X23412.Phospholipids in VLDL,DRAXIN,Draxin,40228,0.012525365360655,0.00400124401078864,0.00468292709950922,0.0203678036218007,0.00174906152252152
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,40332,0.0124828201072068,0.00400008599365916,0.00464265155963482,0.0203229886547787,0.00180783179631227
NMR metabolomics,X23412.Phospholipids in VLDL,FDX2,"Ferredoxin-2, mitochondrial",37562,0.0166693972297994,0.0053417115216119,0.00619964264744013,0.0271391518121588,0.00180868833624349
NMR metabolomics,X23412.Phospholipids in VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,-0.0248983836442635,0.00799139965419286,-0.0405615269664815,-0.00923524032204551,0.00183879435793063
NMR metabolomics,X23412.Phospholipids in VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,0.0118348129150661,0.00382925734490072,0.00432946851906067,0.0193401573110715,0.00200074280542119
NMR metabolomics,X23412.Phospholipids in VLDL,NTF4,Neurotrophin-4,39980,0.0116487438719224,0.0037705748682936,0.00425841713006691,0.0190390706137778,0.00200928052325166
NMR metabolomics,X23412.Phospholipids in VLDL,NCAN,Neurocan core protein,40471,0.010606295669854,0.00343944502806282,0.00386498341485088,0.0173476079248571,0.00204775524285248
NMR metabolomics,X23412.Phospholipids in VLDL,RBPMS,RNA-binding protein with multiple splicing,37598,0.0184712932036111,0.00599514228743952,0.00672081432022963,0.0302217720869925,0.00206702792800686
NMR metabolomics,X23412.Phospholipids in VLDL,FABP1,"Fatty acid-binding protein, liver",40357,0.0263443104045508,0.00856703857382735,0.00955291479984921,0.0431357060092524,0.00210804413087355
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,-0.011005511222402,0.00358550104551184,-0.0180330932716052,-0.0039779291731988,0.00214878365087752
NMR metabolomics,X23412.Phospholipids in VLDL,STX3,Syntaxin-3,37942,0.0109799760524884,0.00358009027991177,0.00396299910386137,0.0179969530011155,0.00216679480768692
NMR metabolomics,X23412.Phospholipids in VLDL,LAG3,Lymphocyte activation gene 3 protein,40305,-0.0116411571979441,0.00379711440084743,-0.019083501423605,-0.00419881297228311,0.00217460575460205
NMR metabolomics,X23412.Phospholipids in VLDL,PTTG1,Securin,37714,0.0117378640320701,0.00383017938064521,0.00423071244600544,0.0192450156181347,0.00218418747950743
NMR metabolomics,X23412.Phospholipids in VLDL,MYO6,Unconventional myosin-VI,37959,0.0105797893620343,0.00346640049836903,0.00378564438523104,0.0173739343388376,0.00227690322050412
NMR metabolomics,X23412.Phospholipids in VLDL,SIL1,Nucleotide exchange factor SIL1,37628,0.00903512587843034,0.00296176833327877,0.00323005994520395,0.0148401918116567,0.00228850028607484
NMR metabolomics,X23412.Phospholipids in VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,37598,-0.0175984326777359,0.00580045586269653,-0.0289673261686211,-0.0062295391868507,0.0024182647710623
NMR metabolomics,X23412.Phospholipids in VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,0.0136118520024955,0.00449206989144069,0.00480739501527177,0.0224163089897193,0.00244857485246273
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,-0.00676260524452296,0.00223218994774518,-0.0111376975421035,-0.00238751294694242,0.00245280166358835
NMR metabolomics,X23412.Phospholipids in VLDL,TERF1,Telomeric repeat-binding factor 1,37598,-0.00834424872026045,0.00275707411328317,-0.0137481139822955,-0.00294038345822544,0.00247892318123114
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,-0.0089264943726275,0.00295297588257439,-0.0147143271024733,-0.0031386616427817,0.00250864515584559
NMR metabolomics,X23412.Phospholipids in VLDL,NDRG1,Protein NDRG1,39961,0.0191925617149552,0.00635548491468983,0.00673581128216313,0.0316493121477473,0.0025331788685017
NMR metabolomics,X23412.Phospholipids in VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,0.017304418875294,0.00573377482741594,0.00606622021355875,0.0285426175370292,0.00254951815307091
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM26,Tripartite motif-containing protein 26,37482,0.0153697118959685,0.00510382974243983,0.0053662056007864,0.0253732181911505,0.00260538011108663
NMR metabolomics,X23412.Phospholipids in VLDL,SCP2,Non-specific lipid-transfer protein,39980,0.0216946845052042,0.0072068793663166,0.0075692009472237,0.0358201680631848,0.00261431034301999
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN7,Septin-7,37714,0.0145758042132891,0.00486377128676203,0.00504281249123553,0.0241087959353427,0.00273324453298307
NMR metabolomics,X23412.Phospholipids in VLDL,MAPK13,Mitogen-activated protein kinase 13,37482,0.0114641033506521,0.0038295115813506,0.00395826065120496,0.0189699460500993,0.00276206066327511
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,-0.0113065371639428,0.00379077247857018,-0.0187364512219404,-0.00387662310594527,0.00286292878570002
NMR metabolomics,X23412.Phospholipids in VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,0.0151625671795966,0.00510741324469859,0.00515203721998739,0.0251730971392059,0.00299483459163246
NMR metabolomics,X23412.Phospholipids in VLDL,DDA1,DET1- and DDB1-associated protein 1,37562,0.0112288546330177,0.00378312008360131,0.00381393926915913,0.0186437699968763,0.00300142985831981
NMR metabolomics,X23412.Phospholipids in VLDL,SCN2B,Sodium channel subunit beta-2,37572,-0.00815956864204319,0.00275042862878809,-0.0135504087544679,-0.00276872852961853,0.00301602776890316
NMR metabolomics,X23412.Phospholipids in VLDL,F3,Tissue factor,40393,-0.00766203277226354,0.00259160588893412,-0.0127415803145744,-0.00258248522995267,0.00311627606311519
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP2,Metalloproteinase inhibitor 2,37990,-0.00682758496330974,0.00231065063219625,-0.0113564602024144,-0.00229870972420509,0.00313377751126895
NMR metabolomics,X23412.Phospholipids in VLDL,CRNN,Cornulin,39857,0.0181241782725622,0.00613567369767965,0.00609825782511011,0.0301500987200143,0.00314257933166991
NMR metabolomics,X23412.Phospholipids in VLDL,MBL2,Mannose-binding protein C,37810,-0.0289737146896263,0.00986196494209272,-0.0483031659761281,-0.0096442634031246,0.00330981445630983
NMR metabolomics,X23412.Phospholipids in VLDL,SEZ6L,Seizure 6-like protein,40411,0.00739221472083879,0.00253328224873764,0.00242698151331301,0.0123574479283646,0.00352732546350474
NMR metabolomics,X23412.Phospholipids in VLDL,SPARCL1,SPARC-like protein 1,40346,-0.00742114872524981,0.0025453563801381,-0.0124100472303205,-0.00243225022017913,0.0035554251012381
NMR metabolomics,X23412.Phospholipids in VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,0.00728471563335306,0.00250156637610438,0.00238164553618847,0.0121877857305176,0.00359560770269661
NMR metabolomics,X23412.Phospholipids in VLDL,PLIN3,Perilipin-3,40359,0.0113873230110533,0.00391430931526421,0.00371527675313546,0.0190593692689712,0.00362911705815026
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL12,Stromal cell-derived factor 1,40044,0.0108713989077378,0.00375086349919758,0.00351970644931052,0.018223091366165,0.00375627747905941
NMR metabolomics,X23412.Phospholipids in VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,-0.00697626369010913,0.00241266746595781,-0.0117050919233864,-0.00224743545683182,0.00384001807190751
NMR metabolomics,X23412.Phospholipids in VLDL,AMPD3,AMP deaminase 3,37942,0.0192758361688269,0.00670648967412208,0.00613111640754766,0.0324205559301062,0.00405676967787908
NMR metabolomics,X23412.Phospholipids in VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,0.0111640394460695,0.00388451724443944,0.00355038564696815,0.0187776932451708,0.00405867674594242
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,0.0117204715406591,0.00407890809836216,0.00372581166786924,0.0197151314134489,0.00406681187509523
NMR metabolomics,X23412.Phospholipids in VLDL,IL20RA,Interleukin-20 receptor subunit alpha,40044,0.0122772811479433,0.00427296907344611,0.0039022617639889,0.0206523005318977,0.00406829252230471
NMR metabolomics,X23412.Phospholipids in VLDL,TFF3,Trefoil factor 3,40309,0.0141375681946146,0.00492640030110005,0.00448182360445848,0.0237933127847707,0.0041133128216713
NMR metabolomics,X23412.Phospholipids in VLDL,ACE,Angiotensin-converting enzyme,37987,-0.00678303332435043,0.00236414062955373,-0.0114167489582757,-0.00214931769042513,0.0041223592991182
NMR metabolomics,X23412.Phospholipids in VLDL,TYMP,Thymidine phosphorylase,40257,0.0176034827201277,0.00614885471106369,0.00555172748644285,0.0296552379538125,0.00420350760925228
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.0137800722944345,0.00483226826061357,0.00430882650363187,0.0232513180852371,0.00435571130654755
NMR metabolomics,X23412.Phospholipids in VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,0.00946304926036342,0.00333273819933867,0.00293088238965961,0.0159952161310672,0.00452641185612489
NMR metabolomics,X23412.Phospholipids in VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,0.0131993629842534,0.00466245071955904,0.0040609595739177,0.0223377663945892,0.00464726643375971
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,0.00714149001808946,0.00253074394325206,0.00218123188931542,0.0121017481468635,0.00477995604248871
NMR metabolomics,X23412.Phospholipids in VLDL,TLR4,Toll-like receptor 4,37598,0.00743427820450391,0.00263766037298441,0.00226446387345446,0.0126040925355534,0.00483188359403539
NMR metabolomics,X23412.Phospholipids in VLDL,CENPJ,Centromere protein J,37714,0.0190971733331606,0.00679178467540088,0.00578527536937488,0.0324090712969463,0.00493367015090412
NMR metabolomics,X23412.Phospholipids in VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,0.013817328323198,0.00491538159357818,0.00418318039978477,0.0234514762466112,0.00494542576735437
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,0.00706730680193426,0.00252245067090164,0.00212330348696704,0.0120113101169015,0.00508853065019926
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC7A,C-type lectin domain family 7 member A,40516,0.0151297229447846,0.00540489816056485,0.00453612255007754,0.0257233233394917,0.00512807311764487
NMR metabolomics,X23412.Phospholipids in VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.0128582156783469,0.00459952989062625,0.00384313709271943,0.0218732942639743,0.00518868424295382
NMR metabolomics,X23412.Phospholipids in VLDL,MUC2,Mucin-2,37998,0.0234456840380919,0.00839401768243594,0.00699340938051743,0.0398979586956663,0.00522720016811878
NMR metabolomics,X23412.Phospholipids in VLDL,SH3GL3,Endophilin-A3,37643,0.0214383764376965,0.00767918797942238,0.00638716799802865,0.0364895848773644,0.00524991743669809
NMR metabolomics,X23412.Phospholipids in VLDL,CD160,CD160 antigen,40516,0.0117260771905716,0.00421490564842531,0.00346486211965805,0.0199872922614852,0.00540797589840424
NMR metabolomics,X23412.Phospholipids in VLDL,TFF2,Trefoil factor 2,40396,0.0146078171113248,0.00525589333394187,0.00430626617679874,0.0249093680458509,0.00545363730559921
NMR metabolomics,X23412.Phospholipids in VLDL,VCAN,Versican core protein,40471,-0.00770113247651683,0.00277421780179939,-0.0131385993680436,-0.00226366558499001,0.00551019395443096
NMR metabolomics,X23412.Phospholipids in VLDL,WNT9A,Protein Wnt-9a,40044,0.00735095781604439,0.00264849287010471,0.00215991179063916,0.0125420038414496,0.00551783506353636
NMR metabolomics,X23412.Phospholipids in VLDL,TMOD4,Tropomodulin-4,37482,-0.0107607835988165,0.00388676678018764,-0.0183788464879843,-0.00314272070964873,0.00563825480658603
NMR metabolomics,X23412.Phospholipids in VLDL,AIF1L,Allograft inflammatory factor 1-like,37628,0.0148378640676423,0.00536717294942589,0.00431820508676756,0.025357523048517,0.0057079103518948
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,37901,0.0141392180269753,0.00511473744195786,0.00411433264073791,0.0241641034132127,0.00571039358278999
NMR metabolomics,X23412.Phospholipids in VLDL,ARG1,Arginase-1,40227,0.0134817820177569,0.00488143138626359,0.00391417650068028,0.0230493875348336,0.00575413423723275
NMR metabolomics,X23412.Phospholipids in VLDL,PGLYRP1,Peptidoglycan recognition protein 1,40451,0.0108694983744296,0.00394553642743112,0.00313624697666459,0.0186027497721946,0.0058779168981389
NMR metabolomics,X23412.Phospholipids in VLDL,CTSV,Cathepsin L2,40444,0.0107605313037086,0.00391822191609263,0.00308081634816707,0.0184402462592502,0.00603428459394354
NMR metabolomics,X23412.Phospholipids in VLDL,CFD,Complement factor D,38013,0.00481889199354446,0.00176132215249959,0.00136670057464527,0.00827108341244365,0.00622811125274799
NMR metabolomics,X23412.Phospholipids in VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,-0.0104496236254008,0.00382168813080057,-0.0179401323617699,-0.00295911488903168,0.00625979098811759
NMR metabolomics,X23412.Phospholipids in VLDL,APOF,Apolipoprotein F,37987,-0.00610211262622329,0.00223238914265691,-0.0104775953458308,-0.00172662990661575,0.00627570439417401
NMR metabolomics,X23412.Phospholipids in VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,-0.00867725767395562,0.00317510572462642,-0.0149004648942234,-0.00245405045368783,0.00628629962062832
NMR metabolomics,X23412.Phospholipids in VLDL,SAT1,Diamine acetyltransferase 1,37562,-0.0132431783027511,0.00485006382363018,-0.0227493033970662,-0.00373705320843595,0.00633196991139628
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RL1,Interleukin-1 receptor-like 1,40490,-0.0114070932272722,0.00417947061989776,-0.0195988556422718,-0.00321533081227256,0.00635351903673145
NMR metabolomics,X23412.Phospholipids in VLDL,SULT1A1,Sulfotransferase 1A1,40471,-0.0323688753435827,0.0118658382590845,-0.0556259183313883,-0.009111832355777,0.00638074847157827
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC6A,C-type lectin domain family 6 member A,39980,0.0117889922424244,0.00432317354385577,0.00331557209646704,0.0202624123883817,0.00639983436742823
NMR metabolomics,X23412.Phospholipids in VLDL,NRXN3,Neurexin-3,37572,0.00878091264722993,0.00323161036938129,0.00244695632324261,0.0151148689712173,0.00659243553150556
NMR metabolomics,X23412.Phospholipids in VLDL,NGF,Beta-nerve growth factor,40228,0.00305896974105311,0.00112676087100153,0.000850518433890105,0.00526742104821611,0.00663809331782798
NMR metabolomics,X23412.Phospholipids in VLDL,CLC,Galectin-10,40333,-0.016431397458948,0.00606972426263354,-0.0283280570137098,-0.00453473790418631,0.00679448105974462
NMR metabolomics,X23412.Phospholipids in VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,40405,-0.0127215297345736,0.00470404655209554,-0.0219414609766809,-0.00350159849246638,0.00685045545710026
NMR metabolomics,X23412.Phospholipids in VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.0122131290092694,0.00452302094625194,0.00334800795461563,0.0210782500639233,0.00693862735259465
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB2,Integrin beta-2,40221,0.00714339186175273,0.00264679344539758,0.00195567670877347,0.012331107014732,0.00696462701332444
NMR metabolomics,X23412.Phospholipids in VLDL,SAFB2,Scaffold attachment factor B2,37959,0.00689815997835774,0.00256223514622288,0.00187617909176089,0.0119201408649546,0.007106068063585
NMR metabolomics,X23412.Phospholipids in VLDL,FMR1,Synaptic functional regulator FMR1,39980,0.00871495245089771,0.00324440862756577,0.0023559115408688,0.0150739933609266,0.00723585659545674
NMR metabolomics,X23412.Phospholipids in VLDL,CLMP,CXADR-like membrane protein,40489,0.00504312984176066,0.00188201078574436,0.00135438870170172,0.00873187098181959,0.0073774462974343
NMR metabolomics,X23412.Phospholipids in VLDL,SCG3,Secretogranin-3,40379,-0.00823161644582211,0.00307639512360046,-0.014261350888079,-0.00220188200356522,0.00746419538647721
NMR metabolomics,X23412.Phospholipids in VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,0.0157714895084897,0.00590102285447773,0.00420548471371339,0.0273374943032661,0.0075326671151124
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RAP,Interleukin-1 receptor accessory protein,40332,-0.0106107532349697,0.003976015057968,-0.018403742748587,-0.00281776372135243,0.00762249754703864
NMR metabolomics,X23412.Phospholipids in VLDL,NOP56,Nucleolar protein 56,37562,0.0272042902704609,0.0102729151830556,0.00706937651167187,0.0473392040292499,0.00810288748387079
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,-0.0119003888661214,0.00449669514311157,-0.0207139113466201,-0.00308686638562276,0.00814322690713996
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC12A,C-type lectin domain family 12 member A,37598,0.00502341656843185,0.00189823065867435,0.00130288447743012,0.00874394865943359,0.00814582020250974
NMR metabolomics,X23412.Phospholipids in VLDL,GFRAL,GDNF family receptor alpha-like,37477,-0.0151482455118854,0.00573609526801073,-0.0263909922371864,-0.00390549878658438,0.00827936707063233
NMR metabolomics,X23412.Phospholipids in VLDL,PLAUR,Urokinase plasminogen activator surface receptor,40264,0.00649483355261673,0.00246306688220127,0.00166722246350224,0.0113224446417312,0.00837520468287753
NMR metabolomics,X23412.Phospholipids in VLDL,CD2,T-cell surface antigen CD2,37562,0.0093331749101443,0.00354544210243678,0.00238410838936822,0.0162822414309204,0.00848725632007546
NMR metabolomics,X23412.Phospholipids in VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,0.0291958507922958,0.0110968899849242,0.00744594642184427,0.0509457551627473,0.0085219278552624
NMR metabolomics,X23412.Phospholipids in VLDL,SAG,S-arrestin,37541,-0.0130225409498523,0.00495167027696302,-0.0227278146926998,-0.00331726720700477,0.00855026389034317
NMR metabolomics,X23412.Phospholipids in VLDL,STX1B,Syntaxin-1B,37572,0.0104730700098802,0.00398426892235064,0.00266390292207292,0.0182822370976874,0.00858357261927133
NMR metabolomics,X23412.Phospholipids in VLDL,CA11,Carbonic anhydrase-related protein 11,39980,0.00803145481454763,0.00305744777050527,0.0020388571843573,0.014024052444738,0.00862641026586291
NMR metabolomics,X23412.Phospholipids in VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,0.0215734090073304,0.00825631386008619,0.00539103384156149,0.0377557841730994,0.00898651783988372
NMR metabolomics,X23412.Phospholipids in VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.0114438988396888,0.00438311429073625,0.00285299482984577,0.0200348028495319,0.00904023059090514
NMR metabolomics,X23412.Phospholipids in VLDL,SOX9,Transcription factor SOX-9,37572,0.00654666543877896,0.00251705335872033,0.00161324085568711,0.0114800900218708,0.00930772613792391
NMR metabolomics,X23412.Phospholipids in VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,0.0119247926139399,0.00459800425197419,0.00291270428007048,0.0209368809478093,0.00951016984031553
NMR metabolomics,X23412.Phospholipids in VLDL,PADI2,Protein-arginine deiminase type-2,40044,0.0134296179656294,0.00518023563212359,0.00327635612666717,0.0235828798045916,0.00953777470327162
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA11,Integrin alpha-11,40341,-0.0081442954877468,0.00314328873928988,-0.014305141416755,-0.00198344955873865,0.00957819083858661
NMR metabolomics,X23412.Phospholipids in VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,0.00681108073525223,0.00263254604116567,0.00165129049456751,0.0119708709759369,0.00968465290840022
NMR metabolomics,X23412.Phospholipids in VLDL,BMP4,Bone morphogenetic protein 4,40203,-0.0108039951646975,0.004195333671146,-0.0190268491601437,-0.00258114116925133,0.010026063802158
NMR metabolomics,X23412.Phospholipids in VLDL,AREG,Amphiregulin,40305,-0.0117452447962905,0.00457101245105906,-0.0207044292003662,-0.00278606039221471,0.0101934136789533
NMR metabolomics,X23412.Phospholipids in VLDL,IL17C,Interleukin-17C,40044,-0.0166424997513865,0.00648211126285,-0.0293474378265725,-0.00393756167620047,0.0102541783947139
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.00928127519523623,0.00362582822327436,0.0021746518776185,0.016387898512854,0.0104853508648674
NMR metabolomics,X23412.Phospholipids in VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,-0.00766775138810137,0.00299653655074222,-0.0135409630275561,-0.00179453974864662,0.0105106554168997
NMR metabolomics,X23412.Phospholipids in VLDL,CDH6,Cadherin-6,40359,-0.00891794022332968,0.00349907143630676,-0.0157761202384909,-0.00205976020816843,0.0108231056705339
NMR metabolomics,X23412.Phospholipids in VLDL,TK1,"Thymidine kinase, cytosolic",37714,0.010536324674414,0.00414166041591004,0.00241867025923036,0.0186539790895977,0.010970803530221
NMR metabolomics,X23412.Phospholipids in VLDL,AMBN,Ameloblastin,40044,-0.00691688529845213,0.002742416413809,-0.0122920214695178,-0.0015417491273865,0.0116726623393148
NMR metabolomics,X23412.Phospholipids in VLDL,IL17RA,Interleukin-17 receptor A,40332,0.0102112226510201,0.00404952537496863,0.00227415291608158,0.0181482923859586,0.0116924446486464
NMR metabolomics,X23412.Phospholipids in VLDL,RSPO1,R-spondin-1,40228,0.00821229117086321,0.00327149602609703,0.00180015895971302,0.0146244233820134,0.01207430605944
NMR metabolomics,X23412.Phospholipids in VLDL,RLN1,Prorelaxin H1,37959,-0.0191300031140879,0.00763962639318072,-0.0341036708447221,-0.0041563353834537,0.0122897790079427
NMR metabolomics,X23412.Phospholipids in VLDL,LEO1,RNA polymerase-associated protein LEO1,37959,0.00717628311439669,0.00286657741616786,0.00155779137870768,0.0127947748500857,0.0123112191860634
NMR metabolomics,X23412.Phospholipids in VLDL,TNN,Tenascin-N,37998,0.0101368126481117,0.00405169733357855,0.00219548587429778,0.0180781394219257,0.0123656891844591
NMR metabolomics,X23412.Phospholipids in VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,40357,0.0673064317936518,0.0269870568209914,0.0144118004245087,0.120201063162795,0.0126403887251214
NMR metabolomics,X23412.Phospholipids in VLDL,NAPRT,Nicotinate phosphoribosyltransferase,37942,0.00762581025247584,0.00306228551354334,0.0016237306459309,0.0136278898590208,0.0127778092801954
NMR metabolomics,X23412.Phospholipids in VLDL,SEZ6,Seizure protein 6 homolog,37572,-0.00719405788048898,0.00289848378427979,-0.0128750860976774,-0.00151302966330059,0.0130768784146258
NMR metabolomics,X23412.Phospholipids in VLDL,PRR4,Proline-rich protein 4,37577,-0.0158173602159127,0.00638098115933711,-0.0283240832882135,-0.003310637143612,0.0131939218536238
NMR metabolomics,X23412.Phospholipids in VLDL,CDH23,Cadherin-23,37942,-0.00605962637343028,0.00244611271392964,-0.0108540072927324,-0.00126524545412818,0.0132521661245604
NMR metabolomics,X23412.Phospholipids in VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,-0.0140957802435293,0.00569579536689243,-0.0252595391626384,-0.00293202132442011,0.0133447942711537
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH12,Protocadherin-12,37959,0.00585644478121886,0.00236995708242735,0.00121132889966125,0.0105015606627765,0.0134813626073512
NMR metabolomics,X23412.Phospholipids in VLDL,PEAR1,Platelet endothelial aggregation receptor 1,40536,0.00514176026937259,0.00208199118532389,0.00106105754613775,0.00922246299260742,0.0135353651209392
NMR metabolomics,X23412.Phospholipids in VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,0.0130721617829854,0.00529835103784033,0.00268739374881832,0.0234569298171524,0.0136275881274804
NMR metabolomics,X23412.Phospholipids in VLDL,SSB,Lupus La protein,39961,0.0137680710473752,0.00558394362441463,0.00282354154352253,0.0247126005512279,0.0136870937401301
NMR metabolomics,X23412.Phospholipids in VLDL,MKI67,Proliferation marker protein Ki-67,37598,0.00863076022938161,0.00350232892426494,0.00176619553782234,0.0154953249209409,0.0137411307372484
NMR metabolomics,X23412.Phospholipids in VLDL,DCN,Decorin,40042,-0.00517760922895749,0.00210474331952395,-0.00930290613522443,-0.00105231232269056,0.0139055637742414
NMR metabolomics,X23412.Phospholipids in VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,-0.0110387313104062,0.00450150679393668,-0.0198616846265221,-0.00221577799429028,0.014210319930617
NMR metabolomics,X23412.Phospholipids in VLDL,SUMF1,Formylglycine-generating enzyme,37598,0.0152689101579938,0.00622786109793826,0.00306230240603479,0.0274755179099528,0.0142308311873592
NMR metabolomics,X23412.Phospholipids in VLDL,BLVRB,Flavin reductase,40332,0.0150048718711755,0.00612249989278014,0.00300477208132638,0.0270049716610245,0.0142655945995985
NMR metabolomics,X23412.Phospholipids in VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,0.0154932396080467,0.00633418862628205,0.00307822990053385,0.0279082493155595,0.0144589992699197
NMR metabolomics,X23412.Phospholipids in VLDL,HMBS,Porphobilinogen deaminase,40489,0.0102603869752339,0.00419522796329945,0.00203774016716694,0.0184830337833008,0.0144666699503213
NMR metabolomics,X23412.Phospholipids in VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,0.0213934097496405,0.00878807058966224,0.00416879139390253,0.0386180281053785,0.0149306856254558
NMR metabolomics,X23412.Phospholipids in VLDL,INSL4,Early placenta insulin-like peptide,37900,-0.0121991726517534,0.00501442335208342,-0.0220274424218369,-0.00237090288166987,0.014994833176885
NMR metabolomics,X23412.Phospholipids in VLDL,CD33,Myeloid cell surface antigen CD33,40411,0.0177749778134082,0.00732550726007763,0.00341698358365601,0.0321329720431603,0.015258349337735
NMR metabolomics,X23412.Phospholipids in VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,-0.0134959168335284,0.00556318587685297,-0.0243997611521602,-0.00259207251489661,0.0152824868431659
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN4,Contactin-4,40332,-0.00542837628608326,0.002243597225378,-0.00982582684782413,-0.00103092572434238,0.0155531556928018
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL14,C-X-C motif chemokine 14,40044,0.0136944811164125,0.00567638336126327,0.00256876972833645,0.0248201925044885,0.0158534251089911
NMR metabolomics,X23412.Phospholipids in VLDL,FGFR4,Fibroblast growth factor receptor 4,37671,0.0118960420024792,0.00495224632073766,0.00218963921383338,0.021602444791125,0.0163126989781273
NMR metabolomics,X23412.Phospholipids in VLDL,TCN2,Transcobalamin-2,40497,0.00660273550220676,0.00275352903478945,0.00120581859401945,0.0119996524103941,0.0164999313288947
NMR metabolomics,X23412.Phospholipids in VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,0.00964291025120847,0.00404401372886617,0.00171664334263078,0.0175691771597862,0.0171165308194843
NMR metabolomics,X23412.Phospholipids in VLDL,NPTN,Neuroplastin,39980,0.0185563223740252,0.00780698237227715,0.00325463692436196,0.0338580078236884,0.017471436062415
NMR metabolomics,X23412.Phospholipids in VLDL,FAM3D,Protein FAM3D,37901,0.0180751926805583,0.00761277881443999,0.00315414620425593,0.0329962391568607,0.017595135011119
NMR metabolomics,X23412.Phospholipids in VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,0.00669878120401779,0.00282376211315617,0.0011642074622317,0.0122333549458039,0.0176925429066689
NMR metabolomics,X23412.Phospholipids in VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,0.0110112710091217,0.00466245740410663,0.00187285449707275,0.0201496875211707,0.0182040115205523
NMR metabolomics,X23412.Phospholipids in VLDL,COL9A1,Collagen alpha-1(IX) chain,40341,0.0102618907423579,0.00435303914259763,0.00172993402286654,0.0187938474618492,0.018415054966395
NMR metabolomics,X23412.Phospholipids in VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,0.0063409282413576,0.00269358408225182,0.00106150344014403,0.0116203530425712,0.0185829522864383
NMR metabolomics,X23412.Phospholipids in VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.0197901243816133,0.0084117798182846,0.00330303593777549,0.0362772128254511,0.0186540596873117
NMR metabolomics,X23412.Phospholipids in VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,-0.0141986920391356,0.0060478570904776,-0.0260524919364717,-0.00234489214179956,0.0189033804774838
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,0.00748272459368322,0.00319312776591789,0.00122419417248416,0.0137412550148823,0.0191218800324358
NMR metabolomics,X23412.Phospholipids in VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,0.0059127891622432,0.00252595086134867,0.00096192547399981,0.0108636528504866,0.0192561181354926
NMR metabolomics,X23412.Phospholipids in VLDL,HBQ1,Hemoglobin subunit theta-1,40489,-0.0127616069095911,0.00545393354969492,-0.0234513166669931,-0.00207189715218905,0.019301597644748
NMR metabolomics,X23412.Phospholipids in VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,0.0121662898841761,0.00520667253785497,0.00196121170998037,0.0223713680583718,0.0194710149770661
NMR metabolomics,X23412.Phospholipids in VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,39961,0.0104828272845684,0.00449314975018471,0.00167625377420642,0.0192894007949305,0.0196572543691848
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC10A,C-type lectin domain family 10 member A,40228,-0.00776338706964389,0.00333186638004993,-0.0142938451745417,-0.00123292896474602,0.0198165023748868
NMR metabolomics,X23412.Phospholipids in VLDL,CCND2,G1/S-specific cyclin-D2,37714,0.00788621726548065,0.00340007224266745,0.00122207566985245,0.0145503588611088,0.020387040023323
NMR metabolomics,X23412.Phospholipids in VLDL,SELL,L-selectin,38013,0.0049697810777547,0.00214332164153023,0.000768870660355448,0.00917069149515395,0.0204245498882672
NMR metabolomics,X23412.Phospholipids in VLDL,CLSPN,Claspin,39925,0.00729764408364891,0.0031551567623751,0.00111353682939372,0.0134817513379041,0.0207397582201173
NMR metabolomics,X23412.Phospholipids in VLDL,TMEM132A,Transmembrane protein 132A,37628,0.0134366424654744,0.00581979682836126,0.00202984068188631,0.0248434442490625,0.0209710765410855
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA11,Serpin A11,40536,0.00854447525508732,0.00370424647331107,0.00128415216739761,0.015804798342777,0.0210858525804562
NMR metabolomics,X23412.Phospholipids in VLDL,WIF1,Wnt inhibitory factor 1,40489,0.00728380068023596,0.00315941205532462,0.00109135305179971,0.0134762483086722,0.0211552493706227
NMR metabolomics,X23412.Phospholipids in VLDL,GBP6,Guanylate-binding protein 6,37562,-0.0101565919002415,0.00440814960204982,-0.0187965651202591,-0.00151661868022383,0.0212354626346742
NMR metabolomics,X23412.Phospholipids in VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,0.0131928393698932,0.00573638068075068,0.0019495332356219,0.0244361455041646,0.0214720709881478
NMR metabolomics,X23412.Phospholipids in VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,0.00899724533442441,0.00391499037187407,0.00132386420555124,0.0166706264632976,0.0215686904796656
NMR metabolomics,X23412.Phospholipids in VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,0.00560798371059807,0.00244249595184582,0.000820691644980263,0.0103952757762159,0.0216885397886913
NMR metabolomics,X23412.Phospholipids in VLDL,TMEM25,Transmembrane protein 25,37959,-0.00929105433371279,0.00405526994770125,-0.0172393834312072,-0.00134272523621834,0.0219725937911368
NMR metabolomics,X23412.Phospholipids in VLDL,GPA33,Cell surface A33 antigen,40305,-0.0288061915153899,0.0125796995092589,-0.0534624025535373,-0.00414998047724247,0.0220404762168094
NMR metabolomics,X23412.Phospholipids in VLDL,CPVL,Probable serine carboxypeptidase CPVL,40465,0.00855715247291305,0.00374245293020717,0.001221944729707,0.0158923602161191,0.0222374884184936
NMR metabolomics,X23412.Phospholipids in VLDL,MYH7B,Myosin-7B,37482,-0.00967257016317623,0.00424219444022449,-0.0179872712660162,-0.00135786906033623,0.0226186421283793
NMR metabolomics,X23412.Phospholipids in VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.0138702759892792,0.00610391724414142,-0.0258339537877964,-0.00190659819076204,0.0230809671846097
NMR metabolomics,X23412.Phospholipids in VLDL,GPR101,Probable G-protein coupled receptor 101,37541,-0.0135909481975887,0.00598939045548357,-0.0253301534903365,-0.00185174290484088,0.0232741611849519
NMR metabolomics,X23412.Phospholipids in VLDL,DDI2,Protein DDI1 homolog 2,37671,0.0163929878171527,0.00723725326683077,0.00220797141416439,0.030578004220141,0.0235236292234112
NMR metabolomics,X23412.Phospholipids in VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,37598,0.00774307919881469,0.00342660692654906,0.00102692962277853,0.0144592287748509,0.0238566184812752
NMR metabolomics,X23412.Phospholipids in VLDL,MATN3,Matrilin-3,40203,-0.00651835345255007,0.00288808639627987,-0.0121790027892586,-0.000857704115841528,0.0240229623365741
NMR metabolomics,X23412.Phospholipids in VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,0.00893892680235776,0.00398418919584989,0.00112991597849198,0.0167479376262235,0.0248722045099951
NMR metabolomics,X23412.Phospholipids in VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,0.0124065083475851,0.00555343308694772,0.00152177949716756,0.0232912371980026,0.0254953412216258
NMR metabolomics,X23412.Phospholipids in VLDL,CHRDL2,Chordin-like protein 2,40359,0.011692534488948,0.00525395667742899,0.0013947794011872,0.0219902895767088,0.0260635192095609
NMR metabolomics,X23412.Phospholipids in VLDL,COL1A1,Collagen alpha-1(I) chain,40536,-0.00532251728590823,0.00239565072527038,-0.0100179927074382,-0.000627041864378274,0.0263146245084251
NMR metabolomics,X23412.Phospholipids in VLDL,PI16,Peptidase inhibitor 16,37987,-0.00506084821799268,0.00227992286963939,-0.00952949704248588,-0.000592199393499484,0.026452564831486
NMR metabolomics,X23412.Phospholipids in VLDL,KLK4,Kallikrein-4,40489,-0.0124484586514441,0.00561486034714209,-0.0234535849318426,-0.00144333237104564,0.0266332491093966
NMR metabolomics,X23412.Phospholipids in VLDL,UNG,Uracil-DNA glycosylase,37900,0.00694098862508255,0.00313917080185892,0.000788213853439058,0.013093763396726,0.027046377697391
NMR metabolomics,X23412.Phospholipids in VLDL,CLSTN1,Calsyntenin-1,39961,0.0107343526295017,0.00485875346115373,0.00121119584564043,0.020257509413363,0.0271696481162164
NMR metabolomics,X23412.Phospholipids in VLDL,MYH4,Myosin-4,37562,-0.00976136547300841,0.0044183449755999,-0.0184213216251842,-0.00110140932083262,0.0271723278877728
NMR metabolomics,X23412.Phospholipids in VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,-0.00783455338023615,0.00354633226805195,-0.014785364625618,-0.000883742134854326,0.0271780340079939
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA1,Alpha-1-antitrypsin,37779,-0.00165819868370313,0.000751622639285398,-0.00313137905670251,-0.000185018310703747,0.0273898995563764
NMR metabolomics,X23412.Phospholipids in VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.0096471605667355,0.00437415682050665,0.00107381319854247,0.0182205079349285,0.0274364869053669
NMR metabolomics,X23412.Phospholipids in VLDL,UNC5D,Netrin receptor UNC5D,37598,0.00546255363564437,0.00248141583939754,0.0005989785904252,0.0103261286808635,0.0277260349659021
NMR metabolomics,X23412.Phospholipids in VLDL,TNXB,Tenascin-X,40332,-0.00516267209837887,0.00235160254825932,-0.00977181309296713,-0.000553531103790608,0.0281504357270897
NMR metabolomics,X23412.Phospholipids in VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,-0.00784339250412489,0.0035745761748337,-0.0148495618067989,-0.000837223201450839,0.0282343051491278
NMR metabolomics,X23412.Phospholipids in VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,-0.00848212148570138,0.00387041358026536,-0.0160681321030215,-0.000896110868381276,0.0284280697000767
NMR metabolomics,X23412.Phospholipids in VLDL,SCGN,Secretagogin,40044,-0.00887339708263753,0.00405347393019541,-0.0168182059858205,-0.000928588179454522,0.0286054711380212
NMR metabolomics,X23412.Phospholipids in VLDL,CDK1,Cyclin-dependent kinase 1,37482,0.00742083798419709,0.00339639137176135,0.000763910895544844,0.0140777650728493,0.0289125821870501
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,-0.00606393785192701,0.00278866721623324,-0.0115297255957442,-0.000598150108109863,0.0296854888409069
NMR metabolomics,X23412.Phospholipids in VLDL,CLIC5,Chloride intracellular channel protein 5,37572,-0.00650256032774221,0.00299205377530201,-0.0123669857273341,-0.000638134928150272,0.0297773371812462
NMR metabolomics,X23412.Phospholipids in VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,-0.0041159071967126,0.00189652200595294,-0.00783309032838035,-0.000398724065044841,0.0300065020847923
NMR metabolomics,X23412.Phospholipids in VLDL,DOCK9,Dedicator of cytokinesis protein 9,37541,0.0240002572549156,0.011082380630779,0.00227879121858879,0.0457217232912424,0.030358015923944
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,-0.00645128113074558,0.00297896189875477,-0.0122900464523049,-0.000612515809186228,0.0303586659035933
NMR metabolomics,X23412.Phospholipids in VLDL,IL19,Interleukin-19,39924,0.0135519322175,0.00626653208513815,0.00126952933062925,0.0258343351043708,0.0305880906355583
NMR metabolomics,X23412.Phospholipids in VLDL,TXNL1,Thioredoxin-like protein 1,37525,0.019089308748967,0.00884237535567202,0.00175825305184984,0.0364203644460842,0.0308804113467185
NMR metabolomics,X23412.Phospholipids in VLDL,RAD51,DNA repair protein RAD51 homolog 1,37714,0.0108191490878806,0.00503446063908197,0.000951606235279911,0.0206866919404812,0.0316509754004529
NMR metabolomics,X23412.Phospholipids in VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,0.0113650503517186,0.00530703741911944,0.000963257010244521,0.0217668436931927,0.032251694204275
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN8,Tetraspanin-8,37901,0.0205090168777817,0.00961460645312714,0.00166438822965253,0.0393536455259109,0.0329337222038123
NMR metabolomics,X23412.Phospholipids in VLDL,SOD3,Extracellular superoxide dismutase,37987,-0.0116616160751973,0.00547295440506639,-0.0223886067091274,-0.000934625441267215,0.0331259321979856
NMR metabolomics,X23412.Phospholipids in VLDL,IL33,Interleukin-33,40044,0.00761425288966321,0.00357380492258509,0.000609595241396436,0.01461891053793,0.0331399262318309
NMR metabolomics,X23412.Phospholipids in VLDL,VIM,Vimentin,40042,0.0232491907620483,0.0109339635117701,0.00181862227897887,0.0446797592451177,0.0334916389651731
NMR metabolomics,X23412.Phospholipids in VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,-0.00554332610045278,0.00261662501372657,-0.0106719111273569,-0.000414741073548709,0.0341481384103942
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA4C,Semaphorin-4C,40305,0.005514318302108,0.00261569446644751,0.000387557147870875,0.0106410794563451,0.0350322794328209
NMR metabolomics,X23412.Phospholipids in VLDL,IL2RG,Cytokine receptor common subunit gamma,37900,0.00753783293533544,0.00357786223663259,0.000525222951535568,0.0145504429191353,0.0351535671946563
NMR metabolomics,X23412.Phospholipids in VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.00824134866432343,0.00391478651810597,0.000568367088835727,0.0159143302398111,0.0352936512389838
NMR metabolomics,X23412.Phospholipids in VLDL,MYL4,Myosin light chain 4,37628,-0.0102372732485015,0.00487048298946369,-0.0197834199078504,-0.000691126589152692,0.0355808785727308
NMR metabolomics,X23412.Phospholipids in VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,0.0110632251188151,0.00530265695964681,0.000670017477907405,0.0214564327597229,0.0369623616903814
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA6C,Semaphorin-6C,37598,0.005153296474584,0.00247037169943789,0.000311367943685736,0.00999522500548225,0.0369941459089677
NMR metabolomics,X23412.Phospholipids in VLDL,CEP290,Centrosomal protein of 290 kDa,37714,0.0102548331580268,0.00493921291780993,0.000573975839119356,0.0199356904769343,0.0378939379247992
NMR metabolomics,X23412.Phospholipids in VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,0.0288023546991063,0.0138868557369303,0.0015841174547229,0.0560205919434897,0.0380885839917527
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP30,Rho GTPase-activating protein 30,37714,0.00724072167539298,0.00349284153517533,0.000394752266449338,0.0140866910843366,0.0381899155890862
NMR metabolomics,X23412.Phospholipids in VLDL,AIDA,"Axin interactor, dorsalization-associated protein",37572,0.0158495811760218,0.00775634174223466,0.00064715136124191,0.0310520109908018,0.0410293156925575
NMR metabolomics,X23412.Phospholipids in VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,37572,0.0113958876295898,0.00560545259535538,0.000409200542693243,0.0223825747164863,0.0420725684343446
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,-0.00632680806239492,0.00311278874686535,-0.012427874006251,-0.000225742118538842,0.0421210672322539
NMR metabolomics,X23412.Phospholipids in VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,-0.00391792436586791,0.00192916048686076,-0.007699078920115,-0.000136769811620819,0.0422824770290274
NMR metabolomics,X23412.Phospholipids in VLDL,APOA4,Apolipoprotein A-IV,38013,0.00691505512865072,0.00340491952157842,0.000241412866357019,0.0135886973909444,0.0422844861433606
NMR metabolomics,X23412.Phospholipids in VLDL,ART3,Ecto-ADP-ribosyltransferase 3,40403,-0.00620421507927456,0.00306530503252748,-0.0122122129430284,-0.000196217215520691,0.0429855218620075
NMR metabolomics,X23412.Phospholipids in VLDL,CEP164,Centrosomal protein of 164 kDa,40044,0.0119435916923321,0.00591011996971487,0.000359756551690939,0.0235274268329732,0.0433101495232609
NMR metabolomics,X23412.Phospholipids in VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,0.0167046068995889,0.00827376945304862,0.000488018771613575,0.0329211950275642,0.0435093772557982
NMR metabolomics,X23412.Phospholipids in VLDL,ID4,DNA-binding protein inhibitor ID-4,37714,-0.00848537661916069,0.00422089475099381,-0.0167583303311086,-0.000212422907212819,0.0444168508105992
NMR metabolomics,X23412.Phospholipids in VLDL,COL3A1,Collagen alpha-1(III) chain,37998,-0.00429470282332228,0.00213955104756187,-0.00848822287654354,-0.000101182770101025,0.0447384513803777
NMR metabolomics,X23412.Phospholipids in VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,0.00608393827665607,0.00303233960496998,0.000140552650914907,0.0120273239023972,0.0448391860972882
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,0.00744691658409579,0.003718952114937,0.000157770438819264,0.0147360627293723,0.0452597756181718
NMR metabolomics,X23412.Phospholipids in VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.00437428847697236,0.00218765199920185,-0.00866208639540797,-8.64905585367427e-05,0.0455704065284462
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL6,Fc receptor-like protein 6,40341,0.0124621110963181,0.0062337080894749,0.000244043240947305,0.0246801789516889,0.0456092388409847
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.00837555395747997,0.0041910098892516,0.000161174574546841,0.0165899333404131,0.0456872101941194
NMR metabolomics,X23412.Phospholipids in VLDL,GSTP1,Glutathione S-transferase P,39871,-0.0127923699800512,0.00645354653473558,-0.025441321188133,-0.000143418771969502,0.0474719831800358
NMR metabolomics,X23412.Phospholipids in VLDL,LIFR,Leukemia inhibitory factor receptor,40341,-0.00447378569437534,0.00226039133531623,-0.00890415271159515,-4.34186771555269e-05,0.0478097728252894
NMR metabolomics,X23412.Phospholipids in VLDL,CPE,Carboxypeptidase E,40360,-0.0069807263183216,0.00353016017413335,-0.013899840259623,-6.16123770202318e-05,0.0480076660696781
NMR metabolomics,X23412.Phospholipids in VLDL,GHRHR,Growth hormone-releasing hormone receptor,39961,0.0101739754541136,0.00517149705909012,3.78412182970144e-05,0.0203101096899303,0.0491644411672775
NMR metabolomics,X23412.Phospholipids in VLDL,DCC,Netrin receptor DCC,37572,0.00425442663942831,0.00216603969294611,8.9888412539308e-06,0.00849986443760269,0.0495337903019877
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,37572,0.00535307044841926,0.00273527261245431,-8.06387199118932e-06,0.0107142047688297,0.0503625425902867
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B4,Protein ATP1B4,37482,-0.00767813311506087,0.00392581294964837,-0.0153727264963717,1.64602662499217e-05,0.0505092122524081
NMR metabolomics,X23412.Phospholipids in VLDL,ADRA2A,Alpha-2A adrenergic receptor,37562,-0.0130450622913514,0.00668144420810026,-0.0261406929392279,5.05683565250811e-05,0.0509082468435703
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC11A,C-type lectin domain family 11 member A,40296,0.00863842878947239,0.00442559533618938,-3.57380694588003e-05,0.0173125956484036,0.0509647383050906
NMR metabolomics,X23412.Phospholipids in VLDL,SLC51B,Organic solute transporter subunit beta,37562,-0.0144143025692385,0.00738971948590893,-0.02889815276162,6.95476231429622e-05,0.0511272825980391
NMR metabolomics,X23412.Phospholipids in VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,0.0124602550228125,0.00639413063377022,-7.22410193770787e-05,0.0249927510650022,0.0513517021086828
NMR metabolomics,X23412.Phospholipids in VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,37598,0.01233390455248,0.00633736020548758,-8.73214502756549e-05,0.0247551305552357,0.0516494561996368
NMR metabolomics,X23412.Phospholipids in VLDL,CSH1,Chorionic somatomammotropin hormone 1,37987,0.00629751331273272,0.00323604419046565,-4.51333005799612e-05,0.0126401599260454,0.0516690486576102
NMR metabolomics,X23412.Phospholipids in VLDL,CEP152,Centrosomal protein of 152 kDa,37482,0.00749847209542801,0.00385589924846357,-5.90904315605845e-05,0.0150560346224166,0.0518355553975462
NMR metabolomics,X23412.Phospholipids in VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,-0.00991887805030837,0.00510765311862005,-0.0199298781628037,9.21220621869345e-05,0.052162894992742
NMR metabolomics,X23412.Phospholipids in VLDL,RLN2,Prorelaxin H2,37643,0.0250519206368122,0.013053664405608,-0.000533261598179426,0.0506371028718038,0.0549870926990201
NMR metabolomics,X23412.Phospholipids in VLDL,RETN,Resistin,40283,0.00732815642447292,0.00382394705544937,-0.000166779804207845,0.0148230926531537,0.0553340399098128
NMR metabolomics,X23412.Phospholipids in VLDL,THBS2,Thrombospondin-2,40332,-0.00631858986694751,0.0033044614925853,-0.0127953343924147,0.000158154658519675,0.0558763350147497
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA2013,Uncharacterized protein KIAA2013,37900,0.0101729930648621,0.00532856041204595,-0.000270985342747988,0.0206169714724721,0.0562646835706538
NMR metabolomics,X23412.Phospholipids in VLDL,LTO1,Protein LTO1 homolog,40044,0.00725115966981613,0.00380329255763452,-0.00020329374314752,0.0147056130827798,0.0565975131784714
NMR metabolomics,X23412.Phospholipids in VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,0.015688894432333,0.00823547099855238,-0.000452628724829693,0.0318304175894956,0.0567968448974138
NMR metabolomics,X23412.Phospholipids in VLDL,LYPLA2,Acyl-protein thioesterase 2,37541,0.0189667085797705,0.0100341704316291,-0.000700265466222573,0.0386336826257635,0.0587516946417277
NMR metabolomics,X23412.Phospholipids in VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,40225,0.0101384563557541,0.00538622220542737,-0.000418539166883515,0.0206954518783918,0.0598144355235616
NMR metabolomics,X23412.Phospholipids in VLDL,BCAN,Brevican core protein,40228,0.00582497049858235,0.00309691275290818,-0.000244978497117685,0.0118949194942824,0.0600044837312265
NMR metabolomics,X23412.Phospholipids in VLDL,CRISP2,Cysteine-rich secretory protein 2,40489,0.010636933585719,0.00565618137973511,-0.000449181918561822,0.0217230490899998,0.0600464101448992
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,-0.00676110379363996,0.0035997897133334,-0.0138166916317734,0.000294484044493499,0.0603729515290196
NMR metabolomics,X23412.Phospholipids in VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.00511926480015944,0.00272606372321396,-0.0104623496976588,0.00022382009733992,0.0604168891368996
NMR metabolomics,X23412.Phospholipids in VLDL,FDX1,"Adrenodoxin, mitochondrial",37562,0.0109237867852291,0.00583577165055145,-0.000514325649851707,0.02236189922031,0.0612472915366511
NMR metabolomics,X23412.Phospholipids in VLDL,PDCL2,Phosducin-like protein 2,37482,0.00934242985994496,0.00500771551025801,-0.000472692540160745,0.0191575522600507,0.0621188033805487
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD6,Programmed cell death protein 6,40359,-0.0119374237470673,0.0064413352318849,-0.0245624408015617,0.000687593307427079,0.0638646109690903
NMR metabolomics,X23412.Phospholipids in VLDL,CADPS,Calcium-dependent secretion activator 1,37572,-0.00773762614539339,0.00417819279340879,-0.0159268840204746,0.000451631729687841,0.0640615711870365
NMR metabolomics,X23412.Phospholipids in VLDL,BOC,Brother of CDO,40042,-0.00403089251579527,0.00217929853866558,-0.00830231765157981,0.000240532619989261,0.0643860368686025
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA4,Ephrin type-A receptor 4,37671,0.00481750896181935,0.00260916343006214,-0.000296451361102439,0.00993146928474113,0.0648592894780113
NMR metabolomics,X23412.Phospholipids in VLDL,MSMB,Beta-microseminoprotein,40236,0.0117756624248403,0.0063875130060706,-0.00074386306705808,0.0242951879167387,0.0652683315566882
NMR metabolomics,X23412.Phospholipids in VLDL,CDHR1,Cadherin-related family member 1,39961,0.00748971500831686,0.0040630439418836,-0.000473851117775004,0.0154532811344087,0.0652932957341893
NMR metabolomics,X23412.Phospholipids in VLDL,PPM1B,Protein phosphatase 1B,37598,0.0108282902383184,0.00588748961767183,-0.000711189412318429,0.0223677698889551,0.0659078302531251
NMR metabolomics,X23412.Phospholipids in VLDL,PGLYRP4,Peptidoglycan recognition protein 4,37562,0.0107415218192781,0.00584468334143548,-0.000714057529935438,0.0221971011684916,0.0661103908378942
NMR metabolomics,X23412.Phospholipids in VLDL,TTN,Titin,37562,-0.0110942662597104,0.00609539029213367,-0.0230412312322924,0.000852698712871601,0.0687654103902545
NMR metabolomics,X23412.Phospholipids in VLDL,EPN1,Epsin-1,37714,0.00745543610555842,0.00409925138894371,-0.000579096616771254,0.0154899688278881,0.0689750036573511
NMR metabolomics,X23412.Phospholipids in VLDL,IFNW1,Interferon omega-1,37562,-0.00619381495875671,0.00341778036066984,-0.0128926644656696,0.000505034548156169,0.0699730419613181
NMR metabolomics,X23412.Phospholipids in VLDL,PON1,Serum paraoxonase/arylesterase 1,37987,-0.00432909450519902,0.00239594918726256,-0.00902515491223363,0.00036696590183559,0.070809579339349
NMR metabolomics,X23412.Phospholipids in VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,0.00590082519089116,0.00328005784904645,-0.000528088193239878,0.0123297385750222,0.072041598837045
NMR metabolomics,X23412.Phospholipids in VLDL,NRTN,Neurturin,40044,0.00819830597234422,0.0045740967463767,-0.000766923650554117,0.0171635355952426,0.0730989703887166
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,0.00685798790501263,0.00382716913978038,-0.000643263608956921,0.0143592394189822,0.0731644140392807
NMR metabolomics,X23412.Phospholipids in VLDL,CHP1,Calcineurin B homologous protein 1,37541,0.0121124437041473,0.00677220126988849,-0.00116107078483413,0.0253859581931287,0.0737098855887689
NMR metabolomics,X23412.Phospholipids in VLDL,GAD1,Glutamate decarboxylase 1,37482,-0.00427621743032805,0.00240052548706781,-0.00898124738498095,0.000428812524324865,0.0748757648507293
NMR metabolomics,X23412.Phospholipids in VLDL,ZPR1,Zinc finger protein ZPR1,37541,0.0160115753620182,0.00901711335245792,-0.00166196680879936,0.0336851175328357,0.0758076697648945
NMR metabolomics,X23412.Phospholipids in VLDL,PAPPA,Pappalysin-1,40044,0.00769758647434018,0.00434458864793356,-0.000817807275609594,0.01621298022429,0.0764532407009412
NMR metabolomics,X23412.Phospholipids in VLDL,MERTK,Tyrosine-protein kinase Mer,40516,0.00426737823260592,0.00241382102306991,-0.000463710972611108,0.00899846743782295,0.0770977069336956
NMR metabolomics,X23412.Phospholipids in VLDL,VASN,Vasorin,40116,0.00447138643142571,0.00253404253772596,-0.000495336942517182,0.0094381098053686,0.0776627827881496
NMR metabolomics,X23412.Phospholipids in VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,37541,-0.00817479877733421,0.004652200508787,-0.0172931117745567,0.000943514219888314,0.0789088585369154
NMR metabolomics,X23412.Phospholipids in VLDL,GPR158,Probable G-protein coupled receptor 158,37959,0.00598881450516276,0.0034149390888199,-0.000704466108924238,0.0126820951192498,0.0795028060750602
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB116,Beta-defensin 116,37541,-0.0127745244746392,0.00733817467107857,-0.0271573468299532,0.00160829788067476,0.0817366437547243
NMR metabolomics,X23412.Phospholipids in VLDL,FGF12,Fibroblast growth factor 12,37598,0.00778550159623078,0.004475458142319,-0.000986396362714468,0.016557399555176,0.0819528953308544
NMR metabolomics,X23412.Phospholipids in VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,0.00427424587262715,0.00245953238653138,-0.000546437604974356,0.00909492935022867,0.0822646343574348
NMR metabolomics,X23412.Phospholipids in VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,0.0183138147157229,0.0105431672037493,-0.00235079300362576,0.0389784224350715,0.0824043877626061
NMR metabolomics,X23412.Phospholipids in VLDL,SLC12A2,Solute carrier family 12 member 2,37562,-0.00461175461692259,0.00265511614035667,-0.00981578225202166,0.000592273018176473,0.0824227662105691
NMR metabolomics,X23412.Phospholipids in VLDL,SLITRK1,SLIT and NTRK-like protein 1,37598,0.00517267051251603,0.00298957573531737,-0.000686897928706022,0.0110322389537381,0.0836116503724207
NMR metabolomics,X23412.Phospholipids in VLDL,MSLNL,Mesothelin-like protein,37572,-0.00602128844356413,0.00348800308319812,-0.0128577744866325,0.000815197599504193,0.0843196405246782
NMR metabolomics,X23412.Phospholipids in VLDL,BABAM1,BRISC and BRCA1-A complex member 1,37598,0.00471386027123534,0.0027313925918524,-0.000639669208795371,0.0100673897512661,0.0844053868109152
NMR metabolomics,X23412.Phospholipids in VLDL,GLI2,Zinc finger protein GLI2,37598,-0.00538503192244887,0.00312492221380616,-0.0115098794615089,0.000739815616611208,0.0848662780698809
NMR metabolomics,X23412.Phospholipids in VLDL,CNTNAP2,Contactin-associated protein-like 2,40341,0.00637632028862563,0.00370586552117075,-0.000887176132869047,0.0136398167101203,0.0853425072879498
NMR metabolomics,X23412.Phospholipids in VLDL,MB,Myoglobin,40536,-0.0077811073370605,0.0045309808631091,-0.0166618298287543,0.00109961515463333,0.0859414499187537
NMR metabolomics,X23412.Phospholipids in VLDL,GUK1,Guanylate kinase,37562,-0.00637233776376229,0.00372920112917073,-0.0136815719769369,0.000936896449412342,0.0875176908740593
NMR metabolomics,X23412.Phospholipids in VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,0.00810978855532127,0.00475176616208707,-0.00120367312236939,0.0174232502330119,0.0878998075573169
NMR metabolomics,X23412.Phospholipids in VLDL,RALB,Ras-related protein Ral-B,37598,0.0046831095785169,0.00274806863793206,-0.000703104951829941,0.0100693241088637,0.0883774869793206
NMR metabolomics,X23412.Phospholipids in VLDL,CHIT1,Chitotriosidase-1,40398,0.0233557850113877,0.0137754000250215,-0.00364399903765433,0.0503555690604298,0.0900057152770777
NMR metabolomics,X23412.Phospholipids in VLDL,ZP4,Zona pellucida sperm-binding protein 4,37482,-0.00509427941604318,0.00302171682746951,-0.0110168443978834,0.000828285565797066,0.0918411069835104
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,40341,0.0101498478098084,0.00602990727714851,-0.00166877045340267,0.0219684660730195,0.0923461455236344
NMR metabolomics,X23412.Phospholipids in VLDL,SPRING1,SREBP regulating gene protein,37482,0.00898887039988166,0.00534817220255807,-0.00149354711713215,0.0194712879168955,0.0928379969711317
NMR metabolomics,X23412.Phospholipids in VLDL,ENDOU,Poly(U)-specific endoribonuclease,36973,0.00782476899378493,0.00465587735778325,-0.00130075062747024,0.0169502886150401,0.092861341543338
NMR metabolomics,X23412.Phospholipids in VLDL,SOX2,Transcription factor SOX-2,37937,0.00362840776663599,0.00215954371987776,-0.00060429792432443,0.0078611134575964,0.0929467586989506
NMR metabolomics,X23412.Phospholipids in VLDL,RGS8,Regulator of G-protein signaling 8,40044,0.0103123017277626,0.00614306836141795,-0.00172811226061662,0.0223527157161418,0.0932326951584202
NMR metabolomics,X23412.Phospholipids in VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.0132530993636911,0.00789820745450941,-0.0287335859745295,0.00222738724714738,0.0933726277451499
NMR metabolomics,X23412.Phospholipids in VLDL,OSTN,Osteocrin,37572,-0.00669758744809992,0.00399243551497313,-0.0145227610574473,0.00112758616124742,0.0934550198952871
NMR metabolomics,X23412.Phospholipids in VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,0.00682538740252733,0.00407352992805599,-0.0011587312564624,0.0148095060615171,0.0938465853980878
NMR metabolomics,X23412.Phospholipids in VLDL,PXDNL,Peroxidasin-like protein,37900,0.00907913286669917,0.00542807951227681,-0.00155990297736338,0.0197181687107617,0.0944247163332826
NMR metabolomics,X23412.Phospholipids in VLDL,FGF9,Fibroblast growth factor 9,37457,0.00630047111667772,0.00376959771891006,-0.00108794041238599,0.0136888826457414,0.0946685621656934
NMR metabolomics,X23412.Phospholipids in VLDL,LY6D,Lymphocyte antigen 6D,40268,0.00574709340407575,0.0034493925841633,-0.00101371606088432,0.0125079028690358,0.0957098130899054
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,40359,0.00411907750063209,0.00247967033530611,-0.000741076356567887,0.00897923135783206,0.0967052079341968
NMR metabolomics,X23412.Phospholipids in VLDL,PRND,Prion-like protein doppel,37942,-0.00825275001985425,0.00496905721663963,-0.0179921021644679,0.00148660212475943,0.0967712083353057
NMR metabolomics,X23412.Phospholipids in VLDL,GH2,Growth hormone variant,39980,0.0258943225300926,0.015597837655398,-0.00467743927448751,0.0564660843346727,0.0969099863284034
NMR metabolomics,X23412.Phospholipids in VLDL,BTLA,B- and T-lymphocyte attenuator,37482,0.0136574286214785,0.00824994860821575,-0.00251247065062441,0.0298273278935813,0.0978560744616092
NMR metabolomics,X23412.Phospholipids in VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,0.010302589829416,0.0062582940499645,-0.00196366650851437,0.0225688461673465,0.0997367290674499
NMR metabolomics,X23412.Phospholipids in VLDL,KIF20B,Kinesin-like protein KIF20B,37541,0.0118737009076249,0.00724731106402995,-0.00233102877787381,0.0260784305931236,0.101370758625691
NMR metabolomics,X23412.Phospholipids in VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,-0.00517631076868133,0.00316421979975442,-0.0113781815762,0.00102556003883732,0.101882685507024
NMR metabolomics,X23412.Phospholipids in VLDL,CALY,Neuron-specific vesicular protein calcyon,37562,-0.0058030248001886,0.00355319801051426,-0.0127672929007965,0.00116124330041935,0.102454397007011
NMR metabolomics,X23412.Phospholipids in VLDL,FBN2,Fibrillin-2,37572,0.00922932093505116,0.00565234741612941,-0.00184928000056248,0.0203079218706648,0.102528807873841
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,40451,0.00449485955247304,0.00275307506605242,-0.000901167576989701,0.00989088668193578,0.102558367765016
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB104A_DEFB104B,Beta-defensin 104,37541,0.00851105844238676,0.00525977480167171,-0.00179810016888979,0.0188202170536633,0.105656260801139
NMR metabolomics,X23412.Phospholipids in VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.00436390531635522,0.00270048105403854,-0.000929037549560313,0.00965684818227076,0.106120314730078
NMR metabolomics,X23412.Phospholipids in VLDL,SCARB1,Scavenger receptor class B member 1,39961,0.00882587531206748,0.00548091793151073,-0.00191672383369355,0.0195684744578285,0.107354594867453
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,0.0108537630260934,0.00678946771925127,-0.00245359370363909,0.0241611197558259,0.109928919065831
NMR metabolomics,X23412.Phospholipids in VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,0.00464904775544597,0.002909039106574,-0.00105266889343908,0.010350764404331,0.110031991318339
NMR metabolomics,X23412.Phospholipids in VLDL,HIP1,Huntingtin-interacting protein 1,37562,0.00504974116568191,0.0031610159344963,-0.00114585006593083,0.0112453323972947,0.110177115068362
NMR metabolomics,X23412.Phospholipids in VLDL,AXL,Tyrosine-protein kinase receptor UFO,40403,0.00402062864808781,0.00253790234161701,-0.000953659941481535,0.00899491723765715,0.113160529668579
NMR metabolomics,X23412.Phospholipids in VLDL,DPEP1,Dipeptidase 1,40192,-0.00742067948152404,0.00469508498688055,-0.0166230460558099,0.00178168709276185,0.114007740630515
NMR metabolomics,X23412.Phospholipids in VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,-0.00716804293096595,0.0045468732349962,-0.0160799144715585,0.00174382860962659,0.114939931224942
NMR metabolomics,X23412.Phospholipids in VLDL,HMCN2,Hemicentin-2,37648,-0.00833915344357238,0.00529306495435401,-0.0187135607541062,0.00203525386696148,0.115168117657245
NMR metabolomics,X23412.Phospholipids in VLDL,ZNF75D,Zinc finger protein 75D,37714,0.00865773994305611,0.00551477416585956,-0.00215121742202862,0.0194666973081408,0.116458184770904
NMR metabolomics,X23412.Phospholipids in VLDL,PFDN4,Prefoldin subunit 4,37482,0.00789409607758002,0.00504673113624354,-0.00199749694945732,0.0177856891046174,0.117794927391295
NMR metabolomics,X23412.Phospholipids in VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,39865,0.00545018133990569,0.00349022164389935,-0.00139065308213704,0.0122910157619484,0.11841282895391
NMR metabolomics,X23412.Phospholipids in VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,0.0132168643106068,0.00849342655651977,-0.00343025174017194,0.0298639803613856,0.119701367792765
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD5,Sushi domain-containing protein 5,37604,-0.0049112980781394,0.00316902800125353,-0.0111225929605963,0.00129999680431751,0.121218248977163
NMR metabolomics,X23412.Phospholipids in VLDL,CD209,CD209 antigen,40382,-0.00554873331633944,0.00358162420731783,-0.0125687167626824,0.00147125013000351,0.121348073509054
NMR metabolomics,X23412.Phospholipids in VLDL,PALM3,Paralemmin-3,37562,0.010417388650494,0.00673249856167215,-0.00277830853038338,0.0236130858313714,0.121808127765923
NMR metabolomics,X23412.Phospholipids in VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.00831207581679104,0.0053724611262972,-0.00221794799075148,0.0188420996243336,0.121847998764553
NMR metabolomics,X23412.Phospholipids in VLDL,AKAP12,A-kinase anchor protein 12,37671,-0.00312071614138525,0.0020187941961829,-0.00707755276590372,0.000836120483133228,0.12216914802729
NMR metabolomics,X23412.Phospholipids in VLDL,CRHR1,Corticotropin-releasing factor receptor 1,40042,0.00905979123640793,0.00586662793066307,-0.00243879950769169,0.0205583819805075,0.122537714737045
NMR metabolomics,X23412.Phospholipids in VLDL,KLK15,Kallikrein-15,37880,0.00728274458867324,0.0047447931717107,-0.00201705002787972,0.0165825392052262,0.124833944315591
NMR metabolomics,X23412.Phospholipids in VLDL,REXO2,"Oligoribonuclease, mitochondrial",37562,-0.00696149305801378,0.00455134052656074,-0.0158821204900728,0.00195913437404528,0.12615281627573
NMR metabolomics,X23412.Phospholipids in VLDL,SCN3B,Sodium channel subunit beta-3,37541,0.00646982527251552,0.00425861125544108,-0.00187705278814899,0.01481670333318,0.128727861989886
NMR metabolomics,X23412.Phospholipids in VLDL,GPHA2,Glycoprotein hormone alpha-2,37901,0.00687737385027851,0.00453605088214016,-0.0020132858787162,0.0157680335792732,0.129502683827894
NMR metabolomics,X23412.Phospholipids in VLDL,CDH22,Cadherin-22,37714,-0.00414171696453886,0.0027328111017814,-0.00949802672403042,0.00121459279495269,0.129656538935278
NMR metabolomics,X23412.Phospholipids in VLDL,IL20,Interleukin-20,40044,0.00712061437427472,0.00471431917745371,-0.00211945121353454,0.016360679962084,0.130955881979762
NMR metabolomics,X23412.Phospholipids in VLDL,POF1B,Protein POF1B,37598,-0.00648811730891584,0.00430511638976365,-0.0149261454328526,0.00194991081502092,0.131816413752124
NMR metabolomics,X23412.Phospholipids in VLDL,GUCA2A,Guanylin,40276,-0.00464243688194721,0.00309127337515097,-0.0107013326972431,0.00141645893334869,0.133171853503534
NMR metabolomics,X23412.Phospholipids in VLDL,ACTN4,Alpha-actinin-4,40044,0.00450834632714329,0.00300205197585964,-0.00137567554554161,0.0103923681998282,0.133180664718777
NMR metabolomics,X23412.Phospholipids in VLDL,DENND2B,DENN domain-containing protein 2B,37562,-0.00731668167787167,0.00487410249920764,-0.0168699225763186,0.0022365592205753,0.133344952262341
NMR metabolomics,X23412.Phospholipids in VLDL,BSND,Barttin,37482,-0.00477372698352194,0.00318446812047688,-0.0110152844996566,0.00146783053261274,0.133880810780442
NMR metabolomics,X23412.Phospholipids in VLDL,DUSP29,Dual specificity phosphatase 29,37572,-0.00925409001322716,0.00618357787526833,-0.0213739026487531,0.00286572262229877,0.134532062000669
NMR metabolomics,X23412.Phospholipids in VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,-0.0101333018898809,0.00678766299901167,-0.0234371213679438,0.003170517588182,0.135483112667874
NMR metabolomics,X23412.Phospholipids in VLDL,PSMC3,26S proteasome regulatory subunit 6A,37482,-0.004176461738509,0.00280310827599931,-0.00967055395946765,0.00131763048244964,0.136264349100558
NMR metabolomics,X23412.Phospholipids in VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,0.00951359672769476,0.0064067846829573,-0.00304370125090154,0.0220708947062911,0.13758393490886
NMR metabolomics,X23412.Phospholipids in VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,37482,-0.00352004996270065,0.00237160768510879,-0.00816840102551388,0.00112830110011259,0.137767776296379
NMR metabolomics,X23412.Phospholipids in VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,-0.00906588816104673,0.00611277720801311,-0.0210469314887524,0.00291515516665897,0.138070634702631
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G1B,Phospholipase A2,40514,-0.0057225660539012,0.00386615543101751,-0.0133002306986955,0.00185509859089312,0.138847582616052
NMR metabolomics,X23412.Phospholipids in VLDL,NLGN2,Neuroligin-2,37541,-0.00662750853601873,0.00448067820328346,-0.0154096378144543,0.00215462074241684,0.139129460657379
NMR metabolomics,X23412.Phospholipids in VLDL,LPA,Apolipoprotein(a),37735,-0.024039592791316,0.0162558674225552,-0.0559010929395242,0.00782190735689223,0.139210646372742
NMR metabolomics,X23412.Phospholipids in VLDL,THY1,Thy-1 membrane glycoprotein,40471,-0.00382218923919222,0.00258523644635454,-0.00888925267404711,0.00124487419566267,0.139302230269552
NMR metabolomics,X23412.Phospholipids in VLDL,LCN15,Lipocalin-15,37959,-0.00872334822017376,0.00590671957504625,-0.0203005185872644,0.0028538221469169,0.139738736482707
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTSL5,ADAMTS-like protein 5,37990,-0.00529196029627424,0.00358959809103316,-0.0123275725546992,0.00174365196215075,0.140437895941287
NMR metabolomics,X23412.Phospholipids in VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,-0.00562852778761786,0.00382887868218108,-0.0131331300046928,0.00187607442945707,0.141580405373674
NMR metabolomics,X23412.Phospholipids in VLDL,TXNDC15,Thioredoxin domain-containing protein 15,40411,0.00368610144967838,0.00250834996674059,-0.00123026448513318,0.00860246738448994,0.14170816314177
NMR metabolomics,X23412.Phospholipids in VLDL,YY1,Transcriptional repressor protein YY1,37598,0.00382991250107817,0.00260694759665274,-0.0012797047883612,0.00893952979051753,0.141824833483901
NMR metabolomics,X23412.Phospholipids in VLDL,AGBL2,Cytosolic carboxypeptidase 2,37541,0.0123929705128606,0.00844696964289556,-0.00416308998721469,0.0289490310129359,0.14235931336211
NMR metabolomics,X23412.Phospholipids in VLDL,MN1,Transcriptional activator MN1,37572,-0.00811188046583566,0.00553526601673063,-0.0189610018586277,0.00273724092695639,0.142811071290125
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB118,Beta-defensin 118,37541,0.00792055610004033,0.0054056135935742,-0.0026744465433651,0.0185155587434458,0.142877711623351
NMR metabolomics,X23412.Phospholipids in VLDL,FBLN2,Fibulin-2,37998,-0.00417822326290653,0.00285550853149562,-0.00977501998463794,0.00141857345882488,0.143431726390288
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,0.00545409867641553,0.00373805863264137,-0.00187249624356156,0.0127806935963926,0.1445689059216
NMR metabolomics,X23412.Phospholipids in VLDL,ENG,Endoglin,40536,-0.00228121270255205,0.00157217729933605,-0.0053626802092507,0.00080025480414661,0.146802295190291
NMR metabolomics,X23412.Phospholipids in VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,-0.0232325742236446,0.0160574456719942,-0.0547051677407531,0.00824001929346398,0.147964706160582
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,-0.0184415868099991,0.0127551186330302,-0.0434416193307382,0.00655844571074009,0.148251243574261
NMR metabolomics,X23412.Phospholipids in VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,-0.00685075350432984,0.00473844119740991,-0.0161380982512533,0.00243659124259358,0.148262229987096
NMR metabolomics,X23412.Phospholipids in VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.00863082617787803,0.0059774273819495,-0.00308493149074299,0.0203465838464991,0.14878984465589
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,0.0059413493691582,0.00413820509152537,-0.00216953261023153,0.0140522313485479,0.151098497394187
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,0.00425100409832396,0.00296178326747523,-0.00155409110592749,0.0100560993025754,0.151225865469518
NMR metabolomics,X23412.Phospholipids in VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.0048339708168448,0.00336891539378426,-0.00176910335497235,0.0114370449886619,0.151346650226569
NMR metabolomics,X23412.Phospholipids in VLDL,MAMDC2,MAM domain-containing protein 2,37990,-0.0045089556611861,0.00314472389580108,-0.0106726144969562,0.00165470317458402,0.151647852784061
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4C,C-type lectin domain family 4 member C,40341,0.00603527065165706,0.00421457718585956,-0.00222530063262769,0.0142958419359418,0.152163755461018
NMR metabolomics,X23412.Phospholipids in VLDL,KRT17,"Keratin, type I cytoskeletal 17",37562,0.00509576533412028,0.00355950319381424,-0.00188086092575563,0.0120723915939962,0.15228373184844
NMR metabolomics,X23412.Phospholipids in VLDL,SHPK,Sedoheptulokinase,37714,-0.00567450813358891,0.00397311126971579,-0.0134618062222319,0.00211278995505403,0.153249838061529
NMR metabolomics,X23412.Phospholipids in VLDL,RTKN2,Rhotekin-2,37562,-0.00698437560784426,0.00489272356483201,-0.016574113794915,0.00260536257922647,0.153458894436167
NMR metabolomics,X23412.Phospholipids in VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,0.0074574782253052,0.00522561916850415,-0.00278473534496294,0.0176996917955733,0.153574377026488
NMR metabolomics,X23412.Phospholipids in VLDL,CTNNA1,Catenin alpha-1,37541,-0.00480025938878748,0.00336541139308282,-0.0113964657192298,0.00179594694165485,0.15379077339063
NMR metabolomics,X23412.Phospholipids in VLDL,TSLP,Thymic stromal lymphopoietin,40042,0.00801455112983875,0.00562740991431736,-0.00301517230222327,0.0190442745619008,0.154408912003505
NMR metabolomics,X23412.Phospholipids in VLDL,COPE,Coatomer subunit epsilon,39961,0.00635577091674358,0.00446842512681002,-0.00240234233180405,0.0151138841652912,0.154937870471899
NMR metabolomics,X23412.Phospholipids in VLDL,IL25,Interleukin-25,37429,0.00458206586781699,0.00324191540846466,-0.00177208833277374,0.0109362200684077,0.157567331827467
NMR metabolomics,X23412.Phospholipids in VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,0.00717390591585553,0.00508826990173982,-0.00279910309155452,0.0171469149232656,0.158595632611265
NMR metabolomics,X23412.Phospholipids in VLDL,SEZ6L2,Seizure 6-like protein 2,40305,-0.00307839494339145,0.00219313368852527,-0.00737693697290098,0.00122014708611807,0.160442299857646
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBR3,Transforming growth factor beta receptor type 3,40536,-0.0042763501290719,0.00304733587456505,-0.0102491284432194,0.0016964281850756,0.160544384974114
NMR metabolomics,X23412.Phospholipids in VLDL,SHH,Sonic hedgehog protein,37598,-0.0056176445001317,0.00403421978974305,-0.0135247152880281,0.00228942628776469,0.163795085104025
NMR metabolomics,X23412.Phospholipids in VLDL,MMP8,Neutrophil collagenase,40442,0.00933094003272317,0.00675761940277533,-0.00391399399671647,0.0225758740621628,0.16735889012176
NMR metabolomics,X23412.Phospholipids in VLDL,CA14,Carbonic anhydrase 14,40489,-0.00438309273325042,0.00318548368968993,-0.0106266407650427,0.00186045529854183,0.168853757224901
NMR metabolomics,X23412.Phospholipids in VLDL,CD70,CD70 antigen,40341,0.00527521939190707,0.00383841013373299,-0.00224806447020959,0.0127985032540237,0.169360484403169
NMR metabolomics,X23412.Phospholipids in VLDL,FZD8,Frizzled-8,37541,0.00571164116398732,0.00416462722924541,-0.00245102820533369,0.0138743105333083,0.170253505558362
NMR metabolomics,X23412.Phospholipids in VLDL,SLK,STE20-like serine/threonine-protein kinase,37714,0.00987838060771058,0.00720303262010151,-0.00423956332768838,0.0239963245431095,0.170267372223192
NMR metabolomics,X23412.Phospholipids in VLDL,ENOPH1,Enolase-phosphatase E1,37900,0.00727513874353009,0.00531132945096628,-0.00313506698036382,0.017685344467424,0.170791044768088
NMR metabolomics,X23412.Phospholipids in VLDL,NRN1,Neuritin,37959,-0.00464012754074383,0.0033916698051514,-0.0112878003588406,0.00200754527735292,0.171305003796736
NMR metabolomics,X23412.Phospholipids in VLDL,CD99,CD99 antigen,40332,-0.00244845511613813,0.00179277267320953,-0.00596228955562881,0.00106537932335255,0.172041019366493
NMR metabolomics,X23412.Phospholipids in VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,37562,0.0041557341634214,0.00304624923958719,-0.00181491434616949,0.0101263826730123,0.172523816653125
NMR metabolomics,X23412.Phospholipids in VLDL,TAP1,Antigen peptide transporter 1,37714,-0.00777534816128254,0.00571596727431379,-0.0189786440189376,0.00342794769637249,0.173762673209767
NMR metabolomics,X23412.Phospholipids in VLDL,CDAN1,Codanin-1,37942,0.00291236949085646,0.00214935148447606,-0.00130035941871661,0.00712509840042953,0.175440508809944
NMR metabolomics,X23412.Phospholipids in VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,0.00815184131126604,0.00601994058972596,-0.00364724224459684,0.0199509248671289,0.175714525411959
NMR metabolomics,X23412.Phospholipids in VLDL,BMP10,Bone morphogenetic protein 10,37671,0.00359474305943233,0.0026568829003533,-0.00161274742526014,0.0088022335441248,0.176081114330521
NMR metabolomics,X23412.Phospholipids in VLDL,FRMD7,FERM domain-containing protein 7,37572,0.00416628493608952,0.00308752895194836,-0.00188527180972927,0.0102178416819083,0.177234574149798
NMR metabolomics,X23412.Phospholipids in VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,-0.00552883395558625,0.00409873220309353,-0.0135623490736496,0.00250468116247708,0.177388147305645
NMR metabolomics,X23412.Phospholipids in VLDL,REG1A,Lithostathine-1-alpha,40274,-0.00604108391784207,0.00450094594050246,-0.0148629379612269,0.00278077012554274,0.179556588913733
NMR metabolomics,X23412.Phospholipids in VLDL,CORO6,Coronin-6,37541,-0.00453213586264924,0.00337999168354508,-0.0111569195623976,0.00209264783709911,0.17998531652046
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,0.00863006729106842,0.00643825277634335,-0.00398890815056455,0.0212490427327014,0.180126524590171
NMR metabolomics,X23412.Phospholipids in VLDL,CNTNAP4,Contactin-associated protein-like 4,37572,0.0125656450443235,0.00941932475753833,-0.00589623148045165,0.0310275215690986,0.182217763215229
NMR metabolomics,X23412.Phospholipids in VLDL,ADA2,Adenosine deaminase 2,40258,0.00515276650892848,0.00386685211255276,-0.00242626363167492,0.0127317966495319,0.182699350065131
NMR metabolomics,X23412.Phospholipids in VLDL,MYBPC1,"Myosin-binding protein C, slow-type",37990,-0.00779866747590627,0.0058619060326467,-0.0192880032998938,0.00369066834808127,0.183409615531166
NMR metabolomics,X23412.Phospholipids in VLDL,HTR1B,5-hydroxytryptamine receptor 1B,37541,-0.00524967522606877,0.00394673706069282,-0.0129852798650267,0.00248592941288915,0.183498463221895
NMR metabolomics,X23412.Phospholipids in VLDL,DPEP2,Dipeptidase 2,40305,0.00352302984222509,0.002648949989377,-0.00166891213695383,0.008714971821404,0.183546565276543
NMR metabolomics,X23412.Phospholipids in VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,0.00563461454870085,0.00424200072153131,-0.00267970686550052,0.0139489359629022,0.184104867448198
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.00231299774510066,0.00175843361727053,-0.00113353214474956,0.00575952763495089,0.188406500294123
NMR metabolomics,X23412.Phospholipids in VLDL,GKN1,Gastrokine-1,39602,0.0033939966894277,0.00258333795624262,-0.00166934570480783,0.00845733908366323,0.1889324624092
NMR metabolomics,X23412.Phospholipids in VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,-0.00603396183617929,0.00460037444893958,-0.0150506957561009,0.0029827720837423,0.189665943818787
NMR metabolomics,X23412.Phospholipids in VLDL,COMMD9,COMM domain-containing protein 9,37900,0.0047612411018944,0.00363551644237081,-0.00236437112515238,0.0118868533289412,0.190337849147128
NMR metabolomics,X23412.Phospholipids in VLDL,LEG1,Protein LEG1 homolog,37231,-0.00843579241698775,0.00645409310077915,-0.0210858148945149,0.00421423006053939,0.191220826086832
NMR metabolomics,X23412.Phospholipids in VLDL,IGLC2,Immunoglobulin lambda constant 2,37978,-0.00293096127563571,0.00224785404423107,-0.0073367552023286,0.00147483265105718,0.192292238367074
NMR metabolomics,X23412.Phospholipids in VLDL,CDH4,Cadherin-4,37541,0.00596457273520508,0.00459452077224153,-0.00304068797838832,0.0149698334487985,0.194244044002902
NMR metabolomics,X23412.Phospholipids in VLDL,DKKL1,Dickkopf-like protein 1,40305,-0.0105102632773241,0.00812243211122389,-0.0264302302153229,0.00540970366067476,0.195691240418461
NMR metabolomics,X23412.Phospholipids in VLDL,DCLRE1C,Protein artemis,37482,-0.00381346057718706,0.00294883858335915,-0.00959318420057099,0.00196626304619686,0.195962181550424
NMR metabolomics,X23412.Phospholipids in VLDL,LPO,Lactoperoxidase,39831,-0.00704818154714091,0.00547432286241648,-0.0177778543574772,0.00368149126319539,0.197940025746427
NMR metabolomics,X23412.Phospholipids in VLDL,GAMT,Guanidinoacetate N-methyltransferase,37562,-0.00465224071645425,0.00361626424911396,-0.0117401186447176,0.00243563721180911,0.19829936431631
NMR metabolomics,X23412.Phospholipids in VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,0.00568142178278936,0.00443238215814412,-0.00300604724717311,0.0143688908127518,0.199935361108617
NMR metabolomics,X23412.Phospholipids in VLDL,DUOX2,Dual oxidase 2,40042,0.00856728955590695,0.00669790070953154,-0.00456059583477487,0.0216951749465888,0.200880631372503
NMR metabolomics,X23412.Phospholipids in VLDL,TP53BP1,TP53-binding protein 1,37598,0.0105414486092594,0.00825300586876592,-0.00563444289352177,0.0267173401120406,0.201523862644538
NMR metabolomics,X23412.Phospholipids in VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.00589601445878238,0.0046218529247774,-0.00316281727378133,0.0149548461913461,0.202090602154742
NMR metabolomics,X23412.Phospholipids in VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.00426536326233011,0.00334482758340387,-0.00229049880114149,0.0108212253258017,0.202256901923677
NMR metabolomics,X23412.Phospholipids in VLDL,BEX3,Protein BEX3,37482,-0.00565212836534374,0.00443561690081556,-0.0143459374909422,0.00304168076025475,0.202594079070646
NMR metabolomics,X23412.Phospholipids in VLDL,METAP1,Methionine aminopeptidase 1,39961,0.003613647534254,0.00283997317857503,-0.00195269989575307,0.00917999496426106,0.203241899741854
NMR metabolomics,X23412.Phospholipids in VLDL,ACTA2,"Actin, aortic smooth muscle",40042,-0.00511595812574169,0.00403240731276427,-0.0130194764587597,0.00278756020727628,0.204563223281883
NMR metabolomics,X23412.Phospholipids in VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.00595183880182979,0.00469734306604324,-0.00325495360761497,0.0151586312112745,0.205154709422506
NMR metabolomics,X23412.Phospholipids in VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,-0.0052518547052614,0.00414529500195024,-0.0133766329090839,0.00287292349856108,0.205198124923406
NMR metabolomics,X23412.Phospholipids in VLDL,CA8,Carbonic anhydrase-related protein,37598,-0.00327003504343169,0.00258251159822899,-0.0083317577759605,0.00179168768909713,0.205455766829778
NMR metabolomics,X23412.Phospholipids in VLDL,PRRT3,Proline-rich transmembrane protein 3,37628,0.00440472478104349,0.00348128343203226,-0.00241859074573973,0.0112280403078267,0.205800916131489
NMR metabolomics,X23412.Phospholipids in VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,-0.0111735478037161,0.00886028557011116,-0.0285397075211339,0.0061926119137018,0.207301836262702
NMR metabolomics,X23412.Phospholipids in VLDL,HLA_A,,37959,0.00381157975117632,0.00302710098204855,-0.00212153817363884,0.00974469767599148,0.207997254939255
NMR metabolomics,X23412.Phospholipids in VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,-0.00615155336099298,0.00490219338580467,-0.0157598523971701,0.00345674567518416,0.209552921196234
NMR metabolomics,X23412.Phospholipids in VLDL,PSMG4,Proteasome assembly chaperone 4,37598,0.00654688194522998,0.00523255188205867,-0.00370891974360502,0.016802683634065,0.210889846069681
NMR metabolomics,X23412.Phospholipids in VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,0.00670814805764545,0.00537871260955631,-0.00383412865708491,0.0172504247723758,0.212359014156171
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH17,Protocadherin-17,40359,-0.00400763228950468,0.00321644779619085,-0.0103118699700387,0.00229660539102938,0.212789783927305
NMR metabolomics,X23412.Phospholipids in VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,0.00919911271397002,0.0074006752542203,-0.00530621078430177,0.0237044362122418,0.213882873651612
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBR1,TGF-beta receptor type-1,37598,0.00248334945313192,0.00199922917154095,-0.00143513972308834,0.00640183862935219,0.214202102104485
NMR metabolomics,X23412.Phospholipids in VLDL,NELL1,Protein kinase C-binding protein NELL1,40411,0.00485691075729225,0.00392053697583202,-0.00282734171533851,0.012541163229923,0.215423664243188
NMR metabolomics,X23412.Phospholipids in VLDL,IL24,Interleukin-24,40044,0.0056343016108238,0.0045585543433341,-0.00330046490211103,0.0145690681237586,0.216483018436562
NMR metabolomics,X23412.Phospholipids in VLDL,L1CAM,Neural cell adhesion molecule L1,40411,0.00320325038774968,0.00261221502458257,-0.00191669106043215,0.00832319183593151,0.22011957647693
NMR metabolomics,X23412.Phospholipids in VLDL,REG3A,Regenerating islet-derived protein 3-alpha,40536,-0.0068914318718129,0.00562122466050785,-0.0179090322064083,0.00412616846278249,0.220229314824842
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS4,Galectin-4,40357,0.0059624031924878,0.00486904639589766,-0.00358092774347161,0.0155057341284472,0.220761990885969
NMR metabolomics,X23412.Phospholipids in VLDL,MORF4L2,Mortality factor 4-like protein 2,37482,-0.00413067842115733,0.00338093896095625,-0.0107573187846316,0.00249596194231691,0.221822466938752
NMR metabolomics,X23412.Phospholipids in VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,37598,0.00252864287527331,0.00207683874182329,-0.00154196105870035,0.00659924680924696,0.223419100639146
NMR metabolomics,X23412.Phospholipids in VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,0.00366338795767518,0.00301827450155648,-0.00225243006537553,0.00957920598072589,0.224870511341973
NMR metabolomics,X23412.Phospholipids in VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,-0.00827438748537647,0.00683731602904791,-0.0216755269023104,0.00512675193155744,0.226231154249275
NMR metabolomics,X23412.Phospholipids in VLDL,TJP3,Tight junction protein ZO-3,37541,-0.00493032119124705,0.00407689384098558,-0.0129210331195788,0.00306039073708469,0.226556881099386
NMR metabolomics,X23412.Phospholipids in VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,-0.00645863581616072,0.00534442635264299,-0.016933711467341,0.00401643983501955,0.226884366058874
NMR metabolomics,X23412.Phospholipids in VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,0.00967424276453386,0.00803838103809944,-0.00608098407014103,0.0254294695992088,0.228802143314502
NMR metabolomics,X23412.Phospholipids in VLDL,TAGLN3,Transgelin-3,37482,-0.00678694771020381,0.00566498312602822,-0.0178903146372191,0.00431641921681149,0.230918335109191
NMR metabolomics,X23412.Phospholipids in VLDL,HDAC8,Histone deacetylase 8,37598,0.00693689202005537,0.00580751239804534,-0.00444583228011349,0.0183196163202242,0.232316212177486
NMR metabolomics,X23412.Phospholipids in VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,37942,0.00440965875520188,0.00369175897867366,-0.00282618884299849,0.0116455063534022,0.232319045221985
NMR metabolomics,X23412.Phospholipids in VLDL,MTR,Methionine synthase,37562,0.00721654658905938,0.0060776886624875,-0.00469572318941611,0.0191288163675349,0.235097940404393
NMR metabolomics,X23412.Phospholipids in VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,0.0041234946988497,0.00347293365795648,-0.002683455270745,0.0109304446684444,0.235121067294659
NMR metabolomics,X23412.Phospholipids in VLDL,TLR2,Toll-like receptor 2,37714,0.00252550636648169,0.00213061895047187,-0.00165050677644317,0.00670151950940654,0.235904561188839
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE10,Inactive ribonuclease-like protein 10,37628,-0.00535963537829241,0.00452406976907826,-0.0142268121256858,0.00350754136910098,0.236160080398142
NMR metabolomics,X23412.Phospholipids in VLDL,AMY2A,Pancreatic alpha-amylase,39695,0.00507733607797264,0.00435544167095818,-0.00345932959710539,0.0136140017530507,0.243735640172012
NMR metabolomics,X23412.Phospholipids in VLDL,JCHAIN,Immunoglobulin J chain,40044,-0.00664103997242016,0.00570621119517299,-0.0178252139149592,0.0045431339701189,0.244512127270566
NMR metabolomics,X23412.Phospholipids in VLDL,CCNE1,G1/S-specific cyclin-E1,37598,0.0101187583141504,0.00869605758614122,-0.00692551455468637,0.0271630311829872,0.24460607181973
NMR metabolomics,X23412.Phospholipids in VLDL,FAM171A2,Protein FAM171A2,37959,0.0172701626559889,0.0148927777160353,-0.0119196816674403,0.046460006979418,0.246218589427644
NMR metabolomics,X23412.Phospholipids in VLDL,RELB,Transcription factor RelB,37598,0.00555012892929762,0.00478661196366442,-0.00383163051948464,0.0149318883780799,0.246269040082718
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB5,Integrin beta-5,40411,0.00394481953940364,0.00341931132084148,-0.00275703064944566,0.0106466697282529,0.248645250693623
NMR metabolomics,X23412.Phospholipids in VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.00625731867711676,0.0054379098605204,-0.00440098464950322,0.0169156220037367,0.249882978587249
NMR metabolomics,X23412.Phospholipids in VLDL,EVI2B,Protein EVI2B,37482,0.00449569389321854,0.00391301315792797,-0.00317381189632029,0.0121651996827574,0.25061482126421
NMR metabolomics,X23412.Phospholipids in VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,40424,0.00222167148377945,0.00193707696136674,-0.00157499936049936,0.00601834232805825,0.251432042470437
NMR metabolomics,X23412.Phospholipids in VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,-0.00279538133680103,0.0024389337339384,-0.0075756914553203,0.00198492878171824,0.251750826724101
NMR metabolomics,X23412.Phospholipids in VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.00606254541230497,0.00530132771331676,-0.00432805690579589,0.0164531477304058,0.252814621186037
NMR metabolomics,X23412.Phospholipids in VLDL,TUBB3,Tubulin beta-3 chain,37541,-0.00294030813125083,0.00257937175248074,-0.00799587676611308,0.00211526050361143,0.254335534693611
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA10,Annexin A10,39961,0.0086764371877066,0.00763019398198301,-0.0062787430169801,0.0236316173923933,0.255506184971427
NMR metabolomics,X23412.Phospholipids in VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,-0.00777535525768052,0.00685347076661612,-0.0212081579602481,0.00565744744488709,0.256596328695205
NMR metabolomics,X23412.Phospholipids in VLDL,CEP350,Centrosome-associated protein 350,37482,0.00394586688600928,0.00348050610230804,-0.00287592507451448,0.010767658846533,0.256939203848891
NMR metabolomics,X23412.Phospholipids in VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,0.00859935423860889,0.00762406445695445,-0.00634381209702184,0.0235425205742396,0.259373396849056
NMR metabolomics,X23412.Phospholipids in VLDL,RBP7,Retinoid-binding protein 7,37901,0.00607834875266051,0.00540669325905983,-0.00451877003509676,0.0166754675404178,0.260936943475942
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.00513199740476537,0.00456501973874729,-0.0140794360927101,0.00381544128317931,0.260944941588971
NMR metabolomics,X23412.Phospholipids in VLDL,RASA1,Ras GTPase-activating protein 1,39961,0.00338183945495933,0.00301179310967961,-0.0025212750400127,0.00928495394993136,0.261511879852135
NMR metabolomics,X23412.Phospholipids in VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,-0.00651976941803817,0.00581530955834387,-0.0179177761523922,0.00487823731631582,0.262249303384293
NMR metabolomics,X23412.Phospholipids in VLDL,PNMA2,Paraneoplastic antigen Ma2,37541,0.00450769819082927,0.00403014451010004,-0.0033913850489668,0.0124067814306253,0.263375986859846
NMR metabolomics,X23412.Phospholipids in VLDL,RYR1,Ryanodine receptor 1,37562,-0.00358851613358956,0.00320935306478746,-0.00987884814057297,0.00270181587339385,0.263526349873277
NMR metabolomics,X23412.Phospholipids in VLDL,KLK14,Kallikrein-14,40489,0.00472426287874741,0.00424164986811899,-0.0035893708627658,0.0130378966202606,0.265390464982749
NMR metabolomics,X23412.Phospholipids in VLDL,GID8,Glucose-induced degradation protein 8 homolog,37959,0.00347987887619155,0.00313228107748351,-0.00265939203567614,0.00961914978805924,0.26659986105129
NMR metabolomics,X23412.Phospholipids in VLDL,PCNA,Proliferating cell nuclear antigen,37482,0.00643383982107261,0.00580645092851485,-0.0049468039988165,0.0178144836409617,0.267860536435097
NMR metabolomics,X23412.Phospholipids in VLDL,KRT8,"Keratin, type II cytoskeletal 8",37541,0.00629689269307837,0.0057063528337883,-0.00488755886114669,0.0174813442473034,0.269835524644075
NMR metabolomics,X23412.Phospholipids in VLDL,KEL,Kell blood group glycoprotein,39961,0.00362949281235795,0.00329188635310369,-0.00282260443972527,0.0100815900644412,0.270236638986961
NMR metabolomics,X23412.Phospholipids in VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,37562,0.0121542513108366,0.011097335191586,-0.00959652566467195,0.0339050282863451,0.273431392609876
NMR metabolomics,X23412.Phospholipids in VLDL,DCUN1D1,DCN1-like protein 1,37541,-0.00756664570414643,0.0069371016462815,-0.0211633649308582,0.0060300735225653,0.275402849389646
NMR metabolomics,X23412.Phospholipids in VLDL,MET,Hepatocyte growth factor receptor,40375,-0.00201844070319962,0.00185290446015569,-0.00565013344510476,0.00161325203870553,0.276020998793735
NMR metabolomics,X23412.Phospholipids in VLDL,DOC2B,Double C2-like domain-containing protein beta,37572,0.00364026994143308,0.00334176978662876,-0.0029095988403593,0.0101901387232255,0.276031052305376
NMR metabolomics,X23412.Phospholipids in VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,0.00275968331378708,0.00253355168745501,-0.00220607799362473,0.00772544462119889,0.276058117362212
NMR metabolomics,X23412.Phospholipids in VLDL,LAMA1,Laminin subunit alpha-1,37562,-0.00564096892086618,0.00521342548498609,-0.0158592828714389,0.00457734502970655,0.279268803136157
NMR metabolomics,X23412.Phospholipids in VLDL,SLC44A4,Choline transporter-like protein 4,37572,-0.00703005042797564,0.00650059209889859,-0.0197712109418169,0.00571111008586559,0.279517886379833
NMR metabolomics,X23412.Phospholipids in VLDL,KIRREL1,Kin of IRRE-like protein 1,37541,0.0061929376224056,0.00572729506903755,-0.005032560712908,0.0174184359577192,0.279582563580615
NMR metabolomics,X23412.Phospholipids in VLDL,KDM3A,Lysine-specific demethylase 3A,37598,-0.00928463709076221,0.00859947664330622,-0.0261396113116424,0.00757033713011797,0.280306886192207
NMR metabolomics,X23412.Phospholipids in VLDL,DCUN1D2,DCN1-like protein 2,37482,0.00810103633088889,0.00751152560533809,-0.00662155385557378,0.0228236265173516,0.280839198694065
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF1,Signaling lymphocytic activation molecule,40044,-0.00589950750294333,0.00549729965945279,-0.0166742148354708,0.00487519982958414,0.283213870010433
NMR metabolomics,X23412.Phospholipids in VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,-0.0051691015816132,0.00484233709362946,-0.0146600822851269,0.00432187912190054,0.285774447774332
NMR metabolomics,X23412.Phospholipids in VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,0.00773430410850086,0.00727583368917522,-0.00652632992228257,0.0219949381392843,0.287795726218429
NMR metabolomics,X23412.Phospholipids in VLDL,MMP13,Collagenase 3,39961,-0.00323791915120984,0.00304739919103585,-0.00921082156564011,0.00273498326322042,0.288016739278923
NMR metabolomics,X23412.Phospholipids in VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,0.00365078770258401,0.0034506017077424,-0.0031123916445911,0.0104139670497591,0.290065443352119
NMR metabolomics,X23412.Phospholipids in VLDL,ERCC1,DNA excision repair protein ERCC-1,37482,0.00323262955937876,0.00311935079424206,-0.00288129799733568,0.00934655711609321,0.300074510547288
NMR metabolomics,X23412.Phospholipids in VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,0.00343923307731386,0.0033455808208391,-0.00311810533153078,0.00999657148615851,0.303971951444705
NMR metabolomics,X23412.Phospholipids in VLDL,NENF,Neudesin,37900,0.0102892221059957,0.010029848077571,-0.00936928012604342,0.0299477243380348,0.304975929860785
NMR metabolomics,X23412.Phospholipids in VLDL,IL21R,Interleukin-21 receptor,37598,0.00533128612756404,0.00520025691619426,-0.0048612174281767,0.0155237896833048,0.30528925808034
NMR metabolomics,X23412.Phospholipids in VLDL,HDDC2,5'-deoxynucleotidase HDDC2,37901,0.0040906346323393,0.00402536920490232,-0.00379908900926924,0.0119803582739479,0.309545997475629
NMR metabolomics,X23412.Phospholipids in VLDL,TEX101,Testis-expressed protein 101,37572,0.0036912238410311,0.00364457450007506,-0.00345214217911602,0.0108345898611782,0.311174536736047
NMR metabolomics,X23412.Phospholipids in VLDL,S100A3,Protein S100-A3,37900,0.00428640837136683,0.00425538073995852,-0.00405413787895186,0.0126269546216855,0.313812890599287
NMR metabolomics,X23412.Phospholipids in VLDL,RAP1A,Ras-related protein Rap-1A,37598,0.00651906035055969,0.00647229141780566,-0.0061666308283394,0.0192047515294588,0.313844708438879
NMR metabolomics,X23412.Phospholipids in VLDL,LAYN,Layilin,40192,-0.00319520669115505,0.00317506564104494,-0.00941833534760313,0.00302792196529304,0.314265828843735
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB5,Serpin B5,40042,-0.00452928094790484,0.00450848504144861,-0.0133659116291441,0.00430734973333443,0.315099012469889
NMR metabolomics,X23412.Phospholipids in VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,-0.0042453158730485,0.00425863579856754,-0.0125922420382409,0.00410161029214388,0.318844948614276
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,40536,0.0026975283211961,0.00272063205040244,-0.00263491049759269,0.00802996713998489,0.321452525451647
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN3,Neuronal-specific septin-3,37959,-0.00676599869999199,0.00682535012840347,-0.0201436849516628,0.00661168755167882,0.32155478819002
NMR metabolomics,X23412.Phospholipids in VLDL,PLB1,"Phospholipase B1, membrane-associated",37942,0.00555837491964448,0.00561487765562664,-0.00544678528538373,0.0165635351246727,0.322222687824394
NMR metabolomics,X23412.Phospholipids in VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,-0.00528909551237666,0.00534462136668227,-0.0157645533910739,0.00518636236632058,0.322382637837984
NMR metabolomics,X23412.Phospholipids in VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,0.00512375359057625,0.0052073315704002,-0.00508261628740815,0.0153301234685606,0.325158284847652
NMR metabolomics,X23412.Phospholipids in VLDL,SMPD1,Sphingomyelin phosphodiesterase,40380,0.00429481011631821,0.0043865965497292,-0.00430291912115103,0.0128925393537874,0.327557444273317
NMR metabolomics,X23412.Phospholipids in VLDL,KLHL41,Kelch-like protein 41,37959,0.00430343193363793,0.00439692947067191,-0.00431454982887902,0.0129214136961549,0.327728106874262
NMR metabolomics,X23412.Phospholipids in VLDL,CD164L2,CD164 sialomucin-like 2 protein,37572,0.00333751073005159,0.00341810803733743,-0.00336198102312978,0.010037002483233,0.328874133611193
NMR metabolomics,X23412.Phospholipids in VLDL,GDF15,Growth/differentiation factor 15,40536,0.00386288430783762,0.00396662829806238,-0.00391170715636465,0.0116374757720399,0.33014775410265
NMR metabolomics,X23412.Phospholipids in VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,-0.00575098988849003,0.0059589277027092,-0.0174304881858001,0.00592850840882,0.33451022073215
NMR metabolomics,X23412.Phospholipids in VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,0.00228770189627191,0.00237263143389158,-0.00236265571415559,0.00693805950669941,0.334960636918927
NMR metabolomics,X23412.Phospholipids in VLDL,IL22,Interleukin-22,37900,-0.00579892311704931,0.0060431938200957,-0.0176435830044369,0.00604573677033825,0.337284291000154
NMR metabolomics,X23412.Phospholipids in VLDL,CA3,Carbonic anhydrase 3,40500,0.00539167003714784,0.00562949350248187,-0.00564213722771662,0.0164254773020123,0.338201237429826
NMR metabolomics,X23412.Phospholipids in VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,37541,-0.00630293483008714,0.00658329951352168,-0.0192062018765896,0.00660033221641535,0.338376653389761
NMR metabolomics,X23412.Phospholipids in VLDL,PSMA1,Proteasome subunit alpha type-1,39980,-0.00410527346628255,0.00430292578932345,-0.0125390080133565,0.00432846108079142,0.340065289995403
NMR metabolomics,X23412.Phospholipids in VLDL,IL1A,Interleukin-1 alpha,40044,0.00473636928306355,0.00497809166426215,-0.00502069037889025,0.0144934289450174,0.341394409494714
NMR metabolomics,X23412.Phospholipids in VLDL,IL5,Interleukin-5,40044,0.0127868380989445,0.0134805887620181,-0.0136351158746111,0.0392087920725,0.342870813796267
NMR metabolomics,X23412.Phospholipids in VLDL,PSCA,Prostate stem cell antigen,37901,0.0226632003463599,0.0240732616407734,-0.024520392469556,0.0698467931622757,0.346503377706713
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,0.00334704640500319,0.00355757417433962,-0.00362579897670247,0.0103198917867088,0.346812937181199
NMR metabolomics,X23412.Phospholipids in VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.00657161518519027,0.0070929150197165,-0.0204737286238346,0.00733049825345407,0.354198442031407
NMR metabolomics,X23412.Phospholipids in VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,37541,0.00646748509251,0.00701056597419871,-0.00727322421691948,0.0202081944019395,0.35626713659864
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,0.00245845429245975,0.0026712385788568,-0.00277717332209959,0.00769408190701908,0.357407628710904
NMR metabolomics,X23412.Phospholipids in VLDL,ERVV_1,,37562,-0.00412711329673214,0.0044896818675265,-0.0129268897570841,0.0046726631636198,0.357984853243447
NMR metabolomics,X23412.Phospholipids in VLDL,ESPL1,Separin,37482,-0.00485482968406177,0.00532327849364247,-0.015288455531601,0.00557879616347747,0.361785619825575
NMR metabolomics,X23412.Phospholipids in VLDL,HLA_DRA,,40288,-0.0030333871379124,0.00332932200509352,-0.0095588582678957,0.0034920839920709,0.362249930761617
NMR metabolomics,X23412.Phospholipids in VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,-0.00428814122077252,0.00471923780227484,-0.0135378473132312,0.00496156487168616,0.363550947112538
NMR metabolomics,X23412.Phospholipids in VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,0.00611552710508937,0.00674687343375565,-0.00710834482507169,0.0193393990352504,0.364728191252307
NMR metabolomics,X23412.Phospholipids in VLDL,PODXL2,Podocalyxin-like protein 2,40411,0.00227969048666198,0.00251905440388245,-0.00265765614494763,0.00721703711827158,0.36549035245531
NMR metabolomics,X23412.Phospholipids in VLDL,EDNRB,Endothelin receptor type B,37598,0.00398176124117298,0.00439991663650225,-0.00464207536637143,0.0126055978487174,0.365501635864234
NMR metabolomics,X23412.Phospholipids in VLDL,CD58,Lymphocyte function-associated antigen 3,40335,-0.00147291399691431,0.00163133847646796,-0.0046703374107915,0.00172450941696289,0.366599662872026
NMR metabolomics,X23412.Phospholipids in VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,0.00222137021369222,0.00246740122164628,-0.00261473618073449,0.00705747660811893,0.367983379091122
NMR metabolomics,X23412.Phospholipids in VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,0.00271149617170622,0.00301688193991902,-0.00320159243053505,0.00862458477394749,0.36878935998471
NMR metabolomics,X23412.Phospholipids in VLDL,FZD10,Frizzled-10,37572,0.00507808330232713,0.00565155490560856,-0.00599896431266564,0.0161551309173199,0.368920333075163
NMR metabolomics,X23412.Phospholipids in VLDL,ANK2,Ankyrin-2,37562,0.0061760183330841,0.00689577733870407,-0.00733970525077587,0.0196917419169441,0.370470471475188
NMR metabolomics,X23412.Phospholipids in VLDL,OFD1,Oral-facial-digital syndrome 1 protein,37714,0.00563335370918532,0.00630105629947742,-0.00671671663779043,0.0179834240561611,0.371320336413258
NMR metabolomics,X23412.Phospholipids in VLDL,SPESP1,Sperm equatorial segment protein 1,37990,0.00228448085121871,0.00255529505818782,-0.00272389746282943,0.00729285916526684,0.37132792846581
NMR metabolomics,X23412.Phospholipids in VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,0.0035557613620893,0.00397926162216822,-0.00424359141736041,0.011355114141539,0.371566705198416
NMR metabolomics,X23412.Phospholipids in VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,-0.00299611985440061,0.00336089976429767,-0.00958348339242404,0.00359124368362282,0.372696863323265
NMR metabolomics,X23412.Phospholipids in VLDL,TNR,Tenascin-R,40228,-0.00349299326291649,0.00392120295047393,-0.0111785510458454,0.00419256452001242,0.373052020156664
NMR metabolomics,X23412.Phospholipids in VLDL,SPP1,Osteopontin,40497,-0.00391151235097423,0.00439217616916958,-0.0125201776425466,0.00469715294059814,0.37317667153945
NMR metabolomics,X23412.Phospholipids in VLDL,COL5A1,Collagen alpha-1(V) chain,37671,0.00325806028137074,0.00368002832027961,-0.0039547952263773,0.0104709157891188,0.375991729229402
NMR metabolomics,X23412.Phospholipids in VLDL,TP73,Tumor protein p73,37572,0.00286685047682138,0.00324425093351866,-0.00349188135287519,0.00922558230651796,0.376890029685736
NMR metabolomics,X23412.Phospholipids in VLDL,RRP15,RRP15-like protein,37541,-0.00744766266133512,0.00845721375685486,-0.0240238016247706,0.00912847630210041,0.378535148097369
NMR metabolomics,X23412.Phospholipids in VLDL,NCAM1,Neural cell adhesion molecule 1,40403,-0.00223782917563043,0.002548451853064,-0.00723279480763588,0.00275713645637502,0.379895524208075
NMR metabolomics,X23412.Phospholipids in VLDL,CAPN3,Calpain-3,37900,0.00302031971495112,0.00344011691302089,-0.00372230943456982,0.00976294886447207,0.379975642085952
NMR metabolomics,X23412.Phospholipids in VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,0.0102478890626094,0.0116950080516083,-0.0126743267185428,0.0331701048437616,0.380901269881454
NMR metabolomics,X23412.Phospholipids in VLDL,TFRC,Transferrin receptor protein 1,40391,-0.00318690548178339,0.00364836236734637,-0.0103376957217823,0.0039638847582155,0.382394663762516
NMR metabolomics,X23412.Phospholipids in VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,-0.00201550691474873,0.00231322943468097,-0.00654943660672343,0.00251842277722596,0.383608145982105
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA5,Annexin A5,39896,0.00246078073004848,0.00282623278020629,-0.00307863551915586,0.00800019697925281,0.383935406012691
NMR metabolomics,X23412.Phospholipids in VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,-0.00236381971557024,0.00272960454069363,-0.00771384461532976,0.00298620518418928,0.386509545338132
NMR metabolomics,X23412.Phospholipids in VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,0.00205927335172876,0.00238281759266933,-0.00261104912990313,0.00672959583336065,0.387484073248761
NMR metabolomics,X23412.Phospholipids in VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,0.00305316850885434,0.00354308802098003,-0.00389128401226651,0.0099976210299752,0.388854470663163
NMR metabolomics,X23412.Phospholipids in VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,0.00338532407617026,0.00394636641664536,-0.00434955410045463,0.0111202022527952,0.390999803080409
NMR metabolomics,X23412.Phospholipids in VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",37562,-0.00326921499163883,0.00382408088994035,-0.0107644135359219,0.00422598355264426,0.392620940061944
NMR metabolomics,X23412.Phospholipids in VLDL,NEB,Nebulin,37562,0.00288346852766477,0.00338209279071192,-0.00374543334213059,0.00951237039746013,0.393913760811604
NMR metabolomics,X23412.Phospholipids in VLDL,AMIGO1,Amphoterin-induced protein 1,37572,0.00394705011308703,0.00463421585875499,-0.00513601297007274,0.0130301131962468,0.394385568306632
NMR metabolomics,X23412.Phospholipids in VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,-0.00404874261893117,0.00477155293127609,-0.0134009863642323,0.00530350112636996,0.396165861536375
NMR metabolomics,X23412.Phospholipids in VLDL,PYDC1,Pyrin domain-containing protein 1,37628,-0.00333681210262039,0.00395413479387591,-0.0110869162986172,0.00441329209337639,0.398752233301321
NMR metabolomics,X23412.Phospholipids in VLDL,IL36A,Interleukin-36 alpha,37598,-0.00461109932963745,0.00548929970013976,-0.0153701267419114,0.00614792808263647,0.400914717405727
NMR metabolomics,X23412.Phospholipids in VLDL,IL36G,Interleukin-36 gamma,37551,0.00537864388105612,0.00640319560780169,-0.0071716195102352,0.0179289072723474,0.400927257613508
NMR metabolomics,X23412.Phospholipids in VLDL,CHEK2,Serine/threonine-protein kinase Chk2,40042,-0.00261518513107739,0.00311654090849069,-0.00872360531171914,0.00349323504956437,0.401408840863698
NMR metabolomics,X23412.Phospholipids in VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.00215260972150433,0.00257108963763599,-0.00719194541127087,0.0028867259682622,0.402474495426448
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAX,Integrin alpha-X,37714,0.00427205245991521,0.00512096301686087,-0.0057650350531321,0.0143091399729625,0.404167351775551
NMR metabolomics,X23412.Phospholipids in VLDL,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.00637143027878976,0.00764918019289148,-0.0213638234568571,0.00862096289927754,0.404884661818288
NMR metabolomics,X23412.Phospholipids in VLDL,MMP15,Matrix metalloproteinase-15,37990,0.00384470285405935,0.00462001560707917,-0.00521052773581583,0.0128999334439345,0.4053197986682
NMR metabolomics,X23412.Phospholipids in VLDL,UBQLN3,Ubiquilin-3,37562,-0.00348417554004364,0.00419119095704588,-0.0116989098158536,0.00473055873576629,0.405814127110832
NMR metabolomics,X23412.Phospholipids in VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,0.00252270345449726,0.0030399419028125,-0.00343558267501523,0.00848098958400976,0.406634877871839
NMR metabolomics,X23412.Phospholipids in VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,37883,0.00318785444255885,0.00390014052564246,-0.00445642098770037,0.0108321298728181,0.413732014028956
NMR metabolomics,X23412.Phospholipids in VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.00476335851583525,0.00584937559109747,-0.00670141764271579,0.0162281346743863,0.415466976761289
NMR metabolomics,X23412.Phospholipids in VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,0.00427539968696309,0.00526528173013285,-0.00604455250409729,0.0145953518780235,0.416804760088019
NMR metabolomics,X23412.Phospholipids in VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,-0.00317412901932709,0.00392099516957017,-0.0108592795516846,0.00451102151303044,0.418230049678206
NMR metabolomics,X23412.Phospholipids in VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.00218366970389621,0.00273340341368307,-0.00754114039471502,0.00317380098692259,0.424372232826892
NMR metabolomics,X23412.Phospholipids in VLDL,SMC3,Structural maintenance of chromosomes protein 3,37482,0.00413341497873525,0.00518336190817361,-0.00602597436128503,0.0142928043187555,0.425210643140038
NMR metabolomics,X23412.Phospholipids in VLDL,ART5,Ecto-ADP-ribosyltransferase 5,37541,0.0046978546516543,0.00590534435751464,-0.0068766202890744,0.016272329592383,0.426322050861316
NMR metabolomics,X23412.Phospholipids in VLDL,CLNS1A,Methylosome subunit pICln,37572,0.00246494107385867,0.00311716690036074,-0.00364470605084839,0.00857458819856573,0.429096444009347
NMR metabolomics,X23412.Phospholipids in VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,40332,0.00251085271868291,0.00317680523316403,-0.0037156855383186,0.00873739097568442,0.429323305252738
NMR metabolomics,X23412.Phospholipids in VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,-0.00367662647886129,0.00468283219431365,-0.012854977579716,0.00550172462199346,0.432392323083078
NMR metabolomics,X23412.Phospholipids in VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,-0.00333202351757415,0.00426043309995293,-0.0116824723934819,0.00501842535833358,0.434178335512735
NMR metabolomics,X23412.Phospholipids in VLDL,UPK3A,Uroplakin-3a,37541,0.00359700023653548,0.0046448297328347,-0.00550686603982054,0.0127008665128915,0.438702659797048
NMR metabolomics,X23412.Phospholipids in VLDL,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00405734762782519,0.00524242374221156,-0.00621780290690947,0.0143324981625598,0.438977360081573
NMR metabolomics,X23412.Phospholipids in VLDL,NLGN1,Neuroligin-1,37572,-0.00499929445969691,0.00646694550761895,-0.0176745076546301,0.00767591873523624,0.439504682333373
NMR metabolomics,X23412.Phospholipids in VLDL,PKLR,Pyruvate kinase PKLR,40374,-0.00473510375838729,0.00613632026709033,-0.0167622914818843,0.00729208396510976,0.440332023723936
NMR metabolomics,X23412.Phospholipids in VLDL,PITHD1,PITH domain-containing protein 1,37457,-0.00586970923205354,0.00762332836833198,-0.0208114328339842,0.00907201436987714,0.441333612432532
NMR metabolomics,X23412.Phospholipids in VLDL,CGN,Cingulin,37572,0.00297969785839545,0.00389423552214824,-0.0046530037650151,0.010612399481806,0.444192391826061
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN5,Contactin-5,40367,0.00260961974630462,0.00342169893300002,-0.00409691016237543,0.00931614965498466,0.445672816175345
NMR metabolomics,X23412.Phospholipids in VLDL,KRT19,"Keratin, type I cytoskeletal 19",40310,0.00477468335626902,0.00627605594816747,-0.00752638630213923,0.0170757530146773,0.446801172814391
NMR metabolomics,X23412.Phospholipids in VLDL,IL17A,Interleukin-17A,40028,0.00299674358863905,0.0039419246747082,-0.00472942877378903,0.0107229159510671,0.44713253493546
NMR metabolomics,X23412.Phospholipids in VLDL,AOC3,Membrane primary amine oxidase,40403,-0.00212241476225543,0.00280409492469037,-0.00761844081464855,0.00337361129013769,0.449121956163772
NMR metabolomics,X23412.Phospholipids in VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,-0.00216387677546563,0.00285910673394157,-0.0077677259739911,0.00343997242305984,0.449159212774397
NMR metabolomics,X23412.Phospholipids in VLDL,CBX2,Chromobox protein homolog 2,37562,-0.00287749995554898,0.00381951337642074,-0.0103637461733336,0.00460874626223566,0.45124220922921
NMR metabolomics,X23412.Phospholipids in VLDL,GSTM4,Glutathione S-transferase Mu 4,37562,-0.00499181200460229,0.00665333843130435,-0.0180323553299588,0.00804873132075423,0.453104505350792
NMR metabolomics,X23412.Phospholipids in VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.00536504999612981,0.00720761739362413,-0.0194919800876331,0.00876188009537348,0.45667273192438
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,40332,-0.00222830632653805,0.00299976115127647,-0.00810783818303992,0.00365122552996383,0.457596859728017
NMR metabolomics,X23412.Phospholipids in VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00501854882185458,0.00677505294774155,-0.00826055495571886,0.018297652599428,0.458864737853507
NMR metabolomics,X23412.Phospholipids in VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.00822924788033061,0.0111953547619025,-0.0137136474529983,0.0301721432136595,0.462314576451305
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJA1,DnaJ homolog subfamily A member 1,37482,-0.00317818337403587,0.00436291228176031,-0.0117294914462861,0.00537312469821433,0.466348462242511
NMR metabolomics,X23412.Phospholipids in VLDL,IL10,Interleukin-10,40044,0.00578566044461796,0.00794807930304015,-0.00979257498934075,0.0213638958785767,0.466666207331667
NMR metabolomics,X23412.Phospholipids in VLDL,IL20RB,Interleukin-20 receptor subunit beta,37598,0.0028795588161008,0.0039620734928967,-0.00488610522997674,0.0106452228621783,0.467373207225682
NMR metabolomics,X23412.Phospholipids in VLDL,ALMS1,Alstrom syndrome protein 1,37714,0.00298010725763467,0.00417798494170965,-0.00520874322811624,0.0111689577433856,0.475680003665082
NMR metabolomics,X23412.Phospholipids in VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,37562,-0.00344115113591491,0.00484817432783272,-0.012943572818467,0.00606127054663723,0.477851411010812
NMR metabolomics,X23412.Phospholipids in VLDL,REG1B,Lithostathine-1-beta,40536,0.00365774875424108,0.00515439927440717,-0.00644487382359697,0.0137603713320791,0.47793999933074
NMR metabolomics,X23412.Phospholipids in VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.00538783094533061,0.00764400952468451,-0.0203700896137122,0.00959442772305103,0.480919969937455
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM2,Intercellular adhesion molecule 2,40536,0.0020097023267202,0.00287436123671265,-0.0036240456972366,0.007643450350677,0.484448258873981
NMR metabolomics,X23412.Phospholipids in VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.00228768849911246,0.00327428740361138,-0.00870529181019077,0.00412991481196585,0.484760377240185
NMR metabolomics,X23412.Phospholipids in VLDL,ACHE,Acetylcholinesterase,37671,-0.00205958134798668,0.00295695490753088,-0.00785521296674719,0.00373605027077384,0.486114824001312
NMR metabolomics,X23412.Phospholipids in VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,37562,-0.00374839121220992,0.00538618958934889,-0.0143053228073337,0.00680854038291391,0.486487296763708
NMR metabolomics,X23412.Phospholipids in VLDL,TBR1,T-box brain protein 1,37572,0.00312897170400595,0.00452626220458215,-0.00574250221697505,0.012000445624987,0.489393893581465
NMR metabolomics,X23412.Phospholipids in VLDL,TNNI3,"Troponin I, cardiac muscle",40042,0.00539991726949879,0.00782303137435033,-0.00993322422422785,0.0207330587632254,0.490041645457873
NMR metabolomics,X23412.Phospholipids in VLDL,HK2,Hexokinase-2,40042,-0.00175661305064448,0.00255592850807561,-0.00676623292647267,0.00325300682518371,0.491922807480714
NMR metabolomics,X23412.Phospholipids in VLDL,REST,RE1-silencing transcription factor,37482,-0.00228696260492206,0.00332940285044349,-0.0088125921917913,0.00423866698194718,0.492158768692609
NMR metabolomics,X23412.Phospholipids in VLDL,ABO,Histo-blood group ABO system transferase,37987,0.00916007689385784,0.0133550859050821,-0.0170158914801031,0.0353360452678188,0.492796253992053
NMR metabolomics,X23412.Phospholipids in VLDL,EXOSC10,Exosome component 10,37562,0.00400149905607811,0.00583480593095107,-0.00743472056858599,0.0154377186807422,0.492852536166709
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM3,Intercellular adhesion molecule 3,40536,-0.00159578947975531,0.00232802178541185,-0.00615871217916254,0.00296713321965191,0.493057159576231
NMR metabolomics,X23412.Phospholipids in VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.0031438700231225,0.00458863061550185,-0.00584984598326112,0.0121375860295061,0.493265562954901
NMR metabolomics,X23412.Phospholipids in VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,37714,0.00284875024569658,0.0041682216349507,-0.00532096415880679,0.0110184646502,0.49433763133714
NMR metabolomics,X23412.Phospholipids in VLDL,GJA8,Gap junction alpha-8 protein,37482,0.00394461706306543,0.00578407997214529,-0.00739217968233933,0.0152814138084702,0.495264790320466
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC2L,C-type lectin domain family 2 member L,37572,0.00312983019540004,0.00460454847524661,-0.00589508481608332,0.0121547452068834,0.496690116497953
NMR metabolomics,X23412.Phospholipids in VLDL,PRTN3,Myeloblastin,39897,-0.00293624673578757,0.00434170995399272,-0.0114459982456133,0.00557350477403816,0.498867879235529
NMR metabolomics,X23412.Phospholipids in VLDL,UGDH,UDP-glucose 6-dehydrogenase,37562,0.00610078289117665,0.00902651400667942,-0.011591184561915,0.0237927503442683,0.499132796077156
NMR metabolomics,X23412.Phospholipids in VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,-0.00309194775660575,0.00459865242308006,-0.0121053065058427,0.00592141099263116,0.50136676580009
NMR metabolomics,X23412.Phospholipids in VLDL,H2AP,Huntingtin-interacting protein M,37482,-0.00321332443715314,0.00483931644431352,-0.0126983846680076,0.00627173579370136,0.506699637208218
NMR metabolomics,X23412.Phospholipids in VLDL,ZNF830,Zinc finger protein 830,37900,-0.00496112477314284,0.00748545562909332,-0.0196326178061658,0.00971036825988007,0.507490140582933
NMR metabolomics,X23412.Phospholipids in VLDL,SELENOP,Selenoprotein P,38013,0.00138263723838459,0.00209095121120048,-0.00271562713556836,0.00548090161233754,0.508464538051243
NMR metabolomics,X23412.Phospholipids in VLDL,DLGAP5,Disks large-associated protein 5,37959,-0.00328927494043447,0.00497696404678964,-0.0130441244721422,0.00646557459127322,0.508687795027188
NMR metabolomics,X23412.Phospholipids in VLDL,MLLT1,Protein ENL,37482,0.00439593411842696,0.00665333675199787,-0.00864460591548887,0.0174364741523428,0.508809219544307
NMR metabolomics,X23412.Phospholipids in VLDL,PROK1,Prokineticin-1,40341,-0.00419723330975648,0.00635871194005984,-0.0166603087122738,0.00826584209276081,0.509214610481969
NMR metabolomics,X23412.Phospholipids in VLDL,RAB6B,Ras-related protein Rab-6B,39961,0.00294365011851817,0.00450998643506664,-0.00589592329421244,0.0117832235312488,0.51396195424593
NMR metabolomics,X23412.Phospholipids in VLDL,SCIN,Adseverin,37541,0.00443590875603468,0.00681204283499784,-0.00891569520056109,0.0177875127126305,0.51493768497097
NMR metabolomics,X23412.Phospholipids in VLDL,PGM2,Phosphoglucomutase-2,37572,0.00361034449634289,0.00556565443328378,-0.00729833819289331,0.0145190271855791,0.516554754953952
NMR metabolomics,X23412.Phospholipids in VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,0.00339419075459297,0.00524264580229749,-0.00688139501791012,0.0136697765270961,0.517371930236415
NMR metabolomics,X23412.Phospholipids in VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,-0.00187135007258101,0.00293563143373711,-0.00762518768270574,0.00388248753754373,0.523835861476703
NMR metabolomics,X23412.Phospholipids in VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,0.00248267193093393,0.00390609212250569,-0.00517326862917721,0.0101386124910451,0.525054946400525
NMR metabolomics,X23412.Phospholipids in VLDL,DNLZ,DNL-type zinc finger protein,37541,-0.00557108718511122,0.00882598891365578,-0.0228700254558766,0.0117278510856541,0.527911674431696
NMR metabolomics,X23412.Phospholipids in VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,-0.00221761716869797,0.0035141411444477,-0.00910533381181547,0.00467009947441953,0.528015410188392
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,0.00693306158569098,0.0109982808529034,-0.0146235688859997,0.0284896920573817,0.528457127450148
NMR metabolomics,X23412.Phospholipids in VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,0.0021720885001174,0.00346768453001711,-0.00462457317871613,0.00896875017895093,0.531074844479365
NMR metabolomics,X23412.Phospholipids in VLDL,MAPT,Microtubule-associated protein tau,39961,0.00307152059195157,0.00491235488313078,-0.00655669497898475,0.0126997361628879,0.531806745504947
NMR metabolomics,X23412.Phospholipids in VLDL,CRYBB2,Beta-crystallin B2,37942,-0.00397362665919718,0.00636372678399886,-0.0164465311558349,0.00849927783744058,0.532363552389757
NMR metabolomics,X23412.Phospholipids in VLDL,MAG,Myelin-associated glycoprotein,37572,0.00268533446886589,0.00432483862694354,-0.00579134923994345,0.0111620181776752,0.534669792148724
NMR metabolomics,X23412.Phospholipids in VLDL,IL4R,Interleukin-4 receptor subunit alpha,40341,-0.00208015581310438,0.00335060699746661,-0.00864734552813893,0.00448703390193017,0.534720687646455
NMR metabolomics,X23412.Phospholipids in VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,-0.00349802364093731,0.00564692210105017,-0.0145659909589956,0.00756994367712103,0.535626313677108
NMR metabolomics,X23412.Phospholipids in VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,0.00329040701515575,0.0053560546661898,-0.00720746013057625,0.0137882741608877,0.539005252082788
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA10,Ephrin type-A receptor 10,39961,0.00370369593186595,0.00604248818494537,-0.00813958091062698,0.0155469727743589,0.539923554042953
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,40422,0.0015654878123298,0.00256725340572336,-0.00346632886288799,0.00659730448754759,0.542008993950035
NMR metabolomics,X23412.Phospholipids in VLDL,MORF4L1,Mortality factor 4-like protein 1,37714,-0.00230053355349615,0.00378912941917322,-0.00972722721507566,0.00512616010808336,0.543768134928104
NMR metabolomics,X23412.Phospholipids in VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,0.00199993956496975,0.0032944828684034,-0.0044572468571009,0.00845712598704041,0.543821824692492
NMR metabolomics,X23412.Phospholipids in VLDL,GIPR,Gastric inhibitory polypeptide receptor,37598,0.00274910386667258,0.00454283865068178,-0.00615485988866371,0.0116530676220089,0.545089040696379
NMR metabolomics,X23412.Phospholipids in VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,0.00262197820072702,0.00440745814277728,-0.00601663975911645,0.0112605961605705,0.551923412891218
NMR metabolomics,X23412.Phospholipids in VLDL,GAGE2A,G antigen 2A,37482,0.00340475427839971,0.00578378221354406,-0.00793145886014666,0.0147409674169461,0.556091106733095
NMR metabolomics,X23412.Phospholipids in VLDL,BTNL10,Butyrophilin-like protein 10,37482,0.00228500774136666,0.00388699346683016,-0.00533349945362045,0.00990351493635377,0.556636495723017
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN7,Tetraspanin-7,37541,0.00498572728314864,0.00849922372524459,-0.0116727512183308,0.021644205784628,0.557475966949434
NMR metabolomics,X23412.Phospholipids in VLDL,TLR1,Toll-like receptor 1,37598,0.00141986178151528,0.00242971720236407,-0.00334238393511831,0.00618210749814886,0.558979235650634
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP3L,Microfibrillar-associated protein 3-like,37572,0.00362677543612848,0.00623017210391124,-0.00858436188753756,0.0158379127597945,0.560488543582327
NMR metabolomics,X23412.Phospholipids in VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,-0.0010737209420271,0.00187550648246742,-0.00474971364766324,0.00260227176360903,0.566995457333183
NMR metabolomics,X23412.Phospholipids in VLDL,AMY2B,Alpha-amylase 2B,39311,0.00254524255086667,0.00445542728883597,-0.00618739493525182,0.0112778800369852,0.567826703718816
NMR metabolomics,X23412.Phospholipids in VLDL,TCP11,T-complex protein 11 homolog,37714,-0.00318908505230493,0.00563502720627016,-0.0142337383765944,0.00785556827198458,0.571444414858251
NMR metabolomics,X23412.Phospholipids in VLDL,NPHS2,Podocin,37598,-0.00550114025897257,0.00974016951153005,-0.0245918725015715,0.0135895919836263,0.572226950512256
NMR metabolomics,X23412.Phospholipids in VLDL,ENPEP,Glutamyl aminopeptidase,37562,0.00240806828592617,0.00430754847944578,-0.00603472673378756,0.0108508633056399,0.576147712025694
NMR metabolomics,X23412.Phospholipids in VLDL,ISM2,Isthmin-2,37998,-0.00230191601966004,0.00412940066791075,-0.0103955413287651,0.00579170928944504,0.577232263583848
NMR metabolomics,X23412.Phospholipids in VLDL,IL9,Interleukin-9,37714,0.00296875611557106,0.0053300015743748,-0.00747804697020354,0.0134155592013457,0.577543848192568
NMR metabolomics,X23412.Phospholipids in VLDL,SPRR1B,Cornifin-B,37714,0.00438873912093651,0.00790113462747199,-0.0110974847489086,0.0198749629907816,0.578591605881275
NMR metabolomics,X23412.Phospholipids in VLDL,HMMR,Hyaluronan mediated motility receptor,37460,-0.00250945697837053,0.00452384501730458,-0.0113761932122875,0.00635727925554645,0.579097293528985
NMR metabolomics,X23412.Phospholipids in VLDL,IGFL4,Insulin growth factor-like family member 4,37598,-0.00402828120360422,0.00730845030512868,-0.0183528438016564,0.010296281394448,0.581518759180689
NMR metabolomics,X23412.Phospholipids in VLDL,KLK1,Kallikrein-1,40209,-0.00645113631682324,0.0117789103958718,-0.0295378006927319,0.0166355280590854,0.583915750895858
NMR metabolomics,X23412.Phospholipids in VLDL,IL2RB,Interleukin-2 receptor subunit beta,40044,0.00195282901686325,0.00358815140229238,-0.00507994773162981,0.00898560576535632,0.58628152368431
NMR metabolomics,X23412.Phospholipids in VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,0.00244420027659096,0.00450576875977201,-0.00638710649256218,0.0112755070457441,0.587510705347453
NMR metabolomics,X23412.Phospholipids in VLDL,CDSN,Corneodesmosin,40456,0.00215557971473031,0.00398432281364335,-0.00565369300001066,0.00996485242947128,0.588504547583671
NMR metabolomics,X23412.Phospholipids in VLDL,ALPI,Intestinal-type alkaline phosphatase,37598,-0.00604440551509064,0.0112596977339028,-0.0281134130735402,0.0160246020433589,0.5914025996001
NMR metabolomics,X23412.Phospholipids in VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,37598,0.00250725808285842,0.00468719844610564,-0.00667965087150862,0.0116941670372255,0.592716896976285
NMR metabolomics,X23412.Phospholipids in VLDL,RBP1,Retinol-binding protein 1,37572,0.0034145753536324,0.00639241417720198,-0.00911455643368348,0.0159437071409483,0.593239523754366
NMR metabolomics,X23412.Phospholipids in VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,0.00139711690649124,0.00261580801765756,-0.00372986680811758,0.00652410062110006,0.593277719687042
NMR metabolomics,X23412.Phospholipids in VLDL,IL18RAP,Interleukin-18 receptor accessory protein,40128,0.00862915222125814,0.0161647576160182,-0.0230537727061376,0.0403120771486539,0.593470163894581
NMR metabolomics,X23412.Phospholipids in VLDL,TPT1,Translationally-controlled tumor protein,40044,0.00327056065426896,0.0061466925125157,-0.00877695667026181,0.0153180779787997,0.594674958556178
NMR metabolomics,X23412.Phospholipids in VLDL,HEBP1,Heme-binding protein 1,40042,0.00266208058614112,0.00503366565726763,-0.00720390410210343,0.0125280652743857,0.59691338563143
NMR metabolomics,X23412.Phospholipids in VLDL,CD177,CD177 antigen,40316,-0.0062320733451977,0.011796685247588,-0.0293535764304701,0.0168894297400747,0.597305314227417
NMR metabolomics,X23412.Phospholipids in VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,-0.00275200418832636,0.00521401576288741,-0.0129714750835857,0.00746746670693297,0.597640931730099
NMR metabolomics,X23412.Phospholipids in VLDL,BRD2,Bromodomain-containing protein 2,37541,0.00169110182863797,0.00320463829757987,-0.00458998923461857,0.00797219289189451,0.59771344251572
NMR metabolomics,X23412.Phospholipids in VLDL,SLC39A14,Zinc transporter ZIP14,39961,0.00162098027119649,0.00308787171414024,-0.00443124828851838,0.00767320883091135,0.599624999811891
NMR metabolomics,X23412.Phospholipids in VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.00418762576700634,0.00799336207017611,-0.0198546154245515,0.0114793638905388,0.600365413053332
NMR metabolomics,X23412.Phospholipids in VLDL,FGF20,Fibroblast growth factor 20,37598,0.00216507040495036,0.00415108352235668,-0.00597105329886874,0.0103011941087695,0.601980258062374
NMR metabolomics,X23412.Phospholipids in VLDL,CSRP3,Cysteine and glycine-rich protein 3,37562,-0.00465570434294644,0.00897563400373167,-0.0222479469902605,0.0129365383043676,0.60397537635583
NMR metabolomics,X23412.Phospholipids in VLDL,TEX33,Testis-expressed protein 33,37714,-0.00189296136936924,0.00366061062229209,-0.00906775818906173,0.00528183545032325,0.60508360941788
NMR metabolomics,X23412.Phospholipids in VLDL,PRR5,Proline-rich protein 5,37598,0.00231544150471428,0.00447905799181724,-0.00646351215924752,0.0110943951686761,0.605200932197283
NMR metabolomics,X23412.Phospholipids in VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,-0.00336185949546577,0.00655469076770597,-0.0162090534001695,0.00948533440923794,0.608034333493153
NMR metabolomics,X23412.Phospholipids in VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,-0.00193080142169401,0.00376781139633854,-0.00931571175851755,0.00545410891512952,0.608347207300891
NMR metabolomics,X23412.Phospholipids in VLDL,OMG,Oligodendrocyte-myelin glycoprotein,40305,0.0029722401402786,0.00581185778813296,-0.008419001124462,0.0143634814050192,0.609071363836107
NMR metabolomics,X23412.Phospholipids in VLDL,IL17F,Interleukin-17F,40044,0.00373366008075966,0.00735160721553121,-0.0106754900616815,0.0181428102232008,0.611551763476801
NMR metabolomics,X23412.Phospholipids in VLDL,IL13,Interleukin-13,40044,0.00224685767424497,0.00443317699167759,-0.00644216922944311,0.010935884577933,0.612282763061479
NMR metabolomics,X23412.Phospholipids in VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,-0.00296407477798105,0.00591506667041115,-0.0145576054519869,0.0086294558960248,0.616304915200807
NMR metabolomics,X23412.Phospholipids in VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,0.00276707392707496,0.00557034458381722,-0.0081508014572068,0.0136849493113567,0.619373022384927
NMR metabolomics,X23412.Phospholipids in VLDL,OGN,Mimecan,40332,0.00186384937101906,0.003759288969224,-0.00550435700865998,0.00923205575069811,0.620043531107949
NMR metabolomics,X23412.Phospholipids in VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,0.00135346750935991,0.00273533893910886,-0.00400779681129344,0.00671473183001327,0.620743702543012
NMR metabolomics,X23412.Phospholipids in VLDL,RUVBL1,RuvB-like 1,39980,0.00485082140138428,0.00992872151598379,-0.014609472769944,0.0243111155727125,0.625156912200286
NMR metabolomics,X23412.Phospholipids in VLDL,TG,Thyroglobulin,37900,-0.00528297533803749,0.0108793557813847,-0.0266065126695516,0.0160405619934766,0.627261303764299
NMR metabolomics,X23412.Phospholipids in VLDL,TXK,Tyrosine-protein kinase TXK,37714,0.00341036184883146,0.00703474171711983,-0.0103777319167234,0.0171984556143863,0.627834391517456
NMR metabolomics,X23412.Phospholipids in VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,0.00153084648712788,0.00320340644277616,-0.0047478301407134,0.00780952311496916,0.632743041282066
NMR metabolomics,X23412.Phospholipids in VLDL,TPSG1,Tryptase gamma,37598,0.001204788462697,0.00253423580685354,-0.00376231371873593,0.00617189064412994,0.634506205132169
NMR metabolomics,X23412.Phospholipids in VLDL,CASQ2,Calsequestrin-2,37562,-0.00221356934407039,0.00465751395382598,-0.0113422966935693,0.00691515800542853,0.634603576012023
NMR metabolomics,X23412.Phospholipids in VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,-0.00125149643499278,0.00264653089338389,-0.00643869698602522,0.00393570411603965,0.636305356984506
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC1A,C-type lectin domain family 1 member A,40042,0.00143711951056873,0.00305190844949239,-0.00454462105043636,0.00741886007157381,0.637724394182811
NMR metabolomics,X23412.Phospholipids in VLDL,OTOA,Otoancorin,37541,-0.00238650913247952,0.00508454484190449,-0.0123522170226123,0.00757919875765328,0.638816334693015
NMR metabolomics,X23412.Phospholipids in VLDL,TFF1,Trefoil factor 1,40261,0.00336310526640164,0.00717630656084678,-0.010702455592858,0.0174286661256613,0.639333346838931
NMR metabolomics,X23412.Phospholipids in VLDL,CD27,CD27 antigen,40411,0.00175948460982208,0.00375501626342739,-0.00560034726649561,0.00911931648613976,0.639384064766378
NMR metabolomics,X23412.Phospholipids in VLDL,MUCL3,Mucin-like protein 3,37482,-0.00195038643989666,0.00418578944353599,-0.0101545337492272,0.00625376086943387,0.641256026763728
NMR metabolomics,X23412.Phospholipids in VLDL,ESR1,Estrogen receptor,37598,0.00251716514865367,0.00540522290509129,-0.00807707174532525,0.0131114020426326,0.641444213117319
NMR metabolomics,X23412.Phospholipids in VLDL,PALLD,Palladin,37598,0.00178468815714044,0.00385477782924641,-0.00577067638818253,0.00934005270246341,0.643385786954898
NMR metabolomics,X23412.Phospholipids in VLDL,PRG3,Proteoglycan 3,37998,0.00214561938690709,0.00463823562099241,-0.00694532243023804,0.0112365612040522,0.64366293052808
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,0.00154666583056341,0.00335058956489582,-0.00502048971663239,0.00811382137775921,0.644367306198032
NMR metabolomics,X23412.Phospholipids in VLDL,LY96,Lymphocyte antigen 96,40228,-0.00147860619152589,0.00320651302949325,-0.00776337172933267,0.00480615934628088,0.644714641176814
NMR metabolomics,X23412.Phospholipids in VLDL,SHD,SH2 domain-containing adapter protein D,37531,0.00373769936651179,0.00815540649237156,-0.0122468973585365,0.01972229609156,0.646737794310189
NMR metabolomics,X23412.Phospholipids in VLDL,STC2,Stanniocalcin-2,40309,-0.00114769831436984,0.00250664346589027,-0.00606071950751477,0.00376532287877509,0.647057426019614
NMR metabolomics,X23412.Phospholipids in VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,0.00269777691875676,0.00591472776844703,-0.00889508950739941,0.0142906433449129,0.648317212450206
NMR metabolomics,X23412.Phospholipids in VLDL,HBZ,Hemoglobin subunit zeta,37990,0.00441011037444269,0.00972229124670611,-0.0146455804691013,0.0234658012179867,0.650118169994596
NMR metabolomics,X23412.Phospholipids in VLDL,SLC1A4,Neutral amino acid transporter A,37572,-0.00219702730200504,0.00487417657111627,-0.0117504133813929,0.00735635877738285,0.652178341846054
NMR metabolomics,X23412.Phospholipids in VLDL,OPTC,Opticin,40305,0.00187080441846106,0.00416230960202545,-0.00628732240150882,0.0100289312384309,0.653103793346254
NMR metabolomics,X23412.Phospholipids in VLDL,IL15,Interleukin-15,40341,0.00134525161261534,0.00302662976049271,-0.00458694271795036,0.00727744594318105,0.656707558114119
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP3,Microfibril-associated glycoprotein 3,40042,0.00202980260627238,0.00460008645750462,-0.00698636685043667,0.0110459720629814,0.659035863588376
NMR metabolomics,X23412.Phospholipids in VLDL,IKZF2,Zinc finger protein Helios,39980,0.00380038187703586,0.00865811879634837,-0.0131695309638069,0.0207702947178787,0.660712189641559
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD4,Sushi domain-containing protein 4,37900,0.0018042241886851,0.00413257029352652,-0.00629561358662688,0.00990406196399708,0.662418301246845
NMR metabolomics,X23412.Phospholipids in VLDL,MMP9,Matrix metalloproteinase-9,40312,0.00243975645413056,0.00564333490970046,-0.00862117996888235,0.0135006928771435,0.665510879864504
NMR metabolomics,X23412.Phospholipids in VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,37572,-0.00155595743393086,0.00359947429953532,-0.00861092706102008,0.00549901219315836,0.665549733115774
NMR metabolomics,X23412.Phospholipids in VLDL,CRX,Cone-rod homeobox protein,40042,0.00429096837559617,0.00992850796627422,-0.0151689072383013,0.0237508439894936,0.66561175499086
NMR metabolomics,X23412.Phospholipids in VLDL,MYL6B,Myosin light chain 6B,37572,-0.00370945974597514,0.0085842974140861,-0.0205346826775839,0.0131157631856336,0.665660187810718
NMR metabolomics,X23412.Phospholipids in VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,0.0021237694765963,0.00502238426572535,-0.00772010368422539,0.011967642637418,0.672403753315798
NMR metabolomics,X23412.Phospholipids in VLDL,HCG22,Protein PBMUCL2,37562,0.00208736765304124,0.00496099628629229,-0.00763618506809165,0.0118109203741741,0.673940352513567
NMR metabolomics,X23412.Phospholipids in VLDL,CBLN1,Cerebellin-1,37541,0.00382341837371676,0.00910574905678776,-0.0140238497775872,0.0216706865250208,0.674572271850055
NMR metabolomics,X23412.Phospholipids in VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.00211715353095999,0.00504279661140202,-0.012001034889308,0.00776672782738797,0.674611199727689
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G2A,"Phospholipase A2, membrane associated",40293,-0.00223557243946383,0.00533494758942545,-0.0126920697147377,0.00822092483581006,0.675190389034651
NMR metabolomics,X23412.Phospholipids in VLDL,CEP112,Centrosomal protein of 112 kDa,37562,0.00180047445669465,0.00438344307307906,-0.0067910739665403,0.0103920228799296,0.681266719236814
NMR metabolomics,X23412.Phospholipids in VLDL,NCLN,Nicalin,40044,-0.00199451368414799,0.00493612615268794,-0.0116693209434164,0.00768029357512037,0.686170780685481
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,0.00122311801089721,0.00304097684776071,-0.00473719661071378,0.0071834326325082,0.687534223374209
NMR metabolomics,X23412.Phospholipids in VLDL,APOH,Beta-2-glycoprotein 1,40332,0.00130761385197545,0.00327522150010815,-0.00511182028823653,0.00772704799218743,0.689718497464963
NMR metabolomics,X23412.Phospholipids in VLDL,DHODH,Dihydroorotate dehydrogenase,37562,0.00177911177815442,0.00448987023512514,-0.00702103388269085,0.0105792574389997,0.69192694321597
NMR metabolomics,X23412.Phospholipids in VLDL,GUCY2C,Heat-stable enterotoxin receptor,37714,-0.00311612983174931,0.00787034192103881,-0.0185419999969854,0.0123097403334868,0.692160661538924
NMR metabolomics,X23412.Phospholipids in VLDL,CD200,OX-2 membrane glycoprotein,40341,-0.000947380200447904,0.00240101673319256,-0.00565337299750532,0.00375861259660951,0.693162162975744
NMR metabolomics,X23412.Phospholipids in VLDL,PCARE,Photoreceptor cilium actin regulator,37541,0.00314211934775236,0.00799208327520565,-0.0125223638716507,0.0188066025671554,0.694212160234864
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,0.00286423102180745,0.00749268329348303,-0.0118214282334193,0.0175498902770342,0.702266047633151
NMR metabolomics,X23412.Phospholipids in VLDL,PLXDC2,Plexin domain-containing protein 2,37942,0.000939131764736754,0.00247266624823631,-0.00390729408180641,0.00578555761127992,0.704095921171367
NMR metabolomics,X23412.Phospholipids in VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,0.00234033098199749,0.00618129831042377,-0.0097750137064331,0.0144556756704281,0.704980075885841
NMR metabolomics,X23412.Phospholipids in VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,-0.00228452820038303,0.00612724748472993,-0.0142939332704537,0.00972487686968763,0.709268061271599
NMR metabolomics,X23412.Phospholipids in VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,0.00101091324103069,0.00278184865396339,-0.00444151012073756,0.00646333660279894,0.716314805693763
NMR metabolomics,X23412.Phospholipids in VLDL,IFNL2,Interferon lambda-2,37541,0.00217944521862143,0.00600773161896757,-0.00959570875455501,0.0139545991917979,0.716780022404806
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN15,Tetraspanin-15,37562,-0.00171749833754609,0.00474162603710558,-0.011011085370273,0.00757608869518084,0.717195592299108
NMR metabolomics,X23412.Phospholipids in VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.00157315091877702,0.00437774916287198,-0.00700723744045206,0.0101535392780061,0.719336856232542
NMR metabolomics,X23412.Phospholipids in VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.00200955365847501,0.00559752635492272,-0.00896159799717351,0.0129807053141235,0.719595307370888
NMR metabolomics,X23412.Phospholipids in VLDL,HRAS,GTPase Hras,37697,-0.00320988946568286,0.00912584144390148,-0.0210965386957298,0.014676759764364,0.725041649533232
NMR metabolomics,X23412.Phospholipids in VLDL,HTR1A,5-hydroxytryptamine receptor 1A,37541,0.00257548719458645,0.00750627271440382,-0.012136807325645,0.0172877817148179,0.731520220126758
NMR metabolomics,X23412.Phospholipids in VLDL,ZNF174,Zinc finger protein 174,37598,-0.00122945343117328,0.00360454847666518,-0.00829436844543703,0.00583546158309046,0.733045876601555
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,0.00265666474962946,0.00786629128298697,-0.012761266165025,0.0180745956642839,0.735572832495046
NMR metabolomics,X23412.Phospholipids in VLDL,FGF3,Fibroblast growth factor 3,37598,0.00094473389417303,0.00282924837337068,-0.0046005929176335,0.00649006070597956,0.738447580082489
NMR metabolomics,X23412.Phospholipids in VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.00207852619610128,0.00624081827568908,-0.0101534776242493,0.0143105300164519,0.739099245802456
NMR metabolomics,X23412.Phospholipids in VLDL,S100A16,Protein S100-A16,39934,-0.00191107302101653,0.00574699312279472,-0.0131751795416942,0.00935303349966112,0.739490256267472
NMR metabolomics,X23412.Phospholipids in VLDL,TOP1,DNA topoisomerase 1,37901,0.00326711492813299,0.00988570093729542,-0.016108858908966,0.022643088765232,0.741035688312148
NMR metabolomics,X23412.Phospholipids in VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,-0.00199378262899298,0.00606573789115941,-0.0138826288956654,0.00989506363767946,0.742390059648913
NMR metabolomics,X23412.Phospholipids in VLDL,FGF7,Fibroblast growth factor 7,37482,0.00243295031148631,0.00752590033429211,-0.0123178143437262,0.0171837149666988,0.746490675939975
NMR metabolomics,X23412.Phospholipids in VLDL,SAP18,Histone deacetylase complex subunit SAP18,37714,0.0021981272314004,0.00692448959380389,-0.0113738723724552,0.015770126835256,0.750912866742518
NMR metabolomics,X23412.Phospholipids in VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,0.00148025868233947,0.00468750082400476,-0.00770724293270986,0.0106677602973888,0.752168044528165
NMR metabolomics,X23412.Phospholipids in VLDL,SPINT3,Kunitz-type protease inhibitor 3,37901,0.00375749314151485,0.0119226175553828,-0.0196108372670354,0.0271258235500651,0.752647547986498
NMR metabolomics,X23412.Phospholipids in VLDL,PFDN6,Prefoldin subunit 6,37572,0.00192321848311949,0.00613600642429182,-0.0101033541084925,0.0139497910747315,0.753957740723296
NMR metabolomics,X23412.Phospholipids in VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,0.00408890298330244,0.0131427530412734,-0.0216708929775935,0.0298486989441984,0.755718442923958
NMR metabolomics,X23412.Phospholipids in VLDL,IFNL1,Interferon lambda-1,39961,0.00130133314778887,0.00419017218013159,-0.00691140432526904,0.00951407062084678,0.756133275319474
NMR metabolomics,X23412.Phospholipids in VLDL,LMOD2,Leiomodin-2,37541,0.00185394265530561,0.00603165415080414,-0.0099680994802705,0.0136759847908817,0.758567518561712
NMR metabolomics,X23412.Phospholipids in VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,-0.00170325079921283,0.0056303679318883,-0.0127387719457139,0.00933227034728823,0.76226703061606
NMR metabolomics,X23412.Phospholipids in VLDL,FH,"Fumarate hydratase, mitochondrial",37541,0.00238456999928155,0.00793874344355947,-0.013175367150095,0.0179445071486581,0.763898789384944
NMR metabolomics,X23412.Phospholipids in VLDL,HSP90B1,Endoplasmin,39878,-0.00194834752974743,0.00648902908725235,-0.014666844540762,0.0107701494812672,0.7639885699701
NMR metabolomics,X23412.Phospholipids in VLDL,CDC123,Cell division cycle protein 123 homolog,37482,0.00178048792903243,0.00595365574803427,-0.00988867733711474,0.0134496531951796,0.764900619021468
NMR metabolomics,X23412.Phospholipids in VLDL,FOLR3,Folate receptor gamma,40355,0.00506516763612566,0.0170128836804624,-0.0282800843775806,0.038410419649832,0.765916643113666
NMR metabolomics,X23412.Phospholipids in VLDL,DAND5,DAN domain family member 5,37598,-0.00150320974428594,0.00505526231393824,-0.0114115238796049,0.00840510439103301,0.766199858857662
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS11B,Transmembrane protease serine 11B,37541,0.00212168555192629,0.00728975243757576,-0.0121662292257222,0.0164096003295748,0.771017365336812
NMR metabolomics,X23412.Phospholipids in VLDL,KLK12,Kallikrein-12,39980,-0.00379310919466677,0.0132327699110879,-0.0297293382203991,0.0221431198310656,0.774387871085655
NMR metabolomics,X23412.Phospholipids in VLDL,WFDC12,WAP four-disulfide core domain protein 12,40465,-0.00168871292021864,0.00589735712996634,-0.0132475328949527,0.00987010705451539,0.774613159450026
NMR metabolomics,X23412.Phospholipids in VLDL,VNN2,Vascular non-inflammatory molecule 2,40305,-0.00118291646541067,0.00414732826694569,-0.00931167986862423,0.00694584693780289,0.775476462190203
NMR metabolomics,X23412.Phospholipids in VLDL,HDAC9,Histone deacetylase 9,37541,-0.00167604132817079,0.00588368868820974,-0.0132080711570619,0.00985598850072029,0.775754116120086
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,0.0019270071569579,0.00684921624436331,-0.0114974566819942,0.01535147099591,0.778448632146153
NMR metabolomics,X23412.Phospholipids in VLDL,CHGB,Secretogranin-1,40406,0.00103995515484998,0.00372265949051583,-0.00625645744656105,0.008336367756261,0.779973629137905
NMR metabolomics,X23412.Phospholipids in VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,0.00105567561775912,0.00381823899580311,-0.00642807281401497,0.00853942404953321,0.782181937285823
NMR metabolomics,X23412.Phospholipids in VLDL,EVPL,Envoplakin,37714,-0.000882021433491888,0.00319909718371568,-0.00715225191357462,0.00538820904659084,0.782775506432291
NMR metabolomics,X23412.Phospholipids in VLDL,UPK3BL1,Uroplakin-3b-like protein 1,37692,0.00139624795157619,0.00516689780663032,-0.00873087174941925,0.0115233676525716,0.786987949364326
NMR metabolomics,X23412.Phospholipids in VLDL,TNPO1,Transportin-1,37714,0.000883301336533186,0.00328933980562158,-0.00556380468248511,0.00733040735555148,0.788292072128699
NMR metabolomics,X23412.Phospholipids in VLDL,CSF2RB,Cytokine receptor common subunit beta,37598,0.00109030409062856,0.00411096760038954,-0.00696719240613493,0.00914780058739206,0.790845409380714
NMR metabolomics,X23412.Phospholipids in VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,37482,0.00119243947898981,0.00458046146914563,-0.00778526500053562,0.0101701439585152,0.794612009276401
NMR metabolomics,X23412.Phospholipids in VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,0.00225040050659221,0.00870819956811187,-0.0148176706469071,0.0193184716600915,0.796084385044031
NMR metabolomics,X23412.Phospholipids in VLDL,PLXDC1,Plexin domain-containing protein 1,39980,-0.000807353150109192,0.00313660720505294,-0.00695510327201295,0.00534039697179457,0.79687576233555
NMR metabolomics,X23412.Phospholipids in VLDL,PSAPL1,Proactivator polypeptide-like 1,37901,-0.00118889962014252,0.00468341028600861,-0.0103683837807194,0.00799058454043435,0.799612698416855
NMR metabolomics,X23412.Phospholipids in VLDL,IL2RA,Interleukin-2 receptor subunit alpha,40208,-0.000927624264745574,0.00371860918519469,-0.00821609826772717,0.00636084973823602,0.803012386413724
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX2,Peroxiredoxin-2,37763,0.00143577008600812,0.00581053932046385,-0.00995288698210104,0.0128244271541173,0.804836533129686
NMR metabolomics,X23412.Phospholipids in VLDL,MYOC,Myocilin,40332,-0.00102723332523791,0.0042325000686572,-0.00932293345980602,0.00726846680933019,0.808239924464015
NMR metabolomics,X23412.Phospholipids in VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,-0.00127766934001258,0.00529261371336754,-0.011651192218213,0.0090958535381878,0.809244142648458
NMR metabolomics,X23412.Phospholipids in VLDL,S100G,Protein S100-G,37959,-0.000991809727813587,0.00411747877659709,-0.00906206812994389,0.00707844867431672,0.809653390816853
NMR metabolomics,X23412.Phospholipids in VLDL,GAL,Galanin peptides,40422,-0.00137193954143288,0.00575917911701873,-0.0126599306107896,0.00991605152792383,0.811715152615845
NMR metabolomics,X23412.Phospholipids in VLDL,OMP,Olfactory marker protein,37541,0.00111482352858285,0.00469914630309328,-0.00809550322547998,0.0103251502826457,0.812474639641937
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,40203,-0.000734324085979191,0.00310322305198353,-0.00681664126786691,0.00534799309590853,0.812944817633829
NMR metabolomics,X23412.Phospholipids in VLDL,PRC1,Protein regulator of cytokinesis 1,37900,-0.00100113521111732,0.00432320651665824,-0.00947461998376747,0.00747234956153283,0.816873687258223
NMR metabolomics,X23412.Phospholipids in VLDL,PPT1,Palmitoyl-protein thioesterase 1,37572,0.00161766457172649,0.0072440782054984,-0.0125807287110504,0.0158160578545034,0.823298852976733
NMR metabolomics,X23412.Phospholipids in VLDL,IL2,Interleukin-2,40044,-0.000646461854083055,0.00289538624883428,-0.00632141890179825,0.00502849519363214,0.823325889374286
NMR metabolomics,X23412.Phospholipids in VLDL,NXPE4,NXPE family member 4,37562,-0.000742301296527526,0.00337793993905948,-0.00736306357708412,0.00587846098402906,0.82606951502071
NMR metabolomics,X23412.Phospholipids in VLDL,CLINT1,Clathrin interactor 1,37482,0.000935695803891174,0.00426515078258893,-0.00742399972998312,0.00929539133776547,0.826356201636051
NMR metabolomics,X23412.Phospholipids in VLDL,TPBGL,Trophoblast glycoprotein-like,37572,0.000848716046622468,0.00387463335075191,-0.00674556532085127,0.0084429974140962,0.826619007475842
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,0.000921740738667803,0.00425829232127882,-0.00742451221103868,0.00926799368837429,0.828633644754516
NMR metabolomics,X23412.Phospholipids in VLDL,EPO,Erythropoietin,40341,-0.00150348989259903,0.00722696821078103,-0.0156683475857299,0.0126613678005318,0.835201327826338
NMR metabolomics,X23412.Phospholipids in VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,-0.000935652233362062,0.00451709777767408,-0.00978916387760326,0.00791785941087914,0.835907095097677
NMR metabolomics,X23412.Phospholipids in VLDL,CASP4,Caspase-4,37714,-0.0031583408315405,0.0158371810408754,-0.0341992156716563,0.0278825340085753,0.841932820038117
NMR metabolomics,X23412.Phospholipids in VLDL,LRP2BP,LRP2-binding protein,37572,0.00160118335003192,0.00806016767992006,-0.0141967453026114,0.0173991120026752,0.842536604005621
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4M,C-type lectin domain family 4 member M,37969,0.000872219259776297,0.00448675226327442,-0.00792181517624156,0.00966625369579416,0.845866550191481
NMR metabolomics,X23412.Phospholipids in VLDL,SHC1,SHC-transforming protein 1,37482,0.00210387864738335,0.0108462387308761,-0.0191547492651338,0.0233625065599005,0.846199961636028
NMR metabolomics,X23412.Phospholipids in VLDL,RANGAP1,Ran GTPase-activating protein 1,39980,-0.000892262338445878,0.00460308478827324,-0.00991430852346144,0.00812978384656968,0.846303635842615
NMR metabolomics,X23412.Phospholipids in VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,-0.00125766710685407,0.0065038121605784,-0.0140051389415877,0.0114898047278796,0.846669197851407
NMR metabolomics,X23412.Phospholipids in VLDL,PMCH,Pro-MCH,37562,-0.00147520531327982,0.007891703676562,-0.0169429445193413,0.0139925338927817,0.851717501149931
NMR metabolomics,X23412.Phospholipids in VLDL,DIPK1C,Divergent protein kinase domain 1C,37572,-0.000716868749915025,0.00398227641954806,-0.00852213053222923,0.00708839303239918,0.857143718224335
NMR metabolomics,X23412.Phospholipids in VLDL,TPSD1,Tryptase delta,37959,-0.000633758258974564,0.00353758278530598,-0.00756742051817428,0.00629990400022515,0.857822542544397
NMR metabolomics,X23412.Phospholipids in VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,0.000686767670155708,0.00383362717898125,-0.00682714160064754,0.00820067694095895,0.857828144993456
NMR metabolomics,X23412.Phospholipids in VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,-0.000766760783737517,0.00428971098759604,-0.00917459431942576,0.00764107275195073,0.85814092825181
NMR metabolomics,X23412.Phospholipids in VLDL,IL3RA,Interleukin-3 receptor subunit alpha,40044,0.000521334075006186,0.00294349329952002,-0.00524791279205304,0.00629058094206542,0.859421091802361
NMR metabolomics,X23412.Phospholipids in VLDL,FGF6,Fibroblast growth factor 6,37598,-0.000653650954394861,0.00399416736695769,-0.00848221899363194,0.00717491708484222,0.870008119558436
NMR metabolomics,X23412.Phospholipids in VLDL,CYTH3,Cytohesin-3,37482,0.00109263249794719,0.00685102135932718,-0.0123353693663341,0.0145206343622285,0.873289551233429
NMR metabolomics,X23412.Phospholipids in VLDL,KCNIP4,Kv channel-interacting protein 4,39961,0.000750117995697209,0.00474623783031366,-0.00855250815171756,0.010052744143112,0.874423589976964
NMR metabolomics,X23412.Phospholipids in VLDL,PGR,Progesterone receptor,37598,0.00147770125430936,0.00961429181686401,-0.0173663107067441,0.0203217132153628,0.87784990682838
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC50,Coiled-coil domain-containing protein 50,37959,-0.00111529839812921,0.00726226642474444,-0.0153493405906283,0.0131187437943699,0.877947596969397
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJA4,DnaJ homolog subfamily A member 4,37942,-0.00100416500429194,0.00659393847893899,-0.0139282844230124,0.0119199544144285,0.878963585445463
NMR metabolomics,X23412.Phospholipids in VLDL,EPB41L5,Band 4.1-like protein 5,37572,0.000893334913267494,0.00590963299848577,-0.0106895457637646,0.0124762155902996,0.879847183407514
NMR metabolomics,X23412.Phospholipids in VLDL,ARG2,"Arginase-2, mitochondrial",37900,0.000616700312887753,0.00411923838323616,-0.00745700691825511,0.00869040754403062,0.880993913726652
NMR metabolomics,X23412.Phospholipids in VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,0.00046865271929252,0.00314315612704219,-0.00569193328971016,0.0066292387282952,0.881474979300259
NMR metabolomics,X23412.Phospholipids in VLDL,STEAP4,Metalloreductase STEAP4,37541,0.00100184794112612,0.00698890592344881,-0.0126964076688335,0.0147001035510858,0.88601730058246
NMR metabolomics,X23412.Phospholipids in VLDL,DCDC2C,Doublecortin domain-containing protein 2C,37482,0.000844351569144605,0.00589671861409764,-0.0107132169144868,0.012401920052776,0.886142283734719
NMR metabolomics,X23412.Phospholipids in VLDL,CD82,CD82 antigen,37714,0.000543171159205602,0.00388222533215346,-0.00706599049181518,0.00815233281022639,0.888731390490365
NMR metabolomics,X23412.Phospholipids in VLDL,DLL1,Delta-like protein 1,40411,-0.000377153319143176,0.00270248777848743,-0.00567402936497853,0.00491972272669218,0.889011125467214
NMR metabolomics,X23412.Phospholipids in VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,-0.00099158085612024,0.00736160269259379,-0.0154203221336041,0.0134371604213636,0.892854042175753
NMR metabolomics,X23412.Phospholipids in VLDL,NECTIN4,Nectin-4,40411,0.000377038637881106,0.00282130857245966,-0.00515272616413983,0.00590680343990204,0.893689228946307
NMR metabolomics,X23412.Phospholipids in VLDL,CNTF,Ciliary neurotrophic factor,37541,-0.00040616449983846,0.00314221951772397,-0.00656491475457745,0.00575258575490053,0.897153603903881
NMR metabolomics,X23412.Phospholipids in VLDL,GFRA3,GDNF family receptor alpha-3,40194,-0.000336639819974884,0.00263822826925324,-0.00550756722771123,0.00483428758776146,0.898466593178355
NMR metabolomics,X23412.Phospholipids in VLDL,SKIV2L,Helicase SKI2W,37562,0.000478170864089877,0.00376950837632606,-0.00691006555350921,0.00786640728168896,0.899059234139395
NMR metabolomics,X23412.Phospholipids in VLDL,NOS2,"Nitric oxide synthase, inducible",37562,-0.000462287349016314,0.00364873124136305,-0.00761380058208788,0.00668922588405526,0.899181285475108
NMR metabolomics,X23412.Phospholipids in VLDL,CDC25A,M-phase inducer phosphatase 1,37482,-0.000471473635326567,0.00380407734148716,-0.00792746522464141,0.00698451795398827,0.901365465674364
NMR metabolomics,X23412.Phospholipids in VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,0.000566263092851524,0.00468944366073841,-0.00862504648219575,0.0097575726678988,0.903888730356247
NMR metabolomics,X23412.Phospholipids in VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,37998,-0.000231822186540199,0.0019606417520058,-0.00407468002047156,0.00361103564739117,0.905880904496218
NMR metabolomics,X23412.Phospholipids in VLDL,GAD2,Glutamate decarboxylase 2,37598,-0.000504706838728126,0.0043987824429628,-0.00912632042693521,0.00811690674947896,0.908654664627228
NMR metabolomics,X23412.Phospholipids in VLDL,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.00267009488306164,0.0243282554138826,-0.0503534754942716,0.0450132857281483,0.912607072535129
NMR metabolomics,X23412.Phospholipids in VLDL,CPLX2,Complexin-2,37482,-0.00030195581577394,0.00287791336285272,-0.00594266600696528,0.0053387543754174,0.916439485015706
NMR metabolomics,X23412.Phospholipids in VLDL,FOS,Proto-oncogene c-Fos,37457,-0.000313021464067013,0.00326084269433885,-0.00670427314497115,0.00607823021683712,0.92352678516919
NMR metabolomics,X23412.Phospholipids in VLDL,KHDC3L,KH domain-containing protein 3,37482,-0.000598501856208759,0.00633528795575036,-0.0130156662494795,0.0118186625370619,0.924736361862384
NMR metabolomics,X23412.Phospholipids in VLDL,RBM25,RNA-binding protein 25,37482,0.000374550227884606,0.00430280518784445,-0.00805894794029051,0.00880804839605973,0.930634762139332
NMR metabolomics,X23412.Phospholipids in VLDL,TET2,Methylcytosine dioxygenase TET2,37697,-0.000757917530291492,0.00933713049642306,-0.0190586933032807,0.0175428582426977,0.935306054800423
NMR metabolomics,X23412.Phospholipids in VLDL,NOS1,"Nitric oxide synthase, brain",39961,0.00037289066553902,0.00461009309267942,-0.00866289179611264,0.00940867312719068,0.935533886025775
NMR metabolomics,X23412.Phospholipids in VLDL,IGLON5,IgLON family member 5,37482,0.000699190418569122,0.00874837202430233,-0.0164476187490634,0.0178459995862017,0.936300244270614
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA2,Protein disulfide-isomerase A2,37482,-0.000295281376850513,0.00386205745345102,-0.00786491398561451,0.00727435123191349,0.93905668634163
NMR metabolomics,X23412.Phospholipids in VLDL,MAGEA3,Melanoma-associated antigen 3,37714,-0.000583255552022765,0.00783819461818464,-0.0159461170036647,0.0147796058996191,0.940683701820143
NMR metabolomics,X23412.Phospholipids in VLDL,DDX1,ATP-dependent RNA helicase DDX1,37901,0.000346535700855051,0.00479208081813387,-0.00904594270268734,0.00973901410439744,0.942352904741617
NMR metabolomics,X23412.Phospholipids in VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,37598,-0.000268060846320003,0.00380990997452512,-0.00773548439638924,0.00719936270374923,0.943909121156698
NMR metabolomics,X23412.Phospholipids in VLDL,KRT14,"Keratin, type I cytoskeletal 14",39530,0.00017494380207826,0.00264196899961833,-0.00500331543717366,0.00535320304133018,0.947205777373538
NMR metabolomics,X23412.Phospholipids in VLDL,MORN4,MORN repeat-containing protein 4,37482,-0.00047801803174342,0.00732700330251073,-0.0148389445046645,0.0138829084411776,0.947983443203666
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,0.000285952962487263,0.00456966186727394,-0.00867058429736967,0.00924249022234419,0.950104781208557
NMR metabolomics,X23412.Phospholipids in VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,-0.000193017481396937,0.00320611532481234,-0.00647700351802913,0.00609096855523526,0.951994949107943
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,-0.000194622644056873,0.00341757634377147,-0.00689307227784895,0.0065038269897352,0.954587808339686
NMR metabolomics,X23412.Phospholipids in VLDL,COL4A4,Collagen alpha-4(IV) chain,37688,-0.000227571250217452,0.00486592764175475,-0.00976478942805675,0.00930964692762185,0.962698585721939
NMR metabolomics,X23412.Phospholipids in VLDL,EFNB2,Ephrin-B2,37572,0.000244329575445004,0.00537248179928023,-0.0102857347511443,0.0107743939020343,0.963727024868827
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS5,Transmembrane protease serine 5,40159,-0.000150548057482878,0.00349079235914725,-0.00699250108141148,0.00669140496644573,0.965600694961578
NMR metabolomics,X23412.Phospholipids in VLDL,INSL3,Insulin-like 3,37942,0.00020091858360363,0.00552454486996789,-0.0106271893615334,0.0110290265287407,0.970989188316938
NMR metabolomics,X23412.Phospholipids in VLDL,EDDM3B,Epididymal secretory protein E3-beta,37900,-0.000137415316625095,0.00395539515635409,-0.0078899898230791,0.00761515918982891,0.97228659479645
NMR metabolomics,X23412.Phospholipids in VLDL,IL4,Interleukin-4,40044,0.000265690704671347,0.00830288736035763,-0.0160079685216296,0.0165393499309723,0.974472622887497
NMR metabolomics,X23412.Phospholipids in VLDL,GSN,Gelsolin,37928,-5.44503280051975e-05,0.00176057288623947,-0.00350517318503456,0.00339627252902416,0.975327721429076
NMR metabolomics,X23412.Phospholipids in VLDL,DBH,Dopamine beta-hydroxylase,37967,-0.000297615794538582,0.00977263550639603,-0.0194519813870748,0.0188567497979976,0.975705432562119
NMR metabolomics,X23412.Phospholipids in VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,-0.000153592118602466,0.00509842333267547,-0.0101465018506464,0.00983931761344145,0.97596748902142
NMR metabolomics,X23412.Phospholipids in VLDL,IL31,Interleukin-31,37598,0.000161757375398004,0.0054042662074709,-0.010430604391245,0.010754119142041,0.97612219986813
NMR metabolomics,X23412.Phospholipids in VLDL,TFAP2A,Transcription factor AP-2-alpha,37541,-0.000164474108564579,0.00562683139570409,-0.0111930636441446,0.0108641154270154,0.976681341616148
NMR metabolomics,X23412.Phospholipids in VLDL,MORC3,MORC family CW-type zinc finger protein 3,37942,-7.33134644664522e-05,0.00261606866416587,-0.00520080804623155,0.00505418111729865,0.977643193420057
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,40305,-0.000136709234391014,0.00505034565543695,-0.0100353867190474,0.0097619682502654,0.978404815338257
NMR metabolomics,X23412.Phospholipids in VLDL,KLK3,Prostate-specific antigen,37998,-0.000107193222113375,0.00529792881565709,-0.0104911337008013,0.0102767472565745,0.98385776668653
NMR metabolomics,X23412.Phospholipids in VLDL,FGF5,Fibroblast growth factor 5,40044,-5.91658482503472e-05,0.00297981472061263,-0.00589960270065111,0.00578127100415041,0.984158861364496
NMR metabolomics,X23412.Phospholipids in VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,37714,-0.000100455130049344,0.00623105401037092,-0.0123133209903763,0.0121124107302777,0.987137551015538
NMR metabolomics,X23412.Phospholipids in VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,-6.5837116877082e-05,0.00468458418134517,-0.00924762211231361,0.00911594787855944,0.988787118679997
NMR metabolomics,X23412.Phospholipids in VLDL,IL3,Interleukin-3,37482,6.56790622320428e-05,0.00559116441409005,-0.0108930031893845,0.0110243613138485,0.990627694852865
NMR metabolomics,X23412.Phospholipids in VLDL,C9orf40,Uncharacterized protein C9orf40,37901,8.32915777684353e-05,0.0076271091501258,-0.0148658423564781,0.015032425512015,0.99128706481843
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,37541,-4.90451873273134e-05,0.00658822796856768,-0.01296197200572,0.0128638816310653,0.99406042276415
NMR metabolomics,X23412.Phospholipids in VLDL,EPGN,Epigen,37900,-2.72727555335796e-05,0.00458476032027182,-0.00901340298326635,0.00895885747219919,0.99525384618101
NMR metabolomics,X23412.Phospholipids in VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,37541,-1.79485160469161e-05,0.00372781951858826,-0.00732447477247991,0.00728857774038607,0.996158474166294
